Sentence,class,file
http://dx.doi.org/10.1016/j.cell.2009.07.048 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ nature03319 .Wnt signaling in stem cell biology and tumorigenesis 35,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2009; 16:65e69.http://dx.doi.org/10.1016/j.tracli.2009.04.006 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/nm979 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1073/ pnas.0701331104 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/ j.stem.2008.06.019 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0092-8674(02)01015-2 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/1270 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/81390 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/nature01593 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.4252/ wjsc.v2.i4.67 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1111/j.1582-4934.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1359/jbmr.2003.18.6.960 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0092-8674(01) 00571-2 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2002;70: 11e19.http://dx.doi.org/10.1086/338450 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/35102167 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ stem.30 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ nature06196 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1186/bcr1855 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1053/j.gastro.2008.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/stem.2083 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/374350a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/0092-8674(95)90297-X .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/nrc2389 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/dev.00164 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ajmg.a.20416 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0166-2236(99) 01397-1 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
February 2002. http://dx.doi.org/10.3892/ ijmm.9.2.107 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/ carcin/23.1.87 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ sj.onc.1205924 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0140-6736(05) 67063-8 .293.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/73448 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
1999;9:15 e21.http://dx.doi.org/10.1016/S0959- 437X(99)80003-3 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ mc.1041 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
"http://dx.doi.org/10.1002/(SICI) 1097-0215(19990827)82 ,5<625::AID-IJC1 >3.0.CO;2-2.",OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0002-9440(10)64045-X .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2003; 199:58 e67.http://dx.doi.org/10.1002/path.1225 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ng892 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/sj.onc.1210259 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-05- 0455 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.ygyno.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-05-0267 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/ j.bbrc.2006.02.084 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/sj.onc.1208910 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/labinvest.3700547 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ijc.11135 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.bone.2011.05.008 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
July 2001. http://dx.doi.org/10.3892/ijo.19.1.117 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/ carcin/23.3.435 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/pbc.22351 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1155/2012/ 704872 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.bbrc.2012.12.118 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1097/IGC.0b013e31820aaadb .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/onc.2009.80 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
May 2012. http://dx.doi.org/10.3892/or.2012.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1158/ 1535-7163.MCT-08-0592 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.bbrc.2012.07.127 .40 M.K.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 763–775Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  763OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9836 7Parkinson’s disease managing reversible  neurodegeneration Marty hinz1 alvin stein2 T ed cole3 Beth McDougali4 Mark Westaway5 1clinical research, Neuro research  clinics, inc., cape coral, Fl, 2stein  Orthopedic associates, Plantation, Fl,   3cole center for healing, cincinnati,   Oh, 4clearc enter of health, Mill  Valley, ca, Usa; 5Four Pillars health,   Brendale, QlD, australiaAbstract:  Traditionally, the Parkinson’s disease (PD) symptom course has been classified  as an irreversible progressive neurodegenerative disease.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"It is  the novel primary hypothesis that if PD symptoms from post-synaptic neuron damage  develop, then compromise at any point in the electrical event chain, to include outside  the post-synaptic dopamine neuron focus, may exacerbate and mimic PD symptoms  and/or disease progression.correspondence: Marty hinz clinical research, Neuroresearch clinics,  inc.,1008 Dolphin Drive, cape coral,  Florida 33904, Usa Tel +1 218 626 2220 Fax +1 218 626 1638 email marty@hinzmd.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hinz et al Running head recto: Reversible neurodegeneration in managing PD DOI: http://dx.doi.org/10.2147/NDT.S98367",Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
Data from schulz et al57 and http://www.genome.jp/kegg-bin/show_pathway?hsa0026 0.696HULQH &\VWDWKLRQLQH+RPRF\VWHLQH /F\VWHLQH PHUFDSWRS\UXYDWH      3\UXYDWH /F\VWHLQHVXOILQDWH  0HWKLRQLQH *OXWDWKLRQH VXOILQRS\UXYDWH6DGHQRV\OKRPRF\VWHLQH6DGHQRV\OPHWKLRQLQH,OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
Available  from: http://www.genome.jp/kegg-bin/show_pathway?org_name =h sa&mapno =00270&mapscale =&show_description =hide.,OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
Available  from: http://www.genome.jp/kegg-bin/show_pathway?hsa0026 0.,OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"Available  from: http://c.ymcdn.com/sites/www.worldpdcoalition.org/resource/ resmgr/docs/npfreport_sinimetshortage201.pd f. Accessed October 10,  2015.",OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
Available from: http://pubchem.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"Available from: https://www.youtube.com/ watch?v=YYvd5-xN-C M. Accessed October 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/ndt-12-763.PMC4827589.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/13/ndt-12-779.PMC4827590.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 779Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/13/ndt-12-779.PMC4827590.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s 779CorrigeNDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10817 3Uncovering the etiology of conversion disorder: insights from functional  neuroimaging [Corrigendum] Ejareh dar M, Kanaan RAA.",Non-OADS,/arxiv_data1/oa_pdf/72/13/ndt-12-779.PMC4827590.pdf
"The hypometabolism of the anterior cingulate  region stands in apparent contrast to the hyperactivation  reported in other studies, however those hyperactivations  were in response to tasks, whereas Arthuis et al’s patients  were at rest.34 This hypoactivation has been found in other  psychiatric conditions such as PTSD and anxiety, as the  authors acknowledge, representing both a possible explana - tion for the finding and a striking analogue.Journal name: Neuropsychiatric Disease and Treatment Article Designation: Corrigendum Y ear: 2016 Volume: 12 Running head verso: Ejareh dar and Kanaan Running head recto: Uncovering the etiology of conversion disorder DOI: http://dx.doi.org/10.2147/NDT.S108173",Non-OADS,/arxiv_data1/oa_pdf/72/13/ndt-12-779.PMC4827590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 407–414Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  407RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10183 5eye surgery in the elderly Dorota Raczyńska Leopold Glasner Ewelina Serkies-Minuth Magdalena A Wujtewicz Kamila Mitrosz Department of Ophthalmology,   Medical University of Gdańsk,   Gdańsk,  PolandAbstract:  Extending life expectancy is a human achievement.",Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
"Correspondence: Dorota Raczyńska Department of Ophthalmology, Medical  University of Gdańsk, Smoluchowskiego  17, 80-952 Gdańsk, Poland Tel +48 58 349 3580 email dorotaraczynska@gumed.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Raczyn ´ska et al Running head recto: Eye surgery in the elderly DOI: http://dx.doi.org/10.2147/CIA.S101835 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
Or use: http://youtu.be/lNwRV6it-P Evideo abstract,Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
Available from:  http://blog.world-statistics.org/2014/03/world-population-ageing-2013.,Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
"Available  from: http://stat.gov.pl/cps/rde/xbcr/gus/L_podst_inf_o_rozwoju_dem_ pl_do_2013.pd f. Accessed October 1, 2015.",OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f5/75/cia-11-407.PMC4827591.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/28/ndt-12-777.PMC4827592.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 777–778Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  777LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10613 0Positron emission tomography in patients with  psychogenic non-epileptic seizures Aileen McGonigal1–3 Marie Arthuis3 Jean-Arthur Micoulaud- Franchi4,5 Fabrice Bartolomei1–3 eric Guedj6–8 1Institut de Neurosciences des  Systèmes, INSerM UM r 1106,   Marseille, France; 2Aix Marseille  University, Faculty of Medicine,   Marseille, France; 3Clinical  Neurophysiology Department,   Timone Hospital, Marseille,   France; 4Department of Functional  Investigation of the Nervous System,   Sleep Clinic, Bordeaux University  Hospital, Bordeaux, France; 5USr  CNrS 3413, University of Bordeaux,   France; 6Biophysics and Nuclear  Medicine Department, Timone  Hospital, Marseille, France; 7Aix- Marseille University, CerIM eD,   Marseille, France; 8Aix-Marseille  University, CN rS, UM r7289, INT,   Marseille, FranceDear editor We have read with interest the recent review entitled “Uncovering the etiology of  conversion disorder: insights from functional neuroimaging” by Maryam Ejareh dar  and Richard AA Kanaan,1 published in Neuropsychiatric Disease and Treatment .",Non-OADS,/arxiv_data1/oa_pdf/1f/28/ndt-12-777.PMC4827592.pdf
"2014;  86(10):1106–1112.Correspondence: Aileen McGonigal INSerM U1106 Institut de  Neurosciences des Systèmes, Service de  Neurophysiologie Clinique CHU Timone,  rue Saint Pierre, 13385 Marseille Cedex  5, France Tel +33 4 91 38 55 40 email aileen.mcgonigal@univ-amu.f r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: McGonigal et al Running head recto: PET in patients with psychogenic non-epileptic seizures DOI: http://dx.doi.org/10.2147/NDT.S106130",Non-OADS,/arxiv_data1/oa_pdf/1f/28/ndt-12-777.PMC4827592.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1f/28/ndt-12-777.PMC4827592.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/28/ndt-12-777.PMC4827592.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/21/jmdh-9-153.PMC4827593.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/d4/21/jmdh-9-153.PMC4827593.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 153–161Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  153Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S10064 0stuck between a rock and a hard place: the  work situation for nurses as leaders in municipal  health care etty r nilsen1 anja H Olafsen1 anne grethe steinsvåg2 Hallgeir Halvari1 ellen K grov3 1Department of strategy and Finance,   school of Business, University college  of southeast-n orway, 2Department  of nursing science, Faculty of  Health sciences, University college  of southeast-n orway, Kongsberg,   3Department of nursing and Health  Promotion, Faculty of Health sciences,   Oslo and akershus University college,   Oslo, norway correspondence: etty r nilsen   school of Business, University college of  southeast-norway, PO Box 235, n-3603  Kongsberg, norway   T el +47 97 021 325   Fax +47 32 117 110   email etty.nilsen@hbv.n oBackground:  The paper aims to present how nursing leaders in the municipal health care  perceive the interaction with and support from their superiors and peers.",Non-OADS,/arxiv_data1/oa_pdf/d4/21/jmdh-9-153.PMC4827593.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/d4/21/jmdh-9-153.PMC4827593.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/21/jmdh-9-153.PMC4827593.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/32/ijn-11-1413.PMC4827594.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1413–1425International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1413OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9585 0hyaluronan-conjugated liposomes encapsulating  gemcitabine for breast cancer stem cells Na-Kyung han1,* Dae hwan shin1,* Jung seok Kim1 Kwon Yeon Weon2 chang-Y oung Jang1 Jin-seok Kim1 1research center for cell Fate  control ( rcc Fc) and college of  Pharmacy, sookmyung Women’s  University, seoul, 2college of  Pharmacy, catholic University  of Daegu, gyeongbuk, Korea *These authors contributed equally  to this workAbstract:  Investigation of potential therapeutics for targeting breast cancer stem cells (BCSCs)  is important because these cells are regarded as culprit of breast cancer relapse.",Non-OADS,/arxiv_data1/oa_pdf/26/32/ijn-11-1413.PMC4827594.pdf
"Keywords:  breast cancer stem cells, targeting, CD44 surface marker, EPR effect, drug delivery  system Introduction Breast cancer is the most common cancer among women and one of the leading causes  of cancer death worldwide.1 It is also considered the main cause of mortality and morbid - ity in women.2,3 Breast cancer presents as malignant tumors with invasion into normal  healthy breast tissue and usually progresses or recurs after radiation therapy, indicating  that the presence of a small fraction of breast cancer cells can cause regrowth of tumor  cells.4 These cells are called breast cancer-initiating cells (BCICs) or breast cancer stem  cells (BCSCs).5 Increasing data also indicate that most kinds of malignant solid cancers  may include cancer stem cells (CSCs).5–9 Normal healthy stem cells have their own  mechanisms that make them particularly resistant to anticancer drugs, such as enhanced  multidrug resistance and increased expression of BCL-2 family proteins or producing  proteins resistant to breast cancer drug.10–13 The increased expression of these proteins  may enhance the resistance of BCSCs to current anticancer therapies.5 For this reason,  an improved therapeutic strategy for targeting BCSCs is required to eliminate breast correspondence: Jin-seok Kim research center for cell Fate control  (rccFc) and college of Pharmacy,  sookmyung Women’s University,  53-12 chungpa-2 Dong, Yongsan-gu,  seoul 140-742, Korea Tel +82 2 710 9574 Fax +82 2 710 0032 email jsk9574@sm.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Han et al Running head recto: Breast cancer stem cell-targeted immunoliposome DOI: http://dx.doi.org/10.2147/IJN.S95850",Non-OADS,/arxiv_data1/oa_pdf/26/32/ijn-11-1413.PMC4827594.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/26/32/ijn-11-1413.PMC4827594.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/32/ijn-11-1413.PMC4827594.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1281–1294International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1281OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9635 2antiviral mechanism of polyanionic carbosilane  dendrimers against hIV-1 enrique Vacas-córdoba1–4 Marek Maly5,6 Francisco J De la Mata4,7 rafael gómez4,7 Marjorie Pion1–4 Mª Ángeles Muñoz- Fernández1–4 1Molecular Immunobiology  laboratory, general Universitary  hospital gregorio Marañon, 2health  research Institute gregorio Marañon,   3spanish hIV hgM BioBanK,   4Networking research center  on Bioengineering, Biomaterials  and Nanomedicine (cIBer-BBN),   Madrid, spain; 5Faculty of science,   Jan Evangelista Purkyně University,   Ústí nad labem, czech republic;   6laboratory of applied Mathematics  and Physics ( laMFI), University of  applied sciences and arts of southern  switzerland, Manno, switzerland;   7Dendrimers for Biomedical  applications group (BioInDen),   University of alcalá, alcalá de  henares, Madrid, spainAbstract:  Nanotechnology-derived platforms, such as dendrimers, are very attractive in several  biological applications.",Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
"The type of core and branching units can be engineered to generate a  broad variety of dendrimers with different sizes, shapes, and surface chemical functional - ized groups that can provide distinct biological and pharmacological properties.18 Unlike  small molecule drugs, dendrimers can bind to their target in a multivalent manner due correspondence: Mª Ángeles Muñoz- Fernández Molecular Immunobiology laboratory,  general Universitary hospital,  gregorio Marañón, c/Doctor  esquerdo 46, 28007 Madrid, spain Tel +34 91 586 8565 Fax +34 91 586 8018 email mmunoz.hgugm@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Vacas-Córdoba et al Running head recto: Anti-HIV mechanism of dendrimers as microbicide DOI: http://dx.doi.org/10.2147/IJN.S96352",Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
Available from: http://www.unaids.org/ sites/default/files/media_asset/GARPR_2014_guidelines_en_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/25/ijn-11-1281.PMC4827595.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/37/dddt-10-1307.PMC4827596.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1307–1322Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1307Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10148 6Identification of new drug candidates against Borrelia  burgdorferi  using high-throughput screening Venkata raveendra  Pothineni1 Dhananjay Wagh1 Mustafeez Mujtaba Babar1 Mohammed inayathullah1 David solow-cordero2 Kwang-Min Kim1 aneesh V samineni1 Mansi B Parekh1 Lobat Tayebi3 Jayakumar rajadas1 1Biomaterials and Advanced Drug  Delivery Laboratory, Stanford  cardiovascular Pharmacology  Division, cardiovascular institute,   Stanford University School of  Medicine, Palo alto, 2chemical &  Systems Biology, Stanford University  School of Medicine, Stanford, CA,   3Department of Developmental  Sciences, Marquette University School  of Dentistry, Milwaukee, WI, USAAbstract:  Lyme disease is the most common zoonotic bacterial disease in North America.",Non-OADS,/arxiv_data1/oa_pdf/82/37/dddt-10-1307.PMC4827596.pdf
"Other members in the group include Borrelia duttonii , Borrelia garinii , Borrelia afzelii ,  and Borrelia miyamotoi , which are involved in infections in Europe, Eurasia, and other  parts of the world.2,3 Important clinical presentations of Lyme disease in humans include  erythema migrans, fatigue, fever, chills, muscle, and joint pain.4,5 Approximately  10%–20% of the patients who have been treated with antibiotic therapy reported the correspondence: Jayakumar rajadas Biomaterials and Advanced Drug Delivery  Laboratory, Stanford Cardiovascular  Pharmacology Division, cardiovascular  Institute, Stanford University School  of Medicine, 1050 Arastradero Road,  Building A, Room A148, Palo Alto,  CA 94304, USA Tel +1 650 724 6806 Fax +1 650 724 4694 email jayraja@stanford.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pothineni et al Running head recto: High-throughput screening of drugs for Lyme disease DOI: http://dx.doi.org/10.2147/DDDT.S101486",Non-OADS,/arxiv_data1/oa_pdf/82/37/dddt-10-1307.PMC4827596.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/82/37/dddt-10-1307.PMC4827596.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/37/dddt-10-1307.PMC4827596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/46/opth-10-617.PMC4827597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 617–626Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  617Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9643 3Omega-3 fatty acid supplementation improves dry  eye symptoms in patients with glaucoma: results  of a prospective multicenter study Jesús T ellez-Vazquez On behalf of the Dry eye  in glaucoma study group  (Deigsg) glaucoma section, Ophthalmology  Department, hospital de la santa  Creu i sant Pau, Barcelona, spainPurpose:  The purpose of this study is to assess the effectiveness and tolerability of a dietary  supplement with a combination of omega-3 fatty acids and antioxidants on dry eye symptoms  caused by chronic instillation of antihypertensive eye drops in patients with glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/42/46/opth-10-617.PMC4827597.pdf
"The  symptoms of ocular surface disease may include dryness, burning or stinging, itch - ing, irritation, tearing, photophobia, redness, fatigue, fluctuating visual acuity, and  blurred vision.5 Also, there is a poor relationship between dry eye signs and symp - toms.6 These visual disturbances and discomforts often compromise compliance with  intraocular pressure (IOP)-lowering medications and impair the quality of life of the  patients as well as their physical, social, and psychological functioning.7,8 Ocular Correspondence: Jesús Tellez-Vazquez glaucoma section, Ophthalmology  Department, hospital de la santa Creu  i sant Pau, C/sant antoni Maria Claret,  167, 08025 Barcelona, spain Tel +34 93 291 9000 email jesustellez22@yahoo.e s Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tellez-Vazquez Running head recto: Fatty acid supplements for improving dry eye symptoms in patients with glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S96433",Non-OADS,/arxiv_data1/oa_pdf/42/46/opth-10-617.PMC4827597.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/42/46/opth-10-617.PMC4827597.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/46/opth-10-617.PMC4827597.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/97/dddt-10-1323.PMC4827598.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1323–1333Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1323Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10312 2Optimized nano-transfersomal films for enhanced  sildenafil citrate transdermal delivery: ex vivo and  in vivo evaluation shaimaa M Badr-eldin1,2 Osamaa aa ahmed1,3 1Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, King abdulaziz University,   Jeddah, Kingdom of saudi arabia;   2Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, cairo University, cairo,   egypt; 3Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, Minia University,   Minia,  egyptAbstract:  Sildenafil citrate (SLD) is a selective cyclic guanosine monophosphate-specific  phosphodiesterase type 5 inhibitor used for the oral treatment of erectile dysfunction and, more  recently, for other indications, including pulmonary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/69/97/dddt-10-1323.PMC4827598.pdf
"Keywords:  sildenafil citrate, central composite design, transfersomes, edge activator, perme - ation, transdermal, pharmacokinetics Introduction Sildenafil citrate (SLD), chemically known as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-  propyl-1 H-pyrazolo[4,3- d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpip - erazine citrate, is a selective inhibitor of cyclic guanosine monophosphate-specific  phosphodiesterase type 5.1 It was approved by the US Food and Drug Administration  in 1998 for the oral treatment of erectile dysfunction.2 Recently, it has been used for  the treatment of pulmonary arterial hypertension and the enhancement of uteroplacental  perfusion in case of fetal growth retardation.3,4 However, the drug suffers from poor oral  bioavailability ( ~40%) that could be attributed to its low water solubility (3.5 mg/mL)  and extensive presystemic metabolism, in addition to absorption hindrance by food,  especially fat-rich meals.5–9 To surpass this problem, researchers have been attracted correspondence: shaimaa M Badr-eldin Department of Pharmaceutics and  industrial Pharmacy, Faculty of Pharmacy,  King abdulaziz University, Building  11, abdullah sulayman, Jeddah 21589,  Kingdom of saudi arabia Tel +966 5 9828 1986 email sbadr5@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Badr-Eldin and Ahmed Running head recto: Optimized sildenafil citrate nano-transfersomal films DOI: http://dx.doi.org/10.2147/DDDT.S103122",Non-OADS,/arxiv_data1/oa_pdf/69/97/dddt-10-1323.PMC4827598.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/69/97/dddt-10-1323.PMC4827598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/97/dddt-10-1323.PMC4827598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/cia-11-397.PMC4827599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 397–405Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  397OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10334 9Delirium in the geriatric unit: proton-pump  inhibitors and other risk factors Iwona Otremba Krzysztof Wilczyński Jan szewieczek Department of geriatrics, school of  health sciences in Katowice, Medical  University of silesia, Katowice, PolandBackground:  Delirium remains a major nosocomial complication of hospitalized elderly.",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/cia-11-397.PMC4827599.pdf
"Multicomponent  nonpharmacological interventions may reduce delirium incidents among elderly  inpatients by up to 44%.12,13 As expected, discontinuation of certain medication Correspondence: Jan szewieczek Department of geriatrics, gCM, ul  Ziolowa 45/47, 40-635, Katowice, Poland Tel +48 32 359 8239 Fax +48 32 205 9483 email jszewieczek@sum.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Otremba et al Running head recto: Delirium in the geriatric unit DOI: http://dx.doi.org/10.2147/CIA.S103349",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/cia-11-397.PMC4827599.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/cia-11-397.PMC4827599.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cf/fc/cia-11-397.PMC4827599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 745–762Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  745OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10063 4a meta-synthesis on parenting a child with autism Khim lynn Ooi Yin sin Ong sabrina anne Jacob Tahir Mehmood Khan school of Pharmacy, Monash  University Malaysia, Bandar sunway,   selangor, MalaysiaBackground:  The lifelong nature of autism in a child has deep implications on parents as  they are faced with a range of challenges and emotional consequences in raising the child.",Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
"Instead,  development is described as delayed or absent.2,7–9 Parents realize either that their child  does not respond to parental cues of affection or communication or that the child does  not show affection or speak.2,9 The child’s behavior may also become abnormal or  disruptive.1,2,9 These symptoms spark concern, prompting parents to seek professional  help, leading to a diagnosis of ASD.2 Core symptoms include deficits in social interaction and communication, described  as the inability to initiate and respond to both verbal and nonverbal social cues.7,9 correspondence: Tahir Mehmood Khan school of Pharmacy, Monash University  Malaysia, Jalan lagoon selatan, 47500  Bandar sunway, selangor, Malaysia Tel +60 3 5514 4418 Fax +60 3 5514 6364 email tahir.mehmood@monash.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ooi et al Running head recto: Parenting a child with autism DOI: http://dx.doi.org/10.2147/NDT.S100634",Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
2011; Available from: http://www.nimh.nih.gov/health/ publications/depression/index.shtml?ct =39994.,Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
Avail - able from: http://www.crd.york.ac.uk/PROSPERO/display_record.,Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/ba/ndt-12-745.PMC4827600.pdf
"2016;21(1):1-8 http://dx.doi.org/10.3746/pnf.2016.21.1.1 pISSN 2287-1098 ㆍeISSN 2287-8602Review Article Received 11 February 2016; Accepted 12 March 2016; Published online 31 March 2016 Correspondence to Harjinder Singh, Tel: +64-6-9517317, E-mail: h.singh@massey.ac.nz Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/0b/62/pnfs-21-001.PMC4827628.pdf
http://www.euromo nitor.com/navigating-wellbeing-today-and-tomorrow-in-f unctional-food-and-drinks/report (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/0b/62/pnfs-21-001.PMC4827628.pdf
"2016;21(1):9-13 http://dx.doi.org/10.3746/pnf.2016.21.1.9 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 10 December 2015; Accepted 16 February 2016; Published online 31 March 2016 Correspondence to Kwang Suk Ko, Tel: +82-2-3277-6859, E-mail: kko@ewha.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/b7/3b/pnfs-21-009.PMC4827629.pdf
"2016;21(1):14-23 http://dx.doi.org/10.3746/pnf.2016.21.1.14 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 16 November 2015; Accepted 16 February 2016; Published online 31 March 2016 Correspondence to Mohammad Shafiur Rahman, Tel: +968-2414-1273, E-mail: shafiur@squ.edu.om Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/3b/cf/pnfs-21-014.PMC4827630.pdf
"2016;21(1):24-30 http://dx.doi.org/10.3746/pnf.2016.21.1.24 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 11 January 2016; Accepted 5 February 2016; Published online 31 March 2016 Correspondence to Mi Young Kang, Tel: +82-53-950-6235, E-mail: mykang@knu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/b8/ad/pnfs-21-024.PMC4827631.pdf
"2016;21(1):31-37 http://dx.doi.org/10.3746/pnf.2016.21.1.31 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 30 October 2015; Accepted 5 January 2016; Published online 31 March 2016 Correspondence to Hyungchul Han, Tel: +1-970-988-3679, E-mail: hyungchul.han@colostate.edu Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/71/c0/pnfs-21-031.PMC4827632.pdf
"2016;21(1):38-43 http://dx.doi.org/10.3746/pnf.2016.21.1.38 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 4 January 2016; Accepted 17 February 2016; Published online 31 March 2016 Correspondence to Chang-Suk Kong, Tel: +82-51-999-5429, E-mail: cskong@silla.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/pnfs-21-038.PMC4827633.pdf
"2016;21(1):44-51 http://dx.doi.org/10.3746/pnf.2016.21.1.44 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 11 February 2016; Accepted 27 February 2016; Published online 31 March 2016 Correspondence to Yang-Bong Lee, Tel: +82-51-629-5829, E-mail: yblee@pknu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/bc/82/pnfs-21-044.PMC4827634.pdf
"2016;21(1):52-56 http://dx.doi.org/10.3746/pnf.2016.21.1.52 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 23 October 2015; Accepted 3 February 2016; Published online 31 March 2016 Correspondence to Chang Ki Huh, Tel: +82-63-644-2181, E-mail: moonerhuh@hanmail.net Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/19/5b/pnfs-21-052.PMC4827635.pdf
"2016;21(1):57-61 http://dx.doi.org/10.3746/pnf.2016.21.1.57 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 10 September 2015; Accepted 16 February 2016; Published online 31 March 2016 Correspondence to Jae-Yong Park, Tel: +82-53-850-3521, E-mail: jaepark@cu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/pnfs-21-057.PMC4827636.pdf
Sequence reads were identified us- ing the EzTaxon-e database (http://eztaxon-e.ezbiocloud.,OADS,/arxiv_data1/oa_pdf/5d/3c/pnfs-21-057.PMC4827636.pdf
"2016;21(1):62-67 http://dx.doi.org/10.3746/pnf.2016.21.1.62 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 7 October 2015; Accepted 5 January 2016; Published online 31 March 2016 Correspondence to Yangha Kim, Tel: +82-2-3277-3101, E-mail: yhmoon@ewha.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/fc/1c/pnfs-21-062.PMC4827637.pdf
"2016;21(1):68-72 http://dx.doi.org/10.3746/pnf.2016.21.1.68 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 2 June 2015; Accepted 10 November 2015; Published online 31 March 2016 Correspondence to Koan Sik Woo, Tel: +82-31-695-4084, E-mail: wooks@korea.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/c8/fd/pnfs-21-068.PMC4827638.pdf
"2016;21(1):73-77 http://dx.doi.org/10.3746/pnf.2016.21.1.73 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 7 October 2015; Accepted 4 January 2016; Published online 31 March 2016 Correspondence to Byoungseung Yoo, Tel: +82-31-961-5141, E-mail: bsyoo@dgu.edu Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/pnfs-21-073.PMC4827639.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"However,  a  close  reading  of  the  report  suggests  that it  simply  summarizes  all  of  the  ﬁndings  and  opinions  that  are already  published  and  suggests  the  same  solutions  that  have http://dx.doi.org/10.1016/j.bdq.2015.11.002 2214-7535/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"In  fact,  there are  numerous  “Minimum  Information”  standards  projects  fol- lowing on from  that  paper,  most  of  which  have  been  registered with  the  Minimum  Information  for  Biological  and  Biomedi- cal Investigations initiative  (http://www.dcc.ac.uk/resources/ metadata-standards/mibbi-minimum-information-biological-and-biomedical-investigations ),  where  they  are  collected  and curated  and  can  be  accessed  through  a  searchable  portal  of inter-related  data  standards,  databases,  and  https://biosharing.",OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"Complementary  information  is  also  available from  the  US  National  Library  of  Medicine  website,  which  lists the  organizations  that  provide  advice  and  guidelines  for  report- ing  research  methods  and  ﬁndings  (https://www.nlm.nih.gov/ services/research  report  guide.html ).",Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"Medical  research  studies,  in particular,  are  well  served  with  reporting  guidelines,  for  example by  the  EQUATOR  Network,  which  aims  to  improve  the  reliability and  value  of  the  medical  research  literature  by  promoting  trans- parent  and  accurate  reporting  (http://www.equator-network.org ).",Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"There  are  reporting  guidelines  for  many  different  study  designs such  as  CONSORT  (www.consort-statement.org )  for  randomized trials,  STARD  for  studies  of  diagnostic  accuracy  (www.stard- statement.org/ )  and  SPIRIT  for  study  protocols  (http://www.spirit- statement.org ).",Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
"There have  been  several  papers  investigating  the  effects  of  technical  and bioinformatics  variability  of  RNA-seq  results  [18–21]  and  stan- dards  for  RNA  sequencing  [22,23]  (http://www.modencode.org/ publications/docs/index.shtml )  as  well  as  Chromatin  immunopre- cipitation  and  high-throughput  DNA  sequencing  (ChIP-seq)  [24] are being  developed,  but  again  there  is  no  decisive  push  for  their universal  acceptance.",Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
(1)  A  PCRmax  Eco  (http://www.pcrmax.com )  was  used  to  amplify  100  pg  of  C. glabrata (A)  and  C.  dublinensis  (B)  and  DNA.,Non-OADS,/arxiv_data1/oa_pdf/33/5d/main.PMC4827640.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"/circlecopyrt  Screening: experimental design  that  enables  the  evaluation  of whether  one  input  factor,  a  set  of  input  factors,  or  a  certain  input http://dx.doi.org/10.1016/j.bdq.2015.12.002 2214-7535/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2015.12.002 .",OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"[4]  International  Organization  for  Standardization,  Statistics  –  Vocabulary  and symbols  –  Part  1:  General  statistical  terms  and  terms  used  in  probability, http://www.iso.org/iso/catalogue detail.htm?csnumber=40145  (last accessed: 03.2015).",Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"[20]  U.S.  Department  of  Health  and  Human  Services/Food  and  Drug Administration, Bioanalytical Method Validation  (2001)  http://www.fda.gov/ downloads/Drugs/Guidances/ucm070107.pdf .",Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"[21]  European  Medicines  Agancy,  Quality  guidelines,  http://www.ema.europa.eu/ ema/index.jsp?curl=pages/regulation/general/general  content  000081. jsp&mid=WC0b01ac0580027546 .",Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"[36]  Visual  OMP  DNA  Software,  http://www.dnasoftware.com/our-products/ visual-omp/  (last  accessed:  12.2015).",OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
"[44] Altona  Diagnostics,  RealStar®hMPV  RT-PCR  Kit,  http://www.altona- diagnostics.com/realstar-mpv-rt-pcr-kit.html  (last  accessed:  03.2015).",Non-OADS,/arxiv_data1/oa_pdf/19/aa/main.PMC4827641.pdf
Available from: https://qccat.health.,Non-OADS,/arxiv_data1/oa_pdf/27/43/rt-2016-1-6124.PMC4827647.pdf
"Available from:https://www.nice.org.uk/guidance/CSG7/documents/service-guidance-for-improving- outcomes-in-children-and-young-people- with-cancer-second-consultation-appen- dix-to-evidence-review2 7.Pentheroudakis GM, Pavlidis N. Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology.",Non-OADS,/arxiv_data1/oa_pdf/27/43/rt-2016-1-6124.PMC4827647.pdf
"Total Composite Flap Facelift and the Deep-Plane Transition Zone: A Critical Consideration in SMAS-Release Midface Lifting Marc Mani, MD, FACSAesthetic Surgery Journal 2016, Vol 36(5) 533 –545 © 2016 The American Society forAesthetic Plastic Surgery, Inc.This is an Open Access articledistributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermits non-commercialreproduction and distribution ofthe work, in any medium, providedthe original work is not altered ortransformed in any way, and thatthe work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/83/sjv250.PMC4827655.pdf
"Commentary Commentary on: Total Composite Flap Facelift and the Deep-Plane Transition Zone: A CriticalConsideration in SMAS-Release Midface Lifting Sam T. Hamra, MDAesthetic Surgery Journal 2016, Vol 36(5) 546 –549 © 2016 The American Society forAesthetic Plastic Surgery, Inc.This is an Open Access articledistributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermits non-commercialreproduction and distribution ofthe work, in any medium, providedthe original work is not altered ortransformed in any way, and thatthe work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/67/sjw019.PMC4827656.pdf
The  absence  of  method  val- idation  brings  into  question  the  reliability  of  the  generated  data http://dx.doi.org/10.1016/j.bdq.2016.01.001 2214-7535/Published by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/a6/51/main.PMC4827694.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/51/main.PMC4827694.pdf
"For  the  qPCR  assay,  primer  and  probe  speciﬁcity  was  veriﬁed using  Primer  BLAST  (results  available  at  http://dx.doi.org/10.6084/ m9.ﬁgshare.875419 ).",OADS,/arxiv_data1/oa_pdf/a6/51/main.PMC4827694.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.01.001 .",OADS,/arxiv_data1/oa_pdf/a6/51/main.PMC4827694.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC4827695.pdf
Droplets  exhibit- ing  ﬂuorescence  ranging  between  those  of  explicit  positive  and http://dx.doi.org/10.1016/j.bdq.2015.12.003 2214-7535/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC4827695.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC4827695.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2015.12.003 .",OADS,/arxiv_data1/oa_pdf/72/43/main.PMC4827695.pdf
[8]  European  Reference  Laboratory  for  GM  Food  &  Feed  Status  of  dossiers (07.07.2015) http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx .,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC4827695.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4827696.pdf
http://dx.doi.org/10.1016/j.bjm.2015.11.023 1517-8382/©  2015  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4827696.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4827696.pdf
http://dx.doi.org/10.1016/j.bjm.2015.11.016 1517-8382/©  2015  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
Available  from: http://tree.bio.ed.ac.uk/software/beast .,OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
Available from:  http://tree.bio.ed.ac.uk/software/beast .23.,OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
Available  from: http://tree.bio.ed.ac.uk/software/beast .,OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
Available  from: http://tree.bio.ed.ac.uk/software/tracer/ .,OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
Available  from: http://tree.bio.ed.ac.uk/software/ﬁgtree/ .,OADS,/arxiv_data1/oa_pdf/b5/1c/main.PMC4827697.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/c7/main.PMC4827698.pdf
http://dx.doi.org/10.1016/j.bjm.2015.11.025 1517-8382/©  2015  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/a4/c7/main.PMC4827698.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/c7/main.PMC4827698.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/16/nihms769270.PMC4827700.pdf
"*Correspondence: ana.cano@cragenomica.es.7Present Address: Departments of Medicine and Pharmacology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN  55455, USA8Present address: School of Plant Sciences, University of Arizona, Tucson, AZ 85721, USA Supplemental Information: Supplemental Information includes Supplemental Experimental Procedures, six figures, and two movies  and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.04.013 .",Non-OADS,/arxiv_data1/oa_pdf/58/16/nihms769270.PMC4827700.pdf
"In order to achieve trans - parency and encourage improvements, we have released source  code under an open source license (Mozilla Public License  Version 2.0) at https://github.com/qfo/b enchmark-webservic e  (also Supplementary Software ).",Non-OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
reprints and permissions information is available online at http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
"These  complete, nonredundant reference proteomes are publicly avail - able at ftp://ftp.ebi.",OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
OrthoInspector 30 is a database of precomputed orthology and  inparalogy relationships and a stand-alone package allowing large-scale predictions of orthology between thousands of proteomes  (http://lbgi.fr/orthoinspector /).,OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
"PANTHER 8.022 is based on version 8.0 of the PANTHER data - base ( http://pantherdb.or g), released in 2012 (the current version  is 10.0, released in 2015).",OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
"The database  is no longer maintained, but the source code is still available at  https://github.com/ todddeluca/reciproca l_smallest_distance /.",OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
"Wikipedia, The Free Encyclopedia  https://en.wikipedia.org/w/index.",Non-OADS,/arxiv_data1/oa_pdf/b3/1c/41592_2016_Article_BFnmeth3830.PMC4827703.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LongitudinalDiffusionMRIALSFRS-RALSBiomarker 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/81/main.PMC4827722.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0112213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/81/main.PMC4827722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/81/main.PMC4827722.pdf
"Cortical thickness measurements were obtained using FreeSurfer ( http://surfer.nmr.mgh.harvard.edu/; version 5.3.0) ( Fischl and Dale, 2000 ).",OADS,/arxiv_data1/oa_pdf/7c/81/main.PMC4827722.pdf
"The bias- ﬁeld corrected TP1 and TP3 images were then non-linearly registered to their corresponding average image inhalfway space (Technical report TR07JA1, http://www.fmrib.ox.ac.uk/ analysis/techrep ).",Non-OADS,/arxiv_data1/oa_pdf/7c/81/main.PMC4827722.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HuntingtonMRI Shape DiffeomorphometryAtrophyDTI 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/cb/main.PMC4827723.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.014 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/cb/main.PMC4827723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/cb/main.PMC4827723.pdf
from http://www.mristudio.org .,Non-OADS,/arxiv_data1/oa_pdf/ac/cb/main.PMC4827723.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/09/main.PMC4827724.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.006 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/09/main.PMC4827724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/09/main.PMC4827724.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: IntraoperativeOptical intrinsic signal imagingResting stateEpileptogenic Eloquent 1.,Non-OADS,/arxiv_data1/oa_pdf/72/07/main.PMC4827725.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.015 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/72/07/main.PMC4827725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/07/main.PMC4827725.pdf
The program ImageJ(http://imagej.nih.gov/ij/ ) was used to perform edge detections on these images and thereby identify the vessel network.,OADS,/arxiv_data1/oa_pdf/72/07/main.PMC4827725.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cerebral amyloid angiopathy Functional magnetic resonance imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.0202213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
"ap-value of 0.05 (using Alphasim, part of the AFNI image analysis pack- age,http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim ).",OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
"NeuroImage 11, 66–84.http://dx.doi.org/10.1006/nimg.1999.0516 .",OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1111/ j.1749-6632.2010.05446.x .,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1161/STROKEAHA.113.002267 .,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1046/j.1471-4159.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
"http://dx.doi.org/10.1016/ S1474-4422(07)70178 –3.Dumas, A., et al., 2012.",OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
"72,7 6–81.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1016/S1474- 4422(14)70003 –1.,OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1212/01.wnl.,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1016/S1474- 4422(11)70307-6 .,OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1002/ana.24320 .,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1161/01.str.18.2.311 .,Non-OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
http://dx.doi.org/10.1016/S1474-4422(13)70124 –8.,OADS,/arxiv_data1/oa_pdf/b1/fc/main.PMC4827726.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MRINeurodegenerative diseasesClassi ﬁcation VolumetryTBMVBM Alzheimer's disease Frontotemporal lobar degenerationVascular dementiaDementia with Lewy bodies 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/main.PMC4827727.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.019 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/main.PMC4827727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/main.PMC4827727.pdf
"For this purpose we use a set of 60 subjects from the ADNI database ( http://adni.loni.usc.edu /), consisting of 20 elderly healthy controls, 20 mild-cognitive impairment subjects and 20 AD subjects.For each atlas image (T1 MR images of the 60 subjects), a whole brainsegmentation ( http://www.neuromorphometrics.com /) containing 139 regions (98 cortical parcellations and 41 sub-cortical regions) wasgenerated.",Non-OADS,/arxiv_data1/oa_pdf/ab/3b/main.PMC4827727.pdf
http://dx.doi.org/10.1111/j.1468-1331.2006.01605.x .,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/main.PMC4827727.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
4 http://repository.edm-forum.org/egems/vol4/iss2/4 DOI: 10.13063/2327-9214.1206,Non-OADS,/arxiv_data1/oa_pdf/ba/d8/egems1206.PMC4827782.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
5 http://repository.edm-forum.org/egems/vol4/iss2/5 DOI: 10.13063/2327-9214.1213,Non-OADS,/arxiv_data1/oa_pdf/ac/5f/egems1213.PMC4827783.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
7 http://repository.edm-forum.org/egems/vol4/iss2/7 DOI: 10.13063/2327-9214.1207,Non-OADS,/arxiv_data1/oa_pdf/12/fd/egems1207.PMC4827784.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
2 http://repository.edm-forum.org/egems/vol4/iss2/2 DOI: 10.13063/2327-9214.1216,Non-OADS,/arxiv_data1/oa_pdf/2e/92/egems1216.PMC4827785.pdf
6 http://repository.edm-forum.org/egems/vol4/iss2/6 DOI: 10.13063/2327-9214.1214,Non-OADS,/arxiv_data1/oa_pdf/ee/41/egems1214.PMC4827786.pdf
6 http://repository.edm-forum.org/egems/vol4/iss2/6 DOI: 10.13063/2327-9214.1214,Non-OADS,/arxiv_data1/oa_pdf/ee/41/egems1214.PMC4827786.pdf
6 http://repository.edm-forum.org/egems/vol4/iss2/6 DOI: 10.13063/2327-9214.1214,Non-OADS,/arxiv_data1/oa_pdf/ee/41/egems1214.PMC4827786.pdf
9 http://repository.edm-forum.org/egems/vol4/iss2/9 DOI: n/a,Non-OADS,/arxiv_data1/oa_pdf/44/9b/egems1261.PMC4827787.pdf
9 http://repository.edm-forum.org/egems/vol4/iss2/9 DOI: n/a,Non-OADS,/arxiv_data1/oa_pdf/44/9b/egems1261.PMC4827787.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
8 http://repository.edm-forum.org/egems/vol4/iss2/8 DOI: 10.13063/2327-9214.1204,Non-OADS,/arxiv_data1/oa_pdf/c9/1b/egems1204.PMC4827788.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
3 http://repository.edm-forum.org/egems/vol4/iss2/3 DOI: 10.13063/2327-9214.1212,Non-OADS,/arxiv_data1/oa_pdf/01/42/egems1212.PMC4827789.pdf
1 http://repository.edm-forum.org/egems/vol4/iss2/1 DOI: 10.13063/2327-9214.1205,Non-OADS,/arxiv_data1/oa_pdf/fe/13/egems1205.PMC4827790.pdf
1 http://repository.edm-forum.org/egems/vol4/iss2/1 DOI: 10.13063/2327-9214.1205,Non-OADS,/arxiv_data1/oa_pdf/fe/13/egems1205.PMC4827790.pdf
1 http://repository.edm-forum.org/egems/vol4/iss2/1 DOI: 10.13063/2327-9214.1205,Non-OADS,/arxiv_data1/oa_pdf/fe/13/egems1205.PMC4827790.pdf
1 http://repository.edm-forum.org/egems/vol4/iss2/1 DOI: 10.13063/2327-9214.1205,Non-OADS,/arxiv_data1/oa_pdf/fe/13/egems1205.PMC4827790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/b0/main.PMC4827796.pdf
"In the alternative pathway IKK α phosphorylates p100, which is then partially degraded into p52.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.03.005 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/2a/b0/main.PMC4827796.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/b0/main.PMC4827796.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sleep Children Disorders of consciousnessEEG 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4827803.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0122213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4827803.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4827803.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/84/main.PMC4827804.pdf
It is wellContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.03.006 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/f7/84/main.PMC4827804.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/84/main.PMC4827804.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/c2/tcrm-12-545.PMC4827879.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 545–547Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  545Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9268 4Dysplasia epiphysealis hemimelica (Trevor disease)  in the ankle Fırat Ozan1 Fatih Dog ˘ar1 Kaan Gürbüz1 Yakup ekinci2 Ökkeş Bilal3 eyyüp sabri Öncel1 1Department of orthopedics and  Traumatology, Kayseri Training and  Research Hospital, 2Department  of orthopedics and Traumatology,   Develi Hatice Muammer Kocatürk  state Hospital, Kayseri, 3Department  of orthopedics and Traumatology,   Kahramanmaraş Sütçü I ˙mam  University Medical Faculty,   Kahramanmaraş, T urkeyAbstract:  Dysplasia epiphysealis hemimelica, also termed Trevor disease, is a rare disorder  that, although benign in nature, can be locally aggressive, particularly when affecting the ankle  joint, which is the joint most frequently affected, followed by the knee.",Non-OADS,/arxiv_data1/oa_pdf/f1/c2/tcrm-12-545.PMC4827879.pdf
"Histological examination Correspondence: Fırat Ozan Department of orthopedics and  Traumatology, Kayseri Training and  Research Hospital, sanayi Mahallesi  Atatürk Bulvarı, Hastane Caddesi 38010  Kocasinan, Kayseri, Turkey Tel +90 352 336 88 84 Fax +90 352 320 73 13 email firatozan9@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Ozan et al Running head recto: Dysplasia epiphysealis hemimelica in the ankle DOI: http://dx.doi.org/10.2147/TCRM.S92684",Non-OADS,/arxiv_data1/oa_pdf/f1/c2/tcrm-12-545.PMC4827879.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f1/c2/tcrm-12-545.PMC4827879.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/c2/tcrm-12-545.PMC4827879.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/e6/a6/imcrj-9-091.PMC4827880.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Bilateral congenital venous tortuosity and  dilatation combined with cilioretinal artery:  a photographic essay Nuo Xu1 Yi Cui2 Zhonghai Gao1 1Department of Ophthalmology, Fujian  Provincial Hospital, 2Department of  Ophthalmology, The Union Hospital of  Fujian Medical University, Fuzhou City,   Fujian Province, People’s Republic of  China Correspondence: Nuo Xu   Department of Ophthalmology, Fujian  Provincial Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/e6/a6/imcrj-9-091.PMC4827880.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e6/a6/imcrj-9-091.PMC4827880.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/a6/imcrj-9-091.PMC4827880.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2027–2034OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2027Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9617 5Patient-reported outcomes of brentuximab  vedotin in hodgkin lymphoma and anaplastic  large-cell lymphoma robert chen1 suzanne allibone2 nancy l Bartlett3 Pauline Brice4 andy chen5 Katrina Pose6 lynn rich7 Vijay Bonthapally8 Phillip M garfin9 Michelle Fanale10 1Department of hematology &  hematopoietic cell Transplantation,   city of hope, Duarte, ca, Usa; 2The  lymphoma service of the christie  nhs Foundation Trust, Manchester,   UK; 3Department of Medical  Oncology, Washington University  school of Medicine, st louis, MO,   Usa; 4Department of hemato- Oncology, hôpital saint-louis, Paris,   France; 5Knight cancer institute,   Oregon health & science University,   Portland, Or, 6lymphoma and cancer  survivorship stanford comprehensive  cancer center, stanford, ca,   7lymphoma Program, James P .",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"For example, the US Food and Drug Administration has provided guidance on the  incorporation and evaluation of PRO measures in clinical trials, and both the National correspondence: robert chen city of hope, 1500 east Duarte road,  Duarte, ca 91010, Usa Tel +1 626 359 8111 email rchen@coh.or g Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: PROs of BV in HL and ALCL DOI: http://dx.doi.org/10.2147/OTT.S96175",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ survivorship.pd f. Accessed April 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"Avail - able from: http://www.cancer.org/research/survivaltreatmentresearch/ cancer-survivorship-grant s. Accessed April 22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
Available from: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/90/ott-9-2027.PMC4827881.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 535–544Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  535ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10385 3safe medication management and use of narcotics  in a Joint Commission international-accredited  academic medical center hospital in the People’s  Republic of China Xu Fang1,2 ling-ling Zhu3 sheng-dong Pan4 Ping Xia4 Meng Chen5 Quan Zhou5 1Office of hospital administration,   2Office of Party and administration  Council, 3geriatric ViP Care Ward,   Division of nursing, 4Division of  Medical administration, 5Department  of Pharmacy, the second affiliated  hospital, school of Medicine, Zhejiang  University, hangzhou, Zhejiang  Province, People’s Republic of ChinaAbstract:  Safe medication management and use of high-alert narcotics should arouse concern.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Opioid prescribing errors were common in  inpatients2 and also in emergency departments.3 Logan et al3 reported that 10.3% of Correspondence: Quan Zhou Department of Pharmacy, the second  Affiliated Hospital, School of Medicine,  Zhejiang University, no 88 Jiefang Road,  shangcheng District, hangzhou 310009,  Zhejiang Province, People’s Republic   of China Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Fang et al Running head recto: Safe medication management and use of narcotics DOI: http://dx.doi.org/10.2147/TCRM.S103853",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
Available from: http://www.ismp.org/Tools/highAlertMedicationLists.,OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Available from: http://www.jointcommission.org/ assets/1/18/sea_49_opioids_8_2_12_final.pd f. Accessed February 18,  2015.",OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
Available from: http://www.jointcommissioninternational.,Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Available from: http://www.nhfpc.gov.cn/yzygj/s3572/200804/ dd4277bbf3784ff589b9f12b6a0422ab.shtm l. Accessed January 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
Available from: http://www.nhfpc.,Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
Available from: http://www.rxlist.com/oxycontin-drug.,Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Available from: http://www.rxlist.com/duragesic-side- effects-drug-center.ht m. Accessed January 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"Available from:  http://en.nhfpc.gov.cn/2015-09/11/content_21845393.ht m. Accessed  January 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/tcrm-12-535.PMC4827882.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ott-9-2081.PMC4827883.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2081–2088OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9541 4Overexpression of long noncoding rna hOTTiP  promotes tumor invasion and predicts poor  prognosis in gastric cancer heng Ye1 Kun liu2 Keqing Qian1 1Department of Oncology,   2Department of general surgery,   The affiliated hospital of nanjing  Medical University, changzhou no 2  People’s hospital, changzhou, Jiangsu,   People’s republic of chinaPurpose:  Long noncoding RNAs have been proved to play important roles in the tumorigenesis  and development of human gastric cancer (GC).",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ott-9-2081.PMC4827883.pdf
"Long noncoding RNA (lncRNA), .200 nucleotides in length, is a type of noncoding  RNA molecule that can regulate gene expression in transcriptional or post-transcriptional  level.7,8 Recent research has shown that lncRNAs participate in a large number of cellular  processes, such as cell proliferation, differentiation, apoptosis, and cell cycle progres - sion.9 Emerging evidence indicates that lncRNAs play important roles in the biology of correspondence: Keqing Qian Department of Oncology, The Affiliated  hospital of nanjing Medical University,  changzhou no 2 People’s hospital,  213000 changzhou, Jiangsu, People’s  republic of china email docqiankeq@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y e et al Running head recto: Increased LncRNA HOTTIP in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S95414",OADS,/arxiv_data1/oa_pdf/e6/6d/ott-9-2081.PMC4827883.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ott-9-2081.PMC4827883.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ott-9-2081.PMC4827883.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p and  incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/fb/ibpc-9-059.PMC4827884.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Integrated Blood Pressure Control 2016:9 59–67Integrated Blood Pressure Control Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/20/fb/ibpc-9-059.PMC4827884.pdf
"Or use: http://youtu.be/jYp3ivMMuC 4Dove press submit your manuscript | www.dovepress.co m Dove press  59RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S7432 0Personalized medicine and treatment approaches  in hypertension: current perspectives James Brian Byrd Division of Cardiovascular Medicine,   Department of Medicine, University  of Michigan, Ann Arbor, MI, USA Correspondence: James Brian Byrd   Division of Cardiovascular Medicine,  Department of Medicine, University  of Michigan, 20-209w North Campus  Research Complex, 2800 Plymouth Road,  Ann Arbor, MI 48109-2800, USA   T el +1 734 998 7991   Fax +1 855 230 1379   email jbbyrd@umich.ed uAbstract:  In the US, hypertension affects one in three adults.",Non-OADS,/arxiv_data1/oa_pdf/20/fb/ibpc-9-059.PMC4827884.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/20/fb/ibpc-9-059.PMC4827884.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/fb/ibpc-9-059.PMC4827884.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/copd-11-731.PMC4827885.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 731–738International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  731OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9698 5relationship between vitamin D-binding protein  polymorphisms and blood vitamin D level in  Korean patients with COPD Y oungmok Park,1 Young sam  Kim,1 Y oung ae Kang,1 Ju  hye shin,1 Yeon Mok Oh,2  Joon Beom seo,3 Ji Ye Jung,1  sang Do lee2 On behalf of the KO lD  study 1Division of Pulmonology, Department  of Internal Medicine, severance  hospital, Institute of Chest Diseases,   Y onsei University College of Medicine,   2Department of Pulmonary and  Critical Care Medicine, Clinical  research Center for Chronic  Obstructive airway Diseases,   3Department of radiology and  research Institute of radiology, asan  Medical Center, University of Ulsan  College of Medicine, seoul, republic  of KoreaBackground:  In chronic obstructive pulmonary disease (COPD), the blood vitamin D3 level is  generally low, and genetic polymorphisms of vitamin D-binding protein encoded by the GC gene  are associated with COPD development.",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/copd-11-731.PMC4827885.pdf
"It was first described by J Hirschfeld in 1959 as a marker Correspondence: Ji Ye Jung Division of Pulmonology, Department  of Internal Medicine, severance hospital,  Institute of Chest Diseases, Yonsei  University College of Medicine, 50-1  Yonsei-ro, seodaemun-gu, seoul 03722,  republic of Korea Tel +82 2 2228 1980 Fax +82 2 393 6884 email stopyes@yuhs.a c sang Do lee Department of Pulmonary and Critical  Care Medicine, Clinical research  Center for Chronic Obstructive  airway Diseases, asan Medical Center,  University of Ulsan College of Medicine,  88 Olympic-ro 43-gil, songpa-gu, seoul  05505, republic of Korea Tel +82 2 3010 3140 Fax +82 2 3010 6968 email sdlee@amc.seoul.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Park et al Running head recto: GC polymorphisms and vitamin D level in patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S96985",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/copd-11-731.PMC4827885.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/copd-11-731.PMC4827885.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/6e/copd-11-731.PMC4827885.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/41/ceg-9-083.PMC4827886.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical and Experimental Gastroenterology 2016:9 83–88Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  83REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S7217 2Profile of acotiamide in the treatment of  functional dyspepsia Masahiro Ueda1 Eisuke iwasaki1 Hidekazu Suzuki2 1Department of Internal Medicine,   Division of Gastroenterology and  Hepatology, 2Medical Education  Center, Keio University School of  Medicine, T okyo, Japan Correspondence: Hidekazu Suzuki   Medical Education Center, Keio  University School of Medicine,   35 Shinanomachi, Shinjuku-ku,   Tokyo 160-8582, Japan   Tel +81 3 5363 3914   Fax +81 3 5363 3967   Email hsuzuki.a6@keio.j pAbstract:  Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia  was shown by several clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/39/41/ceg-9-083.PMC4827886.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/39/41/ceg-9-083.PMC4827886.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/41/ceg-9-083.PMC4827886.pdf
"Several research groups have reported that S phase cells in control, untreated, cultures of both © Idun Dale Rein, Caroline Stokke, Marwa Jalal, June H Myklebust, Sebastian Patzke, and Trond Stokke *Correspondence to: Trond Stokke; Email: tstokke@rr-research.noSubmitted: 05/20/2015; Revised: 08/18/2015; Accepted: 08/22/2015 http://dx.doi.org/10.1080/15384101.2015.1087617 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Proc Natl Acad Sci U S A 1975; 72:4994-8; PMID:174089; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Proc Natl Acad Sci U S A 1992;89:7491-5; PMID:1323840; http://dx.doi.org/ 10.1073/pnas.89.16.7491 5.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Biochim Biophys Acta 2001; 1519:1-12; PMID:11406266; http://dx.doi.org/10.1016/S0167-4781(01)00204-4 8.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
DNA Repair (Amst) 2004; 3:997- 1007; PMID:15279786; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Math Biosci2008; 211:1-17; PMID:17942127; http://dx.doi.org/ 10.1016/j.mbs.2007.08.009 10.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
CancerCell 2003; 3:247-58; PMID:12676583; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Radiat Res 2003; 159:759- 67; PMID:12751958; http://dx.doi.org/10.1667/ RR3003 15.,Non-OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Cell Cycle 2010; 9:662-9; PMID:20139725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Biochem Biophys Res Commun 2005; 336:807-12; PMID:16153602; http://dx.doi.org/10.1016/j.bbrc.2005.08.164 18.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
Radiother Oncol 2011; 101:24-7; PMID:21722983;http://dx.doi.org/10.1016/j.radonc.2011.05.060 21.,OADS,/arxiv_data1/oa_pdf/3e/02/kccy-14-20-1087617.PMC4827887.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/01/opth-10-643.PMC4827889.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 643–647Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  643Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9915 7Efficacy and safety of low-dose topical tacrolimus  in vernal keratoconjunctivitis samir s shoughy1 Mahmoud O Jaroudi1 Khalid F Tabbara1–3 1The eye Center and The eye  Foundation for research in  Ophthalmology, 2Department of  Ophthalmology, College of Medicine,   King saud University, riyadh, saudi  arabia; 3Wilmer Ophthalmological  institute of the Johns hopkins  University school of Medicine,   Baltimore, MD, UsaObjective:  The objective of this study was to evaluate the efficacy and safety of topical low-dose  tacrolimus (0.01%) solution in patients with vernal keratoconjunctivitis (VKC).",Non-OADS,/arxiv_data1/oa_pdf/a5/01/opth-10-643.PMC4827889.pdf
"VKC requires Correspondence: samir s shoughy The eye Center and The eye Foundation  for research in Ophthalmology, PO Box  55307, riyadh 11534, saudi arabia Tel +966 1 1464 9614 Fax +966 1 1462 9675 email samir.shawki@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shoughy et al Running head recto: Low-dose topical tacrolimus in vernal keratoconjunctivitis DOI: http://dx.doi.org/10.2147/OPTH.S99157",Non-OADS,/arxiv_data1/oa_pdf/a5/01/opth-10-643.PMC4827889.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a5/01/opth-10-643.PMC4827889.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/01/opth-10-643.PMC4827889.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ClinicoEconomics and Outcomes Research 2016:8 73–76ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  73LEttERopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CEOR.S10101 3Designing economic evaluations to facilitate  optimal decisions: the need to avoid bias Karen M Lee1,3 Kathryn Coyle2 Doug Coyle2,3 1Canadian Agency for Drugs and  technologies in Health (CADtH),   Ottawa, ON, Canada; 2Health  Economics Research Group, Brunel  University, Uxbridge, UK; 3School  of Epidemiology, Public Health and  Preventive Medicine, University of  Ottawa, Ottawa, ON, Canada Correspondence: Karen M Lee   Canadian Agency for Drugs and  technologies in Health (CADtH),   600-865 Carling Avenue, Ottawa,   ON K1S 5S8, Canada   tel +1 613 864 2553   Email karenl@cadth.c aDear editor Guertin et al1 argue in their article “Bias within economic evaluations” that if researchers   fail to incorporate the future availability of generics entrants for new patented drugs,  the incremental cost-effectiveness ratio (ICER) will be overestimated.1 Before address - ing the validity of this argument, it is first worthwhile to consider the nature of both  bias and economic evaluation.",Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
"Available  from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/patregbrev/index- eng.ph p. Accessed November 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
"Available from: https://www.cadth.ca/about-cadth/how-we-do-it/ methods-and-guidelines/guidelines-for-the-economic-evaluation-of- health-technologies-canada/updat e. Accessed on December 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/bc/ceor-8-073.PMC4827890.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f7/3a/jir-9-021.PMC4827891.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/f7/3a/jir-9-021.PMC4827891.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Inflammation Research 2016:9 21–25Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  21ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S9790 6In children allergic to ragweed pollen,  nasal inflammation is not influenced by  monosensitization or polysensitization Matteo gelardi1 Mariangela Bosoni2 Marco Morelli2  silvia Beretta2 cristoforo Incorvaia3 serena Buttafava4 Massimo landi5 simonetta Masieri6 Franco Frati4 nicola Quaranta1 gian Vincenzo Zuccotti2 1Otolaryngology section, Department  of neuroscience and sensory Organs,   University of Bari, 2Department  of Pediatrics, luigi sacco hospital,   University of Milan, 3allergy/ Pulmonary Rehabilitation Unit, I cP  hospital, 4Medical and scientific  Department, stallergenes Italy,   Milan, 5Department of Pediatrics,   asl TO1, T urin, 6Department of  Otorhinolaryngology, sapienza  University of Rome, Rome, Italy correspondence: F Frati   Medical and scientific Department,  stallergenes Italy, Via Tibullo 2,  20151 Milan, Italy   T el +39 33 5528 5619   Fax +39 2 7005 8783   email ffrati@stallergenes.co mBackground:  In patients polysensitized to pollen allergens, the priming effect, by which the  sensitivity of the nasal mucosa to an allergen is increased by the previous exposure to another  allergen, is a known phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/f7/3a/jir-9-021.PMC4827891.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/f7/3a/jir-9-021.PMC4827891.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/3a/jir-9-021.PMC4827891.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b1/1f/bctt-8-053.PMC4827892.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/b1/1f/bctt-8-053.PMC4827892.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Breast Cancer: Targets and Therapy Breast Cancer: Targets and Therapy 2016:8 53–58Dove press submit your manuscript | www.dovepress.co m Dove press  Original researChopen access to scientific and medical research Open access Full T ext article 53 http: //dx.doi.org/10.2147/BCTT .S9935 0Breast cancer characteristics in very young  egyptian women 35 years Omar Farouk1 Mohamed a ebrahim2 ahmad senbel1 Ziad emarah2 Waleed abozeed3 Mohamed O seisa4 summer Mackisack4 salah abdel Jalil4 safaa abdelhady4 1surgical Oncology Unit, 2Medical  Oncology Unit, Oncology Center,   Faculty of Medicine, 3Clinical  Oncology and nuclear Medicine  Department, 4Faculty of Medicine,   Mansoura University, Mansoura, egypt Correspondence: Omar Farouk   surgical Oncology Unit, Oncology Center,  Faculty of Medicine, Mansoura University,  gehan street, 35511, Mansoura, egypt   T el +20 122 690 2626   email dr_omarfarouk@yahoo.co mBackground:  Breast cancer in very young patients represents a unique issue that needs more  attention as the number of cases is increasing and it has special characteristics at presentation,  diagnosis, and biologic behaviors which reflect on both treatment strategies and survival.",Non-OADS,/arxiv_data1/oa_pdf/b1/1f/bctt-8-053.PMC4827892.pdf
Available  from: http://www.cancer.fi/@Bin/70942478/SR_2008-2009_030112.,Non-OADS,/arxiv_data1/oa_pdf/b1/1f/bctt-8-053.PMC4827892.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/b1/1f/bctt-8-053.PMC4827892.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/ff/dddt-10-1355.PMC4827893.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1355–1364Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1355Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10389 4Multiple-unit tablet of probiotic bacteria for  improved storage stability, acid tolerability, and  in vivo intestinal protective effect hee Jun Park1 ga hyeon lee1 Joonho Jun1 Miwon son1 Myung Joo Kang2 1Dong-a Pharmaceutical co. ltd.,   Y ongin, gyeonggi, 2college of  Pharmacy, Dankook University,   cheonan, chungnam, KoreaAbstract:  The aim of this study was to formulate probiotics-loaded pellets in a tablet form to  improve storage stability, acid tolerability, and in vivo intestinal protective effect.",Non-OADS,/arxiv_data1/oa_pdf/c7/ff/dddt-10-1355.PMC4827893.pdf
"Few of them exhibit resistance to adverse environmental  conditions to colonize the mucosal membrane of small and/or large intestine.8,9 Enteric coating techniques have been explored in order to protect living bacteria  from the unfavorable interaction within the dosage form, adverse gastrointestinal envi - ronments (pH, enzymes, bile salts, etc), and to deliver bacteria to the human  intestine.10 correspondence: Myung Joo Kang college of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  cheonan 330-714, chungnam, Korea   Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Park et al Running head recto: Probiotic tablet with improved intestinal protective effect DOI: http://dx.doi.org/10.2147/DDDT.S103894",Non-OADS,/arxiv_data1/oa_pdf/c7/ff/dddt-10-1355.PMC4827893.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c7/ff/dddt-10-1355.PMC4827893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/ff/dddt-10-1355.PMC4827893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/e2/ott-9-2007.PMC4827894.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2007–2016OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2007Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9689 9Mechanism-based management for mucositis:  option for treating side effects without  compromising the efficacy of cancer therapy Y oungjoo Kwon Department of Food Science and  engineering, ewha womans University,   Seoul, South KoreaAbstract:  Mucositis is a major side effect induced by chemotherapy and radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/97/e2/ott-9-2007.PMC4827894.pdf
"Mucositis predominantly  (60%–100%) occurs in patients undergoing radiotherapy, high-dose chemotherapy, and  bone marrow transplantation.6–8 An estimated 40% of patients that receive standard- dose chemotherapy develop mucositis.9 Conventional chemotherapeutic drugs most  frequently associated with mucositis include antimetabolites, such as 5-fluorouracil  (5-FU), methotrexate, and purine antagonists.10 Anthracycline antitumor antibiotics  (eg, doxorubicin) and taxanes (eg, paclitaxel and docetaxel) are other chemothera - peutic drugs that commonly cause mucositis.10,11 Other treatment-related risk factors Correspondence: Youngjoo Kwon Department of Food Science and  engineering, ewha womans University,  52 ewhayeodae-gil, Seodaemun-gu,  Seoul 03760, South Korea email y oungjoo.kwon@ewha.ac.k r Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Kwon Running head recto: Mechanism-based management of mucositis DOI: http://dx.doi.org/10.2147/OTT.S96899",Non-OADS,/arxiv_data1/oa_pdf/97/e2/ott-9-2007.PMC4827894.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/97/e2/ott-9-2007.PMC4827894.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/e2/ott-9-2007.PMC4827894.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/83/dddt-10-1335.PMC4827895.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1335–1343Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1335Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9995 8neuroprotective effects of salidroside through  Pi3K/akt pathway activation in alzheimer’s  disease models Bei Zhang1,2 Ying Wang1 hui li1 ran Xiong1 Zongbo Zhao1 Xingkun chu2 Qiongqiong li1 suya sun1 shengdi chen1,2 1Department of n eurology, institute  of neurology, ruijin hospital,   shanghai Jiao Tong University school  of Medicine, shanghai, People’s  republic of china; 2laboratory  of neurodegenerative Diseases, The  institute of health sciences, shanghai  institutes for Biological sciences,   chinese academy of sciences,   shanghai Jiao Tong University school  of Medicine, shanghai, People’s  republic of chinaAbstract:  Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized  by deposits of aggregated amyloid- β (Aβ) peptide and neurofibrillary tangles in the brain paren - chyma.",Non-OADS,/arxiv_data1/oa_pdf/c1/83/dddt-10-1335.PMC4827895.pdf
"Many novel compounds isolated from Chinese herbal medicines,  some of which improve dementia with fewer side effects, may be useful for the pre - vention and treatment of AD.5 Salidroside (Sal) is an active ingredient extracted from correspondence: shengdi chen; suya sun Department of neurology, institute of  neurology, ruijin hospital, shanghai  Jiao Tong University school of Medicine,  197 rui Jin er road, shanghai 200025,  People’s republic of china email chen_sd@medmail.com.c n;  sunsuya@shsmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: Neuroprotective effects of salidroside on AD DOI: http://dx.doi.org/10.2147/DDDT.S99958",Non-OADS,/arxiv_data1/oa_pdf/c1/83/dddt-10-1335.PMC4827895.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c1/83/dddt-10-1335.PMC4827895.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/83/dddt-10-1335.PMC4827895.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/d2/ott-9-1969.PMC4827896.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1969–1979OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9559 7Triterpenoid saponin flaccidoside II from Anemone  flaccida  triggers apoptosis of NF1-associated  malignant peripheral nerve sheath tumors via the  MAPK-HO-1 pathway Lin-tao Han1 Yin Fang1 Yan cao2 Feng-hua Wu1 e liu2 Guo-yan Mo2 Fang huang1 1China Key Laboratory of TCM  resource and Prescription, Ministry  of Education, 2Department of  Pharmacy, Hubei University of  Chinese Medicine, Wuhan, Hubei,   People’s Republic of ChinaAbstract:  Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft tissue  neoplasms that are extremely rare and are frequently associated with neurofibromatosis type 1  patients.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/ott-9-1969.PMC4827896.pdf
"Since the progress of MPNST is associated with additional genetic  changes in oncogenes8 or loss of tumor suppressors,9 genetic modeling alongside NF1  has been considered to prevent MPNST development;10 although eventual resistance  or tumor burden hinders its efficacy,11 new strategies for inhibition of both prolifera - tion and survival are in need.Correspondence: Guo-yan Mo Department of Pharmacy, Hubei  University of Chinese Medicine,  1 Tan-Hua-Lin Road, Wuhan, Hubei  430065, People’s Republic of China email mogy.metabonomics@gmail.co m  Fang huang China Key Laboratory of TCM Resource  and Prescription, Ministry of Education,  Wuhan, Hubei 430065, People’s Republic  of China email tracy.metabonomics@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Han et al Running head recto: Flaccidoside II triggers apoptosis via MAPK-HO-1 pathway DOI: http://dx.doi.org/10.2147/OTT.S95597",Non-OADS,/arxiv_data1/oa_pdf/73/d2/ott-9-1969.PMC4827896.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/ott-9-1969.PMC4827896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d2/ott-9-1969.PMC4827896.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/55/ijn-11-1435.PMC4827897.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1435–1442International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1435OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10042 4Polyether ether ketone implants achieve increased   bone fusion when coated with nano-sized  hydroxyapatite: a histomorphometric study in  rabbit bone Pär Johansson1 ryo Jimbo1 Y oshihito Naito2 Per Kjellin3 Fredrik currie3 ann Wennerberg1 1Department of Prosthodontics,   Faculty of Odontology, Malmö  University, Malmö, sweden; 2Oral  Implant center, Tokushima University  hospital, T okushima, Japan; 3Promimic  aB, stena center, göteborg, swedenAbstract:  Polyether ether ketone (PEEK) possesses excellent mechanical properties similar  to those of human bone and is considered the best alternative material other than titanium for  orthopedic spine and trauma implants.",Non-OADS,/arxiv_data1/oa_pdf/93/55/ijn-11-1435.PMC4827897.pdf
"To overcome these problems, PEEK was introduced into the orthopedic field as an  implant material due to its similar elastic modulus as that of human cortical bone.6  For the past 2 decades, PEEK has become a common alternative to metal implants in  several orthopedic applications.7,8 However, PEEK has shown both in vivo and in vitro studies to have low bioactive  features due to the relatively bioinert surface.9–11 Therefore, many studies have been  conducted to improve the biocompatible state of PEEK by incorporating bioactive  substances into the substrate or onto the surface as a coating.12–14 The authors have correspondence: Pär Johansson Department of Prosthodontics, Faculty  of Odontology, Malmö University, carl  gustafs väg 34, 214 21 Malmö, sweden Tel +46 40 665 8514 email par.johansson@mah.s e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Johansson et al Running head recto: Nano-sized hydroxyapatite coating on PEEK implants in rabbit femur DOI: http://dx.doi.org/10.2147/IJN.S100424",Non-OADS,/arxiv_data1/oa_pdf/93/55/ijn-11-1435.PMC4827897.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/93/55/ijn-11-1435.PMC4827897.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/55/ijn-11-1435.PMC4827897.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/93/ijn-11-1443.PMC4827898.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1443–1450International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1443OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10076 8Probing the nanoadhesion of Streptococcus  sanguinis  to titanium implant surfaces by atomic  force microscopy sebastian aguayo1 Nikolaos Donos2 Dave spratt3 laurent Bozec1 1Department of Biomaterials and  Tissue engineering, 2Periodontology  Unit, 3Division of Microbial Diseases,   Ucl eastman Dental Institute,   University college london,   london,  UKAbstract:  As titanium (Ti) continues to be utilized in great extent for the fabrication of artificial  implants, it is important to understand the crucial bacterium–Ti interaction occurring during the  initial phases of biofilm formation.",Non-OADS,/arxiv_data1/oa_pdf/ac/93/ijn-11-1443.PMC4827898.pdf
"Keywords:  atomic force microscopy, biophysics, bacterial adhesion, dental implants,  titanium Introduction Amidst rising efforts to combat biofilm-mediated diseases, the prevalence of orthopedic  and dental implant infections continues to increase in the population.1 Although many  biomaterials (such as stainless steel and cobalt–chromium alloys) have been introduced  into the clinical setting, titanium (Ti) continues to be considered the “gold standard”  material for the elaboration of artificial implants mainly due to its highly biocompatible  properties.2,3 Ti dental implants have shown excellent survival rates in the past years,4  however, the issue of bacterial colonization remains a problem as biofilm formation  on the implant surface can lead to loss of osseointegration with subsequent treatment  failure.5–7 Thus, many chemical disinfection protocols have been developed to try and  clean implants after surface infection, in hopes of avoiding surgical intervention and  increase the survival rates of affected implants.8 Biofilm formation comprises of a series of stages, starting with the initial adhe - sion of early colonizing species9 and continued by the attachment of secondary and  increasingly pathogenic bacteria that can lead to disease.10 In this context, Streptococcus  sanguinis  has been consistently reported as an initial colonizer in the process of oral correspondence: laurent Bozec Division of Biomaterials and  Tissue engineering, Ucl eastman  Dental Institute, University college  london, 256 gray’s Inn road, london,  Wc1X 8lD, UK email l.bozec@ucl.ac.u k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Aguayo et al Running head recto: Probing the nanoadhesion of S. sanguinis to titanium implant surfaces by AFM DOI: http://dx.doi.org/10.2147/IJN.S100768",Non-OADS,/arxiv_data1/oa_pdf/ac/93/ijn-11-1443.PMC4827898.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ac/93/ijn-11-1443.PMC4827898.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/93/ijn-11-1443.PMC4827898.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 781–783Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  781Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10156 9Does amantadine induce acute psychosis?",Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
"His family history was negative for  psychotic disorders.Correspondence: shao-hua Hu Department of psychiatry, The First  Affiliated Hospital of Zhejiang University  school of Medicine, No 79, Qingchun  road, Hangzhou 310003, Zhejiang,  people’s republic of China Tel +86 571 5672 3001 email dorhushaohua@zju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Xu et al Running head recto: Psychosis induced by amantadine DOI: http://dx.doi.org/10.2147/NDT.S101569",Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
"Available from: http://www.cdc.gov/flu/professionals/antivirals/ antiviral-dosage.ht m. Accessed November 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/38/9b/ndt-12-781.PMC4827899.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 163–172Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  163Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S10068 8experiences of persons with multiple chemical  sensitivity with mental health providers Pamela reed gibson sharon D lockaby Jenna Michele Bryant Department of Psychology, James  Madison University, Harrisonburg, V a,   Usa correspondence: Pamela reed gibson   Department of Psychology, James  Madison University, Msc 7704,  Harrisonburg, V a 22807, Usa   T el +1 540 568 6195   Fax +1 540 568 3322   email gibsonpr@jmu.ed uAbstract:  In this paper, we summarize the results of an online survey of persons in the United  States with chemical intolerance/multiple chemical sensitivity who sought help from mental  health providers, including counselors, psychologists, psychiatrists, and others.",Non-OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
Available from: http://www.bbc.co.uk/ news/mobile/world-latin-america-1640426 8.,Non-OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/38/jmdh-9-163.PMC4827900.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/5a/opth-10-609.PMC4827901.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 609–615Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  609Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9599 3Application of different Scheimpflug-based lens  densitometry methods in phacodynamics prediction Fernando Faria-Correia1–5 Bernardo T lopes5,6 isaac C ramos5,6 Tiago Monteiro1,2 nuno Franqueira1 Renato Ambrósio Jr5–8 1Ophthalmology Department,   hospital de Braga, Braga, Portugal;   2life and health sciences research  institute ( iCVs), school of health  sciences, University of Minho, Braga,   Portugal; 3ICVS/3B’s - PT Government  Associate Laboratory, Braga, Portugal;   4ICVS/3B’s - PT Government  Associate Laboratory, Guimarães,   Portugal; 5Rio de Janeiro Corneal  Tomography and Biomechanics  Study Group, Rio de Janeiro, Brazil;   6Instituto de Olhos Renato Ambrósio,   Rio de Janeiro, Brazil; 7Visarerio, rio  de Janeiro, Brazil; 8Department of  Ophthalmology and Visual sciences,   Federal University of São Paulo, São  Paulo, BrazilPurpose:  To evaluate the correlations between preoperative Scheimpflug-based lens  densitometry metrics and phacodynamics.",Non-OADS,/arxiv_data1/oa_pdf/6e/5a/opth-10-609.PMC4827901.pdf
"Previous studies have enabled objective measurements of lens  density, providing more precise and reliable assessments compared to the LOCS III  grading system.4–7 Different approaches have been described to quantify cataract den - sity from the Scheimpflug images, and some correlated better with lens grading and Correspondence: Fernando Faria-Correia life and health sciences research  institute (iCVs), Universidade do Minho,  Campus de Gualtar, 4710-057 Braga,  Portugal email f.faria.correia@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Faria-Correia et al Running head recto: Scheimpflug-based lens densitometry metrics and phacodynamics DOI: http://dx.doi.org/10.2147/OPTH.S95993",Non-OADS,/arxiv_data1/oa_pdf/6e/5a/opth-10-609.PMC4827901.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6e/5a/opth-10-609.PMC4827901.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/5a/opth-10-609.PMC4827901.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/93/ott-9-1989.PMC4827902.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1989–1995OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1989ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10030 3Detection of EML4-ALK  fusion gene and features  associated with EGFR mutations in Chinese  patients with non-small-cell lung cancer Miaomiao Wen Xuejiao Wang Ying Sun Jinghua Xia Liangbo Fan Hao Xing Zhipei Zhang Xiaofei Li Department of Thoracic Surgery,   Tangdu Hospital, The Fourth Military  Medical University, Xi’an, Shaanxi,   People’s Republic of ChinaPurpose:  Echinoderm microtubule-associated protein-like  4–anaplastic lymphoma kinase   (EML4-ALK ) and epidermal growth factor receptor  (EGFR ) define specific molecular subsets  of lung cancer with distinct clinical features.",Non-OADS,/arxiv_data1/oa_pdf/0c/93/ott-9-1989.PMC4827902.pdf
"In patients carrying the EGFR  mutation  who have been previously untreated, EGFR -TKIs have been demonstrated to be  superior to cytotoxic chemotherapy.5Correspondence: Zhipei Zhang; Xiaofei Li Department of Thoracic Surgery, Tangdu  Hospital, The Fourth Military Medical  University, 1 Xinsi Road, Xi’an, 710038,  Shaanxi, People’s Republic of China Tel +86 29 8477 7934 Email zzpzyy@fmmu.edu.c n;  l_tdxw@163.co mJournal name: OncoTargets and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 9 Running head verso: Wen et al Running head recto: EML4-ALK  fusion gene associated with EGFR mutations DOI: http://dx.doi.org/10.2147/OTT.S100303",Non-OADS,/arxiv_data1/oa_pdf/0c/93/ott-9-1989.PMC4827902.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0c/93/ott-9-1989.PMC4827902.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/93/ott-9-1989.PMC4827902.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/ndt-12-785.PMC4827903.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 785–786Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  785LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10553 8Virtual reality for the treatment of posttraumatic  disorders Thiago Mazzoli Moraes1 Almir Ferreira de Andrade2 Wellingson Silva Paiva2,3 1Division of Psychology, 2Division  of Neurosurgery, University of São  Paulo Medical School, São Paulo, SP ,   Brazil; 3Neurology Center, Samaritano  Hospital, São Paulo, SP , BrazilDear editor We read with great interest the recent study by Botella et al1 published in the journal  Neuropsychiatric Disease and Treatment .",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/ndt-12-785.PMC4827903.pdf
"These small  caveats, however, do not take away the main relevant messages and discussion raised  by Botella et al.1Correspondence: Wellingson Silva Paiva Division of Neurosurgery, University  of São Paulo Medical School, Alves  Guimarães Street 470, 05410000 São  Paolo, SP, Brazil Tel +55 11 2548 6900 Fax +55 11 2548 6906 email wellingsonpaiva@yahoo.com.b r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Moraes et al Running head recto: Virtual reality for the treatment of posttraumatic disorders DOI: http://dx.doi.org/10.2147/NDT.S105538",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/ndt-12-785.PMC4827903.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/ndt-12-785.PMC4827903.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/ae/ndt-12-785.PMC4827903.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9c/8b/pgpm-9-017.PMC4827904.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/9c/8b/pgpm-9-017.PMC4827904.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Pharmacogenomics and Personalized Medicine 2016: 9 17–29submit your manuscript | www.dovepress.co m Dove press  17 http: //dx.doi.org/10.2147/PGPM.S8485 4Pharmacogenetics in type 2 diabetes: influence on  response to oral hypoglycemic agents Adem Yesuf Dawed  Kaixin Zhou  ewan Robert Pearson  Division of Cardiovascular and  Diabetes Medicine, Medical Research  institute, University of Dundee,   Dundee, Scotland, UK Correspondence: ewan Robert Pearson   Division of Cardiovascular and Diabetes  Medicine, School of Medicine, University of  Dundee, Dundee, Scotland DD1 9SY, UK   T el +44 1382 383 387   Fax +44 1382 383 598   email e.z.pearson@dundee.ac.u kAbstract:  Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming  a significant proportion of public health spending.",Non-OADS,/arxiv_data1/oa_pdf/9c/8b/pgpm-9-017.PMC4827904.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/9c/8b/pgpm-9-017.PMC4827904.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9c/8b/pgpm-9-017.PMC4827904.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 739–746International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  739OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9639 1Does COPD risk vary by ethnicity?",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
DOI: http://dx.doi.org/10.2147/COPD.S96391,Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"Available from:  https://www.nice.org.uk/guidance/cg101/resources/guidance-chronic- obstructive-pulmonary-disease-pd f. Accessed December 5, 2013.",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
Avail - able from http://www.goldcopd.org.,Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"Available from: https://www.gov.uk/government/statistics/tables-for- drug-misuse-findings-from-the-2013-to-2014-cse w. Accessed July 22,  2015.",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"Available  from: http://www.ons.gov.uk/ons/dcp171778_227150.pd f. Accessed  August 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/12/41/copd-11-739.PMC4827905.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2049–2056OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2049Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10272 3associations between FAS rs2234767 and FASL  rs763110 polymorphisms and the risk of lung  cancer: a meta-analysis of 39,736 subjects Xiongjie Yu1,* Yanli li2,* Yuandong Yu1 Jinhua lei1 guoxing Wan1 Fengjun cao1 1Department of Oncology,   2Department of endocrinology,   renmin hospital, hubei University  of Medicine, shiyan, hubei, People’s  republic of china *These authors contributed equally  to this workBackground:  Previous studies have investigated the associations between the common poly - morphisms in FAS/FASL  genes and lung cancer risk; however, the results remain inconsistent  and inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
"Keywords:  FAS, FAS ligand, polymorphism, lung cancer, meta-analysis, risk, apoptosis Introduction Apoptosis is a genetically mediated physiological mechanism of programmed cell  death, playing a vital role in the regulation of cell growth, homeostasis, and develop - ment of adult multicellular organisms, and elimination of unwanted or potentially  dangerous cells.1,2 However, defects in the regulation of apoptosis result in unchecked  cell growth and proliferation, causally contributing to tumorigenesis.3 Acquired abil - ity to resist apoptosis is one of the hallmarks of malignancies including lung cancer,  which usually arises from the genetic alterations of apoptotic genes such as FAS,  FASL, TNF, TP53, Bcl-2, and so on.4–6 Acting as an important member of the tumor necrosis factor superfamily, FAS (also  known as TNFSF6, CD95, or APO-1, located on chromosome 10q24.1), a cell surface  receptor, has been delineated as a primary contributor to programmed cell death by  the interaction with its natural ligand FASL (also CD95L, located on chromosome  1q23) to initiate the extrinsic pathway of apoptosis.7,8 In the FAS/FASL signaling correspondence: Fengjun cao;   guoxing Wan Department of Oncology,  renmin hospital, hubei University of  Medicine, 39 chaoyang road, shiyan,  hubei 442000, People’s republic of china Tel +86 719 8637 385 Fax +86 719 8637 385 email fengjuncaoshiyan@126.co m;  wangx198807@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yu et al Running head recto: FAS/FASL  polymorphisms and lung cancer risk DOI: http://dx.doi.org/10.2147/OTT.S102723",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
"statistical analysis Individual ORs with 95% CIs were utilized to evalu - ate the strength of associations between FAS rs2234767  and FASL  rs763110 polymorphisms and lung cancer risk  using Review Manager version 5.2 software (Cochrane  Collaboration, Oxford, UK; http://www.cochrane.org/ software/ revman .htm) in five genetic models (allele model,  homozygote model, heterozygote model, dominant model,  and recessive model).",OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/bd/ott-9-2049.PMC4827906.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f5/5b/ijnrd-9-081.PMC4827907.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/f5/5b/ijnrd-9-081.PMC4827907.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nephrology and Renovascular Disease 2016:9 81–86International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  81ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S9817 9The effect of ONce Renal on minerals and  electrolytes in predialysis patients with chronic  kidney disease Bancha satirapoj1 Janjira Prapakorn2 Dollapas Punpanich2 chantima Pongsuparbchon3 Ouppatham supasyndh1 1Division of Nephrology, Department  of Medicine, 2Research Unit,   Department of Medicine, 3clinical  Research center, Phramongkutklao  hospital, Phramongkutklao college of  Medicine, Bangkok, Thailand correspondence: Bancha satirapoj   Division of Nephrology, Department of  Medicine, Phramongkutklao hospital and  college of Medicine, 315 Rajavithi Road,  Bangkok 10400, Thailand   T el/fax +66 2 644 4676   email satirapoj@yahoo.co mBackground:  Malnutrition is one common adverse consequence in patients with advanced  chronic kidney disease (CKD), and most patients have a lower-than-normal dietary energy  intake.",Non-OADS,/arxiv_data1/oa_pdf/f5/5b/ijnrd-9-081.PMC4827907.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/f5/5b/ijnrd-9-081.PMC4827907.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/5b/ijnrd-9-081.PMC4827907.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 719–730International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  719OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10249 4a randomized, blinded study to evaluate the  efficacy and safety of umeclidinium 62.5 µg  compared with tiotropium 18 µg in patients  with COPD gregory Feldman1 François Maltais2 sanjeev Khindri3 Mitra Vahdati-Bolouri3 alison Church4 William a Fahy3 roopa Trivedi4,5 1s.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"Keywords:  tiotropium, umeclidinium, COPD, non-inferiority, long-acting muscarinic  antagonist Introduction COPD contributes significantly to morbidity and mortality, and is predicted to be the  third leading cause of death worldwide by 2030.1,2 COPD is characterized by chronic  and progressive breathlessness, cough, and sputum production, which can all be a  major cause of disability.1 Bronchodilators are central to the pharmacological management of COPD.1 Long- acting muscarinic antagonists (LAMAs) are an integral part of management in stable Correspondence: gregory Feldman s. Carolina Pharmaceutical research,  151 Harold Fleming Court, Spartanburg,  sC 29303, Usa Tel +1 864 515 0092 Fax +1 864 515 0094 email gfeld3232@aol.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Feldman et al Running head recto: Umeclidinium versus tiotropium in COPD DOI: http://dx.doi.org/10.2147/COPD.S102494",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
Available from:  http://www.who.int/respiratory/copd/burden/en /.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"Available from: https://www.gsksource.com/pharma/content/dam/ GlaxoSmithKline/US/en/Prescribing_Information/Incruse_Ellipta/pdf/ INCRUSE-ELLIPTA-PI-PIL.PD F. Accessed August 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
Available from: https://www.medicines.org.uk/emc/ medicine/2939 4.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"Available from: http://www.wma.net/ en/30publications/10policies/b3/17c.pd f. Accessed September 29,  2015.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"Available from:  https://www.medicines.org.uk/emc/PIL.16286.latest.pd f. Accessed  October 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
Available from: https://www.medicines.org.uk/ emc/medicine/1003 9.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/copd-11-719.PMC4827908.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/53/ott-9-2057.PMC4827909.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 2057–2068OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2057Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9405 7Use of micro-positron emission tomography with  18F-fallypride to measure the levels of dopamine  receptor-D2 and 18F-FDg as molecular imaging  tracer in the pituitary glands and prolactinomas  of Fischer-344 rats Ping li1–3,* songbai gui2,* lei cao2 hua gao1 Jiwei Bai2 chuzhong li1 Yazhuo Zhang1 1Beijing neurosurgical institute,   2Department of n eurosurgery, Beijing  Tiantan hospital, capital Medical  University, Beijing, 3Department of  neurosurgery, The second affiliated  hospital of anhui Medical University,   cerebral Vascular Disease research  center, anhui Medical University,   hefei, People’s republic of china *These authors contributed equally  to this workAbstract:  Dopamine receptor-D2 (DRD2) is the most important drug target in prolactinoma.",Non-OADS,/arxiv_data1/oa_pdf/15/53/ott-9-2057.PMC4827909.pdf
"But little research has been done to detect the DRD2 level in pituitary  tumors by using noninvasive molecular imaging methods.correspondence: Yazhuo Zhang Beijing neurosurgical institute, capital  Medical University, Tiantan Xili 6,  chongwen District, Beijing 100050,  People’s republic of china Tel +86 10 6702 2826 Fax +86 10 6705 7391 email zyz2004520@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Molecular imaging tracer used in F344 rat prolactinoma models DOI: http://dx.doi.org/10.2147/OTT.S94057",Non-OADS,/arxiv_data1/oa_pdf/15/53/ott-9-2057.PMC4827909.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/15/53/ott-9-2057.PMC4827909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/53/ott-9-2057.PMC4827909.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 549–562Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  549Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6383 3Patient considerations in the management  of menopausal symptoms: role of conjugated  estrogens with bazedoxifene Risa Kagan,1,2 Steven R  Goldstein,3 James H Pickar,4  Barry S Komm5 1Department of Obstetrics,   Gynecology and Reproductive  Sciences, University of California, San  Francisco, 2east Bay Physicians Medical  Group, Berkeley, CA, 3Department  of Obstetrics and Gynecology, New  Y ork University School of Medicine,   4Department of Obstetrics and  Gynecology, Columbia University  Medical Center, New Y ork, NY,   5Global Medical Affairs, Pfizer inc.,   Collegeville, PA, USAAbstract:  Menopausal symptoms (eg, hot flushes and vaginal symptoms) are common, often  bothersome, and can adversely impact women’s sexual functioning, relationships, and quality  of life.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"CE/BZA is a relatively new treatment Correspondence: Risa Kagan east Bay Physicians Medical Group,  Affiliated with Sutter East Bay Medical  Foundation, 2500 Milvia Street,  Berkeley, CA 94704, USA Tel +1 510 204 5600 Fax +1 510 204 5461 email kaganr@sutterhealth.or g Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Kagan et al Running head recto: Managing menopausal symptoms with CE/BZA DOI: http://dx.doi.org/10.2147/TCRM.S63833 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Or use: http://youtu.be/wMOwVcNIPn Qvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Available from: http://www.menopause.org/ docs/default-source/2015/2015-nams-hormone-therapy-after-age-65.,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"Available from:  https://www.endocrine.org/news-room/press-release-archives/2012/ first-of-its-kind-menopause-map-helps-women-navigate-treatmen t.  Accessed July 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"Available from:  http://www.acog.org/Resources-And-Publications/Committee-Opinions/ Committee-on-Gynecologic-Practice/Compounded- Bioidentica l- Menopausal-Hormone-Therap y. Accessed August 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Available from: https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/ NCT01942668?term =REPLENISH&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"Available from:  http://www.fda.gov/downloads/drugs/guidancecomplianceregulatory - information/guidances/ucm071643.pd f. Accessed January 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/6e/tcrm-12-549.PMC4827910.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).risk Management and healthcare Policy 2016:9 33–42submit your manuscript | www.dovepress.co m Dove press  33 http: //dx.doi.org/10.2147/RMHP .S10134 3effect of health development assistance on health  status in sub-saharan africa Keneni gutema negeri1 Damen halemariam2 1school of Public and environmental  health, health service Management  Unit, college of Medicine and  health sciences, hawassa University,   hawassa, 2college of Medicine and  health sciences, school of Public  health, addis ababa University, addis  ababa, ethiopia correspondence: Keneni gutema negeri   school of Public and environmental  health, health service Management  Unit, college of Medicine and health  sciences, hawassa University, PO Box  156, southern nations, nationalities and  People’s region, hawassa, ethiopia   T el +251 0 91 142 4467   Fax +251 46 220 8755   email kenenigut2000@yahoo.co mIntroduction:  Data on the effect of health aid on the health status in developing countries are  inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"Available from: http://www.who.int/nh a.  Accessed October 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"Available from: http://data.worldbank.org/data-catalog/ worldwide-governance-indicator s. Accessed July 21, 2014.",OADS,/arxiv_data1/oa_pdf/84/7d/rmhp-9-033.PMC4827911.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/32/ott-9-2089.PMC4827912.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2089–2098OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2089Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10012 0Are compression corsets beneficial for the  treatment of breast cancer-related lymphedema?",Non-OADS,/arxiv_data1/oa_pdf/61/32/ott-9-2089.PMC4827912.pdf
"Risk factors for the development of edema include surgical invasiveness, severity of  the cancer (metastasis), obesity (high body mass index), chemotherapy, radiotherapy,  and individual factors.3–5Correspondence: Jacek Teodorczyk  Department of Nuclear Medicine,   Medical University of Gdansk,   Debinki 7 st, gdansk, Poland  Tel +48 660 199 199 email badklin@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Hansdorfer-Korzon et al Running head recto: New opportunities in physiotherapy treatment DOI: http://dx.doi.org/10.2147/OTT.S100120",Non-OADS,/arxiv_data1/oa_pdf/61/32/ott-9-2089.PMC4827912.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/61/32/ott-9-2089.PMC4827912.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/32/ott-9-2089.PMC4827912.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/7f/dddt-10-1345.PMC4827914.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1345–1354Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1345Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9676 6Clinicopathological significance and a potential drug  target of RARβ in non-small-cell lung carcinoma:   a meta-analysis and a systematic review Xiaoyun song* Kang shi* shi-Jie Zhou Da-Ping Yu Zhidong liu Yi han Department of Thoracic surgery,   Beijing chest hospital, capital  Medical University, Beijing,   People’s  republic of china *These authors contributed equally  to this workAbstract:  Lung cancer is the leading cause of cancer-related mortality in men worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0f/7f/dddt-10-1345.PMC4827914.pdf
"Hypermethylation in promoter  regions of many tumor suppressor genes inactivates gene transcription and contributes correspondence: Zhidong liu; Yi han Department of Thoracic surgery,  Beijing chest hospital, capital  Medical University, no 97, Machang,  Tongzhou District, Beijing 101149,  People’s republic of china email zhidongliu66@yahoo.co m;  hanyi588@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Song et al Running head recto: Clinicopathological significance and a potential drug target of RARβ DOI: http://dx.doi.org/10.2147/DDDT.S96766",Non-OADS,/arxiv_data1/oa_pdf/0f/7f/dddt-10-1345.PMC4827914.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0f/7f/dddt-10-1345.PMC4827914.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/7f/dddt-10-1345.PMC4827914.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/44/ijn-11-1427.PMC4827915.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1427–1433International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1427OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10408 2cytoprotective effects of cerium and selenium  nanoparticles on heat-shocked human dermal  fibroblasts: an in vitro evaluation Bo Yuan Thomas J Webster amit K roy chemical engineering Department,   college of engineering, Northeastern  University, Boston, M a, UsaAbstract:  It is a widely accepted fact that environmental factors affect cells by modulating  the components of subcellular compartments and altering metabolic enzymes.",Non-OADS,/arxiv_data1/oa_pdf/2f/44/ijn-11-1427.PMC4827915.pdf
"The recent expansion of nanotechnology provides a large assortment of NPs that  differ in chemical composition, size, shape, surface charge and chemistry, and coating  and dispersion status.5 NPs are intriguing for numerous medical applications due to Correspondence: Thomas J Webster chemical engineering Department,  college of engineering, Northeastern  University, 313 snell engineering center,  360 huntington avenue, Boston,  Ma 02115, Usa email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yuan et al Running head recto: Cytoprotective effects of cerium and selenium NPs on heat-shocked HDF DOI: http://dx.doi.org/10.2147/IJN.S104082",Non-OADS,/arxiv_data1/oa_pdf/2f/44/ijn-11-1427.PMC4827915.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2f/44/ijn-11-1427.PMC4827915.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/44/ijn-11-1427.PMC4827915.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/2d/opth-10-627.PMC4827918.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 627–633Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  627Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9552 4Prevalence of vitreomacular adhesion: an optical  coherence tomography analysis in the retina  clinic setting elias reichel1 glenn J Jaffe2 srinivas r sadda3 stefanie schuman2 amir h hariri3 Keegan skidmore1 Jake Duker1 1Department of Ophthalmology,   new england eye Center, Tufts  Medical Center, Tufts University  school of Medicine, Boston,   Ma, 2Duke eye Center, Duke  reading Center, Durham, nC,   3Department of Ophthalmology,   Doheny eye Centers, University  of California, los angeles, C a, UsaPurpose:  The aims of this study were to determine the prevalence of vitreomacular adhesion  (VMA) in a random sample of clinical patients at three US retina clinics and to assess comorbid  retinal conditions, ocular diseases, prior treatment history, and other medical histories.",Non-OADS,/arxiv_data1/oa_pdf/66/2d/opth-10-627.PMC4827918.pdf
"In some cases, however, VMA can be symptomatic, contrib - uting to the pathogenesis and clinical course of various ocular conditions,5 including  vitreomacular traction (VMT) syndrome,6 idiopathic macular hole (MH),7 cystoid  macular edema,8 diabetic macular edema (DME),9 and age-related macular degeneration  (AMD).10 Symptomatic VMA can be associated with loss of visual function.11 It has Correspondence: elias reichel Department of Ophthalmology,  new england eye Center, Tufts Medical  Center, Tufts University school of  Medicine, 800 Washington street,  Box 450, Boston, Ma 02111, Usa Tel +1 617 636 1648 Fax +1 617 636 4866 email ereichel@tuftsmedicalcenter.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Reichel et al Running head recto: Prevalence of vitreomacular adhesion in retina clinic patients DOI: http://dx.doi.org/10.2147/OPTH.S95524",Non-OADS,/arxiv_data1/oa_pdf/66/2d/opth-10-627.PMC4827918.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/66/2d/opth-10-627.PMC4827918.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/2d/opth-10-627.PMC4827918.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/20/ott-9-2035.PMC4827919.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2035–2047OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2035Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9237 8Downregulation of microrna-122 promotes  proliferation, migration, and invasion of human  hepatocellular carcinoma cells by activating  epithelial–mesenchymal transition nanyao Wang Qiong Wang Dong shen Xia sun Xiangming cao Dan Wu Department of Oncology, The  affiliated Jiangyin hospital,   school of Medicine, southeast  University, Jiangyin, Jiangsu,   People’s republic of chinaObjective:  To investigate the effects of microRNA-122 (miR-122) on proliferation,  migration, and invasion in human hepatocellular carcinoma (HCC) cells by activating  epithelial–mesenchymal transition (EMT) pathways.",Non-OADS,/arxiv_data1/oa_pdf/b0/20/ott-9-2035.PMC4827919.pdf
"Despite promising therapeutic strategies for HCC, surgical resection or liver  transplant remains the best options currently available.2 Several studies explored the correspondence: Qiong Wang Department of Oncology, The Affiliated  Jiangyin hospital, school of Medicine,  southeast University, shoushan road  no 163, Jiangyin 214400, Jiangsu,  People’s republic of china Tel +86 510 8697 6131 email wangqiongwq0709@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: miR-122 downregulation and migration and invasion DOI: http://dx.doi.org/10.2147/OTT.S92378",Non-OADS,/arxiv_data1/oa_pdf/b0/20/ott-9-2035.PMC4827919.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b0/20/ott-9-2035.PMC4827919.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/20/ott-9-2035.PMC4827919.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 635–641Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  635Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8990 4a combined analysis of four observational studies  evaluating the intraocular pressure-lowering  ability and tolerability of bimatoprost 0.01% in  patients with primary open-angle glaucoma or  ocular hypertension annemie stevens1 Milko e iliev2 leo de Jong3 ioana grobeiu4 anton hommer5 1Department of Ophthalmology,   ghent University hospital,   ghent, Belgium; 2Department of  Ophthalmology, University of Bern,   Bern, switzerland; 3Department of  Ophthalmology, academic Medical  Centre, amsterdam, the netherlands;   4allergan holdings ltd, Marlow, UK;   5Private Office, Vienna, austriaObjective:  Combine and evaluate data from four clinical practice studies investigating the  intraocular pressure (IOP)-lowering ability, tolerability of and patient adherence to bimatoprost  0.01% therapy in patients with primary open-angle glaucoma or ocular hypertension.",Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
com Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Stevens et al Running head recto: Combined analysis of four observational studies of bimatoprost 0.01% DOI: http://dx.doi.org/10.2147/OPTH.S89904,Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
Available  from http://www.medicines.org.uk/EMC/medicine/22807/SPC/ Lumigan+0.1mg+ml/.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/opth-10-635.PMC4827922.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1451–1460International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1451OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10062 1Novel in situ self-assembly nanoparticles for  formulating a poorly water-soluble drug in oral  solid granules, improving stability, palatability,  and bioavailability shujie guo1 Kevin Pham2 Diana li2 scott r Penzak3 Xiaowei Dong2 1state Key laboratory of Medical  genomics, shanghai Key laboratory  of hypertension, ruijin hospital,   shanghai Jiao Tong University school  of Medicine, shanghai, People’s  republic of china; 2Department of  Pharmaceutical sciences, 3Department  of Pharmacotherapy, University of  North T exas health science center,   Fort Worth, TX, UsaPurpose:  The purpose of this study was to develop a novel lipid-based nanotechnology to  formulate poorly water-soluble drugs in oral solid granules to improve stability, palatability,  and bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
"For oral administration, low solubility could lead to low bioavailability of drugs.1–3  Lipid-based nanoparticles (NPs), which take advantage of NPs as well as lipid- based formulations, have been studied as a means of improving drug solubility and  bioavailability.4–6 They are prepared from biodegradable and biocompatible lipids  and surfactants, reducing the likelihood of excipient-safety concerns.7–9 However, correspondence: Xiaowei Dong Department of Pharmaceutical sciences,  school of Pharmacy, University of  North Texas health science center,  University of North Texas system,  3500 camp Bowie Boulevard,  Fort Worth, TX 76107, Usa Tel +1 817 735 2785 Fax +1 817 735 2603 email xiaowei.dong@unthsc.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Guo et al Running head recto: Novel nanoparticle-based ritonavir granules DOI: http://dx.doi.org/10.2147/IJN.S100621",Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
Available from:  http://www.hivclinic.ca/main/drugs_extra_files/Crushing%20and%20 Liquid%20ARV%20Formulations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/1a/ijn-11-1451.PMC4827924.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/71/ott-9-2069.PMC4827925.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2069–2080OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2069Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9856 6Diffuse large B-cell lymphoma of the breast:  prognostic factors and treatment outcomes Yao sun1 Monika Joks2 li-Ming Xu1 Xiu-li chen1 Dong Qian1 Jin-Qiang Y ou1 Zhi-Y ong Yuan1 1Department of radiation Oncology,   cyberKnife center, Key laboratory  of cancer Prevention and Therapy,   Tianjin Medical University cancer  institute and hospital, national  clinical research center for cancer,   Tianjin, People’s republic of china;   2Department of hematology and  Bone Marrow Transplantation, Poznan  University of Medical science, Poznan,   PolandBackground:  The breast is a rare site of extranodal involvement of diffuse large B-cell  lymphoma (DLBCL).",Non-OADS,/arxiv_data1/oa_pdf/7f/71/ott-9-2069.PMC4827925.pdf
"Because of the rarity of the disease, most correspondence: Zhi-Yong Yuan Department of radiation Oncology,  cyberKnife center, Tianjin Medical  University cancer institute and hospital,  huan-hu-Xi road, Ti-Yuan-Bei, he  Xi District, Tianjin 300060, People’s  republic of china email zhiyong0524@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sun et al Running head recto: Diffuse large B-cell lymphoma of the breast DOI: http://dx.doi.org/10.2147/OTT.S98566",Non-OADS,/arxiv_data1/oa_pdf/7f/71/ott-9-2069.PMC4827925.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7f/71/ott-9-2069.PMC4827925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/71/ott-9-2069.PMC4827925.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e52110 | Page 1 of 8Video Article Measurement of Greenhouse Gas Flux from Agricultural Soils Using Static Chambers Sarah M. Collier1, Matthew D. Ruark2, Lawrence G. Oates3,4, William E. Jokela5, Curtis J. Dell6 1Office of Sustainability, University of Wisconsin-Madison 2Department of Soil Science, University of Wisconsin-Madison 3Department of Agronomy, University of Wisconsin-Madison 4Great Lakes Bioenergy Research Center, University of Wisconsin-Madison 5USDA-ARS Dairy Forage Research Center 6USDA-ARS Pasture Systems Watershed Management Research Unit Correspondence to: Curtis J. Dell at curtis.dell@ars.usda.gov URL: http://www.jove.com/video/52110 DOI: doi:10.3791/52110 Keywords: Environmental Sciences, Issue 90, greenhouse gas, trace gas, gas flux, static chamber, soil, field, agriculture, climate Date Published: 8/3/2014 Citation: Collier, S.M., Ruark, M.D., Oates, L.G., Jokela, W.E., Dell, C.J.",Non-OADS,/arxiv_data1/oa_pdf/52/25/jove-90-52110.PMC4827936.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52110/ Introduction Understanding the contributions of both human activities and natural systems to radiative properties of the atmosphere is an area of critical importance as we strive to mitigate anthropogenic contributions to the greenhouse effect.,Non-OADS,/arxiv_data1/oa_pdf/52/25/jove-90-52110.PMC4827936.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51804 | Page 1 of 6Video Article Olfactory Assays for Mouse Models of Neurodegenerative Disease Andrew M. Lehmkuhl1, Emily R. Dirr2,3, Sheila M. Fleming1,2 1Department of Psychology, University of Cincinnati 2Department of Neurology, University of Cincinnati 3Department of Neuroscience, Cell Biology, and Physiology, Wright State University Correspondence to: Sheila M. Fleming at fleminsa@ucmail.uc.edu URL: http://www.jove.com/video/51804 DOI: doi:10.3791/51804 Keywords: Neuroscience, Issue 90, olfaction, mouse, Parkinson’s disease, detection, discrimination, sniffing Date Published: 8/25/2014 Citation: Lehmkuhl, A.M., Dirr, E.R., Fleming, S.M.",Non-OADS,/arxiv_data1/oa_pdf/0a/7a/jove-90-51804.PMC4827975.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51804/ Introduction Olfactory dysfunction is linked to a number of neurodegenerative disorders including Parkinson’s disease (PD), Alzheimer’s disease, and Huntington’s disease1.",Non-OADS,/arxiv_data1/oa_pdf/0a/7a/jove-90-51804.PMC4827975.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e3368 | Page 1 of 9Video Article Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale Barry M. Lester1,2, Lynne Andreozzi-Fontaine1,2, Edward Tronick3, Rosemarie Bigsby1,2 1Center for the Study of Children at Risk, Alpert Medical School, Brown University 2Women & Infants Hospital of Rhode Island 3University of Massachusetts, Boston Correspondence to: Barry M. Lester at Barry_Lester@Brown.edu URL: http://www.jove.com/video/3368 DOI: doi:10.3791/3368 Keywords: Behavior, Issue 90, NICU Network Neurobehavioral Scale, NNNS, High risk infant, Assessment, Evaluation, Prediction, Long term outcome Date Published: 8/25/2014 Citation: Lester, B.M., Andreozzi-Fontaine, L., Tronick, E., Bigsby, R. Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale.",Non-OADS,/arxiv_data1/oa_pdf/42/46/jove-90-3368.PMC4828009.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3368/ Introduction There has been a long-standing interest in the assessment of the neurobehavioral integrity of the newborn infant.,Non-OADS,/arxiv_data1/oa_pdf/42/46/jove-90-3368.PMC4828009.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51960 | Page 1 of 9Video Article Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection Marten B. Maeß1, Berith Wittig1, Stefan Lorkowski1 1Institute of Nutrition, Friedrich Schiller University Jena Correspondence to: Stefan Lorkowski at stefan.lorkowski@uni-jena.de URL: http://www.jove.com/video/51960 DOI: doi:10.3791/51960 Keywords: Infection, Issue 91, THP-1 macrophages, transfection, electroporation, siRNA, plasmid DNA, protocol, polarization, Nucleofection Date Published: 9/2/2014 Citation: Maeß, M.B., Wittig, B., Lorkowski, S. Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection.",Non-OADS,/arxiv_data1/oa_pdf/73/73/jove-91-51960.PMC4828023.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51960/ Introduction Among the cellular components of the human immune system, macrophages are of great importance for the innate immune response.",Non-OADS,/arxiv_data1/oa_pdf/73/73/jove-91-51960.PMC4828023.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51709 | Page 1 of 6Video Article Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons Sylvie Sanschagrin1, Etienne Yergeau1 1Energy, Mining and Environment, National Research Council Canada Correspondence to: Etienne Yergeau at etienne.yergeau@cnrc-nrc.gc.ca URL: http://www.jove.com/video/51709 DOI: doi:10.3791/51709 Keywords: Molecular Biology, Issue 90, Metagenomics, Bacteria, 16S ribosomal RNA gene, Amplicon sequencing, Next-generation sequencing, benchtop sequencers Date Published: 8/29/2014 Citation: Sanschagrin, S., Yergeau, E. Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons.",Non-OADS,/arxiv_data1/oa_pdf/29/b1/jove-90-51709.PMC4828026.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51709/ Introduction Metagenomic sequencing is a very powerful technology as it targets the entirety of the genetic information contained in an environmental sample.,Non-OADS,/arxiv_data1/oa_pdf/29/b1/jove-90-51709.PMC4828026.pdf
Download the Greengenes reference files from the Mothur website ( http://www.mothur.org/wiki/ Taxonomy_outline).,OADS,/arxiv_data1/oa_pdf/29/b1/jove-90-51709.PMC4828026.pdf
"For instance, beta diversity can be evaluated by calculating the Unifrac distances between each sample pair using the procedure outlined at http://unifrac.colorado.edu/20.",OADS,/arxiv_data1/oa_pdf/29/b1/jove-90-51709.PMC4828026.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51683 | Page 1 of 7Video Article In Vivo 4-Dimensional Tracking of Hematopoietic Stem and Progenitor Cells in Adult Mouse Calvarial Bone Marrow Mark K. Scott1, Olufolake Akinduro2, Cristina Lo Celso2 1Department of Life Science and Facility for Imaging by Light Microscopy, Imperial College London 2Department of Life Sciences, Imperial College London Correspondence to: Cristina Lo Celso at c.lo-celso@imperial.ac.uk URL: http://www.jove.com/video/51683 DOI: doi:10.3791/51683 Keywords: Cellular Biology, Issue 91, hematopoietic stem cell, multiphoton microscopy, cell tracking, bone marrow niche, calvarium, intra-vital confocal microscopy, time-lapse imaging, multi-modal microscopy Date Published: 9/4/2014 Citation: Scott, M.K., Akinduro, O., Lo Celso, C. In Vivo 4-Dimensional Tracking of Hematopoietic Stem and Progenitor Cells in Adult Mouse Calvarial Bone Marrow.",Non-OADS,/arxiv_data1/oa_pdf/ab/e5/jove-91-51683.PMC4828047.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51683/ Introduction Despite stem cell niches having been recognized for decades3 and well characterized in many tissues such as the olfactory bulb, muscle fiber, hair follicle bulge or CNS subventricular zone4-7, the interactions between hematopoietic stem cells (HSCs) and bone marrow microenvironment (BM) are still poorly understood due to the difficulty of directly observing single cells through the bone as well as the extremely fluid nature of the tissue itself.",Non-OADS,/arxiv_data1/oa_pdf/ab/e5/jove-91-51683.PMC4828047.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51728 | Page 1 of 8Video Article Cell Surface Marker Mediated Purification of iPS Cell Intermediates from a Reprogrammable Mouse Model Christian M. Nefzger*1,2, Sara Alaei*1,2, Anja S. Knaupp1,2, Melissa L. Holmes1,2, Jose M. Polo1,2 1Department of Anatomy and Developmental Biology, Monash University 2Australian Regenerative Medicine Institute, Monash University *These authors contributed equally Correspondence to: Jose M. Polo at Jose.Polo@monash.edu URL: http://www.jove.com/video/51728 DOI: doi:10.3791/51728 Keywords: Stem Cell Biology, Issue 91, Induced pluripotent stem cells; reprogramming; intermediates; fluorescent activated cells sorting; cell surface marker; reprogrammable mouse model; derivation of mouse embryonic fibroblasts Date Published: 9/6/2014 Citation: Nefzger, C.M., Alaei, S., Knaupp, A.S., Holmes, M.L., Polo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/85/85/jove-91-51728.PMC4828052.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51728/ Introduction Embryonic stem (ES) cells are derived from the inner cell mass of blastocyst stage embryos1.,Non-OADS,/arxiv_data1/oa_pdf/85/85/jove-91-51728.PMC4828052.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51057 | Page 1 of 13Video Article A Proboscis Extension Response Protocol for Investigating Behavioral Plasticity in Insects: Application to Basic, Biomedical, and Agricultural Research Brian H. Smith1, Christina M. Burden1 1School of Life Sciences, Arizona State University Correspondence to: Brian H. Smith at BrianHSmith@asu.edu URL: http://www.jove.com/video/51057 DOI: doi:10.3791/51057 Keywords: Neuroscience, Issue 91, PER, conditioning, honey bee, olfaction, olfactory processing, learning, memory, toxin assay Date Published: 9/8/2014 Citation: Smith, B.H., Burden, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/jove-91-51057.PMC4828057.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51057/ Introduction Many insects learn about ecologically relevant stimuli, and they then change their behavioral responses to those stimuli in order to adapt to new predictive relationships in their environment.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/jove-91-51057.PMC4828057.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51554 | Page 1 of 10Video Article Isolation of Human Monocytes by Double Gradient Centrifugation and Their Differentiation to Macrophages in Teflon-coated Cell Culture Bags Kerstin Menck1, Daniel Behme1, Mathias Pantke1, Norbert Reiling2, Claudia Binder1, Tobias Pukrop1, Florian Klemm1 1Department of Hematology and Oncology, University Medical Center Göttingen 2Microbial Interface Biology Group, Research Center Borstel Correspondence to: Florian Klemm at florian.klemm@med.uni-goettingen.de URL: http://www.jove.com/video/51554 DOI: doi:10.3791/51554 Keywords: Immunology, Issue 91, macrophages, monocytes, isolation, PBMCs, density gradient, differentiation, Teflon-coated cell culture bags Date Published: 9/9/2014 Citation: Menck, K., Behme, D., Pantke, M., Reiling, N., Binder, C., Pukrop, T., Klemm, F. Isolation of Human Monocytes by Double Gradient Centrifugation and Their Differentiation to Macrophages in Teflon-coated Cell Culture Bags.",Non-OADS,/arxiv_data1/oa_pdf/a2/85/jove-91-51554.PMC4828059.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51554/ Introduction Cells from the monocytic lineage and their terminally differentiated derivative - macrophages - exhibit a striking plasticity in regard to their biological function, leading to their involvement in such diverse processes as development, tissue repair, and immunity1.",Non-OADS,/arxiv_data1/oa_pdf/a2/85/jove-91-51554.PMC4828059.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51868 | Page 1 of 13Video Article Ex vivo  Culture of Drosophila  Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment Stefanie M. K. Gärtner1, Christina Rathke1, Renate Renkawitz-Pohl*1, Stephan Awe*2 1Fachbereich Biologie, Entwicklungsbiologie, Philipps-Universität Marburg 2Institut für Molekularbiologie und Tumorforschung, Philipps-Universität Marburg *These authors contributed equally Correspondence to: Stephan Awe at awes@staff.uni-marburg.de URL: http://www.jove.com/video/51868 DOI: doi:10.3791/51868 Keywords: Developmental Biology, Issue 91, Ex vivo  culture, testis, male germ-line cells, Drosophila , imaging, pharmacological assay Date Published: 9/11/2014 Citation: Gärtner, S.M.K., Rathke, C., Renkawitz-Pohl, R., Awe, S. Ex vivo  Culture of Drosophila  Pupal Testis and Single Male Germ-line Cysts: Dissection, Imaging, and Pharmacological Treatment.",Non-OADS,/arxiv_data1/oa_pdf/85/1e/jove-91-51868.PMC4828063.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51868/ Introduction The development of male germ cells of many species is a sequential process.,Non-OADS,/arxiv_data1/oa_pdf/85/1e/jove-91-51868.PMC4828063.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51228 | Page 1 of 9Video Article Visualization of ATP Synthase Dimers in Mitochondria by Electron Cryo- tomography Karen M. Davies1, Bertram Daum1, Vicki A. M. Gold1, Alexander W. Mühleip1, Tobias Brandt1, Thorsten B. Blum1, Deryck J. Mills1, Werner Kühlbrandt1 1Department of Structural Biology, Max Planck Institute of Biophysics Correspondence to: Werner Kühlbrandt at werner.kuehlbrandt@biophys.mpg.de URL: http://www.jove.com/video/51228 DOI: doi:10.3791/51228 Keywords: Structural Biology, Issue 91, electron microscopy, electron cryo-tomography, mitochondria, ultrastructure, membrane structure, membrane protein complexes, ATP synthase, energy conversion, bioenergetics Date Published: 9/14/2014 Citation: Davies, K.M., Daum, B., Gold, V.A.M., Mühleip, A.W., Brandt, T., Blum, T.B., Mills, D.J., Kühlbrandt, W. Visualization of ATP Synthase Dimers in Mitochondria by Electron Cryo-tomography.",Non-OADS,/arxiv_data1/oa_pdf/9c/23/jove-91-51228.PMC4828066.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51228/ Introduction Mitochondria are the power-houses of the cell.,Non-OADS,/arxiv_data1/oa_pdf/9c/23/jove-91-51228.PMC4828066.pdf
2.Align the images and generate a tomogram by following the steps detailed in the IMOD tutorial ( http://bio3d.colorado.edu/imod/doc/ etomoTutorial.html).,Non-OADS,/arxiv_data1/oa_pdf/9c/23/jove-91-51228.PMC4828066.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51893 | Page 1 of 9Video Article A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies Inti Zlobec1, Guido Suter1, Aurel Perren1, Alessandro Lugli1 1Institute of Pathology, University of Bern Correspondence to: Inti Zlobec at inti.zlobec@pathology.unibe.ch URL: http://www.jove.com/video/51893 DOI: doi:10.3791/51893 Keywords: Medicine, Issue 91, tissue microarray, biomarkers, prognostic, predictive, digital pathology, slide scanning Date Published: 9/23/2014 Citation: Zlobec, I., Suter, G., Perren, A., Lugli, A.",Non-OADS,/arxiv_data1/oa_pdf/81/98/jove-91-51893.PMC4828107.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51893/ Introduction Over the last two decades, tissue microarrays (TMAs) have had a remarkable impact on biomarker investigation studies.",Non-OADS,/arxiv_data1/oa_pdf/81/98/jove-91-51893.PMC4828107.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51890 | Page 1 of 8Video Article High-throughput Titration of Luciferase-expressing Recombinant Viruses Vanessa Garcia1,2, Ramya Krishnan1,2, Colin Davis1,2, Cory Batenchuk1,2, Fabrice Le Boeuf1,3, Hesham Abdelbary1,3, Jean-Simon Diallo1,2 1Center for Innovative Cancer Research, Ottawa Hospital Research Institute 2Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa 3Faculty of Medicine, University of Ottawa Correspondence to: Jean-Simon Diallo at jsdiallo@ohri.ca URL: http://www.jove.com/video/51890 DOI: doi:10.3791/51890 Keywords: Virology, Issue 91, titration, virus, plaque assay, high-throughput, transgene, luciferase, automated, cytotoxicity assay, Vesicular Stomatitis Virus, Herpes Simplex virus, Vaccinia virus, Adeno-Associated virus Date Published: 9/19/2014 Citation: Garcia, V., Krishnan, R., Davis, C., Batenchuk, C., Le Boeuf, F., Abdelbary, H., Diallo, J.S.",Non-OADS,/arxiv_data1/oa_pdf/f2/6f/jove-91-51890.PMC4828131.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51890/ Introduction Classical viral plaque assays continue to be a mainstay in virus research even though they can be notoriously time-consuming and constitute a significant bottleneck to obtaining results from experiments.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/jove-91-51890.PMC4828131.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51747 | Page 1 of 5Video Article Capsular Serotyping of Streptococcus pneumoniae  by Latex Agglutination Barbara D. Porter1, Belinda D. Ortika1, Catherine Satzke1,2 1Pneumococcal Research, Murdoch Childrens Research Institute 2Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne Correspondence to: Catherine Satzke at catherine.satzke@mcri.edu.au URL: http://www.jove.com/video/51747 DOI: doi:10.3791/51747 Keywords: Immunology, Issue 91, Antisera, pneumococci, polysaccharide capsule, slide agglutination Date Published: 9/25/2014 Citation: Porter, B.D., Ortika, B.D., Satzke, C. Capsular Serotyping of Streptococcus pneumoniae  by Latex Agglutination.",Non-OADS,/arxiv_data1/oa_pdf/ea/59/jove-91-51747.PMC4828145.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51747/ Introduction Streptococcus pneumoniae (the pneumococcus) is a major cause of morbidity and mortality in children under the age of five years old world- wide, particularly in resource-poor settings1,2.",Non-OADS,/arxiv_data1/oa_pdf/ea/59/jove-91-51747.PMC4828145.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53658 | Page 1 of 8Video Article Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain Claudia Pösel*1, Karoline Möller*1, Johannes Boltze1,2, Daniel-Christoph Wagner1, Gesa Weise1,3 1Ischemia Research Unit, Fraunhofer Institute for Cell Therapy and Immunology 2Fraunhofer Research Institution for Marine Biotechnology, University of Lubeck 3Department of Neurology, University of Leipzig *These authors contributed equally Correspondence to: Gesa Weise at gesa.weise@izi.fraunhofer.de URL: http://www.jove.com/video/53658 DOI: doi:10.3791/53658 Keywords: Immunology, Issue 108, Ischemic stroke, brain inflammation, repair, cell isolation, flow cytometry, quantification, characterization, cell phenotyping, immune cells, leukocytes Date Published: 2/12/2016 Citation: Pösel, C., Möller, K., Boltze, J., Wagner, D.C., Weise, G. Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain.",Non-OADS,/arxiv_data1/oa_pdf/9a/95/jove-108-53658.PMC4828148.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53658/ Introduction Cerebral stroke triggers a sustained inflammatory response that starts rapidly after cessation of the local blood flow and involves virtually all parts of the immune system.,Non-OADS,/arxiv_data1/oa_pdf/9a/95/jove-108-53658.PMC4828148.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2016 |  107  | e53527 | Page 1 of 11Video Article Concurrent Electroencephalography Recording During Transcranial Alternating Current Stimulation (tACS) Kristoffer D. Fehér1, Yosuke Morishima1,2 1Division of Systems Neuroscience of Psychopathology, Translational Research Center, University Hospital of Psychiatry, University of Bern 2Japan Science and Technology Agency, PRESTO Correspondence to: Yosuke Morishima at yosukemorishima@gmail.com URL: http://www.jove.com/video/53527 DOI: doi:10.3791/53527 Keywords: Behavior, Issue 107, Neuroscience, Transcranial alternating current stimulation, Electroencephalography, Neural oscillations, Oscillatory entrainment, Non-invasive brain stimulation Date Published: 1/22/2016 Citation: Fehér, K.D., Morishima, Y. Concurrent Electroencephalography Recording During Transcranial Alternating Current Stimulation (tACS).",Non-OADS,/arxiv_data1/oa_pdf/2b/ed/jove-107-53527.PMC4828151.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53527/ Introduction Rhythmic dynamics of extracellular electrical currents in the brain have been observed for a century1,2.",Non-OADS,/arxiv_data1/oa_pdf/2b/ed/jove-107-53527.PMC4828151.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53632 | Page 1 of 6Video Article Identification of Kinesin-1 Cargos Using Fluorescence Microscopy Clement M. Lee1 1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai Correspondence to: Clement M. Lee at clement.lee@mssm.edu URL: http://www.jove.com/video/53632 DOI: doi:10.3791/53632 Keywords: Biochemistry, Issue 108, c-MYC, Kinesin-1, KLC1, KIF5B, kinesins, myosins, trafficking, dominant negative, fluorescent protein, fluorescence microscopy Date Published: 2/14/2016 Citation: Lee, C.M.",Non-OADS,/arxiv_data1/oa_pdf/1a/3d/jove-108-53632.PMC4828159.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53632/ Introduction Kinesin-1 is a motor protein that mediates anterograde transport of its cargos1,2.",Non-OADS,/arxiv_data1/oa_pdf/1a/3d/jove-108-53632.PMC4828159.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53603 | Page 1 of 18Video Article In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography Elza van Deel1,2, Yanto Ridwan1, J. Nicole van Vliet1, Sasha Belenkov3, Jeroen Essers1,4,5 1Department of Genetics, Erasmus MC, Rotterdam 2Department of Experimental Cardiology, Erasmus MC, Rotterdam 3PerkinElmer, Inc. 4Department of Vascular Surgery, Erasmus MC, Rotterdam 5Department of Radiation Oncology, Erasmus MC, Rotterdam Correspondence to: Jeroen Essers at j.essers@erasmusmc.nl URL: http://www.jove.com/video/53603 DOI: doi:10.3791/53603 Keywords: Bioengineering, Issue 108, Imaging, mouse cardiac functional imaging, LV function, cardiovascular function, perfusion imaging, myocardial infarction, ischemia, LAD artery occlusion, MicroCT, Quantum FX, contrast agent, eXIA160 Date Published: 2/16/2016 Citation: van Deel, E., Ridwan, Y., van Vliet, J.N., Belenkov, S., Essers, J.",Non-OADS,/arxiv_data1/oa_pdf/da/69/jove-108-53603.PMC4828165.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53603/ Introduction Ischemic heart disease (IHD) continues to be the single greatest cause of morbidity and mortality for men and women worldwide1.,Non-OADS,/arxiv_data1/oa_pdf/da/69/jove-108-53603.PMC4828165.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e52950 | Page 1 of 12Video Article Research and Development of High-performance Explosives Rodger Cornell1, Erik Wrobel1, Paul E. Anderson2 1Detonation Physics Branch, US Army ARDEC, Picatinny Arsenal 2Explosives Research Branch, US Army ARDEC, Picatinny Arsenal Correspondence to: Paul E. Anderson at paul.e.anderson64.civ@mail.mil URL: http://www.jove.com/video/52950 DOI: doi:10.3791/52950 Keywords: Engineering, Issue 108, Explosives, Detonation, Testing, Fiber-optic, Photo Doppler Velocimetry Date Published: 2/20/2016 Citation: Cornell, R., Wrobel, E., Anderson, P.E.",Non-OADS,/arxiv_data1/oa_pdf/ac/d0/jove-108-52950.PMC4828176.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52950/ Introduction Development of high explosives for military use involves extensive safety considerations and resource limitations due to test facility requirements.,Non-OADS,/arxiv_data1/oa_pdf/ac/d0/jove-108-52950.PMC4828176.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53765 | Page 1 of 9Video Article Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol J. Moritz Kaths1,2, Juan Echeverri1,3, Nicolas Goldaracena1, Kristine S. Louis1, Paul Yip4, Rohan John4, Istvan Mucsi5, Anand Ghanekar1, Darius Bagli6, Markus Selzner1, Lisa A. Robinson2 1Multi Organ Transplant Program, Department of Surgery, Toronto General Hospital 2Division of Nephrology, The Hospital for Sick Children 3Programa de Doctorat en Medicina, La Universitat Autónoma de Barcelona 4Laboratory Medicine and Pathobiology, Toronto General Hospital 5Department of Medicine, Toronto General Hospital 6Departments of Surgery (Urology) & Physiology, Developmental & Stem Cell Biology, The Hospital for Sick Children Correspondence to: J. Moritz Kaths at moritz.kaths@gmail.com URL: http://www.jove.com/video/53765 DOI: doi:10.3791/53765 Keywords: Medicine, Issue 108, Renal, kidney, organ transplantation, porcine, pig, swine model, auto-allotransplantation, organ shortage, organ preservation technique, marginal graft, delayed graft function (DGF), primary non-function (PNF) Date Published: 2/21/2016 Citation: Kaths, J.M., Echeverri, J., Goldaracena, N., Louis, K.S., Yip, P., John, R., Mucsi, I., Ghanekar, A., Bagli, D., Selzner, M., Robinson, L.A. Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol.",Non-OADS,/arxiv_data1/oa_pdf/40/de/jove-108-53765.PMC4828178.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53765/ Introduction Kidney transplantation is the treatment of choice for patients with end-stage renal disease, due to associated lower rates of morbidity and mortality when compared to dialysis 1-3.",Non-OADS,/arxiv_data1/oa_pdf/40/de/jove-108-53765.PMC4828178.pdf
Source: http://www.transplant-observatory.org/Pages/home.aspx (2014).,Non-OADS,/arxiv_data1/oa_pdf/40/de/jove-108-53765.PMC4828178.pdf
Source: https://www.eurotransplant.org/cms/mediaobject.php?,Non-OADS,/arxiv_data1/oa_pdf/40/de/jove-108-53765.PMC4828178.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53477 | Page 1 of 12Video Article Quantifying Fish Swimming Behavior in Response to Acute Exposure of Aqueous Copper Using Computer Assisted Video and Digital Image Analysis Robin D. Calfee1, Holly J. Puglis1, Edward E. Little1, William G. Brumbaugh1, Christopher A. Mebane2 1Columbia Environmental Research Center, US Geological Survey 2US Geological Survey Correspondence to: Robin D. Calfee at rcalfee@usgs.gov URL: http://www.jove.com/video/53477 DOI: doi:10.3791/53477 Keywords: Neuroscience, Issue 108, Behavior, toxicity, copper, video analysis, swimming activity, digital tracking, diluter, white sturgeon, Acipenser transmontanus Date Published: 2/26/2016 Citation: Calfee, R.D., Puglis, H.J., Little, E.E., Brumbaugh, W.G., Mebane, C.A.",Non-OADS,/arxiv_data1/oa_pdf/7c/dc/jove-108-53477.PMC4828188.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53477/ Introduction Understanding how contaminant exposure can affect behavior is at times very challenging and subjective.,Non-OADS,/arxiv_data1/oa_pdf/7c/dc/jove-108-53477.PMC4828188.pdf
http://www.astm.org/Standards/E1241.htm (2014).,Non-OADS,/arxiv_data1/oa_pdf/7c/dc/jove-108-53477.PMC4828188.pdf
SOURCE: SOURCE: http://www.astm.org/Standards/E1711.htm (2014).,OADS,/arxiv_data1/oa_pdf/7c/dc/jove-108-53477.PMC4828188.pdf
SOURCE: http://www.astm.org/Standards/E729.htm (2014).,Non-OADS,/arxiv_data1/oa_pdf/7c/dc/jove-108-53477.PMC4828188.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53863 | Page 1 of 10Video Article Fluorescence Time-lapse Imaging of the Complete S. venezuelae  Life Cycle Using a Microfluidic Device Susan Schlimpert1, Klas Flärdh2, Mark Buttner1 1Department of Molecular Microbiology, John Innes Centre, Norwich Research Park 2Department of Biology, Lund University Correspondence to: Susan Schlimpert at susan.schlimpert@jic.ac.uk URL: http://www.jove.com/video/53863 DOI: doi:10.3791/53863 Keywords: Immunology, Issue 108, Streptomyces venezuelae , time-lapse microscopy, FtsZ, DivIVA, polar growth, sporulation, development, microfluidic device, Fiji software.",Non-OADS,/arxiv_data1/oa_pdf/cc/2b/jove-108-53863.PMC4828195.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53863/ Introduction Streptomycetes are soil-dwelling bacteria that are characterized by a complex developmental cycle involving morphological differentiation from a multicellular, nutrient-scavenging mycelium to dormant, unigenomic spores 1-3.",Non-OADS,/arxiv_data1/oa_pdf/cc/2b/jove-108-53863.PMC4828195.pdf
Go to Fiji online support for detailed information (http://fiji.sc/Fiji).,Non-OADS,/arxiv_data1/oa_pdf/cc/2b/jove-108-53863.PMC4828195.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2016 |  108  | e53177 | Page 1 of 7Video Article Production of Double-stranded DNA Ministrings Shirley Wong1, Peggy Lam1, Nafiseh Nafissi1, Steven Denniss2, Roderick Slavcev1 1School of Pharmacy, University of Waterloo 2Sgd Health Innovation Correspondence to: Roderick Slavcev at slavcev@uwaterloo.ca URL: http://www.jove.com/video/53177 DOI: doi:10.3791/53177 Keywords: Molecular Biology, Issue 108, DNA Ministring, DNA minivector, Plasmid, Tel Protelomerase, In vivo  production system, Inducible vector processing, Gene therapy Date Published: 2/29/2016 Citation: Wong, S., Lam, P., Nafissi, N., Denniss, S., Slavcev, R. Production of Double-stranded DNA Ministrings.",Non-OADS,/arxiv_data1/oa_pdf/1f/51/jove-108-53177.PMC4828204.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53177/ Introduction The goal is to produce scalable quantities of linear covalently closed (LCC) DNA minivectors using a simple and high efficiency one-step heat- inducible in vivo  DNA ministring production system.,Non-OADS,/arxiv_data1/oa_pdf/1f/51/jove-108-53177.PMC4828204.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53802 | Page 1 of 11Video Article Encapsulating Cytochrome c in Silica Aerogel Nanoarchitectures without Metal Nanoparticles while Retaining Gas-phase Bioactivity Amanda S. Harper-Leatherman1, Elizabeth R. Pacer1, Nina D. Kosciuszek1 1Department of Chemistry & Biochemistry, Fairfield University Correspondence to: Amanda S. Harper-Leatherman at aharper@fairfield.edu URL: http://www.jove.com/video/53802 DOI: doi:10.3791/53802 Keywords: Bioengineering, Issue 109, Cytochrome c, sol-gels, aerogels, silica aerogels, Ultraviolet-Visible, nitric oxide Date Published: 3/1/2016 Citation: Harper-Leatherman, A.S., Pacer, E.R., Kosciuszek, N.D.",Non-OADS,/arxiv_data1/oa_pdf/28/5b/jove-109-53802.PMC4828205.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53802/ Introduction Cytochrome c (cyt.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/jove-109-53802.PMC4828205.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53861 | Page 1 of 7Video Article Fabrication and Operation of Acoustofluidic Devices Supporting Bulk Acoustic Standing Waves for Sheathless Focusing of Particles C. Wyatt Shields IV1,2, Daniela F. Cruz1,2, Korine A. Ohiri1,3, Benjamin B. Yellen1,2,3, Gabriel P. Lopez1,2,3 1NSF Research Triangle Materials Research Science and Engineering Center, Duke University 2Department of Biomedical Engineering, Duke University 3Department of Mechanical Engineering and Materials Science, Duke University Correspondence to: Gabriel P. Lopez at gabriel.lopez@duke.edu URL: http://www.jove.com/video/53861 DOI: doi:10.3791/53861 Keywords: Engineering, Issue 109, Microfluidics, acoustophoresis, acoustofluidics, microfabrication, cellular analysis, bulk acoustic standing waves, negative acoustic contrast particles, elastomeric particles Date Published: 3/6/2016 Citation: Shields, C.W., Cruz, D.F., Ohiri, K.A., Yellen, B.B., Lopez, G.P.",Non-OADS,/arxiv_data1/oa_pdf/fe/db/jove-109-53861.PMC4828217.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53861/ Introduction Acoustofluidic devices are used to exert directional forces on microscopic entities ( e.g., particles or cells) for their concentration, alignment, assembly, confinement or separation within quiescent fluids or laminar flowstreams.1 Within this broad class of devices, forces can be generated from bulk acoustic standing waves, surface acoustic standing waves (SSAWs)2 or acoustic travelling waves.3 While we focus on the fabrication and operation of devices supporting bulk acoustic standing waves, devices supporting SSAWs have received much attention recently due to their ability to precisely manipulate cells along surfaces4 and rapidly sort cells in continuous flow channels.5 Devices supporting bulk acoustic standing waves, however, rearrange particles based on the mechanical vibrations of the walls of the device generated by a piezoelectric transducer, which excites the standing waves in microfluidic cavities at geometrically defined resonant frequencies.",Non-OADS,/arxiv_data1/oa_pdf/fe/db/jove-109-53861.PMC4828217.pdf
"Correspondence to: Linda M. Brennan at linda.m.brennan2.civ@mail.mil URL: http://www.jove.com/video/53555 DOI: doi:10.3791/53555 Keywords: Environmental Sciences, Issue 109, Fish cells, impedance, sensors, biochip, water toxicity, ECIS, monolayer, field-portable Date Published: 3/7/2016 Citation: Brennan, L.M., Widder, M.W., McAleer, M.K., Mayo, M.W., Greis, A.P., van der Schalie, W.H.",Non-OADS,/arxiv_data1/oa_pdf/4d/ac/jove-109-53555.PMC4828219.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53555/ Introduction The overall goal was to develop a method for the cell seeding, storage and testing of fluidic biochips in the ECIS biosensor.",OADS,/arxiv_data1/oa_pdf/4d/ac/jove-109-53555.PMC4828219.pdf
https://www.atcc.org/ ATCCAdvancedCatalogSearch/ProductDetails/tabid/452/Default.aspx?,Non-OADS,/arxiv_data1/oa_pdf/4d/ac/jove-109-53555.PMC4828219.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53738 | Page 1 of 9Video Article RNAi Trigger Delivery into Anopheles gambiae  Pupae Kimberly Regna1, Rachel M. Harrison1, Shannon A. Heyse1, Thomas C. Chiles1, Kristin Michel2, Marc A. T. Muskavitch1,3 1Biology Department, Boston College 2Division of Biology, Kansas State University 3Discovery Research, Biogen Correspondence to: Marc A. T. Muskavitch at marc.muskavitch@biogen.com URL: http://www.jove.com/video/53738 DOI: doi:10.3791/53738 Keywords: Infection, Issue 109, Mosquito, pupa, malaria, gambiae, vector, injection, dsRNA, RNA interference, RNAi, reverse genetics, functional genomics Date Published: 3/8/2016 Citation: Regna, K., Harrison, R.M., Heyse, S.A., Chiles, T.C., Michel, K., Muskavitch, M.A.T.",Non-OADS,/arxiv_data1/oa_pdf/54/48/jove-109-53738.PMC4828232.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53738/ Introduction Malaria is a mosquito-borne infectious disease that affects many millions of individuals every year.,Non-OADS,/arxiv_data1/oa_pdf/54/48/jove-109-53738.PMC4828232.pdf
<http://www.who.int/topics/malaria/en> (2014).,Non-OADS,/arxiv_data1/oa_pdf/54/48/jove-109-53738.PMC4828232.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53735 | Page 1 of 13Video Article A Quantitative Glycomics and Proteomics Combined Purification Strategy Elizabeth S. Hecht*1, James P. McCord*1, David C. Muddiman1 1Department of Chemistry, North Carolina State University *These authors contributed equally Correspondence to: David C. Muddiman at dcmuddim@ncsu.edu URL: http://www.jove.com/video/53735 DOI: doi:10.3791/53735 Keywords: Chemistry, Issue 109, Glycomics, proteomics, glycosylation-site analysis, deamidation, hydrazide tagging, relative quantitation Date Published: 3/8/2016 Citation: Hecht, E.S., McCord, J.P., Muddiman, D.C. A Quantitative Glycomics and Proteomics Combined Purification Strategy.",Non-OADS,/arxiv_data1/oa_pdf/08/14/jove-109-53735.PMC4828233.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53735/ Introduction In the field of proteomics, filter aided sample preparation (FASP) has been widely adopted for its ability to minimize the amount of starting material, decrease sample preparation artifacts, and maximize sample throughput1.",Non-OADS,/arxiv_data1/oa_pdf/08/14/jove-109-53735.PMC4828233.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e52409 | Page 1 of 7Video Article Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats Sudeshna Fisch1, Ronglih Liao1, Li-Li Hsiao2, Tzongshi Lu2 1Cardiac Muscle Research Laboratory, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School 2Renal Division, Brigham and Women's Hospital, Harvard Medical School Correspondence to: Tzongshi Lu at tlu1@rics.bwh.harvard.edu URL: http://www.jove.com/video/52409 DOI: doi:10.3791/52409 Keywords: Medicine, Issue 109, Sonography, real-time imaging, non-invasive methodology, renal toxicity assessment, ethical use of animals in research, drug-induced nephrotoxicity, hemodynamics Date Published: 3/11/2016 Citation: Fisch, S., Liao, R., Hsiao, L.L., Lu, T. Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats.",Non-OADS,/arxiv_data1/oa_pdf/d0/82/jove-109-52409.PMC4828235.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52409/ Introduction Serum creatinine (sCr) has been the gold standard metric to assess kidney function for more than two decades.,Non-OADS,/arxiv_data1/oa_pdf/d0/82/jove-109-52409.PMC4828235.pdf
e-mail: ardofuty@yahoo.co.uk ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/54/a2/jes-27-001.PMC4828245.pdf
e-mail: hajime@equinst.go.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/3d/2e/jes-27-007.PMC4828246.pdf
e-mail: ynambo@obihiro.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/b8/6a/jes-27-013.PMC4828247.pdf
e-mail: ikadai@vmas.kitasato-u.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/1a/87/jes-27-017.PMC4828248.pdf
e-mail: maryeneme@yahoo.com ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/2d/d6/jes-27-019.PMC4828249.pdf
"http://www.equithrive.com/wpcontent/themes/equithrive/documents/EquiThrive.pdf  (Accessed on March 5, 2013).",Non-OADS,/arxiv_data1/oa_pdf/2d/d6/jes-27-019.PMC4828249.pdf
"http://www.easyequetrian.com (Accessed on September  12, 2003).",Non-OADS,/arxiv_data1/oa_pdf/2d/d6/jes-27-019.PMC4828249.pdf
http://www.johnpratt.,Non-OADS,/arxiv_data1/oa_pdf/2d/d6/jes-27-019.PMC4828249.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.147 REVIEW ARTICLE Management of Hidradenitis Suppurativa in Patients  with Metabolic Comorbidities Ziying Vanessa Lim, Hazel H. Oon National Skin Centre, Singapore, Singapore  Hidradenitis suppurativa is a chronic inflammatory skin con- dition associated with an increased prevalence of individual  metabolic conditions such as insulin resistance, obesity, hy- perlipidemia, hypertension, and with the metabolic syn- drome, as a constellation of thes e risk factors.",Non-OADS,/arxiv_data1/oa_pdf/40/32/ad-28-147.PMC4828375.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.152 ORIGINAL ARTICLE Clinical and Histopathological Investigation of  Seborrheic Keratosis Nam Kyung Roh, Hyung Jin Hahn1, Yang Won Lee, Yong Be om Choe, Kyu Joong Ahn Department of Dermatology, Konkuk University School of Medicine, Seoul, 1Department of Dermatology, Uijeongbu St. Mary’s Hospital,  College of Medicine, The Catholic University of Korea, Uijeongbu, Korea Background:  Seborrheic keratosis (SK) is one of the most  common epidermal tumors of the skin.",Non-OADS,/arxiv_data1/oa_pdf/b4/25/ad-28-152.PMC4828376.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.159 ORIGINAL ARTICLE Clinical Efficacy and Safety of Naltrexone Combination  Therapy in Older Patients with Severe Pruritus Jungsoo Lee, Jung U Shin, Seongmin Noh, Chang Ook Park, Kwang Hoon Lee Department of Dermatology and Cutaneous Biology Research Inst itute, Yonsei University Coll ege of Medicine, Seoul, Korea Background:  Severe pruritus is a ch allenging condition, and  it is more difficult to deal with in older patients due to their  limitations in taking oral me dication because of underlying  diseases, possible interaction with concurrent medications, and poor general condition.",Non-OADS,/arxiv_data1/oa_pdf/cb/90/ad-28-159.PMC4828377.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.164 ORIGINAL ARTICLE Smoking and Hand Dermatitis in the United States  Adult Population Yi Chun Lai1, Yik Weng Yew1,2 1Harvard T.H.",Non-OADS,/arxiv_data1/oa_pdf/a4/47/ad-28-164.PMC4828378.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.172 ORIGINAL ARTICLE Clinical Features of Cutaneous Premalignant Lesions in  Busan City and the Eastern Gyeongnam Province, Korea: A Retrospective Review of 1,292 Cases over 19 Years (1995∼2013) Seung-Hwan Choi, Ki-Ho Kim, Ki-Hoon Song Department of Dermatology, Dong-A University College of Medicine, Busan, Korea Background:  The global prevalence of  premalignant lesions  has been continuously increasing  in recent years, but there  has been little research regarding the distribution and in- cidence of cutaneous premal ignant lesions in Korean  populations.",Non-OADS,/arxiv_data1/oa_pdf/8c/4c/ad-28-172.PMC4828379.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.179 ORIGINAL ARTICLE Potential Role of S100A8 in Cutaneous Squamous Cell  Carcinoma Differentiation  Jung-Min Shin*, In-Kyu Chang*, Young-Ho Lee1, Min-Kyung Yeo2, Jin-Man Kim2, Kyung-Cheol Sohn,  Myung Im, Young-Joon Seo, Chang-Deok  Kim, Jeung-Hoon Lee, Young Lee Department of Dermatology and Research Inst itute for Medical Sciences, Departments of 1Anatomy and 2Pathology, Chungnam National  University School of Medicine, Daejeon, Korea Background:  S100A8 is differentially expressed in various  cell types and is associated with a number of malignant  disorders.",Non-OADS,/arxiv_data1/oa_pdf/96/11/ad-28-179.PMC4828380.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.186 ORIGINAL ARTICLE Efficacy of Red or Infrared Light-Emitting Diodes in a  Mouse Model of Propionibacterium acnes -Induced  Inflammation Weon Ju Lee, Kyou Chae Lee, Min Ji Kim, Yong Hyun Jang, Seok-Jong Lee, Do Won Kim  Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea Background:  Laser/light-based devices may provide an alter- native to conventional acne th erapeutics in some patients  with nonresponsive acne.",Non-OADS,/arxiv_data1/oa_pdf/c2/97/ad-28-186.PMC4828381.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.192 ORIGINAL ARTICLE Immunomodulatory Effects of Deokgu Thermomineral  Water Balneotherapy on Oxazolone-Induced Atopic Dermatitis Murine Model Young Bok Lee, Su Jin Kim, Sae Mi Park, Kyung Ho Lee, Hyung Jin Han, Dong Soo Yu, So Youn Woo1,  Seong Taek Yun2, Se-Yeong Hamm3, Hong Jig Kim4, Jin-Wou Kim Department of Dermatology, College of Medicine, The Catholic University of Korea, 1Department of Microbiology, Ewha Woman’s  University School of Medicine, 2Department of Earth and Environmenta l Sciences, Korea University, Seoul, 3Division of Earth  Environmental System, Pusan National University, Pusan, 4Oh&Kim’s Aesthetic Clinic, Seoul, Korea Background:  Although the therapeutic mechanism of bal- neotherapy for atopic dermatitis has not been clarified, many  atopic patients who visit thermomineral springs have shown  clinical improvements.",Non-OADS,/arxiv_data1/oa_pdf/03/61/ad-28-192.PMC4828382.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.199 ORIGINAL ARTICLE Effect of Levothyroxine Treatment on Clinical Symptoms  in Hypothyroid Patients with Chronic Urticaria and Thyroid Autoimmunity Do Hun Kim, Nam Hee Sung, Ai Young Lee Department of Dermatology, Donnguk University Ilsan Hospital, Goyang, Korea Background:  Thyroid autoimmunity has been increasingly  reported to be associated with  chronic urticaria (CU), and the  possible clinical benefit of th yroid hormone or anti-thyroid  drugs in some CU patients w ith autoimmune thyroid disease  has been studied.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/ad-28-199.PMC4828383.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.205 ORIGINAL ARTICLE The Relation of Androgenetic Alopecia Severity with  Epicardial Fat Thickness Emine Colgecen, Huseyin Ede1, Mustafa Fatih Erkoc2, Yurdanur Akyuz2, Ali Riza Erbay1 Departments of Dermatology, 1Cardiology, and 2Radiology, Medical Faculty, Bozok University, Yozgat, Turkey Background:  Androgenetic alopecia (AGA) is the most com- monly encountered baldness pattern in men.",Non-OADS,/arxiv_data1/oa_pdf/db/ac/ad-28-205.PMC4828384.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.210 ORIGINAL ARTICLE The Importance of Collagen Tissue in Papular  Elastorrhexis, Eruptive Collagenoma, and Nevus Anelasticus Seung Ho Lee, Nam Hee Sung Department of Dermatology, Dongguk University Ilsan Hospit al, Dongguk University College of Medicine, Goyang, Korea Background:  Papular elastorrhexis (PE), eruptive collageno- ma (EC), and nevus anelasticus (NA) are described as multi- ple small papules with decrease, fragmentation, or lack of  dermal elastic fibers.",Non-OADS,/arxiv_data1/oa_pdf/f3/c1/ad-28-210.PMC4828385.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.216 ORIGINAL ARTICLE Relation between pH in the Trunk and Face: Truncal pH  Can Be Easily Predicted from Facial pH Sung Ae Kim, Bo Ri Kim, Mi Young Chun, Sang Woong Youn  Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  Korea Background:  The clinical symptoms of facial and truncal  acne differ.",Non-OADS,/arxiv_data1/oa_pdf/0a/87/ad-28-216.PMC4828386.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.222 ORIGINAL ARTICLE The MARCOPOLO Study of Ustekinumab Utilization  and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries  Sang Woong Youn, Tsen-Fang Tsai1, Colin Theng2, Siew-Eng Choon3, Benny E. Wiryadi4,  Antonio Pires5, Weihao Tan6, Min-Geol Lee7; on behalf of the MARCOPOLO Investigators Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Ko rea,  1Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan, 2National Skin Centre, Singapore, Singapore,  3Department of Dermatology, Hospital Su ltanah Aminah, Johor Bahru, Malaysia, 4Private Practice, Jakarta, Indonesia, 5Janssen Asia  Pacific, Medical Affairs, Melbourne, Australia, 6Janssen China, Biostatist ics, Beijing, China, 7Department of Dermatology and Cutaneous  Biology Research Institute, Severance Hospital, Yons ei University College of Medicine, Seoul, Korea Background:  Ustekinumab is a fully human monoclonal anti- body approved for the treatment of chronic moderate-to-severe  plaque psoriasis in adults.",Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ad-28-222.PMC4828387.pdf
Available at: http://www.stelarainfo.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ad-28-222.PMC4828387.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.232 CASE REPORT Melkersson-Rosenthal Syndrome with Genitalia  Involved in a 12-Year-Old Boy  Zhaowei Chu, Yanting Liu, Huan Zhang, Weihui Zeng, Songmei Geng Department of Dermatology, Second Affiliated Hosp ital of Xi'an Jiaotong University, Xi'an, China Melkersson –Rosenthal syndrome (MRS) is an uncommon  granulomatous disease characterized by the triad of relaps- ing facial paralysis, orofacial swelling, and fissured tongue.",Non-OADS,/arxiv_data1/oa_pdf/e2/52/ad-28-232.PMC4828388.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.237 CASE REPORT Onychomatricoma: A Rare T umor of Nail Matrix Hong Jin Joo, Mi Ri Kim, Baik Kee Cho, Gyeol Yoo1, Hyun Jeong Park Department of Dermatology, College of Medicine, The Catholic University of Korea, 1Department of Plastic and Reconstructive Surgery,  Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Onychomatricoma is a rare tumor of the nail matrix.",Non-OADS,/arxiv_data1/oa_pdf/66/5e/ad-28-237.PMC4828389.pdf
"2, 2016 http://dx.doi.org/10.5021/ad.2016.28.2.242 LETTER TO THE EDITOR Received February 26, 2015, Revised April 7, 2015, Accepted for publication April 8, 2015 Corresponding author:  Hyo Hyun Ahn, Department of Dermatology, Korea University Co llege of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea.",Non-OADS,/arxiv_data1/oa_pdf/34/18/ad-28-242.PMC4828390.pdf
"Clin Exp Dermatol 2005;30:409-413. http://dx.doi.org/10.5021/ad.2016.28.2.245 Periorbital Lipogranuloma after Autologous Fat Injection  for Forehead Augmentation Hyun Soo Lee, You Chan Kim Department of Dermatology, Ajou University School of Medicine, Suwon, Korea Dear Editor: Autologous fat injection (AFI) for facial augmentation has  become a popular cosmetic pr ocedure at local plastic sur- gery clinics.",Non-OADS,/arxiv_data1/oa_pdf/34/18/ad-28-242.PMC4828390.pdf
"Clin Exp Dermatol 2005;30:409-413. http://dx.doi.org/10.5021/ad.2016.28.2.245 Periorbital Lipogranuloma after Autologous Fat Injection  for Forehead Augmentation Hyun Soo Lee, You Chan Kim Department of Dermatology, Ajou University School of Medicine, Suwon, Korea Dear Editor: Autologous fat injection (AFI) for facial augmentation has  become a popular cosmetic pr ocedure at local plastic sur- gery clinics.",Non-OADS,/arxiv_data1/oa_pdf/29/d3/ad-28-245.PMC4828391.pdf
"Arch  Aesthetic Plast Surg 2014;20:85-91. http://dx.doi.org/10.5021/ad.2016.28.2.247 Cutaneous Metastasis of Giant Cell-Rich Osteosarcoma  Ji Yoon Choo, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Cutaneous metastasis from osteosarcoma is exceedingly  rare, with only 11 cases reported in the literature1.",Non-OADS,/arxiv_data1/oa_pdf/29/d3/ad-28-245.PMC4828391.pdf
"Arch  Aesthetic Plast Surg 2014;20:85-91. http://dx.doi.org/10.5021/ad.2016.28.2.247 Cutaneous Metastasis of Giant Cell-Rich Osteosarcoma  Ji Yoon Choo, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Cutaneous metastasis from osteosarcoma is exceedingly  rare, with only 11 cases reported in the literature1.",Non-OADS,/arxiv_data1/oa_pdf/53/c3/ad-28-247.PMC4828392.pdf
"(C)  Vitiliginous lesions on the left side  of the trunk.http://dx.doi.org/10.5021/ad.2016.28.2.249 A Case of Segmental Vitiligo with Generalized Morphea  Stabilized by Antimalarial Medication Hee Jung Kim, Dongyun Shin1, Sang Ho Oh1 Yonsei University Co llege of Medicine, 1Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei  University College of Medicine, Seoul, Korea Dear Editor: A 10-year-old girl presented with a round, brown to whit- ish, atrophic plaque on the ri ght side of her back, which  she has had for 5 years.",Non-OADS,/arxiv_data1/oa_pdf/39/bf/ad-28-249.PMC4828393.pdf
"(C) Mi croscopic morphology obtained from 25oC culture showing septate hyphae and hyaline or  slightly pigmented conidia that grouped in rose ttes at the tips of the conidiophores (×400).http://dx.doi.org/10.5021/ad.2016.28.2.251 A Case of Sporotrichosis Caused by Sporothrix globosa in  Japan Mana Watanabe, Koremasa Hayama, Hideki Fujita, Michiko Yagoshi1, Kyoko Yarita2,  Katsuhiko Kamei2, Tadashi Terui Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, 1Department of Clinical Pathology, Nihon  University School of Medicine, Tokyo, 2Division of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan Dear Editor: Sporotrichosis is the most common subcutaneous mycosis.",Non-OADS,/arxiv_data1/oa_pdf/2e/d2/ad-28-251.PMC4828394.pdf
"http://dx.doi.org/10.5021/ad.2016.28.2.253 Segmental Neurofibromatosis with Visceral Neurofibromas Hee Won Jang, Hwa Jung Ryu, Il-Hwan Kim, Sang Wook Son Department of Dermatology, Korea University College of Medicine, Seoul, Korea Dear Editor: Segmental neurofibromatosi s 1 (NF1) is generally ac- cepted to be the result of somatic mosaicism for a NF1  mutation that occurs early in  embryogenesis.",Non-OADS,/arxiv_data1/oa_pdf/61/6d/ad-28-253.PMC4828395.pdf
"A single 2-cm sized flesh-toned subcutaneous round  nodule on the right cheek.http://dx.doi.org/10.5021/ad.2016.28.2.255 A Case of Acinic Cell Carcinoma Involving Skin Kwang Hee Won, Mi Hye Lee, Woo Jin Lee, Mi Woo Lee Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Dear Editor: A 62-year-old man presented with a 5-month history of soli- tary subcutaneous nodule on the right cheek that.",Non-OADS,/arxiv_data1/oa_pdf/3e/5f/ad-28-255.PMC4828396.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.2.257 Erythema Annulare Centrifugum: Analysis of Associated  Diseases and Clinical Outcomes according to Histopathologic Classification Dae Hong Kim, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Erythema annulare centrifugum (EAC), a chronic in- flammatory skin disease with an unknown etiology, is considered a hypersensitivity reaction caused by cuta- neous or systemic infection, malignant neoplasms, drugs,  and various autoimmune dise ases, among other factors 1,2.",Non-OADS,/arxiv_data1/oa_pdf/ba/55/ad-28-257.PMC4828397.pdf
"(B and C) Subsequently, two small yellow lesions d eveloped on the patient’s back and thigh, with similar appearan ces  to the scalp lesion.http://dx.doi.org/10.5021/ad.2016.28.2.260 Coexistence of Classic and a Mononuclear Variant of  Juvenile Xanthogranuloma in an Adult Patient Hae-Eul Lee, Sue-Jeong Kim, Myung Im, Young Lee, Chang-Deok Kim, Jeung-Hoon Lee, Young-Joon Seo Department of Dermatology, Chungnam National University School of Medicine, Daejeon, Korea Dear Editor: Juvenile xanthogranuloma (JXG) is histologically charac- terized by dense mononuclear cells with foamy histiocytes  and Touton giant cells in a background of lymphocytes  and eosinophils1-3.",Non-OADS,/arxiv_data1/oa_pdf/31/b6/ad-28-260.PMC4828398.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.2.262 A Case of Adult Generalized Cutaneous Langerhans Cell  Histiocytosis  Wei-Guo Sun, Lian-Sheng Zhong1, Hao Chen2 Department of Dermatology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, 1Department of Dermatology, Affiliated  Hospital of Xuzhou Medical College, Xuzhou, 2Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences,  Peking Union Medical College, Nanjing, China  Dear Editor: Langerhans cell histiocytosis (LCH) is a rare disease and  generally affects infants and children.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/ad-28-262.PMC4828399.pdf
"http://dx.doi.org/10.5021/ad.2016.28.2.264 Mucocutaneous Telangiectasia as a Diagnostic Clue of  Hereditary Hemorrhagic T elangiectasia: An Activin Receptor-Like Kinase-1 Mutation in a Korean Patient  Jimyung Seo, Howard Chu, Jin Sung Lee1, Do Young Kim Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Clinical Genetics, Yonsei  University College of Medicine, Seoul, Korea Dear Editor: Hereditary hemorrhagic telang iectasia (HHT), also known  as Osler-Weber-Rendu syndro me, is an autosomal domi- nant vascular disorder manife sted by variable-sized arte- riovenous malformations (AVMs) of the skin, central nerv- ous system, and respiratory, gastrointestinal, and urogen- ital tracts1,2.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/ad-28-262.PMC4828399.pdf
"http://dx.doi.org/10.5021/ad.2016.28.2.264 Mucocutaneous Telangiectasia as a Diagnostic Clue of  Hereditary Hemorrhagic T elangiectasia: An Activin Receptor-Like Kinase-1 Mutation in a Korean Patient  Jimyung Seo, Howard Chu, Jin Sung Lee1, Do Young Kim Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Clinical Genetics, Yonsei  University College of Medicine, Seoul, Korea Dear Editor: Hereditary hemorrhagic telang iectasia (HHT), also known  as Osler-Weber-Rendu syndro me, is an autosomal domi- nant vascular disorder manife sted by variable-sized arte- riovenous malformations (AVMs) of the skin, central nerv- ous system, and respiratory, gastrointestinal, and urogen- ital tracts1,2.",Non-OADS,/arxiv_data1/oa_pdf/d5/14/ad-28-264.PMC4828400.pdf
"J Cutan Laser Ther 2000;2:  191-193. http://dx.doi.org/10.5021/ad.2016.28.2.266 Lymphoplasmacytic Plaque in Children Jimyung Seo, Ji-Ye Kim1, Soo Hee Kim1, Sang Ho Oh Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Pathology, Severance Hospital,  Yonsei University College of Medicine, Seoul, Korea  Dear Editor: Fried et al.1 reported on a specific disease entity using the  term “Pretibial lymphoplasmacytic plaque in children”.",OADS,/arxiv_data1/oa_pdf/d5/14/ad-28-264.PMC4828400.pdf
"J Cutan Laser Ther 2000;2:  191-193. http://dx.doi.org/10.5021/ad.2016.28.2.266 Lymphoplasmacytic Plaque in Children Jimyung Seo, Ji-Ye Kim1, Soo Hee Kim1, Sang Ho Oh Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Pathology, Severance Hospital,  Yonsei University College of Medicine, Seoul, Korea  Dear Editor: Fried et al.1 reported on a specific disease entity using the  term “Pretibial lymphoplasmacytic plaque in children”.",OADS,/arxiv_data1/oa_pdf/34/29/ad-28-266.PMC4828401.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.2.269 Symptomless Pulmonary Cryptococcosis in a Psoriatic  Arthritis Patient during Infliximab Therapy Saori Yamada, Ikko Kajihara, Takamitsu Johno, Satoshi Fukushima, Masatoshi Jinnin,  Aiko Masunaga1, Hirotsugu Kohrogi1, Hironobu Ihn Departments of Dermatology and Plastic Surgery, 1Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan Dear Editor: Pulmonary cryptococcosis is a common opportunistic in- fection in immuno suppressed patients1.",Non-OADS,/arxiv_data1/oa_pdf/b4/ec/ad-28-269.PMC4828402.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.2.271 A Case of Cyclosporine-Induced Sebaceous Hyperplasia  in a Renal Transplant Patient Successfully Treated with Isotretinoin Hwa Young Jung, Miri Kim, Baik Kee Cho, Hyun Jeong Park Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Sebaceous hyperplasia (SH) is a benign proliferation of the  sebaceous glands that develops as a result of intrinsic ag-ing, photo-aging, exposure to ultraviolet radiation, and ge- netic predisposition.",Non-OADS,/arxiv_data1/oa_pdf/60/72/ad-28-271.PMC4828403.pdf
"(C) Improved skin lesion with fibrotic scar after treatment with  oral itraconazole 200 mg/day and topical sertaconazole applica tion  for 3 months.http://dx.doi.org/10.5021/ad.2016.28.2.273 A Case of Cutaneous Protothecosis in an  Immunocompetent Patient Ju Yun Woo, Eun Ah Suhng, Ji Yeon  Byun, Hae Young Choi, Sun Hee Sung1, You Won Choi Departments of Dermatology and 1Pathology, Ewha Womans University School of Medicine, Seoul, Korea Dear Editor: Protothecosis is a rare infection, caused by the genus  Prototheca , achlorophyllous algae which are saprophytes  in soil, and occasionally affect dogs and cats1.",Non-OADS,/arxiv_data1/oa_pdf/b1/82/ad-28-273.PMC4828404.pdf
"Erythematous papules and plaques with ar eas of brownish hyperpigmentation on (A), (B) right upper back and (C) left thigh.http://dx.doi.org/10.5021/ad.2016.28.2.275 Extranodal Natural Killer/T-Cell Lymphoma, Nasal T ype  Involving Skin Masquerading as Eczema Ji Seok Kim, Misoo Choi, Chan Hee Nam, Myung Hwa Kim Department of Dermatology, Dankook University Medical College, Cheonan, Korea Dear Editor: Extranodal natural killer (NK)/T-cell lymphoma, nasal type  (ENKTL) is an uncommon type of lymphoma that is en-demic to East Asia and pa rts of Central and South  America1.",Non-OADS,/arxiv_data1/oa_pdf/ff/89/ad-28-275.PMC4828405.pdf
"Interestingly, national and international bodies2)3) issued pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.1 REVIEW J Cardiovasc Ultrasound  2016;24(1):1-6 statements clarifying their views on the use of these hand-held  echo machines.",Non-OADS,/arxiv_data1/oa_pdf/89/38/jcu-24-1.PMC4828408.pdf
"•	Received: December 20, 2015  •	Revised: January 7, 2016  •	Accepted: February 1, 2016 •		Address for Correspondence: Julia Grapsa, Echocardiography Department, Hammersmith Hospital, Du Cane Rd, London W12 0HS, United Kingdom       Tel: +44-7478707021, Fax: +44-208-383-4392, E-mail: jgrapsa@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/38/jcu-24-1.PMC4828408.pdf
"In this issue of the Journal, Kim et al.5) nicely demonstrated  that global LA longitudinal strain by speckle tracking echo - cardiography can predict AF occurrence in 228 patients with pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.18 acute ischemic stroke independently of LA size.",Non-OADS,/arxiv_data1/oa_pdf/9a/ec/jcu-24-18.PMC4828409.pdf
"•	Received: February 18, 2016  •	Revised: February 23, 2016  •	Accepted: February 23, 2016 •		Address for Correspondence: Sung-Hee Shin, Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine, 27 Inhang-ro,   Jung-gu, Incheon 22332, Korea   Tel: +82-32-890-2200, Fax: +82-32-890-2447, E-mail: sshin@inha.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Would Left Atrial Strain Provide a Role   as a New Prognostigator for Atrial  Fibrillation?",Non-OADS,/arxiv_data1/oa_pdf/9a/ec/jcu-24-18.PMC4828409.pdf
http://dx.doi.org/10.1093/ ehjci/jev354.,Non-OADS,/arxiv_data1/oa_pdf/9a/ec/jcu-24-18.PMC4828409.pdf
"Incidental impairment of au - tonomic nervous system, which is reported in upto 40% of  acute ischemic stroke patients, may trigger a new onset AF.2-5)  Also, various cardiovascular diseases accompanied with stroke  could attribute to arrhythmogenic remodeling of left atrium pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.20 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(1):20-27 (LA), promoting AF.6)7) AF in acute ischemic stroke patients is associated with high - er in hospital mortality and poorer neurological outcomes.",Non-OADS,/arxiv_data1/oa_pdf/bc/f6/jcu-24-20.PMC4828410.pdf
"Also, no consensus has been made for  •	Received: November 12, 2015  •	Revised: January 25, 2016  •	Accepted: February 1, 2016 •		Address for Correspondence: Chi Young Shim, Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8453, Fax: +82-2-2227-7742, E-mail: cysprs@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Incremental Value of Left Atrial Global  Longitudinal Strain for Prediction   of Post Stroke Atrial Fibrillation   in Patients with Acute Ischemic Stroke Darae Kim, MD1, Chi Young Shim, MD, PhD1, In Jeong Cho, MD1, Young Dae Kim, MD, PhD2,   Hyo Suk Nam, MD, PhD2, Hyuk-Jae Chang, MD, PhD1, Geu-Ru Hong, MD, PhD1,   Jong-Won Ha, MD, PhD1, Ji Hoe Heo, MD, PhD2, and Namsik Chung, MD, PhD1 1Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea   2Department of Neurology, Yonsei University College of Medicine, Seoul, Korea Background:  Atrial fibrillation (AF) is a well-established risk factor for stroke.",Non-OADS,/arxiv_data1/oa_pdf/bc/f6/jcu-24-20.PMC4828410.pdf
http://dx.doi.org/10.1093/ehjci/jev185.,Non-OADS,/arxiv_data1/oa_pdf/bc/f6/jcu-24-20.PMC4828410.pdf
"Such  changes result in compensatory cardiac remodeling.3) In preg - nancy complicated by hypertension, abnormal pressure over - loading would lead to different cardiac remodeling compared pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.28 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(1):28-34 to that of normal pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/2f/bb/jcu-24-28.PMC4828411.pdf
"•	Received: July 3, 2015  •	Revised: October 1, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Mi-Seung Shin, Division of Cardiology, Department of Internal Medicine, Gachon University, Gil Medical Center, 783 Namdong-daero,  Namdong-gu, Incheon 21556, Korea   Tel: +82-32-460-3663, Fax: +82-32-469-1906, E-mail: msshin@gilhospital.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/bb/jcu-24-28.PMC4828411.pdf
Some researches showed the change of  echocardiography just after exercise.7)8) The aim of this study is pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.35 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(1):35-39 to show the change of regional RV function just after tread - mill exercise with strain analysis.,Non-OADS,/arxiv_data1/oa_pdf/be/48/jcu-24-35.PMC4828412.pdf
"•	Received: July 13, 2015  •	Revised: October 30, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Hye-Sun Seo, Division of Cardiology, Department of Internal Medicine, Soonchunhyang University Hospital, 170 Jomaru-ro,  Wonmi-gu, Bucheon 14584, Korea   Tel: +82-32-621-5138, Fax: +82-32-621-6461, E-mail: haesunfree@hotmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/48/jcu-24-35.PMC4828412.pdf
"In these points, TDI can be estimated that the myocardial pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.40 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(1):40-47 velocities would be altered according to the age and growth.3)  The important differences between children and adult TDI ve - locity imaging that preclude a direct extrapolation of the adult  experience to pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/ed/62/jcu-24-40.PMC4828413.pdf
"As described,  there is no well-established unified consensus about the rela - •	Received: July 27, 2015  •	Revised: September 7, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Lucy Youngmin Eun, Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, 211 Eonju-ro,  Gangnam-gu, Seoul 06273, Korea   Tel: +82-2-2019-3350, Fax: +82-2-3461-9473, E-mail: lucyeun@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Myocardial Tissue Doppler Velocity   in Child Growth Sun-Ha Choi, MD, Lucy Youngmin Eun, MD, PhD, Nam Kyun Kim, MD,   Jo Won Jung, MD, PhD, and Jae Young Choi, MD, PhD Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea Background: In adults, tissue Doppler imaging (TDI) is a recommended component of routine echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/ed/62/jcu-24-40.PMC4828413.pdf
"48Introduction Carotid intima-media thickness (CIMT), a surrogate marker  of subclinical atherosclerosis, has been consistently linked to  cardiovascular and cerebrovascular disease (CVD).1)2) CIMT  measurement by ultrasonography is simple and safe, uses no  radiation, and is an inexpensive test to indirectly examine the  presence of coronary atherosclerosis.3) Noninvasive high fre - quency ultrasonography gives valid estimates of the total arte -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.48 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(1):48-54 rial wall thickness and media thickness (MT) in carotid arter - ies.4) The typical B-mode image of the arterial wall is defined  as the “double line pattern,” which demonstrates that the in - ner line is generated by the intimal surface.5) Associations between cardiovascular risk factors and CIMT  have been established across a wide spectrum of ages, includ - ing children and adults.6-10) In a previous study, intima thick - ness (IT) increased exponentially with age.",Non-OADS,/arxiv_data1/oa_pdf/7a/39/jcu-24-48.PMC4828414.pdf
"•	Received: November 4, 2015  •	Revised: November 25, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Ho-Joong Youn, Division of Cardiology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea,  222 Banpo-daero, Seocho-gu, Seoul 06591, Korea   Tel: +82-2-2258-1301, Fax: +82-2-591-1506, Email: younhj@catholic.ac.kr  •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/39/jcu-24-48.PMC4828414.pdf
"Case We report a case of 46-year-old man with end-stage renal fail - ure on chronic hemodialysis, who presented to hospital with a  chief complaint of progressively exertional worsening dyspnea pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.55 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):55-59 of 3-months duration.",Non-OADS,/arxiv_data1/oa_pdf/e5/07/jcu-24-55.PMC4828415.pdf
"Ten days after,  •	Received: June 17, 2015  •	Revised: September 24, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Slama Iskander, Department of Cardiology, Clinical Echocardiography Laboratory, Intercommunity Hospital of Southern Alps,   1 Place Auguste Muret, Gap 05007, France   Tel: +33-77-112-7375, Fax: +33-49-240-6200, E-mail: slamaiskander@live.fr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pneumopericardium: A Rare Complication  of Pericardiocentesis Slama Iskander, MD, Hidoud Amar, MD, Boudes Audrey, MD, and Devemy Fabien, MD Department of Cardiology, Clinical Echocardiography Laboratory, Intercommunity Hospital of Southern Alps,   Gap, France Pneumopericardium is defined by the presence of air in the pericardial cavity.",Non-OADS,/arxiv_data1/oa_pdf/e5/07/jcu-24-55.PMC4828415.pdf
"Case A 66-year-old male with an extensive past medical history pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.60 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):60-63 including hypertension, hyperlipidemia, diabetes, metastatic  prostate cancer treated with prostatectomy along with radia - tion and chemotherapy, previous ischemic stroke, known severe  3-vessel coronary artery disease with coronary bypass grafting  surgery after myocardial infarction, preserved ejection fraction  of 50%, and chronic AF on anti-coagulation with warfarin.",Non-OADS,/arxiv_data1/oa_pdf/f5/50/jcu-24-60.PMC4828416.pdf
"•	Received: June 24, 2015  •	Revised: December 9, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Tarun Jain, Department of Internal Medicine, Henry Ford Hospital, 1350 W Bethune St, Apt 1609, Detroit, MI 48202, USA     Tel: +1-708-527-5753, Fax: +1-313-916-4513, E-mail: tarun93@hotmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Heart within a Heart Tarun Jain, MD1, Jainil Shah, MD1, Sunay Shah, MD2, and Shalini Modi, MD2 Departments of 1Internal Medicine, 2Cardiology, Henry Ford Hospital, Detroit, MI, USA Device based closure of the left atrial appendage (LAA) has emerged as a viable approach for stroke prevention in atrial fibrillation  (AF) patients with contraindications to chronic oral anticoagulation.",Non-OADS,/arxiv_data1/oa_pdf/f5/50/jcu-24-60.PMC4828416.pdf
"Although endomyocardial pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.64 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):64-67 biopsy was not performed, the diagnosis of CA was based on  confirmed plasma-cell dyscrasia with presence of amyloid in  bone marrow biopsy, and typical amyloid CMR (CMR carries  92% positive predictive value).3) Additionally, repeat echocar - diogram and CMR following chemotherapy showed restora - tion of left ventricular systolic function and reduction in sub - endocardial delayed enhancement.",Non-OADS,/arxiv_data1/oa_pdf/18/08/jcu-24-64.PMC4828417.pdf
"•	Received: July 10, 2015  •	Revised: January 4, 2016  •	Accepted: February 1, 2016 •		Address for Correspondence: Michael Chi Yuan Nam, Department of Cardiology, Sunshine Coast Hospital and Health Service, Hospital Road PO BOX 547,  Nambour, QLD 4560, Australia   Tel: +61-5370-3727, Fax: +61-5470-6084, E-mail: dr.michael.nam@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/08/jcu-24-64.PMC4828417.pdf
"Case A 24-year-old male, presented with history of sudden onset  shortness of breath of 20 days duration, which had worsened  from New York Heart Association (NYHA) class I to NYHA  class IV over a course of 3 days along with, orthopnea and ex -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.68 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):68-70 treme fatigue.",Non-OADS,/arxiv_data1/oa_pdf/70/72/jcu-24-68.PMC4828418.pdf
"•	Received: July 22, 2015  •	Revised: September 10, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Avinash Anantharaj, Post Graduate Department of Cardiology, JLN Medical College & Associated Group of Hospitals, Ajmer 305 001,  India   Tel: +91-772-805-0413, E-mail: avinboxer@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/72/jcu-24-68.PMC4828418.pdf
"CAC is gen - erally defined as a hyperattenuated lesion above a threshold of  130 Hounsfield units (HU) with an area ≥ 3 adjacent pixels on pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.7 REVIEW J Cardiovasc Ultrasound  2016;24(1):7-17 non-contrast enhanced cardiac CT.1) Though, there are several  values of CAC cut-points that are often used for the purpose of  stratification in categorizing the risk of CAD: 0 (very low), 1 –99  (mild), 100 –400 (moderate), > 400 (severe).",Non-OADS,/arxiv_data1/oa_pdf/83/67/jcu-24-7.PMC4828419.pdf
"•	Received: December 23, 2015  •	Revised: January 26, 2016  •	Accepted: February 1, 2016 •		Address for Correspondence: James K. Min, Department of Radiology and Medicine, Dalio Institute of Cardiovascular Imaging, NewYork-Presbyterian Hospital  and Weill Cornell Medical College, 413 E, 69th Street, Suite 108, New York, NY 10021, USA     Tel: +1-646-962-6192, Fax: +1-646-962-0129, E-mail: jkm2001@med.cornell.edu •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Multimodality Imaging in Coronary Artery  Disease: Focus on Computed Tomography Ji Hyun Lee, MD1*, Donghee Han, MD1*, Ibrahim Danad, MD1, Bríain ó Hartaigh, PhD1,   Fay Y. Lin, MD1,2, and James K. Min, MD1,2 1Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medical College,  New York, NY, USA   2Department of Radiology and Medicine, Weill Cornell Medical College, New York, NY, USA Coronary artery disease (CAD) is the leading cause of mortality worldwide, and various cardiovascular imaging modalities have  been introduced for the purpose of diagnosing and determining the severity of CAD.",Non-OADS,/arxiv_data1/oa_pdf/83/67/jcu-24-7.PMC4828419.pdf
"Here, we report a  rare case of multiple cardiac tumors that were diagnosed as pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.71 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):71-74 primary myxomas.",Non-OADS,/arxiv_data1/oa_pdf/ef/ff/jcu-24-71.PMC4828420.pdf
"•	Received: July 31, 2015  •	Revised: January 4, 2016  •	Accepted: February 1, 2016 •		Address for Correspondence: Shohei Kataoka , Department of Cardiology, Cardiovascular Center, Ogikubo Hospital, 3-1-24 Imagawa, Suginami-ku,             Tokyo 167-0035, Japan   Tel: +81 -3-3399-1101, Fax: +81 -3-3399-1107, E-mail: shoheikataoka0818@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/ff/jcu-24-71.PMC4828420.pdf
"A transthoracic echocardiogram  (TTE) and transesophageal echocardiogram revealed a huge pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.75 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):75-78 (8.1 × 1.44 cm), highly mobile, echolucent, snake-shaped left  atrial (LA) mass with moderate to severe eccentric mitral re - gurgitation (MR) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/aa/5c/jcu-24-75.PMC4828421.pdf
"She had complained about dark urine and decreased urine  •	Received: August 5, 2015  •	Revised: September 3, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Jung Hyun Choi, Department of Internal Medicine, Pusan National University School of Medicine, 179 Gudeok-ro, Seo-gu,   Busan 49241, Korea   Tel: +82-51-240-7514, Fax: +82-51-240-7796, E-mail: mariahyeon@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Case of Microangiopathic Hemolytic  Anemia after Myxoma Excision and Mitral  Valve Repair Presenting as Hemolytic  Uremic Syndrome Young Joo Park, MD1, Sang Pil Kim, MD2, Ho-Jin Shin, MD1, and Jung Hyun Choi, MD1 Departments of 1Internal Medicine, 2Thoracic Surgery, Pusan National University School of Medicine,   Busan, Korea Microangiopathic hemolytic anemia occurs in a diverse group of disorders, including thrombotic thrombocytopenic purpura, he - molytic uremic syndrome, and prosthetic cardiac valves.",Non-OADS,/arxiv_data1/oa_pdf/aa/5c/jcu-24-75.PMC4828421.pdf
No risk factors were pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.79 CASE REPORT J Cardiovasc Ultrasound  2016;24(1):79-83 evident.,Non-OADS,/arxiv_data1/oa_pdf/7a/c2/jcu-24-79.PMC4828422.pdf
"•	Received: August 10, 2015  •	Revised: November 21, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Ki-Chul Sung, Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University  School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea   Tel: +82-2-2001-2418, Fax: +82-2-2001-2418, E-mail: kcmd.sung@samsung.com  •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/c2/jcu-24-79.PMC4828422.pdf
"They commonly rupture into the right  ventricle or right atrium,1) rarely into the both right cardiac pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.84 chambers as was observed in case presented herein.",Non-OADS,/arxiv_data1/oa_pdf/06/8b/jcu-24-84.PMC4828423.pdf
"Color Doppler study showing the shunt between the IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2016;24(1):84-86 •	Received: July 13, 2015  •	Revised: September 8, 2015  •	Accepted: February 1, 2016 •		Address for Correspondence: Humberto Morais, Department of Cardiology, Principal Military Hospital/Superior Institute, Street Nicolau Gomes Spencer,   Luanda 12195, República de Angola   Tel: +244-923520937, Fax: +244-222325947, E-mail: hmorais1@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Rupture of Right Sinus of Valsalva  Aneurysm into Right Cardiac Chambers:  The Role of Different Imaging Modalities Humberto Morais, MD1, Miguel Sousa-Uva, MD, PhD2,3, Telmo Martins, MD1,   Valdano Manuel, MD2, and João Carlos Costa, MD4 1Department of Cardiology, Principal Military Hospital/Superior Institute, Luanda, República de Angola   2Cardio-Thoracic Center, Girassol Clínic, Luanda, República de Angola   3Red Cross Hospital, Lisboa, Portugal   4Imaging Department, Girassol Clínic, Luanda, República de Angola KEY WORDS:  Echocardiography · Real time three-dimensional echocardiography · Sinus of Valsalva aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/06/8b/jcu-24-84.PMC4828423.pdf
"Do such patients suffer  atypical episodes of TTS,3) which do not reach a severity level pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.1.87 requiring hospitalization?",Non-OADS,/arxiv_data1/oa_pdf/06/1c/jcu-24-87.PMC4828424.pdf
"•	Received: January 14, 2016  •	Revised: February 22, 2016  •	Accepted: February 23, 2016 •		Address for Correspondence: John E. Madias, Division of Cardiology, Elmhurst Hospital Center, 79-01 Broadway, Elmhurst, NY 11373, USA     Tel: +1-718-334-5005, Fax: +1-718-334-5990, E-mail: madiasj@nychhc.org •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Regarding Article, “Biventricular  Takotsubo Cardiomyopathy Associated  with Epilepsy” John E. Madias, MD Icahn School of Medicine at Mount Sinai, New York, NY, USA   Division of Cardiology, Elmhurst Hospital Center, Elmhurst, NY, USALETTER TO THE EDITOR J Cardiovasc Ultrasound  2016;24(1):87-87",Non-OADS,/arxiv_data1/oa_pdf/06/1c/jcu-24-87.PMC4828424.pdf
"Until discharge, we checked the serial ECGs  and the ECG of her 2 days of hospitalization started to develop  •	Received: February 18, 2016  •	Revised: February 22, 2016  •	Accepted: February 23, 2016 •		Address for Correspondence: Ji Yeon Hong, Division of Cardiology, KEPCO Medical Center, 308 Uicheon-ro, Dobong-gu, Seoul 01450, Korea     Tel: +82-2-901-3011, Fax: +82-2-901-3014, E-mail: gladyshong@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Response to Letter Regarding Article,  “Biventricular Takotsubo Cardiomyopathy  Associated with Epilepsy” Ji Yeon Hong, MD Division of Cardiology, KEPCO Medical Center, Seoul, Koreahttp://dx.doi.org/10.4250/jcu.2016.24.1.88 LETTER TO THE EDITOR J Cardiovasc Ultrasound  2016;24(1):88-89 Fig.",Non-OADS,/arxiv_data1/oa_pdf/fa/5b/jcu-24-88.PMC4828425.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/40273_2015_Article_375.PMC4828466.pdf
2015. https://www.rtihs.org/publications/ validation-chronic-spontaneousidiopathic-urticaria-csuciu-health- states-using-weekly .,Non-OADS,/arxiv_data1/oa_pdf/3e/52/40273_2015_Article_375.PMC4828466.pdf
2015. http://www.euroqol.org/faqs/eq-5d- 5l.html .,Non-OADS,/arxiv_data1/oa_pdf/3e/52/40273_2015_Article_375.PMC4828466.pdf
2014. https://www.rtihs.org/sites/default/ﬁles/ISPOR% 202014_CSU%20Health%20states%20Final%20version%20for% 20print_862_6th%20Nov.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3e/52/40273_2015_Article_375.PMC4828466.pdf
2015. https://www.nice.org.uk/guidance/ ta339/chapter/1-guidance .,Non-OADS,/arxiv_data1/oa_pdf/3e/52/40273_2015_Article_375.PMC4828466.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.518 K. Coyle et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
16 Mar 2015. https://www.cadth.ca/drugs-pulmonary-arterial-hypertension .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
http://www.statcan.gc.ca/pub/84-537-x/84-537-x2013005- eng.htm .,OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
http://formulary.drugplan.health.gov.sk.ca .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
http://hsimi.on.ca/hdportal/ .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
2014. http://www.health.gov.on.ca/english/providers/program/ ohip/sob/physserv/physserv_mn.html .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
2014. http://www.health.gov.on.,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
2014. http://www.bankofcanada.ca/rates/related/inﬂation-calculator/ .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
2014. http://www.health.gov.on.ca/en/pro/programs/drugs/pdf/frequently_ requested_drugs.pdf .A c c e s s e d6F e b2 0 1 5 .First-Line Oral Therapies for PAH 519,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
29 Jun 2015; 42.http://health.gov.on.ca/en/pro/programs/drugs/formulary42/edition_ 42.pdf .A c c e s s e d7A p r i l2 0 1 4 .,Non-OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
2014. http://www.auditor.on.ca/en/reports_2010_en.htm .,OADS,/arxiv_data1/oa_pdf/f1/35/40273_2015_Article_366.PMC4828471.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/28/eb/40273_2015_Article_370.PMC4828475.pdf
"Open Access  This article is distributed under the terms of the Creative Commons Attribu-tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c6/3d/134_2016_Article_4308.PMC4828492.pdf
Available at: http://www.uptodate.com/ contents/treatment-of-menopausal-symptoms-with-hormone-therapy.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Available at: http://www.uptodate.com/contents/meno- pausal-hormone-therapy-benefits-and-risks.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Available at: http://www.uptodate.com/contents/treatment-of-vaginal-atrophy.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Available at: http://www.uptodate.com/contents/overview- of-sexual-dysfunction-in-female-cancer-survivors.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Available at:  http://www.uptodate.com/contents/osteoporosis-after-solid-organ-or-stem-cell-transplantation.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Available at: http://www.uptodate.com/contents/liver-transplantation-in-adults-long-term-man- agement-of-transplant-recipients.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/MR-15-27176.PMC4828501.pdf
Dostępne na: http://endometriosis.eshre.eu/docs/ESHRE%20guideline%20on%20   endometriosis%202013_3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/86/MR-15-27183.PMC4828508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/f0/main.PMC4828517.pdf
"http://dx.doi.org/10.1016/j.jccw.2016.01.001Journal of the American College of Clinical Wound Specialists (2016) 6, 32–7",Non-OADS,/arxiv_data1/oa_pdf/83/f0/main.PMC4828517.pdf
"Health- point Biotherapeutics; September, 2012; http://www.health pointbio.com ; September, 2012.Table 4 Effect of comorbidities on microcirculatory response of periwound tissue to HCA exposure.",OADS,/arxiv_data1/oa_pdf/83/f0/main.PMC4828517.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 51 ㆍNumber 1 ㆍMarch 2016 http://dx.doi.org/10.5045/br.2016.51.1.1 Editorial Application of next generation sequencing in the diagnosis and  management of mast cell leukemia Juwon Kim, M.D., Ph.D. Department of Laboratory Medici ne, Yonsei University Wonju College of Medicine, Wonju, Korea Mast cell diseases are difficult to diagnose due to its  protean symptoms and presence  of coexisting conditions  [1].",Non-OADS,/arxiv_data1/oa_pdf/79/4e/br-51-1.PMC4828522.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE A scientific treatment approach for acute mast cell leukemia: using a  strategy based on next-generation sequencing data Jeonghwan Youk1#, Youngil Koh1,2#, Ji-Won Kim3, Dae-Yoon Kim2, Hyunkyung Park1, Woo June Jung2,  Kwang-Sung Ahn2, Hongseok Yun4, Inho Park4, Choong-Hyun Sun4, Seungmook Lee4, Sung-Soo Yoon1,2,5 1Department of Internal Medicine, Se oul National Univ ersity Hospital, 2Cancer Research Institute, Seoul National University College  of Medicine, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 4Bioinformatics Group,  Platform Development Center, CSP R&D, Samsung SDS, 5ClinicalResearch Institute, Seoul Nation al University Hosp ital, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.17Blood Res 2016;51:17-22.",Non-OADS,/arxiv_data1/oa_pdf/b9/12/br-51-17.PMC4828523.pdf
"To find upregulated intracellular signaling pathways, we used the Gene Set Enrichment An alysis (http://www.broadin- stitute.org/gsea/msigdb/annota te.jsp, Broad Institute, MA).",OADS,/arxiv_data1/oa_pdf/b9/12/br-51-17.PMC4828523.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE Plasma cell leukemia in North India: retrospective analysis of a distinct  clinicohematological entity from a tertiary care center and review of literature Karthik Bommannan1, Man Updesh Singh Sachdeva1, Pankaj Malhotra2, Narender Kumar1,  Prashant Sharma1, Shano Naseem1, Jasmina Ahluwalia1, Reena Das1, Neelam Varma1, Gaurav Prakash2,  Alka Khadwal2, Radhika Srinivasan3, Subhash Varma2 Departments of 1Hematology, 2Internal Medicine, and 3Cytopathology, Postgraduate Institute of Medical Education and Research,  Chandigarh, India p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.23Blood Res 2016;51:23-30.",Non-OADS,/arxiv_data1/oa_pdf/c3/9b/br-51-23.PMC4828524.pdf
"3 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 51 ㆍNumber 1 ㆍMarch 2016 http://dx.doi.org/10.5045/br.2016.51.1.3 Perspective Platelet-rich plasma: a healing  virtuoso Nikil Kumar Jain, M.D.S.1, Minkle Gulati, M.D.S.2 1Department of Oral and Maxillofacial Surgery, Kalinga  Institute of Dental Sciences, KIIT University, Bhubaneswar,  Odisha, 2Consultant Periodontist and Implantologist, India Received on November 5, 2015; Revise d on February 21, 2016; Accepted on  March 10, 2016 Platelet-rich plasma (PRP) is an autologous product that  concentrates a large number of  platelets in a small volume  of plasma [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/1f/25/br-51-3.PMC4828525.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE Humanizing NOD/SCID/IL-2R null (NSG) mice using busulfan and  retro-orbital injection of umbilical cord blood-derived CD34+ cells Young Kyung Kang1#, Yunmi Ko1#, Aery Choi1, Hyeong Jwa Choi2, Jin-Hee Seo3, Minyoung Lee2,3,  Jun Ah Lee1 1Department of Pediatrics, Ko rea Cancer Center Hospital, 2Division of Ra diation Effect, 3Laboratory Animal Facility, Korea Institute  of Radiological and Medical Scienc es, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.31Blood Res 2016;51:31-6.",Non-OADS,/arxiv_data1/oa_pdf/64/ae/br-51-31.PMC4828526.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE Long-term course of anti-factor VIII antibody in patients with  hemophilia A at a single center Ki Young Yoo, Sang Chun Joo, Yong Mook Choi Korea Hemophilia Foundation, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.37Blood Res 2016;51:37-43.",Non-OADS,/arxiv_data1/oa_pdf/76/50/br-51-37.PMC4828527.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE Survey of experts on therapeutic policies and proposals for the  optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia Sang Kyun Sohn, Joon Ho Moon, Yoo Ji n Lee, Sung Woo Park, Ji Yoon Kim Department of Hematology, Kyungpook National Universi ty Hospital, Daegu, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.44Blood Res 2016;51:44-9.",Non-OADS,/arxiv_data1/oa_pdf/0d/da/br-51-44.PMC4828528.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016ORIGINAL ARTICLE Influence of genetic polymorphisms in the folate pathway on toxicity  after high-dose methotrexate treatment in pediatric osteosarcoma Jeong A Park1, Hee Young Shin2 1Department of Pediatrics, Haeund ae Paik Hospital, Inje Universi ty College of Medicine, Busan, 2Department of Pediatrics, Cancer  Research Institute, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.50Blood Res 2016;51:50-7.",Non-OADS,/arxiv_data1/oa_pdf/30/38/br-51-50.PMC4828529.pdf
"14, 2015; Accepted on May 7, 2015 http://dx.doi.org/10.5045/br.2016.51.1.58 AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/bc/e4/br-51-58.PMC4828530.pdf
"6 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 51 ㆍNumber 1 ㆍMarch 2016 http://dx.doi.org/10.5045/br.2016.51.1.6 Waldenström macroglobulinemia presenting with neurological  symptoms after chemotherapy Muhammad Shariq Shaikh, Bushra Moiz Section of Haematology, De partment of Pathology and Microbiology, Aga Khan Univ ersity, Karachi, Pakistan Received on December 11, 2014; Revised on January 2, 2015; Accepted on January 29, 2015 Correspondence to Muhammad Shariq Shaikh, FCPS, Section of Haematology, Pathology and Microbiology, The Aga Khan University, Stadium Road,  Karachi 74800, Pakistan, E-mail: muhammad.shariq@aku.edu A 56-year-old man presented with generalized weakness, weig ht loss, rib pain, and an 8- cm palpable splenic mass.",Non-OADS,/arxiv_data1/oa_pdf/61/c3/br-51-6.PMC4828531.pdf
"20, 2015 http://dx.doi.org/10.5045/br.2016.51.1.61 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/06/8a/br-51-61.PMC4828532.pdf
"20, 2015 http://dx.doi.org/10.5045/br.2016.51.1.61 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/24/d4/br-51-63.PMC4828533.pdf
"23, 2015 http://dx.doi.org/10.5045/br.2016.51.1.63 AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/24/d4/br-51-63.PMC4828533.pdf
"21, 2015 http://dx.doi.org/10.5045/br.2016.51.1.66 AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/54/44/br-51-66.PMC4828534.pdf
"9, 2015 http://dx.doi.org/10.5045/br.2016.51.1.67 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/8a/0a/br-51-67.PMC4828535.pdf
"7 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 51 ㆍNumber 1 ㆍMarch 2016 http://dx.doi.org/10.5045/br.2016.51.1.7 Extranasal natural killer/T -cell lymphoma initially presenting as  myelofibrosis Woori Jang, Myungshin Kim Department of Laboratory Medicine, Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea,  Seoul, Korea Received on December 17, 2014; Revised on December 26, 2014; Accepted on January 20, 2015 Correspondence to Myungshin Kim, M.D., Ph.D., Department of Laboratory Medicine, Catholic Genetic Laboratory Center, College of Medicine, The  Catholic University of Korea, 222 Banpodaero, Secho- gu, Seoul 06591, Korea, E-mail: microkim@catholic.ac.kr A 45-year-old woman was admitted with fever, generalized weakness, and 2 kg weight loss in 1 month.",Non-OADS,/arxiv_data1/oa_pdf/59/57/br-51-7.PMC4828536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 51 ㆍNUMBER 1 March 2016REVIEW ARTICLE Recent advances in haploidentical hematopoietic stem cell  transplantation using ex vivo  T cell-depleted graft in children  and adolescents Ho Joon Im, Kyung-Nam Koh, Jong Jin Seo Department of Pediatrics, Univer sity of Ulsan College of Medicine, Asan Medi cal Center Children’s Hospital, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2016.51.1.8Blood Res 2016;51:8-16.",Non-OADS,/arxiv_data1/oa_pdf/92/96/br-51-8.PMC4828537.pdf
"Oh Young Bang Department of Neurology,   Samsung Medical Center,   Sungkyunkwan University   School of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):129-136   /   http://dx.doi.org/10.3988/jcn.2016.12.2.129 Received  September 2, 2015 Revised  November 15, 2015 Accepted  November 17, 2015 Correspondence Oh Y oung Bang, MD, PhD  Department of Neurology,   Samsung Medical Center,   Sungkyunkwan University,  School of Medicine,   81 Irwon-ro, Gangnam-gu,   Seoul 06351, Korea Tel    +82-2-3410-3599 Fax   +82-2-3410-0052 E-mail     ohyoung.bang@samsung.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/7f/74/jcn-12-129.PMC4828557.pdf
"METHODS This narrative overview was carried out using PubMed and Medline to identify articles pub -Michael McManus   David S Liebeskind Neurovascular Imaging  Research Core &  UCLA Stroke Center, University of California,  Los Angeles, CA, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):137-146   /   http://dx.doi.org/10.3988/jcn.2016.12.2.137 Received  December 1, 2014 Revised  August 14, 2015 Accepted  August 17, 2015 Correspondence David S Liebeskind, MD Neurovascular Imaging Research Core & UCLA Department of Neurology, Neuroscience Research Building, 635 Charles E Y oung Drive South,  Suite 225, Los Angeles,  CA 90095-7334, USA Tel    +1-310-963-5539 E-mail     davidliebeskind@yahoo.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/ab/bf/jcn-12-137.PMC4828558.pdf
"However, subsequent studies have revealed that it is  also related to diseases of other systems such as hematological disorders (iron-deficiency  anemia and idiopathic thrombocytopenic purpura),9 cardiovascular diseases (ischemic  heart disease), neurological diseases (stroke, PD, and Alzheimer’s disease), obesity, and der - matological diseases.10Gülşah C¸amcıa  Sıdıka Oğuzb a Arrhythmias Unit, Research and  Application Hospital, Kocaeli University,  Kocaeli, Turkey b Internal Medicine Nursing Department,  Nursing Department, Health Sciences  Faculty, Marmara University, Üsküdar,  Istanbul, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):147-150   /   http://dx.doi.org/10.3988/jcn.2016.12.2.147 Received  July 13, 2015 Revised  November 24, 2015 Accepted  November 25, 2015 Correspondence Gülşah Camcı, MSc Arrhythmias Unit,  Research and Application Hospital,  Kocaeli University,  Umuttepe Campus,  Kocaeli 41380, Turkey  Tel    +90-507 890 79 80 Fax   +90-262 303 10 33 E-mail     gulsah_camci@hotmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/41/19/jcn-12-147.PMC4828559.pdf
Avail - able from: https://clinicaltrials.gov/show/NCT02108704.,Non-OADS,/arxiv_data1/oa_pdf/41/19/jcn-12-147.PMC4828559.pdf
"In contrast, two children with Rasmussen’s syndrome showed impaired word recog - nition in the presence of noise after a hemidecorticectomy was performed.6 Speech rec - ognition scores under adverse listening conditions can decline in patients with epilepsy  after right anterior temporal resection.7 Senbongi et al.8 suggested that unilateral anterior  temporal lobectomy was not associated with detrimental effects, but did yield improvements Su-Hyun Hana,b  Eun Mi Leec  Eun Ju Choia  Han Uk Ryud  Joong Koo Kanga  Jong Woo Chunge aDepartments of Neurology and  e Otolaryngology,   Asan Medical Center,   College of Medicine,   University of Ulsan, Seoul, Korea b  Department of Neurology,   Chung-Ang University   College of Medicine, Seoul, Korea c Department of Neurology,   Ulsan University Hospital,   College of Medicine,   University of Ulsan, Ulsan, Korea d Department of Neurology,   Jeonbuk University Hospital,   College of Medicine,   Jeonbuk University, Jeonju, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):151-159   /   http://dx.doi.org/10.3988/jcn.2016.12.2.151 Received  May 6, 2015 Revised  August 27, 2015 Accepted  August 27, 2015 Correspondence Joong Koo Kang, MD, PhD Department of Neurology,  Asan Medical Center,   College of Medicine,   University of Ulsan, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel    +82-2-3010-3448 Fax   +82-2-474-4691 E-mail     jkkang@amc.seoul.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/7e/32/jcn-12-151.PMC4828560.pdf
"VPA is typically regarded as  being more effective than LTG,7 but patients often stop taking VPA due to adverse effects  such as nausea, vomiting, weight gain, hair loss, and amenorrhea.8 LTG is associated with Hye Ryun Kim   Gun-Ha Kim   So-Hee Eun   Baik-Lin Eun   Jung Hye Byeon Department of Pediatrics,   College of Medicine,   Korea University, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):160-165   /   http://dx.doi.org/10.3988/jcn.2016.12.2.160 Received  May 21, 2015 Revised  September 1, 2015 Accepted  September 2, 2015 Correspondence Jung Hye Byeon, MD, PhD Department of Pediatrics,  College of Medicine, Korea University,  73 Inchon-ro, Seongbuk-gu,  Seoul 02841, Korea Tel    +82-2-920-5090 Fax   +82-2-922-7476 E-mail     byeonagnes@naver.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/2b/7f/jcn-12-160.PMC4828561.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.12.2.160.,Non-OADS,/arxiv_data1/oa_pdf/2b/7f/jcn-12-160.PMC4828561.pdf
"CTS is the most frequent type of nerve entrapment and is most commonly diag - nosed via electrophysiological examinations.1,2 Routine nerve conduction studies (NCS),  including examination of median nerve sensory fibers, are very helpful for diagnosing  CTS,3,4 but other methods such as motor-unit number estimation (MUNE) are also used.5-10  MUNE is a unique electrophysiological technique that can provide a numeric estimate of  the number of axons innervating a muscle or group of muscles.11 The primary causes of  motor disability in patients with CTS are atrophy and weakness, which occur in hand Orhan Yilmaza*  Gulin Suntera*  Celal Salcinia,b  Pınar Kahraman Koytaka  Tulin Tanridaga  Onder Usa  Kayihan Uluca a Department of Neurology, Marmara  University Pendik Education and  Research Hospital, Istanbul, Turkey b Department of Neurology, Uskudar  University, NPIstanbul Neuropsychiatry  Hospital, Istanbul, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):166-171   /   http://dx.doi.org/10.3988/jcn.2016.12.2.166 Received  April 23, 2015 Revised  September 19, 2015 Accepted  September 21, 2015 Correspondence Kayihan Uluc, MD Department of Neurology,  Marmara University Pendik  Education and Research Hospital,  Muhsin Y azicioglu Street,  Fevzi Çakmak Quarter,  Üst Kaynarca – Pendik,  Istanbul 34899, Turkey  Tel    +90-216-657-0606/8035 Fax   +90-216-657-0695 E-mail     kayihanu@yahoo.com *These authors contributed equally   to this work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/b8/46/jcn-12-166.PMC4828562.pdf
"Exploring these is - sues may identify the most important clinical characteristics and underlying factors of fa -Li-Jun Zuoa, Shu-Yang Yub  Fang Wanga, Yang Hub  Ying-Shan Piaob, Yang Dua  Teng-Hong Liana   Rui-Dan Wanga, Qiu-Jin Yua  Ya-Jie Wangc, Xiao-Min Wangd  Piu Chane,f, Sheng-Di Cheng  Yongjun Wanga,h, Wei Zhangb,e,h,i aDepartments of Neurology and   b Geriatrics, cCore Laboratory for Clinical  Medical Research, Beijing Tiantan  Hospital, Capital Medical University,  Beijing, China  d Department of Physiology, Capital  Medical University, Beijing, China  e Center of Parkinson’s Disease, Beijing  Institute for Brain Disorders, Beijing,  China  f Department of Neurobiology, Beijing  Xuanwu Hospital, Capital Medical  University, Beijing, China  g Department of Neurology, Ruijin Hospital  Affiliated to Shanghai Jiaotong University  School of Medicine, Shanghai, China h China National Clinical Research Center  for Neurological Diseases, Beijing, China  i Beijing Key Laboratory on Parkinson’s  Disease, Beijing, China pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):172-180   /   http://dx.doi.org/10.3988/jcn.2016.12.2.172 Received  June 11, 2015 Revised  October 1, 2015 Accepted  October 2, 2015 Correspondence Wei Zhang, MD, PhD Department of Geriatrics,   Beijing Tiantan Hospital,   Capital Medical University,   Beijing 100050, China Tel    +86-13911996107 Fax   +86-10-67098429 E-mail     ttyyzw@163.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/69/f7/jcn-12-172.PMC4828563.pdf
"These symptoms worsen  progressively, and patients deteriorate neurologically and usually die in early childhood.1,2 Since the first report of LS,3 the increasing number of patients diagnosed with LS has broad - ened the clinical spectrum, including cases with late onset and slow progression.4,5 However,  there are few reports on the prognostic outcome according to clinical and/or neuroradiologi - cal features.6,7Jin Sook Leea*  Hunmin Kimb*  Byung Chan Limc  Hee Hwangb  Jieun Choid  Ki Joong Kimc  Yong Seung Hwangc  Jong-Hee Chaec a Department of Pediatrics,   Gachon University Gil Medical Center,  Incheon, Korea b Department of Pediatrics,   Seoul National University   Bundang Hospital, Seongnam, Korea c Department of Pediatrics,   Pediatric Clinical Neuroscience Center,  Seoul National University   Children’s Hospital,   Seoul National University   College of Medicine, Seoul, Korea d Department of Pediatrics,   SMG-SNU Boramae Hospital,   Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):181-187   /   http://dx.doi.org/10.3988/jcn.2016.12.2.181 Received  July 3, 2015 Revised  September 20, 2015 Accepted  September 24, 2015 Correspondence Jong-Hee Chae, MD, PhD Department of Pediatrics, Pediatric Clinical Neuroscience Center,  Seoul National University Children’s  Hospital, Seoul National University  College of Medicine, 101 Daehak-ro Jongno-gu,  Seoul 03080, Korea Tel    +82-2-2072-3622 Fax   +82-2-743-3455 E-mail     chaeped1@snu.ac.kr *These authors contributed equally to  this work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/c7/69/jcn-12-181.PMC4828564.pdf
"Sequence changes were  detected by comparisons with MITOMAP (http://www.mi - tomap.org/MITOMAP) and the Human Mitochondrial  Genome Database.10 Statistical analysis Statistical analyses were performed using SPSS (version 21,  SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/c7/69/jcn-12-181.PMC4828564.pdf
"Key Words zz neuromyelitis optica, neuromyelitis optica spectrum disorder,   magnetic resonance imaging, cerebral cortex.Cerebral Cortex Involvement in Neuromyelitis   Optica Spectrum Disorder INTRODUCTION Neuromyelitis optica (NMO) is an inflammatory disorder of the central nervous system  (CNS) that is distinct from multiple sclerosis (MS).1 The discovery of a specific antibody  against aquaporin-4 (AQP4) in the sera of NMO patients resulted in the concept of NMO  being changed.2 The broadened term “neuromyelitis optica spectrum disorder” (NMOSD)  includes anti-AQP4-antibody-positive patients with limited or inaugural forms of NMO,  and also the cerebral, diencephalic, and brainstem lesions, as well as anti-AQP4-antibody- positive patients with coexisting autoimmune disorders [e.g., systemic lupus erythematosus  (SLE) or Sjögren syndrome (SS)].1 The presence of brain lesions with characteristic locations and configurations is helpful  in the diagnosis of NMOSD.3 The 2015 diagnostic criteria for NMOSD classified typical  NMOSD brain lesion patterns as follows: 1) lesions involving the dorsal medulla, especially  the area postrema, either small and localized, often bilateral, or contiguous with an upper  cervical spinal cord lesion; 2) lesions involving the periependymal surfaces of the fourth Woojun Kima  Jee Eun Leea  Su-Hyun Kimb  So-Young Huhc  Jae-Won Hyunb  In Hye Jeongb  Min-Su Parkd  Joong Yang Choe  Sang-Hyun Leef  Kwang Soo Leea  Ho Jin Kimb a Department of Neurology,   The Catholic University of Korea   College of Medicine,   Seoul, Korea bDepartments of Neurology and   f   Radiolgoy, Research Institute and  Hospital of National Cancer Center,  Goyang, Korea c   Departments of Neurology and      Kosin University College of Medicine,  Busan, Korea d Department of Neurology,   Yeungnam University College of Medicine,  Daegu, Korea e Department of Neurology, Inje University  Ilsan Paik Hospital, Goyang, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):188-193   /   http://dx.doi.org/10.3988/jcn.2016.12.2.188 Received  September 15, 2015 Revised  September 20, 2015 Accepted  September 24, 2015 Correspondence Woojun Kim, MD, PhD Department of Neurology,   The Catholic University of Korea   College of Medicine,   222 Banpo-daero, Seocho-gu,   Seoul 06591, Korea Tel    +82-2-3779-2077 Fax   +82-2-782-8654 E-mail     wjkim@catholic.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/60/b6/jcn-12-188.PMC4828565.pdf
"Most pre - vious epidemiologic studies have investigated the possible determinants of EDS in rela -Young Hwangboa  Won-Joo Kimb  Min Kyung Chuc  Chang-Ho Yund  Kwang Ik Yange a Department of Preventive Medicine,  Soonchunhyang University   College of Medicine, Cheonan, Korea b Department of Neurology,   Gangnam Severance Hospital,   Yonsei University College of Medicine,  Seoul, Korea c Department of Neurology,   Hallym University College of Medicine,  Anyang, Korea d Clinical Neuroscience Center,   Department of Neurology,   Seoul National University   Bundang Hospital, Seongnam, Korea e Sleep Disorders Center,   Department of Neurology,   Soonchunhyang University   College of Medicine, Cheonan Hospital,  Cheonan, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):194-200   /   http://dx.doi.org/10.3988/jcn.2016.12.2.194 Received  August 20, 2015 Revised  October 1, 2015 Accepted  October 1, 2015 Correspondence Kwang Ik Y ang, MD, PhD Sleep Disorders Center, Department of  Neurology, Soonchunhyang University  College of Medicine, Cheonan Hospital,  31 Soonchunhyang 6-gil, Dongnam-gu,  Cheonan 31151, Korea Tel    +82-41-570-2290 Fax   +82-41-592-3810 E-mail     neurofan@schmc.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/78/29/jcn-12-194.PMC4828566.pdf
"A greater intima- media thickness (IMT) has been consistently associated with AD, possibly as a marker of  cerebral microcirculatory involvement,3-5 while severe carotid stenosis may increase the Claudia Altamuraa  Federica Scrasciaa  Carlo Cosimo Quattrocchib  Yuri Erranteb  Emma Gangemib  Giuseppe Curcioc,d  Francesca Ursinia  Mauro Silvestrinie  Paola Maggioa  Bruno Beomonte Zobelb  Paolo Maria Rossinif  Patrizio Pasqualettig  Lorenzo Falsettih  Fabrizio Vernieria a Neurology Unit, Campus Bio-Medico   University, Rome, Italy b Radiology Unit, Campus Bio-Medico  University, Rome, Italy c Clinical Medicine Department, Public  Health, Life and Environment Scinces,  University of L’Aquila, Italy d IRCCS S. Raffaele, Rome - S.Raffaele  Clinic, Cassino (FR), Italy e Neurology Clinic, Università Politecnica  delle Marche, Ancona, Italy f Neurology Clinic, Università Cattolica del  Sacro Cuore, Rome, Italy g Associazione Fatebenefratelli per la   ricerca-AFAR, Rome, Italy h Internal and Subintensive Medicine,  Ospedali Riuniti Ancona, ItalypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):201-208   /   http://dx.doi.org/10.3988/jcn.2016.12.2.201 Received  January 6, 2015 Revised  May 10, 2015 Accepted  May 13, 2015 Correspondence Claudia Altamura, MD, PhD Unità di Neurologia, Università Campus  Bio-Medico di Roma, Via Alvaro del  Portillo, 200, Roma 00122, Italy Tel    +39-06-225411285 Fax   +39-06-225411955 E-mail     c.altamura@unicampus.itcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/fd/0d/jcn-12-201.PMC4828567.pdf
"By contrast, there were substantially more corticospinal white-matter changes in Jong Seok Baea,b*  Michele Fergusonb,c*  Rachel Tanb  Eneida Mioshid  Neil Simonb  James Burrellb  Steve Vucice  John R. Hodgesb,c  Matthew C Kiernanf  Michael Hornbergerg* a Department of Neurology,   Hallym University College of Medicine,   Seoul, Korea b Neuroscience Research Australia,  Sydney, Australia c School of Medical Sciences,   University of New South Wales,   Sydney, Australia d Department of Psychiatry, University   of Cambridge, Cambridge, UK e Department of Neurology, Westmead  Clinical School, University of Sydney,  Westmead, Australia f Brain and Mind Institute, University   of Sydney, Sydney, Australia g Norwich Medical School, University   of East Anglia, Norwich, UKpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):209-217   /   http://dx.doi.org/10.3988/jcn.2016.12.2.209 Received  June 25, 2015 Revised  November 2, 2015 Accepted  November 5, 2015 Correspondence Michael Hornberger Norwich Medical School, University   of East Anglia, Norwich, NR4 7QU, UK Tel    +44-1603-597139 Fax   +44-1603-593752 E-mail     m.hornberger@uea.ac.uk *  These authors contributed equally to  this work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/59/89/jcn-12-209.PMC4828568.pdf
"Some of them assessed the  BRS using a spontaneous method while others used a reflexive method, with no compari -Sankanika Roya  Ashok Kumar Jaryala   Achal Kumar Srivastavab  Kishore Kumar Deepaka a Departments of Physiology and   bNeurology, AIIMS, New Delhi, IndiapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):218-223   /   http://dx.doi.org/10.3988/jcn.2016.12.2.218 Received  August 6, 2015 Revised  November 2, 2015 Accepted  November 5, 2015 Correspondence Sankanika Roy, MBBS, MD Department of Physiology,  Sri Ramachandra Medical College  and Hospital, Porur, Chennai 600116, India Tel    +91-9717686403 Fax   +91-26588641 E-mail     shanksroy2903@gmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/91/74/jcn-12-218.PMC4828569.pdf
"The present study examined whether initial brain MRI and EEG findings have a prog - nostic value at 6 months after the onset in patients who were diagnosed with HSE by posi - tive results of HSV DNA when applying the polymerase chain reaction (PCR) test to cere - brospinal fluid (CSF), and who received appropriate antiviral therapy.Young-Soo Kima,b*  Keun-Hwa Jungc*  Soon-Tae Leec  Bong Su Kangd  Jung Sook Yeome  Jangsup Moonc  Jung-Won Shinc  Sang Kun Leec  Kon Chuc a Departments of Neurology and  e Pediatrics,Gyeongsang National  University Hospital,   Gyeongsang National University   School of Medicine, Jinju, Korea  b Department of Neurology,   Samsung Changwon Hospital,   Sungkyunkwan University   School of Medicine, Changwon, Korea c Department of Neurology,   Seoul National University Hospital,   Seoul, Korea d Department of Neurology,   Korea University Anam Hospital,   Korea University School of Medicine,  Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):224-229   /   http://dx.doi.org/10.3988/jcn.2016.12.2.224 Received  July 2, 2015 Revised  November 9, 2015 Accepted  November 10, 2015 Correspondence Kon Chu, MD, PhD Department of Neurology,   Seoul National University Hospital,   110 Daehak-ro, Jongro-gu,   Seoul 03080, Korea Tel    +82-2-2072-3192 Fax   +82-2-3672-4949 E-mail     stemcell.snu@gmail.com *These authors equally contributed to this  work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/5a/e9/jcn-12-224.PMC4828570.pdf
"However, some people experience a subjective sleep quality  that is worse than their objective sleep quality.2 Individuals who express an extreme overes - timation of sleep latency (SL) and an underestimation of total sleep time (TST) are classi - fied as having a paradoxical insomnia,3 and those who express the opposite are classified as  reverse sleep-state misperception.4,5 Of these two groups, the former is well delineated and  is accepted as a primary form of insomnia.6,7 Although many explanations exist for the lack  of full recognition of sleep, none are definitive.8,9 Insomnia is currently the only known fac - tor associated with sleep misperception.8 Obstructive sleep apnea (OSA) is a heterogeneous group of sleep-related breathing disor -Hyunwoo Nama  Jae-Sung Limb  Jun-Soon Kima  Keon-Joo Leea  Dae Lim Kooa  Chulhee Leec a Department of Neurology,   Seoul National University   Boramae Hospital, Seoul, Korea b Department of Neurology,   Hallym University Sacred Heart Hospital,    Anyang, Korea c Department of Otorhinolaryngology,  Seoul National University   Bundang Hospital, Seongnam, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):230-235   /   http://dx.doi.org/10.3988/jcn.2016.12.2.230 Received  July 13, 2015 Revised  December 20, 2015 Accepted  December 23, 2015 Correspondence Chulhee Lee, MD, PhD Department of Otorhinolaryngology,  Seoul National University   Bundang Hospital,   82 Gumi-ro 173beon-gil,   Bundang-gu,   Seongnam 13620, Korea Tel    +82-31-787-2102 Fax   +82-31-787-2109 E-mail     chulhee@snu.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/bf/b2/jcn-12-230.PMC4828571.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.2.230.,Non-OADS,/arxiv_data1/oa_pdf/bf/b2/jcn-12-230.PMC4828571.pdf
"The rates found in other studies have varied from 6.4% to 19.4%, with  mortality reaching 26 –29% in this group.6,7 The precipitating illness is usually severe, and  PRES may be only a marker of such severity, but novel reports unveil the malignant evolution  of this condition.7,8 Although many terms have been used to describe this event,7 malignant  PRES seems to best encompass the permanent neurological damage or even death that  sometimes accompanies this endothelial breakdown in the brain.William Alves Martins   Luiz Carlos Porcello Marrone Department of Neurology,   Hospital São Lucas,   Pontifícia Universidade Católica do Rio  Grande do Sul (PUCRS), Porto Alegre,  BrazilpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):236-237   /   http://dx.doi.org/10.3988/jcn.2016.12.2.236 Received  July 6, 2015 Revised  July 13, 2015 Accepted  July 16, 2015 Correspondence William Alves Martins, MD Department of Neurology,   Hospital São Lucas da PUCRS,   Avenida Ipiranga 6690, Sala 220, Porto  Alegre, RS 90610-000, Brazil  Tel    +5551 3320 2760 Fax   +5551 3320 2760 E-mail     walvesm.br@gmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/7d/bb/jcn-12-236.PMC4828572.pdf
"Hypertrophic pachymeningitis may be a manifestation of various conditions such as neu - rosyphilis, granulomatosis with polyangiitis, neurosarcoidosis, or dural carcinomatosis.3 Thus,  confirmation of histological features including lymphoplasmacytic infiltration, storiform fi - brosis, and obliterative phlebitis is required for a definitive diagnosis of IgG4-HP .1-3 Although  a pathological study was not performed, our patient met the criteria for a possible diagnosis Sung-Hee Kim   Ji-Soo Kim Department of Neurology,   Seoul National University   College of Medicine,   Seoul National University   Bundang Hospital, Seongnam, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):238-240   /   http://dx.doi.org/10.3988/jcn.2016.12.2.238  Received  August 27, 2015 Revised  August 29, 2015 Accepted  August 31, 2015 Correspondence Ji-Soo Kim, MD, PhD Department of Neurology,   College of Medicine,   Seoul National University,   Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea  Tel    +82-31-787-7461 Fax   +82-31-719-6818  E-mail     jisookim@snu.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/b8/13/jcn-12-238.PMC4828573.pdf
"There is increasing skepticism about the diagnostic utility of TEE in patients with crypto - genic cerebral ischemia, due to both the high intrarater variability for the method and the  low prevalence of identified cardiac conditions that are finally considered to be causally asso - ciated with the ischemic event.2 This controversy led to the currently proposed criteria for the  definition of embolic strokes of undetermined source (ESUS), which do not include TEE in  the mandatory diagnostic workup for an ESUS diagnosis.3 In the present case report, all of  the results obtained in the routine diagnostic stroke workup were normal, whereas TEE fi - nally not only uncovered the missing link between superficial venous thrombosis, migraine,4  and cerebral ischemia and the possible underlying pathophysiological mechanism, but also  had a crucial impact on secondary prophylaxis and prognosis.5 Because of the patient’s young  age, the absence of conventional vascular risk factors, the presence of a superficially located  lesion (risk of paradoxical embolism score=8/10), and the history of lower limb phlebo - thrombosis, the discovered PFO was considered to be stroke-related rather than incidental.6Aristeidis H. Katsanosa  Aidonio Fiolakia  Konstantinos Pappasb  Eleftheria Siaravaa  Georgios Tsivgoulisc  Sotirios Giannopoulosa aDepartments of Neurology and   b Cardiology, University Hospital   of Ioannina, School of Medicine,   University of Ioannina, Ioannina, Greece c Second Department of Neurology,  University of Athens, School of Medicine,  “Attikon” University Hospital, Athens,  GreecepISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):241-242   /   http://dx.doi.org/10.3988/jcn.2016.12.2.241 Received  August 17, 2015 Revised  September 8, 2015 Accepted  September 11, 2015 Correspondence Aristeidis H. Katsanos, MD Department of Neurology,   University of Ioannina   School of Medicine, University Campus,   Ioannina 45110, Greece  Tel    +30 265100514 Fax   +30 2651007011 E-mail     ar.katsanos@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/c4/97/jcn-12-241.PMC4828574.pdf
"In cases of ESUS, we should  continue the thorough search of the locations, from which em - bolic material arrise.8 Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.12.2.241.Conflicts of Interest The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/c4/97/jcn-12-241.PMC4828574.pdf
"The present findings indicate that due to the rare presentation of the posterior  subtype of AHS and the often-transient nature of the symptoms, functional neuroimaging  combined with stimulus-based neuropsychological tasks might provide more information Burak Yuluga  Lütfü Hanoglua  Tansel Cakırb  Burcu Polata  Ahmet Mithat Tavlıa  Nesrin Helvacı Yılmaza aDepartments of Neurology and   b Nuclear Medicine,   University of Istanbul-Medipol,   Istanbul, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):243-244   /   http://dx.doi.org/10.3988/jcn.2016.12.2.243 Received  August 25, 2015 Revised  September 9, 2015 Accepted  September 11, 2015 Correspondence Burak Yulug, MD Department of Neurology,   University of Istanbul-Medipol,    Tem Avrupayolu Goztepe Cikişi,   Istanbul 34214, Turkey  Tel    +90-531 992 89 49 Fax   +90-2124607777 E-mail     burakyulug@gmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/44/8b/jcn-12-243.PMC4828575.pdf
"Hassaneina  Yosra Abdelzaher Ibrahimb aDepartments of Pediatrics and   b Radio-diagnosis, Faculty of Medicine,   Ain Shams University, Cairo, EgyptpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):245-247   /   http://dx.doi.org/10.3988/jcn.2016.12.2.245  Received  September 14, 2015 Revised  October 11, 2015 Accepted  October 13, 2015 Correspondence Sahar M.A.",Non-OADS,/arxiv_data1/oa_pdf/e7/cc/jcn-12-245.PMC4828576.pdf
"Hassanein, MD Department of Pediatrics,   Faculty of Medicine,   Ain Shams University,   Abassia Square 11395,   Cairo 11381, Egypt  Tel    +20-1223183943 Fax   +20-224347006 E-mail     saharhassanein@med.asu.edu.egcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/e7/cc/jcn-12-245.PMC4828576.pdf
"Only 21.4% of patients reportedly show a single lesion, and  AIDS patients may have TE in abnormal locations.2,4 A definitive diagnosis requires a brain  biopsy, with this highly invasive procedure being absolutely justified in situations of atypical  clinicoradiological context for TE, and in cases of neurological deterioration despite the ad - ministration of antitoxoplasma therapy.5 In this regard, diffusion MRI sequences may be useful,  and cerebral abscess should be suspected in all cases of cystic or necrotic masses with hyper - intensity signals in diffusion sequences and a low apparent diffusion coefficient.6 The Toxo - plasma  loose tachyzoites and encapsulated bradyzoites around necrotic lesions usually ap -Moisés León Ruiz Department of Neurology,   Hospital Universitario Príncipe de Asturias,  Alcalá de Henares, Madrid, SpainpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):248-250   /   http://dx.doi.org/10.3988/jcn.2016.12.2.248 Received  September 14, 2015 Revised  October 27, 2015 Accepted  October 29, 2015 Correspondence Moisés León Ruiz, MD Department of Neurology,   Hospital Universitario Príncipe de  Asturias, Carretera Alcalá-Meco s/n,  ES-28805 Alcalá de Henares, Madrid,  Spain  Tel    +34 918 878100 Fax   +34 918 836863 E-mail     pistolpete271285@hotmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/0b/48/jcn-12-248.PMC4828577.pdf
"  Copyright © 2016 Korean Neurological Association   251Erratum to: Epilepsy and Other Neuropsychiatric   Manifestations in Children and Adolescents   with 22q11.2 Deletion Syndrome Eun-Hee Kima*, Mi-Sun Yumb*, Beom-Hee Leec, Hyo-Won Kimd, Hyun-Jeoung Leed,   Gu-Hwan Kimc, Yun-Jeong Leeb, Han-Wook Yooc, Tae-Sung Kob aDepartment of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul, Korea bDepartments of Pediatrics, cMedical Genetics, and dPsychiatry, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea J Clin Neurol 2016;12(1):85-92 / http://dx.doi.org/10.3988/jcn.2016.12.1.85   The publisher wishes to apologize for incorrectly displaying acknowledgement.",Non-OADS,/arxiv_data1/oa_pdf/d6/59/jcn-12-251.PMC4828578.pdf
"So corrected acknowledgement should be as follows; Acknowledgments This study was supported by a grant (2012-0624) from the Asan Institute for Life Sciences, Seoul, Korea.pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(2):251-251   /   http://dx.doi.org/10.3988/jcn.2016.12.2.251 cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ERRATUM",Non-OADS,/arxiv_data1/oa_pdf/d6/59/jcn-12-251.PMC4828578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Daniel Gredig daniel.gredig@fhnw.ch School of Social Work, University of Applied Sciences and Arts Northwestern Switzerland, Riggen- bachstrasse 16, CH-4600 Olten, Switzerland.AIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/68/ae/caic-28-044.PMC4828590.pdf
"S1, 44 –47 http://dx.doi.org/10.1080/09540121.2016.1146212",Non-OADS,/arxiv_data1/oa_pdf/68/ae/caic-28-044.PMC4828590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.This article makes reference to supplementary material available on the publisher ’s website at http://dx.doi.org/10.1080/09540121.2016.1146208.CONTACT Adeline Bernier abernier@coalitionplus.org Coalition Internationale Sida, Tour Essor, 14 rue Scandicci, Pantin, FranceAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/53/d6/caic-28-026.PMC4828591.pdf
"S1, 26 –31 http://dx.doi.org/10.1080/09540121.2016.1146208",Non-OADS,/arxiv_data1/oa_pdf/53/d6/caic-28-026.PMC4828591.pdf
"Retrieved from http://www.eric.ed.gov/ERICWebPortal/ detail?accno = EJ977577 Hosmer, D. W., & Lemeshow, S. ( 2000 ).Applied logistic regression (2nd ed).",OADS,/arxiv_data1/oa_pdf/53/d6/caic-28-026.PMC4828591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.CONTACT Catherine A. Hankins c.hankins@aighd.orgAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"S1, 3 –7 http://dx.doi.org/10.1080/09540121.2016.1146220",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
ORCID Catherine A. Hankins http://orcid.org/0000-0002- 1642-8592 References ANRS.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from http://www.anrs.fr/ VIH-SIDA/Sante-publique-Sciences-sociales/Actualites/UN-IMMENSE-PROGRES-DANS-LA-LUTTE-CONTRE-LE-SIDA Bärnighausen, T. ( 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.1097/ COH.0000000000000205 Beyond aid: Financing Development.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from http://www.economist.com/news/leaders/ 21657389-unheralded-meeting-africa-way-get-beyond-sterile-arguments-about-development-beyond#b07g20t20w15 Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., …Wyatt, R. ( 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"http://doi.org/10.1016/j.chom.2012.09.008 Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., …HPTN 052 study team.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.1056/ NEJMoa1105243 DREAMS: Working Together for an AIDS-free Future for Girls.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.pepfar.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Silver Spring: US Food and Drug Administration.Retrieved from http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm312210.htm Gates, B.",OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from https://twitter.com/billgates/status/ 623982190750269443 Gilead Sciences, Inc. ( 2015, December 23 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Presented at the British HIV Association Conference, Brighton, England.Retrieved from http://www.bhiva.org/documents/ Conferences/2015Brighton/Presentations/150422/AndrewHill.pdf INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., …Neaton, J. D. (2015 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.1056/ NEJMoa1506816 International Drug Policy Consortium.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://idpc.net/policy-advocacy/drug-policy-reform International Partnership for Microbicides.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from http://www.ipmglobal.org/the-ring-study Jewkes, R. K., Dunkle, K., Nduna, M., & Shai, N. ( 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"http://doi.org/10.1016/S0140-6736(10 )60548-X Kates, J., Wexler, A., & Lief, E. ( 2015 , July).",OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Clinical and Experimental Immunology ,182 (3), 289 –301.http://doi.org/10.1111/cei.12692 Lewin, S. R. ( 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Clinical Infectious Diseases ,59(suppl 1), 12 –15.http://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved 4 January 2016, from http://www.mtnstopshiv.org/news/ studies/mtn020/backgrounder Microbicides Trials Network.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.mtnstopshiv.org/news/ studies/mtn017/backgrounder Morbidity and Mortality Weekly Report.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.1016/S0140-6736(15 )60658-46 C. A. HANKINS,OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"http://doi.org/10.1056/NEJMoa0908492 Russian HIV-Aids epidemic worsening under Kremlin pol- icies, says expert.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from http://www.theguardian.com/world/2015/ may/15/russian-hiv-aids-epidemic-worsening-under-kremlin-policies-says-expert Saraﬁs, P., & Tsounis, A.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"http://doi.org/10.1016/S1473- 3099(14 )70017-9 S p r e e n ,W .",OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Journal of Acquired Immune De ﬁciency Syndromes (1999) ,67 (5), 487 –492.http://doi.org/10.1097/QAI.0000000000000365 The TEMPRANO ANRS 12136 Study Group.",Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
http://doi.org/10.1056/NEJMoa1507198 UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.unaids.org/sites/default/ ﬁles/media_asset/JC2686_WAD2014report_en.pdf UNAIDS.,OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.unaids.org/en/resources/ documents/2014/JC2681_2014-Global-Plan-progressUNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"Retrieved from http://www.unaids.org/sites/default/ ﬁles/media_asset/ MDG6Report_en.pdf Vassall, A.",OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.who.int/hiv/pub/guidelines/ arv2013/en/ World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://apps.who.int/iris/bitstream/ 10665/186275/1/9789241509565_eng.pdf World Health Organization.,OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://www.who.int/hiv/pub/guidelines/ strategic-information-guidelines/en/ World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
Retrieved from http://apps.who.int/ iris/bitstream/10665/179870/1/9789241508926_eng.pdf?ua=1&ua=1AIDS CARE 7,Non-OADS,/arxiv_data1/oa_pdf/ec/13/caic-28-003.PMC4828592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT T. R. Thurman tthurma@tulane.eduAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/65/58/caic-28-008.PMC4828594.pdf
"S1, 8 –15 http://dx.doi.org/10.1080/09540121.2016.1146213",Non-OADS,/arxiv_data1/oa_pdf/65/58/caic-28-008.PMC4828594.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.This article makes reference to supplementary material available on the publisher ’s website at http://dx.doi.org/10.1080/09540121.2016.1148112 CONTACT Geoffrey Fatti geoffrey.fatti@khethimpilo.org Kheth ’Impilo, Cape Town, South AfricaAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/caic-28-114.PMC4828595.pdf
"S1, 114 –118 http://dx.doi.org/10.1080/09540121.2016.1148112",Non-OADS,/arxiv_data1/oa_pdf/ac/98/caic-28-114.PMC4828595.pdf
"Retrieved from http://www.who.int/hiv/pub/ guidelines/arv2013/download/en/ Wrottesley, S. V., Lamper, C., & Pisa, P. T. ( 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/ac/98/caic-28-114.PMC4828595.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Catherine Adams catherine.adams6@nhs.net CNWL, Stephenson House, 75 Hampstead Road, London, NW1 2PL London, UKAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/d8/62/caic-28-056.PMC4828597.pdf
"S1, 56 –59 http://dx.doi.org/10.1080/09540121.2016.1146211",Non-OADS,/arxiv_data1/oa_pdf/d8/62/caic-28-056.PMC4828597.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Lucy Selman lucy.selman@kcl.ac.uk Department of Palliative Care, Policy and Rehabilitation, Faculty of Life Sciences and Medicine, Cicely Saunders Institute, King ’s College London, Bessemer Road, London SE5 9PJ, UKAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/fd/77/caic-28-060.PMC4828598.pdf
"S1, 60 –63 http://dx.doi.org/10.1080/09540121.2016.1146214",Non-OADS,/arxiv_data1/oa_pdf/fd/77/caic-28-060.PMC4828598.pdf
"Retrieved from http://www.ijmhs.com/content/9/1/ 21/abstract Creswell, J. W., Plano Clark, V. L., Gutma, M. L., & Hanson, W. E. ( 2002 ).",OADS,/arxiv_data1/oa_pdf/fd/77/caic-28-060.PMC4828598.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Marco Pereira marcopereira@fpce.uc.ptAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/31/43/caic-28-092.PMC4828599.pdf
"S1, 92 –98 http://dx.doi.org/10.1080/09540121.2016.1146209",Non-OADS,/arxiv_data1/oa_pdf/31/43/caic-28-092.PMC4828599.pdf
"ORCID Marco Pereira http://orcid.org/0000-0002-6086-2329 References Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J.",Non-OADS,/arxiv_data1/oa_pdf/31/43/caic-28-092.PMC4828599.pdf
Retrieved from:http://www.unaids.org/en/resources/documents/2014 WHOQOL-HIV Group.,OADS,/arxiv_data1/oa_pdf/31/43/caic-28-092.PMC4828599.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Verusia Chetty chettyve@ukzn.ac.zaAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/b8/d4/caic-28-132.PMC4828600.pdf
"S1, 132 –139 http://dx.doi.org/10.1080/09540121.2016.1146204",Non-OADS,/arxiv_data1/oa_pdf/b8/d4/caic-28-132.PMC4828600.pdf
"ORCID Verusia Chetty http://orcid.org/0000-0003-2934-8687 Jill Hanass-Hancock http://orcid.org/0000-0003-3662- 8548 References Banks, L. M., Zuurmond, M., Ferrand, R., & Kuper, H. ( 2015).",Non-OADS,/arxiv_data1/oa_pdf/b8/d4/caic-28-132.PMC4828600.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Michael Evangeli michael.evangeli@rhul.ac.ukAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/c7/23/caic-28-068.PMC4828603.pdf
"S1, 68 –75 http://dx.doi.org/10.1080/09540121.2016.1146210",Non-OADS,/arxiv_data1/oa_pdf/c7/23/caic-28-068.PMC4828603.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT S. Skeen skeen.sarah@gmail.comAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/aa/b5/caic-28-016.PMC4828604.pdf
"S1, 16 –25 http://dx.doi.org/10.1080/09540121.2016.1146219",Non-OADS,/arxiv_data1/oa_pdf/aa/b5/caic-28-016.PMC4828604.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT William J.",Non-OADS,/arxiv_data1/oa_pdf/32/1b/caic-28-111.PMC4828605.pdf
"S1, 111 –113 http://dx.doi.org/10.1080/09540121.2016.1146399",Non-OADS,/arxiv_data1/oa_pdf/32/1b/caic-28-111.PMC4828605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Chen Zhang chen.zhang.1@vanderbilt.eduAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/68/29/caic-28-124.PMC4828606.pdf
"S1, 124 –131 http://dx.doi.org/10.1080/09540121.2016.1146206",Non-OADS,/arxiv_data1/oa_pdf/68/29/caic-28-124.PMC4828606.pdf
"Retrieved from http://www.unaids.org/sites/default/ ﬁles/ media_asset/2013_HIV-Asia-Paci ﬁc_en_0.pdf Varni, S. E., Miller, C. T., McCuin, T., & Solomon, S. E. ( 2012).",OADS,/arxiv_data1/oa_pdf/68/29/caic-28-124.PMC4828606.pdf
"Retrieved from http://www.who.int/gho/hiv/en/ Wolitski, R. J., Pals, S. L., Kidder, D. P., Courtenay-Quirk, C., & Holtgrave, D. R. ( 2009 ).",Non-OADS,/arxiv_data1/oa_pdf/68/29/caic-28-124.PMC4828606.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Luis Sagaon-Teyssier luis.sagaon-teyssier@inserm.fr UMR912-SESSTIM, Faculté de Médecine Timone, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05 †The members of the ANRS IPERGAY study group are listed in the acknowledgments.AIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"S1, 48 –55 http://dx.doi.org/10.1080/09540121.2016.1146653",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1056/ NEJMoa1108524 Blashill, A. J., Ehlinger, P. P., Mayer, K. H., & Safren, S. A.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1093/cid/civ111 Carlo Hojilla, J., Koester, K. A., Cohen, S. E., Buchbinder, S., Ladzekpo, D., Matheson, T., & Liu, A. Y.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1007/ s10461-015-1055-5 Cassell, M. M., Halperin, D. T., Shelton, J. D., & Stanton, D. (2006 ).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1086/656810 Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., …HPTN 052 Study Team.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/ 10.1056/NEJMoa1105243 Corneli, A. L., Deese, J., Wang, M., Taylor, D., Ahmed, K., Agot, K., …FEM-PrEP Study Group.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1097/ QAI.0000000000000158 Eaton, L. A., & Kalichman, S. ( 2007).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
Retrieved from http://doi.org/10.1089/apc.,Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1016/S1473- 3099(14 )70847-3 Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., …iPrEx Study Team.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1056/NEJMoa1011205 Guest, G., Shattuck, D., Johnson, L., Akumatey, B., Clarke, E. E. K., Chen, P.-L., & MacQueen, K. M. ( 2008 ).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1371/journal.pmed.1001511 Hogben, M., & Liddon, N. ( 2008).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1097/QAI.0b013e31828f097a Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., …Grant, R. M. ( 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1371/ journal.pone.0081997 McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., …Gill, O. N. ( 2015 ).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1016/S0140-673 (15)00056-2 Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., …ANRS  IPERGAY Study Group.",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.180/0954011.2012.748871 Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., …Brooks, J. T. ( 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"Retrieved from http://doi.org/10.1016/j.socscimed.2013.03.020 Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., …Taylor, D. ( 2012).",OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
Retrieved from http://doi.org/10.1093/cid/civ778AIDS CARE 55,Non-OADS,/arxiv_data1/oa_pdf/d5/a3/caic-28-048.PMC4828609.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Caroline Kuo caroline_kuo@brown.eduAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/42/7c/caic-28-106.PMC4828610.pdf
"S1, 106 –110 http://dx.doi.org/10.1080/09540121.2016.1146396",Non-OADS,/arxiv_data1/oa_pdf/42/7c/caic-28-106.PMC4828610.pdf
"Retrieved from https://www.capetown.gov.za/en/ IDP/Documents/Statutory20compliance20plans%202012/AnnexI_City_Health_HIV_Aids_STI_and_TB_Plan_20122013.pdf Gile, K., & Handcock, M. ( 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/42/7c/caic-28-106.PMC4828610.pdf
( 2011).Latest key indictors .R e t r i e v e d from http://www.statssa.gov.za/keyindicators/keyindicators.,OADS,/arxiv_data1/oa_pdf/42/7c/caic-28-106.PMC4828610.pdf
Retrieved from Pretoria: http://www.unaids.org/en/dataanalysis/knowyou rresponse/countryprogressreports/2012countries/ce_ZA_Narrative_Report.pdf UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/42/7c/caic-28-106.PMC4828610.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Shan Qiao shanqiao@mailbox.sc.edu 915 Greene St, Discovery Building I, Room 529, Columbia, SC 29208, USAAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/20/a1/caic-28-037.PMC4828612.pdf
"S1, 37 –43 http://dx.doi.org/10.1080/09540121.2016.1146397",Non-OADS,/arxiv_data1/oa_pdf/20/a1/caic-28-037.PMC4828612.pdf
"Retrieved December 1, 2014, from http://news.gxnews.com.cn/staticpages/ 20141201/newgx547b9ee8 –11700226.shtml Hightow-Weidman, L. B., Phillips, G.2nd, Outlaw, A. Y., Wohl, A. R., Fields, S., Hildalgo, J., & LeGrand, S. ( 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/20/a1/caic-28-037.PMC4828612.pdf
"Retrieved September 20, 2015, from http://www.facesiv.com/studies/family_ scales.html Przybyla, S. M., Golin, C. E., Widman, L., Grodensky, C. A., Earp, J.",Non-OADS,/arxiv_data1/oa_pdf/20/a1/caic-28-037.PMC4828612.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Zohar Mor zohar.mor@rml.health.gov.il Ramla Department of Health, Ministry of Health, 3 Danny Mass St., Ramla 72100, Israel.AIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/37/28/caic-28-064.PMC4828613.pdf
"S1, 64 –67 http://dx.doi.org/10.1080/09540121.2016.1146400",Non-OADS,/arxiv_data1/oa_pdf/37/28/caic-28-064.PMC4828613.pdf
"Retrieved from http://www.cbs.gov.il/reader/shnaton/shnatone_new.htm?CYear=2012&Vol=63&CSubject=2 Hayes, J., Chakraborty, A. T., McManus, S., Bebbington, P., Brugha, T., Nicholson, S., & King, M. ( 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/37/28/caic-28-064.PMC4828613.pdf
Retrieved from http://apps.who.int/iris/bitstream/10665/ 112922/1/9789241507400_eng.pdf World Health Organization.,OADS,/arxiv_data1/oa_pdf/37/28/caic-28-064.PMC4828613.pdf
Retrieved from http://www.unaids.org/ en/media/unaids/contentassets/documents/epidemiology/ 2013/gr2013/UNAIDS_Global_Report_2013_en.pdf Appendix.,Non-OADS,/arxiv_data1/oa_pdf/37/28/caic-28-064.PMC4828613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Katie B. Biello katie_biello@brown.edu Brown University, Box GS-121-8, 121 South Main Street, Providence, RI 02912, USA.AIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/5b/21/caic-28-084.PMC4828614.pdf
"S1, 84 –91 http://dx.doi.org/10.1080/09540121.2016.1146205",Non-OADS,/arxiv_data1/oa_pdf/5b/21/caic-28-084.PMC4828614.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Lorraine Sherr lorrainesherr@gmail.comAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/09/00/caic-28-001.PMC4828616.pdf
"S1, 1 –2 http://dx.doi.org/10.1080/09540121.2016.1153597",Non-OADS,/arxiv_data1/oa_pdf/09/00/caic-28-001.PMC4828616.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Christiana Nöstlinger cnoestlinger@itg.beAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/68/a9/caic-28-119.PMC4828617.pdf
"S1, 119 –123 http://dx.doi.org/10.1080/09540121.2016.1146398",Non-OADS,/arxiv_data1/oa_pdf/68/a9/caic-28-119.PMC4828617.pdf
"Retrieved December 22, 2015, from http://www.nat.org.uk/media/Files/Publications/ NAT-African-Communities-Report-June-2014-FINAL.pdf Nöstlinger, C., Rojas Castro, D., Platteau, T., Dias, S., & Le Gall, J.",Non-OADS,/arxiv_data1/oa_pdf/68/a9/caic-28-119.PMC4828617.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT L. Fernàndez-López lﬂopez@iconcologia.net Centre for Epidemiological Studies on HIV/STI in Catalonia (CEEISCAT), Agència de Salut Pública de Catalunya (ASPC), Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, 08916 Badalona, SpainAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"S1, 32 –36 http://dx.doi.org/10.1080/09540121.2016.1146218",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"ORCID L. Fernàndez-López http://orcid.org/0000-0002-6353- 3942 J. Reyes-Urueña http://orcid.org/0000-0002-3122- 6518 References Birrell, P. J., Gill, O. N., Delpech, V. C., Brown, A. E., Desai, S., Chadborn, T. R., …De Angelis, D. ( 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
http://dx.doi.org/10.1016/S1473- 3099(12)70341 –9 European Centre for Disease Prevention and Control/WHO Regional Of ﬁce for Europe.,Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"HIV Medicine, 9(2), 6 –12.http://doi.org/10.1111/j.1468-1293.2008.00584.x Jakab, Z., & Marmot, M. ( 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"Heterogeneity of community-based voluntary, counselling and testing ser- vices for HIV in Europe: The HIV-COBATEST survey.International Journal of STD & AIDS .http://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"http://doi.org/10.1371/ journal.pmed.1001496 T h o r n t o n ,A .C .",Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
http://doi.org/10.1111/j.1468-1293.2012.00992.x UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/24/94/caic-28-032.PMC4828621.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Wei Wei weiw@mailbox.sc.edu Department of Health Promotion, Education, and Behavior, South Carolina SmartState Center for Healthcare Quality (CHQ), University of South Carolina Arnold School of Public Health, Columbia, SC 29208, USAAIDS CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/3e/1b/caic-28-099.PMC4828627.pdf
"S1, 99 –105 http://dx.doi.org/10.1080/09540121.2016.1146217",Non-OADS,/arxiv_data1/oa_pdf/3e/1b/caic-28-099.PMC4828627.pdf
Available at: http://ms-coalition.org/cms/images/stories/dmt_consensus_ ms_coalition_web_color2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/e3/NEURCLINPRACT2015011049.PMC4828681.pdf
Available at: https://www.aan.com/ uploadedFiles/Website_Library_A ssets/Documents/6.Public_Policy /1.Stay_Informed/2.Position_ Statements/DiseaseModTheraMS_PosStatement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/e3/NEURCLINPRACT2015011049.PMC4828681.pdf
Available at: http://www.popdata.bc.ca/data.,OADS,/arxiv_data1/oa_pdf/32/ae/NEURCLINPRACT2015012096.PMC4828682.pdf
Available at: http://www.popdata.bc.ca/data.,OADS,/arxiv_data1/oa_pdf/32/ae/NEURCLINPRACT2015012096.PMC4828682.pdf
It consists of three main modules:  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/93/nihms767653.PMC4828917.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.mimet.,OADS,/arxiv_data1/oa_pdf/09/93/nihms767653.PMC4828917.pdf
http://dx.doi.org/10.1128/JCM.,Non-OADS,/arxiv_data1/oa_pdf/09/93/nihms767653.PMC4828917.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4828918.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.12.003 2352-3042/Copyright ª2016, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4828918.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3,4 1e47",Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4828918.pdf
"Editor:Gary King †Christiane Hassenr ¨uck,http://orcid.org/0000-0003-1909-1726 ABSTRACT To understand how ocean acidification (OA) influences sediment microbial communities, naturally CO 2-rich sites are increasingly being used as OA analogues.",Non-OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"To characterize the environmental conditions in the sedi- ment along the pH gradient at Reef 1 the following parameters were measured: in situoxygen concentrations, temperature, redox potential and pH using microsensor profiles (temper- ature sensor: UST Umweltsensortechnik GmbH, Gschwenda, Germany; pH sensor: Microelectrodes Inc., Bedford, NH, USA; http://doi.pangaea.de/10.1594/PANGAEA.858091 ); total organic and inorganic carbon and total nitrogen content of the sedi- ment; grain size, porosity and permeability ( http://doi.pangaea.",OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
de/10.1594/PANGAEA.858091 ); and pore water geochem- istry analysed from 6 ml pore water ( http://doi.pangaea.de/ 10.1594/PANGAEA.858033 ).,OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
Data on bottom water carbonate chemistry and nutrient concentrations will further be referred to as ‘bottom water parameters’ and are avail- able in the Pangaea database ( http://doi.pangaea.de/10.1594/ PANGAEA.854018 ).,OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
Fragments between 100 base pairs (bp) and 1000 bp were binned into operational taxonomic units (OTUs) using custom R scripts available at http://www.mpi-bremen.de/en/Software 4.html.,OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
The final OTU tables are accessible at http://doi.pangaea.de/10.1594/PANGAEA.854018 .,Non-OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"The data are available at Pangaea ( http://doi.pangaea.de/10.1594/PANGAEA.858033 , http://doi.pangaea.de/10.1594/PANGAEA.858091 ).For oxygen, pH, temperature and redox potential microprofiles, the PCA was calculated with median values for each sedimentlayer.MissingvalueswerereplacedbythemeanoftherespectiveparameterforthecalculationofthePCA.Thearrowsshowtheloadingsofthe environmen- talparametersscaledto4timestheirvalueforbettervisualization.DIC,dissolvedinorganiccarbon;TA,totalalkalinity;TIC,totalinorganicc arbon;TN,totalnitrogen; TOC, total organic carbon.",OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"2015. http://CRAN.R-project.org/package =FactoMineR (16 March 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"2014. http://CRAN.R-project.org/package =compositions (27 March 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/67/d9/fiw027.PMC4828923.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      An assessment of the occupational and environmental health needs  in seven Southeastern European and West -Central Asian countries   Alexandru Coman, Razvan M. Chereches, Marius I. Ungureanu, Emanuela O.  Marton -Vasarhelyi, Marissa A. Valentine, Tara Sabo -Attwood, Gregory C. Gray   To cite this article : Alexandru Coman, Razvan M. Chereches, Marius I. Ungureanu,  Emanuela O. Marton -Vasarhelyi, Marissa A. Valentine, Tara Sabo -Attwood, Gregory C.  Gray  (2015 ) An assessment of the occupational and environmental health needs in  seven Southeastern European and West -Central Asian countries , Journal of  Epidemiology and Global Health 5:4, 375– 384, DOI:  https://doi.org/10.1016/j.jegh.2015.04.004  To link to this article : https://doi.org/ 10.1016/j.jegh.2015.04.004   Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/4c/2f/JEGH-5-4-375.PMC4828928.pdf
"Comprehensive reviews of the http://dx.doi.org/10.1016/j.jegh.2015.04.004 2210-6006/ ª2015 Ministry of Health, Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/4c/2f/JEGH-5-4-375.PMC4828928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/2f/JEGH-5-4-375.PMC4828928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/2f/JEGH-5-4-375.PMC4828928.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International S228Abstract Background:  Arteriovenous malformations (AVMs) of the corpus callosum (CC)  are rare entities.",Non-OADS,/arxiv_data1/oa_pdf/fc/84/SNI-7-228.PMC4828944.pdf
"http://surgicalneurologyint.com/Arteriovenous-malformations-of-the-corpus- callosum:-Pooled-analysis-and-systematic-review-of-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/fc/84/SNI-7-228.PMC4828944.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS209 Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International Abstract Background:  Ischemic stroke is a well‑described but less frequent consequence  of ruptured or unruptured intracranial aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/1a/cf/SNI-7-209.PMC4828945.pdf
"http://surgicalneurologyint.com/ Middle-cerebral-artery-fusiform-aneurysm- presented-with-stroke-and-delayed-subarachnoid-hemorrhage-trapping,- thrombectomy,-and-bypass /This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/1a/cf/SNI-7-209.PMC4828945.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS214 Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International Giant pseudoaneurysm originated from distal middle cerebral  artery dissection treated by trapping under sensitive evoked  potential and motor evoked potential monitoring: Case report and  discussion Daniel Andrade Gripp, Fábio Jundy Nakasone, Marcos Vinícius Calfat Maldaun,   Paulo Henrique Pires de Aguiar, Luis Roberto Mathias Jr Division of Neurosurgery,  Santa Paula Hospital, São Paulo, SP , Brazil E‑mail: *Daniel Andrade Gripp ‑ danielgripp@uai.com.br; Fábio Jundy Nakasone ‑ fabio.jundy.nakasone@gmail.com;   Marcos Vinícius Calfat Maldaun ‑ marcosmaldaun@gmail.com; Paulo Henrique Pires de Aguiar ‑ phpaneurocir@gmail.com;   Luis Roberto Mathias Jr. ‑ lrmathias_jr@hotmail.com   *Corresponding author Received: 15 September 15  Accepted: 10 January 16  Published: 01 April 16 Abstract Background:  Dissecting giant pseudoaneurysm of the middle cerebral artery  (MCA) is a rare lesion often presenting challenges to neurosurgical teams dealing  with this specific pathology.",Non-OADS,/arxiv_data1/oa_pdf/46/6d/SNI-7-214.PMC4828946.pdf
"http://surgicalneurologyint.com/Giant-pseudoaneurysm-originated-from-distal-middle-cerebral-artery-dissection-treated-by-trapping-under-sensitive-evoked-potential-and- motor-evoked-potential-monitoring:-Case-report-and-discussion/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/46/6d/SNI-7-214.PMC4828946.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS243Abstract Background:  Mixed ganglioglioma and dysembryoplastic neuroepithelial tumor  (DNET) is an extremely rare neuropathological diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/f3/0a/SNI-7-243.PMC4828947.pdf
"http://surgicalneurologyint.com/Long-term-drug-resistant-temporal-lobe-epilepsy- associated-with-a-mixed-ganglioglioma-and-dysembryoplastic-neuroepithelial- tumor-in-an-elderly-patient/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f3/0a/SNI-7-243.PMC4828947.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS201 Editor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI:  Revista Argentina de Neurocirugia, a supplement to SNIOriginal Article Descompresión microvascular en espasmo hemifacial: Reporte  de 13 casos y revisión de la literatura Microvascular decompression in hemifacial spasm: 13 cases report and review of the literature Alvaro Campero1,2,3, Isabel Cuervo‑Arango Herreros1,2,4, Ignacio Barrenechea5, Germán Andjel1,2,   Pablo Ajler6, Albert Rhoton3 1Servicio de Neurocirugía, Hospital Padilla, Tucumán, Argentina, 2Servicio de Neurocirugía, Sanatorio Modelo, Tucumán, Argentina, 3Department of Neurological  Surgery, University of Florida, Gainesville, Florida, USA, 4Servicio de Neurocirugía, Hospital Universitario Central de Asturias, Oviedo, Asturias, España, 5Servicio  de Neurocirugía, Sanatorio Los Arroyos, Rosario, Argentina, 6Servicio de Neurocirugía, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina E‑mail: *Alvaro Campero ‑ alvarocampero@yahoo.com.ar; Isabel Cuervo ‑ Arango Herreros ‑ icuervoarangoherreros@gmail.com;   Ignacio Barrenechea ‑ ijbarrenechea@gmail.com; Germán Andjel ‑ g_andjel@hotmail.com; Pablo Ajler ‑ pablo.ajler@gmail.com;   Albert Rhoton ‑ rhoton@neurosurgery.ufl.edu   *Corresponding author Received: 03 November 15  Accepted: 10 November 15  Published: 01 April 16 Abstract Objective:  The aim of this study is to describe the results of 13 patients with facial  hemispasm, treated with microvascular decompression.",Non-OADS,/arxiv_data1/oa_pdf/35/42/SNI-7-201.PMC4828948.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS223 Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International Abstract Background:  Superficial siderosis (SS) is the occult deposition of hemosiderin  within the cerebral cortex due to repeat microhemorrhages within the central  nervous system.",Non-OADS,/arxiv_data1/oa_pdf/aa/bc/SNI-7-223.PMC4828949.pdf
"http://surgicalneurologyint.com/Intracranial-dural-arteriovenous-fistula-as-a-cause-for- symptomatic-superficial-siderosis:-A-report-of-two-cases-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/aa/bc/SNI-7-223.PMC4828949.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International S219Abstract Background:  Middle meningeal arteriovenous fistulas (MMAVFs) are rare lesions  with a poorly established natural history.",Non-OADS,/arxiv_data1/oa_pdf/77/f9/SNI-7-219.PMC4828950.pdf
"http://surgicalneurologyint.com/Middle-meningeal-arteriovenous-fistulas:-A-rare- and-potentially-high-risk-dural-arteriovenous-fistula/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/77/f9/SNI-7-219.PMC4828950.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS247 Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International Abstract Background: Spontaneous superficial temporal artery (STA) pseudoaneurysms  are very rare; only four cases, including ours, have been reported to date.",Non-OADS,/arxiv_data1/oa_pdf/75/77/SNI-7-247.PMC4828951.pdf
"http://surgicalneurologyint.com/$VSRQWDQHRXVVXSHUILFLDOWHPSRUDODUWHU\ SVHXGRDQHXU\VPSRVVLEO\UHODWHGWRDWKHURVFOHURVLV&DVHUHSRUWDQGUHYLHZRIOLWHUDWXUH/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/75/77/SNI-7-247.PMC4828951.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  To describe the rare finding of a double massa intermedia (MI).",Non-OADS,/arxiv_data1/oa_pdf/c2/13/SNI-7-30.PMC4828952.pdf
"Surg Neurol Int 2016;7:30. http://surgicalneurologyint.com/The-double-massa-intermedia/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/c2/13/SNI-7-30.PMC4828952.pdf
"Surgical Neurology International 2016, 7:30  http://www.surgicalneurologyint.com/content/7/1/30of location and size of the MI is important for surgical  planning in microsurgical and endoscopic approaches to  the third ventricle and pineal region in which it might  be confused for a tumor.",Non-OADS,/arxiv_data1/oa_pdf/c2/13/SNI-7-30.PMC4828952.pdf
"Surgical Neurology International 2016, 7:30  http://www.surgicalneurologyint.com/content/7/1/30its location and connecting structures.",Non-OADS,/arxiv_data1/oa_pdf/c2/13/SNI-7-30.PMC4828952.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - Medknow INTRODUCTION Welcome to this crash course in programming, aimed  at physicians.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surg Neurol Int 2016;7:29. http://surgicalneurologyint.com/Programming-for-physicians:-A-free-online-course/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29can differ from simple math to much more complicated  processes, but the essence remains the same.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29Y ou can notice a few things from the examples.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29doctor_name = ‘...’  print ‘Hello’ + doctor_name What happens here?",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29famous_neurosurgeons.append(‘Spetzler’) print famous_neurosurgeons # Insert an item at a specified index famous_neurosurgeons.insert (3, ‘Verbiest’) print famous_neurosurgeons # Remove the last person from the list famous_neurosurgeons.pop() print famous_neurosurgeons # Remove the second person from the list   # (so with index 1 !",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29body_mass_index=body_mass/ (body_length ** 2) # Return the result print body_mass_index I used parentheses around body_length **2 to ensure that  the calculations are executed in the order that I intend.",OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29additional resources.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29 print ‘The temperature is just fine.’ print ‘This line gets printed in all four cases.’ The order of the statements is important.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29# Countdown from 20 to 0 with steps of ‑2 print ‘ And going down.’ for i in range(20, 0, ‑2):  print i The variable name i is a habit of mine, also seen in many  code examples, and indicates an integer in a loop.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29while i <=10:  print i  i = i + 1 As you see, the iterator gets updated at the end instead of in  the beginning.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29# Decision‑making ‑ the bad way def calculate_bmi (mass, length):  ’’’Calculate Body Mass Index using body  mass (kg) and body length (cm)’’’  return mass/((length / 100) ** 2) def dietary_advice (mass, length):  ’’’Give dietary advice based on Body Mass Index’’’  bmi = mass/((length / 100) ** 2) if bmi > 30:  return ‘No more burgers for you!",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"Surgical Neurology International 2016, 7:29  http://www.surgicalneurologyint.com/content/7/1/29ask for the diameter and print the requested information.",Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
Available from: http://www.continuum.io/ downloads.,Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
Available from: http://www.dign.eu/ nm.,Non-OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
Available from: https://www.python.,OADS,/arxiv_data1/oa_pdf/b8/79/SNI-7-29.PMC4828953.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS237 Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Cerebrovascular, a supplement to  Surgical Neurology International Abstract Background:  Fusiform aneurysms are rare (<1%) and the underlying  pathophysiology is not well known.",Non-OADS,/arxiv_data1/oa_pdf/d8/27/SNI-7-237.PMC4828954.pdf
"http://surgicalneurologyint.com/Radical-surgical-treatment-for-recurrent-giant- fusiform-thrombosed-vertebral-artery-aneurysm-previously-coiled/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/d8/27/SNI-7-237.PMC4828954.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Langerhans cell histiocytosis (LCH) is a rare disease involving clonal  proliferation of cells with characteristics similar to bone marrow‑derived Langerhans  cells.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/SNI-7-31.PMC4828955.pdf
"Surg Neurol Int  2016;7:31. http://surgicalneurologyint.com/A-rare-case-of-solitary-brain-Langerhans-cell- histiocytosis-with-intratumoral-hemorrhage-in-a-patient-affected-by-T urner-syndrome/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/SNI-7-31.PMC4828955.pdf
"Surgical Neurology International 2016, 7:31  http://www.surgicalneurologyint.com/content/7/1/31was admitted.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/SNI-7-31.PMC4828955.pdf
"Surgical Neurology International 2016, 7:31  http://www.surgicalneurologyint.com/content/7/1/31S‑100 and CD1a proteins.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/SNI-7-31.PMC4828955.pdf
"Surgical Neurology International 2016, 7:31  http://www.surgicalneurologyint.com/content/7/1/31histiocytosis lesion of the parieto-occipital lobe: A case report and review  of the literature.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/SNI-7-31.PMC4828955.pdf
MEN1 is typically characterized by the development of neuroendocrine Open AccessJ Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
The immunohistochemical J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
"InGeneReviews , Eds RA Pagon, MP Adam, HH Ardinger, SE Wallace, A Amemiya, LJH Bean, TD Bird, CT Fong, HC Mefford, RJH Smith, K J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 6",Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK1538/ 3 J. R. Siewert (Herausgeber) MR (Herausgeber) VS (Herausgeber).,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
( doi:10.1007/s10689-014- 9702-y ) Received in ﬁnal form 15 February 2016 Accepted 2 March 2016 J Manoharan and others An unusual phenotype of MEN1 syndromeID: 16-0011; April 2016 DOI: 10.1530/EDM-16-0011 http://www.edmcasereports.com 7,Non-OADS,/arxiv_data1/oa_pdf/df/62/edmcr-2016-160011.PMC4828980.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53724 | Page 1 of 8Video Article A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex Vera K. Veith1, Cliodhna Quigley1, Stefan Treue1,2 1Cognitive Neuroscience Laboratory, German Primate Center 2Faculty of Biology and Psychology, Goettingen University Correspondence to: Vera K. Veith at VVeith@dpz.eu URL: http://www.jove.com/video/53724 DOI: doi:10.3791/53724 Keywords: Behavior, Issue 109, visual spatial attention, macaque monkey, pressure injection, scopolamine, extracellular recording, electrophysiology, microinjection, awake behaving animal, drug delivery Date Published: 3/14/2016 Citation: Veith, V.K., Quigley, C., Treue, S. A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex.",Non-OADS,/arxiv_data1/oa_pdf/40/7d/jove-109-53724.PMC4828981.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/53724/ Introduction In cortical and subcortical areas, neuronal activity is affected by various neuromodulators, for example acetylcholine1.",Non-OADS,/arxiv_data1/oa_pdf/40/7d/jove-109-53724.PMC4828981.pdf
Accepted:  2015-12-25 orcid: 0000-0002-7853-5756  (Michael J. Moore)    doi: 10.4103/1673-5374.179034          http://www.nrronline.org/ How to cite this article:  Moore MJ (2016) Microscale tissue-engineered models:  overcoming barriers to adoption for neural regeneration research.,Non-OADS,/arxiv_data1/oa_pdf/2b/15/NRR-11-386.PMC4828987.pdf
"Accepted:  2015-12-29 doi: 10.4103/1673-5374.179037          http://www.nrronline.org/ How to cite this article: Quinlan S, Jimenez-Mateos EM (2016) Can  we protect the brain via preconditioning?",Non-OADS,/arxiv_data1/oa_pdf/4d/d5/NRR-11-388.PMC4828988.pdf
"Accepted:  2015-12-03 doi: 10.4103/1673-5374.179035          http://www.nrronline.org/ How to cite this article: Ingoglia NA, Jalloh B (2016) 76nt RNAs are  transported axonally into regenerating axons and growth cones.",Non-OADS,/arxiv_data1/oa_pdf/49/87/NRR-11-390.PMC4828989.pdf
"Accepted:  2016-01-15 doi: 10.4103/1673-5374.179038          http://www.nrronline.org/ How to cite this article: Zeynalov E, Jones SM (2016) Recent advances and  future directions in preclinical research of arginine-vasopressin (A VP) receptor  blocker conivaptan in the co ntext of stroke.",Non-OADS,/arxiv_data1/oa_pdf/54/c6/NRR-11-392.PMC4828990.pdf
"Accepted:  2016-01-25 doi: 10.4103/1673-5374.179036          http://www.nrronline.org/ How to cite this article:  Naughton MC, McMahon JM, FitzGerald UF  (2016) The role of the unfolded protein response in myelination.",Non-OADS,/arxiv_data1/oa_pdf/06/2b/NRR-11-394.PMC4828991.pdf
"Accepted:  2015-12-22 orcid: 0000-0001-7833-8894  (Attila Szabo)    doi: 10.4103/1673-5374.179041          http://www.nrronline.org/ How to cite this article: Szabo A, Frecska E (2016) Dimethyltrypt - amine (DMT): a biochemical Swiss Army knife in neuroinflammation  and neuroprotection?",Non-OADS,/arxiv_data1/oa_pdf/93/35/NRR-11-396.PMC4828992.pdf
"Accepted:  2016-02-14 orcid: 0000-0001-7945-3237  (Mushfiquddin Khan)    doi: 10.4103/1673-5374.179039          http://www.nrronline.org/ How to cite this article:  Khan M, Singh I (2016) Inhibition of the AMPK/nNOS  pathway for neuroprotection in stroke.",Non-OADS,/arxiv_data1/oa_pdf/bd/74/NRR-11-398.PMC4828993.pdf
"Accepted:  2015-11-12 doi: 10.4103/1673-5374.179040          http://www.nrronline.org/ How to cite this article:  Lioutas VA, Novak V (2016) Intranasal insulin  neuroprotection in ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/14/e8/NRR-11-400.PMC4828994.pdf
"Accepted:  2015-12-22 orcid: 0000-0002-6314-3397  (Maria Marino)    doi: 10.4103/1673-5374.179045          http://www.nrronline.org/ How to cite this article: Nuzzo MT, Marino M (2016) Estrogen/Hun - tingtin: a novel pathway involved in neuroprotection.",Non-OADS,/arxiv_data1/oa_pdf/d7/00/NRR-11-402.PMC4828995.pdf
"Accepted:  2016-02-19orcid: 0000-0002-6527-485X  (Oscar Gonzalez-Perez) 0000-0001-7452-3435  (Tania Campos-Ordonez)    doi: 10.4103/1673-5374.179042          http://www.nrronline.org/ How to cite this article:  Campos-Ordonez T, Gonzalez-Perez O (2016)  Glial plasticity after hexahydrobenzene exposure.",Non-OADS,/arxiv_data1/oa_pdf/ef/15/NRR-11-404.PMC4828996.pdf
"Accepted:  2015-12-31 orcid: 0000-0002-2298-5002  (Antonio Costantini)    doi: 10.4103/1673-5374.179047          http://www.nrronline.org/ How to cite this article: Costantini A, Fancellu R (2016) An open-label pi - lot study with high-dose thiamine in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/2d/d3/NRR-11-406.PMC4828997.pdf
"Accepted:  2015-12-30 orcid: 0000-0003-3056-8310  (Kazuchika Nishitsuji)    doi: 10.4103/1673-5374.179043          http://www.nrronline.org/ How to cite this article: Nishitsuji K, Saito H, Uchimura K (2016) Enzymatic  remodeling of heparan sulfate: a therapeutic strategy for systemic and localized am - yloidoses?",Non-OADS,/arxiv_data1/oa_pdf/5b/b5/NRR-11-408.PMC4828998.pdf
"Accepted:  2016-02-20 orcid: 0000-0001-8620-5063 (Hidehiro Mizusawa)    doi: 10.4103/1673-5374.179048          http://www.nrronline.org/ How to cite this article:  Yokote H, Mizusawa H (2016) Multiple scle - rosis and neuromyelitis optica spectrum disorders: some similarities in  two distinct diseases.",Non-OADS,/arxiv_data1/oa_pdf/01/f9/NRR-11-410.PMC4828999.pdf
"Accepted:  2016-01-18 doi: 10.4103/1673-5374.179044          http://www.nrronline.org/ How to cite this article:  Wu L, Zhao L (2016) ApoE2 and Alzheimer’s disease:  time to take a closer look.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/NRR-11-412.PMC4829000.pdf
"Accepted:  2016-02-17 orcid: 0000-0001-5743-8554  (Florian Simon )  doi: 10.4103/1673-5374.179050          http://www.nrronline.org/ How to cite this article:  Simon F, Oberhuber A (2016) Ischemia and reperfu - sion injury of the spinal cord: experimental strategies to examine postischemic  paraplegia.",Non-OADS,/arxiv_data1/oa_pdf/de/04/NRR-11-414.PMC4829001.pdf
"Accepted:  2016-02-01 orcid: 0000-0003-2961-5466 (Lani C. Keller)    doi: 10.4103/1673-5374.179046          http://www.nrronline.org/ How to cite this article:  Lincoln BL II, Keller LC (2016) Drosophila  neuronal injury model allows for temporal dissection of neurodegen - erative events.",Non-OADS,/arxiv_data1/oa_pdf/78/db/NRR-11-416.PMC4829002.pdf
Accepted:  2015-12-29 doi: 10.4103/1673-5374.179049          http://www.nrronline.org/ How to cite this article: Gomez-Villafuertes R (2016) Contribution of purinergic  receptors to spinal cord injury repair: stem cell-based neuroregeneration.,Non-OADS,/arxiv_data1/oa_pdf/c6/41/NRR-11-418.PMC4829003.pdf
"Accepted:  2016-01-14 doi: 10.4103/1673-5374.179051          http://www.nrronline.org/ How to cite this article: Readdy WJ, Dhall SS (2016) Vasopressor  administration in spinal cord injury: Should we apply a universal  standard to all injury patterns?",Non-OADS,/arxiv_data1/oa_pdf/42/45/NRR-11-420.PMC4829004.pdf
"Accepted:  2016-03-10 orcid: 0000-0002-3508-8060  (Yoonsu Choi)    doi: 10.4103/1673-5374.179052          http://www.nrronline.org/ How to cite this article:  Choi Y, Noh HM (2016) Peripheral nerve  regeneration monitoring using multilayer microchannel scaffolds.",OADS,/arxiv_data1/oa_pdf/53/98/NRR-11-422.PMC4829005.pdf
"Accepted:  2016-02-14 orcid: 0000-0003-1430-0760  (Adriana Di Polo)    doi: 10.4103/1673-5374.179053          http://www.nrronline.org/ How to cite this article:  Cueva Vargas JL, Di Polo A (2016) Neuroin - flammation in glaucoma: soluble tumor necrosis factor alpha and the  connection with excitotoxic damage.",Non-OADS,/arxiv_data1/oa_pdf/c4/f0/NRR-11-424.PMC4829006.pdf
Supplementary data: Supplementary information is available  at http://www.nrronline.org.,OADS,/arxiv_data1/oa_pdf/30/dd/NRR-11-427.PMC4829007.pdf
Accepted:  2015-12-20 orcid: 0000-0002-6654-302X (Hyeok Gyu Kwon)    doi: 10.4103/1673-5374.179080          http://www.nrronline.org/ Figure 1 T2-weighted brain magnetic resonance images and results of  diffusion tensor tractography and transcranial magnetic stimulation in a  71-year-old female patient with an infarct in the left pontine base.,OADS,/arxiv_data1/oa_pdf/c8/90/NRR-11-519.PMC4829022.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53756 | Page 1 of 7Video Article Maintenance of a Drosophila melanogaster  Population Cage Juan Manuel Caravaca1, Elissa P. Lei1 1Laboratory of Cellular and Developmental Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health Correspondence to: Elissa P. Lei at leielissa@niddk.nih.gov URL: http://www.jove.com/video/53756 DOI: doi:10.3791/53756 Keywords: Molecular Biology, Issue 109, Fly, population, cage, Drosophila, embryo, larvae, pupae Date Published: 3/15/2016 Citation: Caravaca, J.M., Lei, E.P.",Non-OADS,/arxiv_data1/oa_pdf/e5/7b/jove-109-53756.PMC4829027.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53756/ Introduction The ability to combine genetic and biochemical approaches has made Drosophila a particularly suitable organism for biochemistry and molecular biology studies1-3.,Non-OADS,/arxiv_data1/oa_pdf/e5/7b/jove-109-53756.PMC4829027.pdf
http://www.flyrnai.org/DRSC-PRC.html.,Non-OADS,/arxiv_data1/oa_pdf/e5/7b/jove-109-53756.PMC4829027.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2016 |  109  | e53618 | Page 1 of 10Video Article Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli Aude G. Bernheim*1, Vincent K. Libis*1, Ariel B. Lindner1, Edwin H. Wintermute1 1U1001, Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes *These authors contributed equally Correspondence to: Edwin H. Wintermute at ehwintermute@gmail.com URL: http://www.jove.com/video/53618 DOI: doi:10.3791/53618 Keywords: Molecular Biology, Issue 109, Synthetic biology, gene expression, sRNA, knockdown, phagemid, Hfq protein, antibiotic resistance Date Published: 3/20/2016 Citation: Bernheim, A.G., Libis, V.K., Lindner, A.B., Wintermute, E.H. Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli .",Non-OADS,/arxiv_data1/oa_pdf/7a/4c/jove-109-53618.PMC4829038.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53618/ Introduction RNA-mediated gene knockdowns proceed in two stages.,Non-OADS,/arxiv_data1/oa_pdf/7a/4c/jove-109-53618.PMC4829038.pdf
"Images were evaluated using Adobe Photoshop (Adobe Systems, San Jose, CA, USA) and ImageJ (http://imagej.nih.gov/ij/; provided in the public domain by the NationalInstitutes of Health, Bethesda, MD, USA) software as published previously.",OADS,/arxiv_data1/oa_pdf/ae/21/i1552-5783-57-4-1728.PMC4829088.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 62",Non-OADS,/arxiv_data1/oa_pdf/bd/9f/i0006-3363-94-3-62.PMC4829089.pdf
Gene enrichment analysis was carried out using publicly available software(http://bioinfo.vanderbilt.edu/webgestalt).,OADS,/arxiv_data1/oa_pdf/bd/9f/i0006-3363-94-3-62.PMC4829089.pdf
Array data were imported using the Bead arraysoftware package (http://www.bioconductor.org/packages/release/bioc/html/beadarray.html) and were quantile normalized.Differential expression was determined using the Limmasoftware package (http://bioconductor.org/packages/release/bioc/html/limma.html).,OADS,/arxiv_data1/oa_pdf/bd/9f/i0006-3363-94-3-62.PMC4829089.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 63",Non-OADS,/arxiv_data1/oa_pdf/be/55/i0006-3363-94-3-63.PMC4829090.pdf
"This is an Open Access article, freely available through Biology of Reproduction’s Authors’ Choice option, and is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described athttp://creativecommons.org/licenses/by-nc/4.0/.eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 68",Non-OADS,/arxiv_data1/oa_pdf/36/3d/i0006-3363-94-3-68.PMC4829091.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 69",Non-OADS,/arxiv_data1/oa_pdf/0d/5f/i0006-3363-94-3-69.PMC4829092.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Adolescent Health, Medicine and Therapeutics Adolescent Health, Medicine and Therapeutics 2016:7 43–57Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"Or use: http://youtu.be/7CdSe4UFbB 0Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 43 http: //dx.doi.org/10.2147/AHMT .S6985 3Using mobile technology to promote safe sex and  sexual health in adolescents: current practices and  future recommendations Judith B Cornelius1 Josephine A Appiah2 1School of Nursing, 2Health Services  Research Doctoral Program, College  of Health and Human Services,   University of North Carolina at  Charlotte, Charlotte, NC, USA Correspondence: Judith B Cornelius   School of Nursing, University of North  Carolina at Charlotte, 9201 University  City Blvd, Charlotte, NC, 28223, USA   T el +1 704 687 7978   email jbcornel@uncc.ed uAbstract:  Y outh and young adults (19–24 years of age) shoulder the burden of sexually trans - mitted infections accounting for nearly half of all new infections annually.",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"Available from: http://www.cdc.gov/ std/stats/sti-estimates-fact-sheet-feb-2013.pd f. Accessed September 22,  2015.",OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"Available from: http://www.pewinternet.org/files/old-media/Files/ Reports/2013/PIP_TeensandTechnology2013.pd f. Accessed September  22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"Available from: http://grants.nih.gov/grants/funding/ children/pol_children_qa.ht m. Accessed September 22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
Avail - able from: http://www.who.int/topics/adolescent_health/en /.,Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/b2/ahmt-7-043.PMC4829103.pdf
Marked in bold fonts are major resistance mutations defined in a n HIV drug resistance database from Stanford (http://hivdb.stanford.edu/DR/PIResiNote.html).,Non-OADS,/arxiv_data1/oa_pdf/88/92/PROT-83-351.PMC4829108.pdf
at http://www.bioinf.org.uk/software/profit/.,Non-OADS,/arxiv_data1/oa_pdf/88/92/PROT-83-351.PMC4829108.pdf
at http://www.pymol.org/.,Non-OADS,/arxiv_data1/oa_pdf/88/92/PROT-83-351.PMC4829108.pdf
"Indeed,  Mesupron®, a small molecule serine protease inhibitor developed  by WILEX, has been used in clinical trials (http://www.wilex.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/ijmm-37-05-1310.PMC4829131.pdf
Studies have  suggested that the drug appears to be safe when combined with  chemotherapy in cases of breast cancer (http://www.wilex.de/ portfolio/mesupron/phase-i-ii-mit-mesupron/).,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/ijmm-37-05-1310.PMC4829131.pdf
"In the present study, bioin - formatics analyses using miRanda (http://www.microrna.org/ microrna/home.do) and miRTarBase (http://mirtarbase.mbc.",OADS,/arxiv_data1/oa_pdf/5a/e4/ijmm-37-05-1274.PMC4829132.pdf
TFs encoded by DEGs were  explored combined with the mouse TF information recorded  in The Animal Transcription Factor DataBase (AnimalTFDB)  (http://www.bioguo.org/AnimalTFDB/index.php)  (16).,OADS,/arxiv_data1/oa_pdf/2f/71/ijmm-37-05-1181.PMC4829133.pdf
"Digital images were obtained at  x40 magnification using a light microscope (Olympus BX40;  Olympus Optical  Co. Ltd., Tokyo, Japan) for the histological  examination of axonal density using ImageJ software (NIH,  http://rsb.info.nih.gov/ij/index.html).",OADS,/arxiv_data1/oa_pdf/25/ef/ijmm-37-05-1170.PMC4829137.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Core Evidence 2016:11 1–10Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  1REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S8177 6Core evidence clinical impact summary for azilsartan Outcome   measuresEvidence Implications Disease-oriented  evidencesRandomized controlled trials  demonstrated that azilsartan is an  effective option for the treatment  of hypertension in several settings,  for example in patients with renal  impairment.Azilsartan represent an optimal  choice as monotherapy for the  treatment of stage i hypertension,  and, in association with  chlorthalidone, for the treatment  of more advanced stages of  hypertension.",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"Available  from: http://www.cdc.gov/bloodpressure/facts.ht m. Accessed July  24,  2011.",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"Available  from: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pd f.  Accessed August 24, 2011.",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/   2011/200796Orig1s000ClinPharmR.pd f. Accessed July 26, 2011.",OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
Available from: http://www.edarbi.com /.,Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
Available from: http://www.edarbi.com /.,Non-OADS,/arxiv_data1/oa_pdf/a8/2c/ce-11-001.PMC4829189.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/21/ppa-10-459.PMC4829190.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 459–468Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  459PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PPA.S9962 7Patient education, nudge, and manipulation:  defining the ethical conditions of the person- centered model of care Gérard reach1,2 1Department of endocrinology,   Diabetes and Metabolic Diseases,   Avicenne Hospital AP-HP , 2eA 3412,   centre de recherche en Nutrition  Humaine Ile-de-France (CRNH-IDF),   Paris 13 University, sorbonne Paris  cité, Bobigny, FranceAbstract:  Patient education (PE) is expected to help patients with a chronic disease to man - age their lives and give them the possibility of adopting, in an appropriate manner, beneficial  changes in health behaviors that are prescribed by their physicians.",Non-OADS,/arxiv_data1/oa_pdf/ba/21/ppa-10-459.PMC4829190.pdf
"However, it is not because a procedure is aimed at improving correspondence: Gérard reach Department of endocrinology, Diabetes  and Metabolic Diseases, Avicenne  Hospital AP-HP, 125 Rue de Stalingrad,  Bobigny 93000, France tel +33 1 4895 5158 Fax +33 1 4895 5560 email gerard.reach@aphp.f rJournal name: Patient Preference and Adherence Article Designation: Perspectives Y ear: 2016 Volume: 10 Running head verso: Reach Running head recto: The ethical conditions of the person-centered model of care DOI: http://dx.doi.org/10.2147/PPA.S99627",Non-OADS,/arxiv_data1/oa_pdf/ba/21/ppa-10-459.PMC4829190.pdf
Available from:  http://www.ars.iledefrance.sante.fr/fileadmin/ILE-DE-FRANCE/ARS/ Presse/8_Communiques_presse_2011_2012/DP_ETP_Vdef_27.06.12.,Non-OADS,/arxiv_data1/oa_pdf/ba/21/ppa-10-459.PMC4829190.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ba/21/ppa-10-459.PMC4829190.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/c3/ppa-10-449.PMC4829191.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 449–457Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  449PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PPA.S10300 7simplistic and complex thought in medicine: the  rationale for a person-centered care model as a  medical revolution Gérard reach1,2 1Department of endocrinology,   Diabetes and Metabolic Diseases,   Avicenne Hospital AP-HP , 2eA 3412,   centre de recherche en Nutrition  Humaine ile-de-France (crNH-iDF),   Paris 13 University, sorbonne Paris  cité, Bobigny, FranceAbstract:  According to the concept developed by Thomas Kuhn, a scientific revolution occurs  when scientists encounter a crisis due to the observation of anomalies that cannot be explained  by the generally accepted paradigm within which scientific progress has thereto been made: a  scientific revolution can therefore be described as a change in paradigm aimed at solving a crisis.",Non-OADS,/arxiv_data1/oa_pdf/0c/c3/ppa-10-449.PMC4829191.pdf
"In 2003, the World  Health Organization published a report recognizing the critical importance of nonadher - ence due to its major deleterious impact on the efficiency of care.3 Indeed, the magnitude  of this phenomenon cannot be overlooked; for instance, consider the fact that whatever the  medication, the ratio of the total day’s supply of medication that was dispensed, divided  by the number of days of the evaluation period, is only ~60% 2  years after the initiation correspondence: Gérard reach Department of endocrinology, Diabetes  and Metabolic Diseases, Avicenne  Hospital AP-HP, 125 rue de stalingrad,  Bobigny 93000, France tel +33 1 4895 5158 Fax +33 1 4895 5560 email gerard.reach@aphp.f r Journal name: Patient Preference and Adherence Article Designation: Perspectives Y ear: 2016 Volume: 10 Running head verso: Reach Running head recto: The rationale for the person-centered model of care DOI: http://dx.doi.org/10.2147/PPA.S103007",Non-OADS,/arxiv_data1/oa_pdf/0c/c3/ppa-10-449.PMC4829191.pdf
"See  webpage on the internet: https://foundation.metaintegral.org/sites/ default/files/Complex_Thought_FINAL.pd f. Accessed February 26,  2016.",Non-OADS,/arxiv_data1/oa_pdf/0c/c3/ppa-10-449.PMC4829191.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0c/c3/ppa-10-449.PMC4829191.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/a4/ppa-10-501.PMC4829192.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 501–510Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  501Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8579 5Managing migraine by patient profile: role  of frovatriptan Roger K Cady Kathleen Farmer Headache Care Center, Springfield,   MO, USAAbstract:  For the last quarter of a century, triptans have been available for acute treatment  of migraine but with little guidance on which of the different triptan products to use for which  patient or which attack of migraine.",Non-OADS,/arxiv_data1/oa_pdf/f6/a4/ppa-10-501.PMC4829192.pdf
"In this article, we explore patient and attack profiles as a viable Correspondence: Roger K Cady Headache Care Center, Banyan Group,  3805 S. Kansas Expressway, Springfield,  MO 65807, USA Tel +1 417 890 7888 Fax +1 417 890 8827 email rcady@headachecare.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Cady and Farmer Running head recto: Managing migraine by patient profile DOI: http://dx.doi.org/10.2147/PPA.S85795",Non-OADS,/arxiv_data1/oa_pdf/f6/a4/ppa-10-501.PMC4829192.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f6/a4/ppa-10-501.PMC4829192.pdf
"2, 134 –139 http://dx.doi.org/10.1080/15476286.2015.1132069",Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
"Candidate knot-forming RNA molecules from Pseudoknot database (http://ekevanbatenburg.nl/PKBASE/PKBGETSUM.HTML#TOP; updated November28, 2014, accessed October 11, 2015).",OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
J Phys A Math Gen 1988; 21:1689-94; http://dx.doi.org/10.1088/0305-4470/21/7/030 2.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Physics Reports 2011; 504:1-73; http://dx.doi.org/10.1016/j.physrep.2011.03.003 3.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Annu Rev Bio- phys 2010; 39:349-66; PMID:20192771; http://dx.doi.org/10.1146/ annurev.biophys.093008.131412 4.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
PLoS Comput Biol 2006; 2:e45; PMID:16710448; http://dx.doi.org/10.1371/journal.pcbi.0020045 5.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Chromosome Res 2011; 19:37-51; PMID:21274616; http://dx.doi.org/10.1007/s10577-010-9177-0 7.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nat Struct Mol Biol 1997; 4:10-9; PMID:8989315; http://dx.doi.org/10.1038/ nsb0197-109.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Biophysical J1994; 66:827-37; PMID:8011915; http://dx.doi.org/10.1016/S0006-3495(94)80859-8 10.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nature 2007; 445:379-81; http://dx.doi.org/10.1038/445379a; PMID:17251970 11.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nat Rev Genetics 2001; PMID:11283701; 2:292-301; http://dx.doi.org/10.1038/35066075 12.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
J Phys Condens Matter 2010;23:033101; PMID:21406854; http://dx.doi.org/10.1088/0953-8984/23/ 3/033101 14.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
PLoS Comput Biol 2010; 6:e1000864;PMID:20686683; http://dx.doi.org/10.1371/journal.pcbi.1000864 15.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
PLos Comput Biol 2006; 2:e122; PMID:16978047;http://dx.doi.org/10.1371/journal.pcbi.0020122 16.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Computational Biol Chem 2007; 31:151-62; PMID:17500039; http://dx.doi.org/10.1016/j.compbiolchem.2007.03.002 17.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Sci- ence 1993; 260:533-6; PMID:8475384; http://dx.doi.org/10.1126/science.8475384 20.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
J Biomol Structure Dynamics 1998; 16:709-13; PMID:10052626; http://dx.doi.org/ 10.1080/07391102.1998.10508282 22.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
J Mol Biol 1980; 139:601-25; PMID:6997498; http://dx.doi.org/10.1016/0022-2836(80)90051-0 23.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
J Mol Biol 1981; 151:519-33; http://dx.doi.org/10.1016/0022- 2836(81)90008-5; PMID:6279861 24.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Proc Natl Acad Sci USA 2008; 105:16153-8; PMID:18845685; http://dx.doi.org/10.1073/ pnas.0808089105 26.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Biophysj 2015; 108:194-202; PMID:25564866; http://dx.doi.org/10.1016/j.bpj.2014.10.070 27.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nucleic Acids Res 2011; 39:e93-3; PMID:21593129; http://dx.doi.org/10.1093/nar/gkr240 28.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nucleic Acids Res 2012; 41:1895-900; PMID:23248008; http://dx.doi.org/10.1093/ nar/gks1204138 A. S. BURTON ET AL.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
RNA 2006; 12:353-9;PMID:16495233; http://dx.doi.org/10.1261/rna.2204506 30.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
RNA 2009; 15:743-9; PMID:19318464; http://dx.doi.org/10.1261/rna.1488609 31.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nature 2012; 491:72-77; PMID:23075853; http://dx.doi.org/10.1038/nature11549 32.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nature 1977; 268:495-500; PMID:329147; http://dx.doi.org/10.1038/268495a0 33.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nat Struct Mol Biol 1994; 1:213-4; PMID:7656045; http://dx.doi.org/10.1038/nsb0494-213 34.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nature 2000; 406:916-9; http://dx.doi.org/10.1038/35022623;PMID:10972297 35.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nat Neurosci 2013; 16:1238-47; PMID:23912945; http://dx.doi.org/10.1038/nn.3479 37.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
RNA 2013; 19:141-57; PMID:23249747;http://dx.doi.org/10.1261/rna.035667.112 38.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nature 2013; 495:333-8; PMID:23446348; http://dx.doi.org/10.1038/nature11928 39.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
PLoS One 2012; 7:e30733; PMID:22319583; http://dx.doi.org/10.1371/journal.pone.0030733 40.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Arti ﬁcial DNA: PNA & XNA 2014; 4:35-6; PMID:23603781; http://dx.doi.org/10.4161/adna.24680 41.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Identi ﬁcation of Rare Slipknots in Pro- t e i n sa n dT h e i rI m p l i c a t i o n sf o rS t a b i l i t ya n dF o l d i n g .J o u r n a lo fM o l Biol 2007; 373:153-66; PMID:17764691; http://dx.doi.org/10.1016/j.jmb.2007.07.042 42.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Nucleic Acids Res 2015; 43:D306-314; PMID:25361973; http://dx.doi.org/10.1093/nar/gku1059 44.,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Mol Cell2008; 30:642-8; PMID:18538662; http://dx.doi.org/10.1016/j.molcel.2008.03.019 45.,OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
Prog Theor Phys Supplement 2011; 191:192-204; http://dx.doi.org/10.1143/PTPS.191.192RNA BIOLOGY 139,Non-OADS,/arxiv_data1/oa_pdf/05/a2/krnb-13-02-1132069.PMC4829277.pdf
"© Andrew J Hudson, Martha R Stark, Naomi M Fast, Anthony G Russell, and Stephen D Rader *Correspondence to: Stephen D Rader; Email: rader@unbc.ca Submitted: 07/24/2015Revised: 09/09/2015Accepted: 09/09/2015 http://dx.doi.org/10.1080/15476286.2015.1094602 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Cold Spring Harbor Perspectives Biol 2011; 3:1-23; http://dx.doi.org/10.1101/cshperspect.a003707 2.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Bioessays 2003; 25:1147-9; PMID:14635248; http://dx.doi.org/10.1002/bies.10394 3.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
"Agafonov DE, Deckert J, Wolf E, Odenw €alder P, Bes- sonov S, Will CL, Urlaub H, L €uhrmann R. Semiquan- titative proteomic analysis of the human spliceosome via a novel two-dimensional gel electrophoresis method.Mol Cell Biol 2011; 31:2667-82; PMID:21536652; http://dx.doi.org/10.1128/MCB.05266-11 4.",OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nat Rev Mol Cell Biol 2003; 4:960-70; PMID:14685174; http://dx.doi.org/ 10.1038/nrm1259 5.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Biol Chem 2005;386:713-24; PMID:16201866; http://dx.doi.org/ 10.1515/BC.2005.084 6.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Wiley Inter- discip Rev RNA 2011; 2:417-34; PMID:21957027; http://dx.doi.org/10.1002/wrna.71 7.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mol Cell 2009; 36:593-608; PMID:19941820; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
"Luz Ambr /C19osio D, Lee JH, Panigrahi AK, Nguyen TN, Cicarelli RMB, G €unzl A. Spliceosomal proteomics in Trypanosoma brucei reveal new RNA splicing factors.Eukaryotic Cell 2009; 8:990-1000; http://dx.doi.org/ 10.1128/EC.00075-09 9.",OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mol Biol Evol 2005; 22:1053-66; PMID:15659557; http://dx.doi.org/10.1093/molbev/msi091 10.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Genome Res 2006; 16:66-77; PMID:16344558; http://dx.doi.org/10.1101/gr.3936206 11.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mol Cell 2012; 45:567-80; PMID:22365833; http://dx.doi.org/10.1016/j.molcel.2011.12.034 12.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
RNA 2010; 16:2384-403; PMID:20980672; http://dx.doi.org/10.1261/rna.2456210 13.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nucleic Acids Res 2012;40:10995-1008; PMID:23019220; http://dx.doi.org/ 10.1093/nar/gks887 15.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nature 2001; 414:450-3; PMID:11719806; http://dx.doi.org/10.1038/35106579 16.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nucleic Acids Res 2008; 36:3001-10; PMID:18390578; http://dx.doi.org/10.1093/nar/gkn142 17.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nature 2004; 428:653-7; PMID:15071595; http://dx.doi.org/10.1038/nature02398 19.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nucleic Acids Res 2004; 32:D271-2; PMID:14681410; http://dx.doi.org/10.1093/nar/gkh024 21.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Curr HIV Res 2006; 4:43-55; PMID:16454710; http://dx.doi.org/ 10.2174/157016206775197655 2 2 .,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
RNA 2013; 19:627-38; PMID:23525800; http://dx.doi.org/10.1261/rna.038422.113 23.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Cell 2015; 160:1125-34; PMID:25768908; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Circ Res 2013; 113:1065-75;PMID:23963726; http://dx.doi.org/10.1161/ CIRCRESAHA.113.301302 25.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
RNA 2001; 7:94-105;PMID:11214185; http://dx.doi.org/10.1017/ S1355838201000218 26.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nature 2000; 408:881-4; PMID:11130730; http://dx.doi.org/10.1038/35048617 28.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mol Cell 2002; 9:1145-50;PMID:12049749; http://dx.doi.org/10.1016/S1097- 2765(02)00505-1 29.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
RNA 2006; 12:235-47; PMID:16428604; http://dx.doi.org/10.1261/rna.2237806 30.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Science 2008;320:77-82; PMID:18388288; http://dx.doi.org/ 10.1126/science.1153803 31.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nat Struct Mol Biol 2014; 21:464-71; PMID:24747940; http://dx.doi.org/10.1038/ nsmb.2815 32.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nature 2013; 493:638-43; PMID:23354046; http://dx.doi.org/10.1038/nature11843 33.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nucleic Acids Res 2012; 40:D187-90; PMID:22080509; http://dx.doi.org/10.1093/nar/gkr1043 35.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Science 2010; 330:920-1; PMID:21071654; http://dx.doi.org/10.1126/science.1198594 36.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
J Mol Evol 1999; 49:169-81; PMID:10441669; http://dx.doi.org/10.1007/PL00006540 37.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Nature 2009; 457:977-80; PMID:19225518; http://dx.doi.org/10.1038/nature 07749 38.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mob DNA 2015; 6:7; PMID:25960782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
PLoS Pathog 2010; 6:e1001090; PMID:20838601; http://dx.doi.org/10.1371/journal.ppat.1001090 40.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Proc Natl Acad Sci USA 1987; 84:8190-4; PMID:3120186; http://dx.doi.org/ 10.1073/pnas.84.23.8190 42.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
J Biol Chem 1999; 274:23691-4; PMID:10446125; http://dx.doi.org/ 10.1074/jbc.274.34.23691 43.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mol Biol Evol 2012; 29:43-9; PMID:21482665; http://dx.doi.org/10.1093/molbev/ msr063 45.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Curr Biol 2011; 21:311-5; PMID:21315596; http://dx.doi.org/10.1016/j.cub.2011.01.025 46.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
J Biol Chem 2011; 286:7116-22; PMID:21209094; http://dx.doi.org/ 10.1074/jbc.C110.208389 47.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
BMC Genomics 2013; 14:207; PMID:23537046; http://dx.doi.org/10.1186/1471-2164-14-207 48.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
PLoS Pathog 2009; 5:e1000261; PMID:19132089; http://dx.doi.org/10.1371/journal.ppat.1000261 49.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth.Genome Res 2012; 22:2478-88; PMID:22813931; http://dx.doi.org/10.1101/gr.142802.112 50.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Cell1992; 71:803-17; PMID:1423631; http://dx.doi.org/ 10.1016/0092-8674(92)90556-R 51.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
RNA 2007; 13:2066-80; PMID:17956975; http://dx.doi.org/10.1261/rna.766607 52.,OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
Mem InstOswaldo Cruz 2007; 102:97-105; http://dx.doi.org/ 10.1590/S0074-02762007000100017 53.,Non-OADS,/arxiv_data1/oa_pdf/76/76/krnb-12-11-1094602.PMC4829280.pdf
"© Katharina Schmid, Kathrin Th €uring, Patrick Keller, Antonia Ochel, Stefanie Kellner, and Mark Helm *Correspondence to: Mark Helm, Email: mhelm@uni-mainz.deSubmitted: 07/17/2015; Revised xx/xx/xxxx; Accepted: 07/22/2015 http://dx.doi.org/10.1080/15476286.2015.1076612 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Annu Rev Biochem 2005; 74:481-514; PMID:15952895; http://dx.doi.org/10.1146/annurev.biochem.74.010904.153721 2.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nat Rev Mol Cell Biol 2013; 14:341-56; PMID:23698584; http://dx.doi.org/10.1038/nrm3589 3.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nat Chem Biol 2014; 10:574-81; PMID:24838012; http://dx.doi.org/10.1038/ nchembio.1532 4.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nat Rev Genetics 2014; 15:293- 306; PMID:24662220; http://dx.doi.org/10.1038/nrg3724 5.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Trends Genet 2013;29:108-15; PMID:23218460; http://dx.doi.org/ 10.1016/j.tig.2012.11.003 6.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nature 2012; 485:201-6;PMID:22575960; http://dx.doi.org/10.1038/ nature11112 8.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Cell 2012; 149:1635-46; PMID:22608085; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Epigenomics 2010; 2:209- 20; PMID:22121871; http://dx.doi.org/10.2217/epi.10.6 10.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
PLoS Genet 2013; 9:e1003602; PMID:23825970; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nucleic Acids Res 2012; 40:5023- 33; PMID:22344696; http://dx.doi.org/10.1093/nar/gks144 13.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nat Genet 2010; 42:920-1; author reply 1; PMID:20980983; http://dx.doi.org/10.1038/ng1110- 920 14.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nat Genet2009; 41:696-702; PMID:19412177; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
"Capuano F, Mulleder M, Kok R, Blom HJ, Ralser M. Cytosine DNA methylation is found in Drosophila melanogaster but absent in Saccharomyces cerevisiae, Schizosaccharomyces pombe, and other yeast species.Anal Chem 2014; 86:3697-702; PMID:24640988; http://dx.doi.org/10.1021/ac500447w 17.",OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Molecules 2013; 18:14268-84;PMID:24252996; http://dx.doi.org/10.3390/ molecules181114268 18.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Methods Enzy- mol 1990; 193:782-90; PMID:1706062; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
PloS one 2013; 8:e67945; PMID:23844135; http://dx.doi.org/10.1371/journal.pone.0067945 22.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nature 2000; 408:740-5; PMID:11130078; http://dx.doi.org/10.1038/35047123 23.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Mol Ther 2008; 16:1833-40;PMID:18797453; http://dx.doi.org/10.1038/ mt.2008.20024.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
RNA Biol 2012;9:828-42; PMID:22617878; http://dx.doi.org/ 10.4161/rna.20206 25.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Nucleic Acids Res 2010; 38:1415-30; PMID:20007150; http://dx.doi.org/10.1093/nar/ gkp1117 26.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Genes Dev 2010; 24:1590-5; PMID:20679393; http://dx.doi.org/10.1101/gad.586710 29.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Wiley Interdiscip Rev RNA 2011; 2:611-31; PMID:21823225; http://dx.doi.org/10.1002/wrna.79 31.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
J Am Chem Soc 2014 Aug 20;136(33):11582-5; http://dx.doi.org/10.1021/ ja505305z 33.,OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
Chembiochem 2015 Mar 23; 16(5):752-5; http://dx.doi.org/10.1002/cbic.201500013 35.,Non-OADS,/arxiv_data1/oa_pdf/80/66/krnb-12-10-1076612.PMC4829282.pdf
"3, 320 –330 http://dx.doi.org/10.1080/15476286.2016.1142038",Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Gene 2006; 367:17-37; PMID:16337753;http://dx.doi.org/10.1016/j.gene.2005.10.019 2.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Cell 2007; 27:339-52; PMID: 17679086; http://dx.doi.org/10.1016/j.molcel.2007.07.014 3.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nature Rev Mol Cell Biol 2011; 12:505-516; PMID: 21779027; http://dx.doi.org/10.1038/nrm3154 4.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
RNA Biol 2013; 10:4-18; PMID:22922795; http://dx.doi.org/10.4161/rna.218795.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Biochim Biophys Acta 2013; 1829:775-90;PMID:23357782; http://dx.doi.org/10.1016/j.bbagrm.2013.01.007 6.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nucleic Acids Res 2011; 39:2260-70; PMID:21062831; http://dx.doi.org/10.1093/nar/gkq1127 7.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nucleic Acids Res 2011; 39:2678-89; PMID:21113024; http://dx.doi.org/10.1093/nar/gkq1206 8.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Curr Opin Cell Biol 2012; 24:431-8;PMID:22464735; http://dx.doi.org/10.1016/j.ceb.2012.03.004 9.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nucleic Acids Res2006; 34:3189-99; PMID:16772403; http://dx.doi.org/10.1093/nar/ gkl419 10.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nucleic Acids Res 2004; 32:5827-33; PMID:15523097; http://dx.doi.org/10.1093/nar/gkh904 11.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
EMBO Rep 2008; 9:1230-6; PMID:18833290; http://dx.doi.org/10.1038/embor.2008.184 12.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
RNA 2014; 20:1173-82; PMID:24947498; http://dx.doi.org/10.1261/rna.044669.114 14.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
G-patch: a new conserved domain in eukary- otic RNA-processing proteins and type D retroviral polyproteins.Trends Biochem Sci 1999; 24:342-4; PMID:10470032; http://dx.doi.org/10.1016/S0968-0004(99)01437-1 15.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Biomed Res Int 2015; 2015:931857;PMID:25692149; http://dx.doi.org/10.1155/2015/931857 16.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
RNA 2004;10:210-20; PMID:14730020; http://dx.doi.org/10.1261/rna.5151404 1 8 .,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell Biol 2004; 24:10101-10;PMID:15542821; http://dx.doi.org/10.1128/MCB.24.23.10101-10110.2004 19.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Genes Dev 2005; 19:2991-3003;PMID:16357217; http://dx.doi.org/10.1101/gad.1377405 20.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell Biol 2006; 26:6016-23; PMID:16880513; http://dx.doi.org/10.1128/MCB.02347-05 21.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
J Biol Chem 2002; 277:17743-50; PMID:11886864; http://dx.doi.org/10.1074/jbc.M200762200328 A. U. HEININGER ET AL.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
"Nucleic Acids Res 2014;42:1509-23; PMID:24234440; http://dx.doi.org/10.1093/nar/gkt1137 2 4 .G e eS ,K r a u s sS W ,M i l l e rE ,A o y a g iK ,A r e n a sJ ,C o n b o yJG .",OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Cell Mol Life Sci 2005; 62:1038-46; PMID:15868102; http://dx.doi.org/10.1007/s00018-005-4547-z 26.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
J Biol Chem 2002; 277:35712-9; PMID:12107183; http://dx.doi.org/10.1074/jbc.M205526200 27.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
EMBO J 2009; 28:3808-19;PMID:19927118; http://dx.doi.org/10.1038/emboj.2009.335 28.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell Biol 2005;25:9269-82; PMID:16227579; http://dx.doi.org/10.1128/ MCB.25.21.9269-9282.2005 29.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nucleic Acids Res 2014; 42:7330-45; PMID:24823796; http://dx.doi.org/10.1093/nar/ gku357 30.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell Biol 2006; 26:523-34; PMID:16382144; http://dx.doi.org/10.1128/MCB.26.2.523-534.2006 31.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell Biol 2006; 26:513-22; PMID:16382143; http://dx.doi.org/10.1128/MCB.26.2.513-522.2006 32.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2012; 511:275-88; PMID:22713325; http://dx.doi.org/10.1016/B978-0-12-396546-2.00013-9 34.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Mol Cell 2009; 36:583-92;PMID: 19941819; http://dx.doi.org/10.1016/j.molcel.2009.09.039 35.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
J Biol Chem 2009;284:35079-91; PMID:19801658; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Wiley Interdiscip Rev RNA 2012; 3:397-414; PMID:22065625; http://dx.doi.org/10.1002/wrna.117 37.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Genes Dev 2007; 21:2312-25; PMID:17875666; http://dx.doi.org/10.1101/gad.1580507 38.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
EMBO J 2010; 29:2194-204; http://dx.doi.org/10.1038/ emboj.2010.10239.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2014; 42:1162-79; PMID:24165877;http://dx.doi.org/10.1093/nar/gkt985 40.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2015; 29:94-107; PMID:25561498; http://dx.doi.org/10.1101/gad.253070.114 41.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
EMBO J 2007; 26:4347-58; PMID:17882259; http://dx.doi.org/10.1038/sj.emboj.7601862 42.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Genetics2009; 183:195-206; PMID:19581443; http://dx.doi.org/10.1534/genetics.109.106955 43.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2010; 107:10020-5; PMID:20463285; http://dx.doi.org/10.1073/ pnas.0906022107 45.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2013; 27:413-28; PMID:23431055; http://dx.doi.org/10.1101/gad.207779.112 46.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Cell 2001; 107:347-59; PMID:11701125;http://dx.doi.org/10.1016/S0092-8674(01)00538-4 48.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2004; 18:387-96; PMID:14977919; http://dx.doi.org/10.1101/gad.1171804 49.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Nat Methods 2013; 10:676-82; PMID: 23749301; http://dx.doi.org/10.1038/nmeth.2519 51.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2012; 586:977-83; PMID:22569250; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2013; 25:1645-53; PMID:23628701;http://dx.doi.org/10.1016/j.cellsig.2013.04.007 53.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2012; 9:751-71; PMID:22699555; http://dx.doi.org/10.4161/ rna.20090 54.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
2008; 36:629- 39; PMID:18063569; http://dx.doi.org/10.1093/nar/gkm1074RNA BIOLOGY 329,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Plant Science 2011; 180:650-4;PMID:21421414; http://dx.doi.org/10.1016/j.plantsci.2011.01.006 56.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
FEBS Lett 2010; 584:3299-304; PMID:20621096; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Yeast 1998; 14:953-61; PMID:9717241; http://dx.doi.org/10.1002/(SICI)1097-0061(199807)14:10 <953::AID-YEA293 >3.0.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Yeast 2004; 21:947-62; PMID:15334558; http://dx.doi.org/10.1002/yea.1142 61.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
Methods Mol Biol 2009; 559:335-42; PMID:19609767; http://dx.doi.org/10.1007/978-1-60327-017-5_23330 A. U. HEININGER ET AL.,OADS,/arxiv_data1/oa_pdf/1b/8f/krnb-13-03-1142038.PMC4829300.pdf
"1, 25 –33 http://dx.doi.org/10.1080/15476286.2015.1128062",Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Rev Drug Discov 2004; 3:318-29;PMID:15060527; http://dx.doi.org/10.1038/nrd1345 2.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Curr Gene Ther 2008; 8:483-8; PMID:19075631; http://dx.doi.org/10.2174/156652308786848067 3.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Science 2002; 296:550-3; PMID:11910072; http://dx.doi.org/10.1126/ science.1068999 5.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Proc Natl Acad Sci U S A2002; 99:1443-8; PMID:11818553; http://dx.doi.org/10.1073/ pnas.032652399 7.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Biotechnol 2002; 20:505-8; PMID:11981566; http://dx.doi.org/10.1038/nbt0502- 505 8.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nature 2006;441:537-41; PMID:16724069; http://dx.doi.org/10.1038/nature04791 10.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Proc Natl Acad Sci U S A2008; 105:5868-73; PMID:18398004; http://dx.doi.org/10.1073/ pnas.0801775105 11.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Mol Ther Nucleic Acids 2014; 3:e145; PMID:24496437;http://dx.doi.org/10.1038/mtna.2013.73 12.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2012; 151:900-11;PMID:23141545; http://dx.doi.org/10.1016/j.cell.2012.09.042 13.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
BMC Mol Biol 2011; 12:34; PMID:21819628; http://dx.doi.org/10.1186/1471-2199-12-34 14.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Genet 2005; 37:1289-95; PMID:16200064; http://dx.doi.org/10.1038/ng1651 17.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
J Biol Chem 2005; 280:27595-603; PMID:15932881; http://dx.doi.org/ 10.1074/jbc.M504714200 19.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
EMBO J2005; 24:138-48; PMID:15565168; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2006; 125:887-901; PMID:16751099; http://dx.doi.org/10.1016/j.cell.2006.03.043 21.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
RNA 2008; 14:1834-44; PMID:18697922; http://dx.doi.org/10.1261/rna.1062908 22.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
RNA 2007; 13:1765-74; PMID:17698642; http://dx.doi.org/10.1261/rna.59910732 C. WATANABE ET AL.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
PLoS One 2011; 6:e26213; PMID:22031824; http://dx.doi.org/10.1371/journal.pone.0026213 24.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Mol Cell 2011; 41:733-46; PMID:21353615; http://dx.doi.org/ 10.1016/j.molcel.2011.02.008 25.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2013; 152:844-58; PMID:23415231; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell Rep 2013; 5:1704- 13; PMID:24332856; http://dx.doi.org/10.1016/j.celrep.2013.11.020 27.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Curr Biol 2002; 12:735-9; PMID:12007417; http://dx.doi.org/10.1016/S0960- 9822(02)00809-6 28.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nucleic Acids Res 2014; 42: D68-73; PMID:24275495; http://dx.doi.org/10.1093/nar/gkt1181 29.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2007; 129:1401-14; PMID:17604727; http://dx.doi.org/10.1016/j.cell.2007.04.040 30.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nature 2001; 411:494-8; PMID:11373684;http://dx.doi.org/10.1038/35078107 31.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Dev Biol 2008;321:482-90; PMID:18598689; http://dx.doi.org/10.1016/j.ydbio.2008.06.015 32.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
BMC Bioinformat- ics 2006; 7:520; PMID:17137497; http://dx.doi.org/10.1186/1471-2105-7-520 33.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Mol Cell2015; 60:131-45; PMID:26412306; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2003;115:199-208; PMID:14567917; http://dx.doi.org/10.1016/S0092-8674 (03)00759-1 35.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Cell 2003; 115:209-16; PMID:14567918;http://dx.doi.org/10.1016/S0092-8674(03)00801-8 36.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Mol Cell 2014; 56(6):796-807; PMID:25435137; http://dx.doi.org/10.1016/j.molcel.2014.10.025 38.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nucleic Acids Res 2014; 42:9424-35;PMID:25056318; http://dx.doi.org/10.1093/nar/gku656 39.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Curr Biol 2008; 18:147-51; PMID:18207740; http://dx.doi.org/10.1016/j.cub.2007.12.049 40.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Cell Biol 2014; 16:10-8; PMID:24366030; http://dx.doi.org/ 10.1038/ncb2895 41.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Methods 2006; 3:707-14; PMID:16929316; http://dx.doi.org/10.1038/nmeth923 42.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Meth- ods 2006; 3:715-9; PMID:16929317; http://dx.doi.org/10.1038/nmeth924 43.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Rev Mol Cell Biol 2014; 15:591-600; PMID:25145850; http://dx.doi.org/10.1038/nrm3860 44.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nat Methods 2009; 6:443-5; PMID:19448642; http://dx.doi.org/10.1038/ nmeth.1330 45.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
PLoS Genet2006; 2:e140; PMID:16965178; http://dx.doi.org/10.1371/journal.pgen.0020140 46.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Aging Cell 2003;2:209-17; PMID:12934714; http://dx.doi.org/10.1046/j.1474- 9728.2003.00054.x 47.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Gene Ther 2006; 13:576-81; PMID:16355113; http://dx.doi.org/10.1038/sj.gt.3302702 48.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Biotechniques 2006; 41:59-63; PMID:16869514; http://dx.doi.org/10.2144/000112203 49.,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
J Mol Biol 1990; 215:403-10; PMID:2231712;http://dx.doi.org/10.1016/S0022-2836(05)80360-2 50.,OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
Nucleic Acids Res 2003; 31:3406-15; PMID:12824337;http://dx.doi.org/10.1093/nar/gkg595RNA BIOLOGY 33,Non-OADS,/arxiv_data1/oa_pdf/59/d6/krnb-13-01-1128062.PMC4829305.pdf
"3, 353 –366 http://dx.doi.org/10.1080/15476286.2016.1146855",Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"a webpage using the JBrowse viewer, and can be assessed by http://jbrowse.molgenrug.nl/.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
The corrected genome hasalso been integrated in a JBrowse webpage (http://jbrowse.molgenrug.nl/).,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
64The gene products of lmRNAs of Campylobacter jejuni have been implicated in stress-responses such as DNA repair.65Genome2D [http://genome2D.molgen rug.nl] predicts the 111 L. lactis lmRNAs to be predominantly involved in the Gene Ontology (GO) classes “Nucleotide Metabolism ”and “DNA/RNA binding ”(Table S10).,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"81Pro- moters of sRNAs and asRNAs were assessed for the presence oftranscription factor binding sites (TFBS) by performing TFBSsearches on http://genome2d.molgenrug.nl/, using ¡100 to ¡1 upstream of the TSS.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Cell 2009; 136:615- 28; http://dx.doi.org/10.1016/j.cell.2009.01.043; PMID:19239884 2.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
RNA Biol 2010; 7:140-4; PMID:20220305; http://dx.doi.org/10.4161/rna.7.2.11056 3.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
TRENDS Genet 2013; 29:92-8; PMID:23141721; http://dx.doi.org/10.1016/j.tig.2012.10.004 4.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Cold Spring Harb Perspect Biol 2011; 3:pii: a003798; PMID:20980440; http://dx.doi.org/10.1101/cshperspect.a003798 5.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nat Rev Microbiol 2010;8:857-66; PMID:21079634; http://dx.doi.org/10.1038/nrmicro2457 6.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Cell host & microbe 2010; 8:116-27; PMID:20638647; http://dx.doi.org/10.1016/j.chom.2010.06.008 7.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Biochimie 2011; 93:1943-9; PMID:21816203; http://dx.doi.org/10.1016/j.biochi.2011.07.016 11.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Curr Opin Microbiol 2007; 10:125-33; PMID:17395525; http://dx.doi.org/10.1016/j.mib.2007.03.015 12.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nature Reviews Microbiology 2011; 9:578-89; PMID:21760622; http://dx.doi.org/10.1038/nrmicro2615 13.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Curr Opin Microbiol 2007; 10:134-9; PMID:17383928; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Trends Microbiol 2009; 17:399- 405; PMID:19733080; http://dx.doi.org/10.1016/j.tim.2009.06.003 15.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
PloS one 2013; 8:e55156; PMID:23457461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
EMBO J 2012; 31:4005-19; PMID:22922465;http://dx.doi.org/10.1038/emboj.2012.229 18.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Microbiol Mol Biol Rev 2011; 75:286-300; PMID:21646430; http://dx.doi.org/10.1128/MMBR.00032-10 2 0 .,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
J Bacteriol 2015; 197:18-28; PMID:25266388; http://dx.doi.org/10.1128/JB.02096-14 21.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
TRENDS in Genetics 2005; 21:399-404; PMID:15913835; http://dx.doi.org/10.1016/j.tig.2005.05.008 22.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Mol Microbiol 2007; 64:1260-73; PMID:17542919; http://dx.doi.org/10.1111/j.1365-2958.2007.05733.x 23.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Genes Dev 2011; 25:294-8; PMID:21325130; http://dx.doi.org/10.1101/gad.2030311 24.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
The seed region of a small RNA drives the controlled destruction of the target mRNA by the endoribonuclease RNase E. Mol Cell 2012; 47:943-53;PMID:22902561; http://dx.doi.org/10.1016/j.molcel.2012.07.015 25.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Genes Dev 2011; 25:385-96; PMID:21289064;http://dx.doi.org/10.1101/gad.2001711 26.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
EMBO J 2013; 32:2963-79; PMID:24141880; http://dx.doi.org/10.1038/emboj.2013.222 27.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
FEMS Microbiol Rev 2006; 30:3-16; PMID:16438677; http://dx.doi.org/10.1111/j.1574-6976.2005.004.x 29.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Cell 2013; 152:17-24; PMID:23332744; http://dx.doi.org/10.1016/j.cell.2012.12.024 30.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Mol Cell 2011; 43:867-79; PMID:21925376; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Base pairing interaction between 5 0-and 30- UTRs controls icaR mRNA translation in Staphylococcus aureus.PLoS genetics 2013; 9:e1004001; PMID:24367275; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Genome Res 2011; 21:1487-97;PMID:21665928; http://dx.doi.org/10.1101/gr.119370.110 34.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nature 2010; 464:250-5; PMID:20164839; http://dx.doi.org/10.1038/nature08756 36.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Envi- ron Microbiol 2012; 14:2006-16; PMID:22533370; http://dx.doi.org/10.1111/j.1462-2920.2012.02759.x 37.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Curr Opin Microbiol 2011; 14:167-73; PMID:21342783;http://dx.doi.org/10.1016/j.mib.2011.01.007 38.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
J Bacteriol 2007;189:3256-70; PMID:17307855; http://dx.doi.org/10.1128/JB.01768-06 39.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
FEMS Microbiol Rev 1999; 23:483-501;PMID:7665513; http://dx.doi.org/10.1111/j.1574-6976.1999.tb00409.x 40.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"J Bacteriol 2007; 189:1366-81; PMID:17028270;http://dx.doi.org/10.1128/JB.01013-06 42. den Hengst CD, van Hijum SA, Geurts JM, Nauta A, Kok J, Kuipers OP.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"J Biol Chem 2005; 280:34332-42; PMID:16040604; http://dx.doi.org/10.1074/jbc.M502349200 43. van Hijum SA, Medema MH, Kuipers OP.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"MicrobiolMol Biol Rev 2009; 73:481,509; PMID:19721087; http://dx.doi.org/ 10.1128/MMBR.00037-08 44. de Jong A, Hansen ME, Kuipers OP, Kilstrup M, Kok J.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
PloS one 2013; 8:e53085; PMID:23349698; http://dx.doi.org/10.1371/journal.pone.0053085 45.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
PloS one 2008; 3:e3197; PMID:18787707; http://dx.doi.org/10.1371/ journal.pone.0003197 46.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2009; 37:W202-8; PMID:19458158; http://dx.doi.org/10.1093/nar/gkp335 47.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
FEMS Microbiol Lett 2000; 192:85-9; PMID:11040433; http://dx.doi.org/10.1111/j.1574-6968.2000.tb09363.x 49.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Curr Opin Microbiol 2013; 16:125-32; PMID:23415757;http://dx.doi.org/10.1016/j.mib.2012.12.005 50.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2013; 41:D233-8; PMID:23203879; http://dx.doi.org/10.1093/nar/gks1264 51.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Cell 2000; 101:613-23; PMID:10892648; http://dx.doi.org/ 10.1016/S0092-8674(00)80873-952.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.Cell 1983; 35:849-57; PMID:6197186; http://dx.doi.org/10.1016/0092-8674(83)90117-4 53.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
EMBO J 1999; 18:3793-9; PMID:10393194; http://dx.doi.org/10.1093/emboj/18.13.3793 54.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Proc NatlAcad Sci U S A 2014; 111:3134-9; PMID:24453212; http://dx.doi.org/ 10.1073/pnas.1315974111 55.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Appl Environ Microbiol 2007; 73:7771-80; PMID:17933937; http://dx.doi.org/10.1128/AEM.01273-07 56.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2011; 39:6879-85; PMID:21609952; http://dx.doi.org/10.1093/nar/gkr390 57.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, Loh E, Gripenland J, Tiensuu T, Vaitkevicius K. The lis-teria transcriptional landscape from saprophytism to virulence.Nature 2009; 459:950-6; PMID:19448609; http://dx.doi.org/10.1038/ nature08080 58.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
FEBS Lett 2010; 584:318-24; PMID:19932103;http://dx.doi.org/10.1016/j.febslet.2009.11.056 59.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
FEMS MicrobiolRev 2005; 29:555-90; PMID:15935511; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Annu Rev Biochem 2014; 83:753-77; PMID:24606146; http://dx.doi.org/10.1146/annurev-biochem-070611-102400 61.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Bioinformatics 2014; 30:1236-40; PMID:24451626; http://dx.doi.org/10.1093/bioinformatics/btu031 63.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"Bioinformatics 2014; 30:971-4; PMID:24371151; http://dx.doi.org/10.1093/bioinformatics/btt752 64. de Groot A, Roche D, Fernandez B, Ludanyi M, Cruveiller S, Pignol D, Vallenet D, Armengaud J, Blanchard L. RNA sequencing and proteo-genomics reveal the importance of leaderless mRNAs in the radiation- tolerant bacterium Deinococcus deserti.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Genome Biol Evol 2014; 6:932-48; PMID:24723731; http://dx.doi.org/10.1093/gbe/evu069 65.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
BMC Genomics 2013; 14:616; PMID:24028687; http://dx.doi.org/10.1186/1471-2164-14-616 66.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Ribo- somes bind leaderless mRNA in escherichia coli through recognition of their 5 0-terminal AUG. RNA 2008; 14:2159-69; PMID:18755843; http://dx.doi.org/10.1261/rna.1089208 67.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Bioinformatics 1998; 14:48-54; PMID:9520501; http://dx.doi.org/10.1093/bioinformatics/14.1.48 68.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
J Mol Biol 2003; 326:1361-72; PMID:12595250; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2013; 41:e140; PMID:23716638;http://dx.doi.or g/10.1093/nar/gkt444 70.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2014; 42:10579-95; PMID:25143534; http://dx.doi.org/10.1093/ nar/gku762 71.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Biol Chem 2008; 389:285-97; PMID:18177266; http://dx.doi.org/10.1515/BC.2008.023 72.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
J Bacteriol 2007; 189:1366-81; PMID:17028270; http://dx.doi.org/10.1128/JB.01013-06 73.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
RNA 2012; 18:530-46; PMID:22274957; http://dx.doi.org/10.1261/rna.027359.111 74.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Annu RevMicrobiol 2014; 68:45-60; PMID:24742053; http://dx.doi.org/10.1146/annurev-micro-092611-150135 75.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Int J Food Microbiol 2011; 145:186-94; PMID:21262549; http://dx.doi.org/10.1016/j.ijfoodmicro.2010.12.01176.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Appl Environ Microbiol 2012; 78:5612-21; PMID:22660716; http://dx.doi.org/10.1128/AEM.00455-12 77.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2007; 35:e55; PMID:17389646; http://dx.doi.org/10.1093/nar/gkm106 78.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nature methods 2012; 9:357-9; PMID:22388286; http://dx.doi.org/ 10.1038/nmeth.1923 80.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Genome Biol 2004; 5:R37; PMID:15128451; http://dx.doi.org/10.1186/gb-2004-5-5-r37 81.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"Brief Bioinform 2013; 14:193-202; PMID:22445902; http://dx.doi.org/10.1093/bib/bbs012 82. de Jong A, van der Meulen S, Kuipers OP, Kok J. T-REx: Transcrip- tome analysis webserver for RNA-seq expression data.",OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
BMC Geno- mics 2015; 16:663; PMID:26335208; http://dx.doi.org/10.1186/ s12864-015-1834-4 83.,Non-OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
Nucleic Acids Res 2003; 31:3406-15; PMID:12824337; http://dx.doi.org/10.1093/nar/gkg595366 S. B.,OADS,/arxiv_data1/oa_pdf/42/d1/krnb-13-03-1146855.PMC4829306.pdf
"7The MSL complex is recruited to transcribed genes.8A histoneKeywords: 1.688Xrepeats, 359 bp repeats, dosage compensation, Drosophilamelanogaster, roX RNA, siRNA, satelliterepeats, X recognition © Debashish U Menon and Victoria H Meller *Correspondence to: Victoria H Meller; Email: vmeller@biology.biosci.wayne.edu Submitted: 07/22/2015Revised: 08/17/2015Accepted: 08/21/2015 http://dx.doi.org/10.1080/15476286.2015.1086864 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
A nn Rev Genet 2005; 39:615-51; http://dx.doi.org/10.1146/ annurev.genet.39.073003.0942 10 3.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nat Genet 2011; 43:1179-85; http://dx.doi.org/ 10.1038/ng.948 4.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cold Spring Harb Symp Quant Biol 2010;75:345-56; http://dx.doi.org/10.1101/sqb.2010.75.030 5.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
"Leung KN, Panning B. X-inactivation: Xist RNA uses chromosome contacts to coat the X. Curr Biol 2014;24:R80-2; PMID:24456982; http://dx.doi.org/ 10.1016/j.cub.2013.11.052 6.",OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 1995; 81:867- 77; PMID:7781064; http://dx.doi.org/10.1016/0092- 8674(95)90007-1 8.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genes Dev 2006; 20:848-57; PMID:16547173; http://dx.doi.org/ 10.1101/gad.14002069.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2000; 5:367-75; PMID:10882077; http://dx.doi.org/10.1016/S1097-2765(00)80431-1 10.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell Biol2000; 20:312-18; http://dx.doi.org/10.1128/ MCB.20.1.312-318.2000 11.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Science 2006; 311:844-47; PMID:16469925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
J Mol Biol 2011; 414:749-64; http://dx.doi.org/10.1016/j.jmb.2011.10.031 13.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nature 2011; 471:115-8; PMID:21368835; http://dx.doi.org/10.1038/ nature09757 14.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell Rep 2013; 5:629-36; PMID:24183666; http://dx.doi.org/10.1016/j.celrep.2013.09.037 15.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2014; 54:920-31; PMID:24837678; http://dx.doi.org/10.1016/j.molcel.2014.04.013 17.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2011; 43:132-44; PMID:21726816; http://dx.doi.org/10.1016/j.molcel.2011.05.015 18.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 2008; 134:599-609;PMID:18724933; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
The chromosomal high-afﬁnity binding sites for the Drosophila dosage compensation complex.PLoS Genet 2008; 4:e1000302; PMID:19079572; http://dx.doi.org/10.1371/journal.pgen.1000302 21.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genes Dev 2007; 21:2030-40; PMID:17699750;http://dx.doi.org/10.1101/gad.430807 23.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2007; 28:121-33; PMID:17936709; http://dx.doi.org/10.1016/j.molcel.2007.08.011 24.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nat Struct Mol Biol 2008; 15:1318-25; PMID:19029895; http://dx.doi.org/ 10.1038/nsmb.1520 25.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell Biol 2008; 28:3401-9; PMID:18347056; http://dx.doi.org/10.1128/ MCB.00006-08 26.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Devel- opment 2009; 136:1399-410; PMID:19363150; http://dx.doi.org/10.1242/dev.029645 27.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genetics 2012; 191:1023-8; PMID:22554892; http://dx.doi.org/10.1534/genetics.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
"Meller VH, Wu KH, Roman G, Kuroda M, David R. roX1 RNA paints the X chromosome of male Drosoph- ila and is regulated by the dosage compensation system.Cell 1997; 88:445-57; PMID:9038336; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
EMBO J 2002; 21:1084-91; PMID:11867536; http://dx.doi.org/10.1093/emboj/ 21.5.1084 30.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genetics 2006; 174:1859-66; PMID:17028315; http://dx.doi.org/10.1534/genetics.106.064568 31.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genes Dev 2003; 17:1334-9; PMID:12782651; http://dx.doi.org/10.1101/gad.1082003 32.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
EMBO J 2001; 20:2236-45;PMID:11331589; http://dx.doi.org/10.1093/emboj/ 20.9.2236 33.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 1999; 98:513-22; PMID:10481915; http://dx.doi.org/10.1016/S0092- 8674(00)81979-0 34.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genes Dev 2007; 21:2300-11; PMID:17875665; http://dx.doi.org/10.1101/gad.1564307 36.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
PLoS Genet 2013; 9:e1003780; PMID:24068954; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Science 2004;303:669-72; PMID:14752161; http://dx.doi.org/ 10.1126/science.1092653 38.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nature 2011; 480:391-5; PMID:22056986; http://dx.doi.org/10.1038/nature 10492 39.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 2006; 125:873-86;PMID:16751098; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nat Genet 2005; 37:809-19; PMID:15976807; http://dx.doi.org/10.1038/ng1602 41.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nat Structural Mol Biol 2013; 20:202-9; http://dx.doi.org/10.1038/nsmb.2477 42.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Int J Dev Biol 2009; 53:245-57;http://dx.doi.org/10.1387/ijdb.082691av 43.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Biol Evolution 2012; 29:7- 11; http://dx.doi.org/10.1093/molbev/msr173 44.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genet- ics 2007; 176:1343-49; PMID:17409066; http://dx.doi.org/10.1534/genetics.107.071720 47.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genome Biol Evol 2014; 6:1279-86; http://dx.doi.org/10.1093/gbe/evu104 49.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mech Dev 2003; 120:759-67; http://dx.doi.org/ 10.1016/S0925-4773(03)00157-6 50.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nat Struct Mol Biol 2013; 20:202-9; http://dx.doi.org/10.1038/nsmb.2477 51.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell Rep 2014; 7:376-85; PMID:24703844; http://dx.doi.org/10.1016/j.celrep.2014.03.011 52.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell Biol 2003; 23:6484-93; PMID:12944475; http://dx.doi.org/10.1128/MCB.23.18.6484-6493.200353.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Trends Biochem Sci 2014; 39:170-82; http://dx.doi.org/ 10.1016/j.tibs.2014.01.002 54.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2013; 51:606-17; PMID:23993744; http://dx.doi.org/10.1016/j.molcel.2013.07.022 55.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nature 2011; 480:391-5; PMID:22056986; http://dx.doi.org/10.1038/nature 10492 56.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
RNAi-independent role for Argo- naute2 in CTCF/CP190 chromatin insulator function.Genes Dev 2011; 25:1686-701; PMID:21852534; http://dx.doi.org/10.1101/gad.16651211 57.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Wiley Interdiscip Rev RNA 2011; 2:748-60; PMID:21823233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Nature 2011; 471:527-31; http://dx.doi.org/ 10.1038/nature09990 60.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Trends Genet 1998; 14:200-4; http://dx.doi.org/10.1016/S0168- 9525(98)01444-9 61.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
PLoS Biol 2009; 7:e1000234; PMID:19859525; http://dx.doi.org/ 10.1371/journal.pbio.1000234 62.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Transcription 2014; 4:238-50; http://dx.doi.org/10.4161/trns.26185 64.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Development 2006; 133:4475-83; PMID:17035293;http://dx.doi.org/10.1242/dev.02620 65.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Cell 2006; 21:811-23; PMID:16543150; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
PLoS Genet 2010; 6:e1000846; PMID:20174442; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
"Genes Dev 2009; 23:2490-5; PMID:19884256; http://dx.doi.org/10.1101/ gad.539509 68. de Wit E, de Laat W. A decade of 3C technologies: insights into nuclear organization.",OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Genes Dev 2012; 26:11-24; PMID:22215806; http://dx.doi.org/10.1101/gad.179804.111 1092 Volume 12 Issue 10 RNA Biology,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 2014; 159:1665-80; PMID:25497547; http://dx.doi.org/10.1016/j.cell.2014.11.021 70.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 2012; 148:458-72; PMID:22265598; http://dx.doi.org/ 10.1016/j.cell.2012.01.010 71.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Genet Genomics 2002; 267:647-55; http://dx.doi.org/10.1007/s00438-002-0698-x 72.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Human Mol Genet 2012; 21:4367-77; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
PLoS Genet 2009;5:e1000394; PMID:19247430; http://dx.doi.org/ 10.1371/journal.pgen.1000394 74.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol Ther 2013; 21:1536-50; http://dx.doi.org/10.1038/mt.2013.131 75.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Cell 2006; 124:886-8; PMID:16530034; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
EMBO J 2003; 22:2463-71; http://dx.doi.org/10.1093/emboj/ cdg241 77.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
Mol General Genet MGG 2000; 264:371-7; PMID:11129040; http://dx.doi.org/ 10.1007/s004380000331 79.,Non-OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
BMC Evol Biol 2014; 14:233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/06/krnb-12-10-1086864.PMC4829311.pdf
"Published with license by Taylor & Francis Group, LLC © Aleksandra E Kornienko, Irena Vlatkovic, J €urgen Neesen, Denise P Barlow, and Florian M Pauler This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"2, 196 –220 http://dx.doi.org/10.1080/15476286.2015.1110676",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"For this purpose we focused on a lncRNA, that was identi ﬁed in a tiling array based study to be close to the SLC38A4 protein- coding gene and named “SLC38A4-down ”.49It is noteworthy that mouse Slc38a4 shows imprinted expression in extra-embryonic, embryonic and adult tissues50as well as in cell culture cells.51No lncRNA has been reported to be involved in regulating Slc38a4 imprinted expression which is, to date, con- sidered a solo imprinted gene ( http://igc.otago.ac.nz).",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
In order to maximize the usefulness of this data for thescienti ﬁc community we provide a UCSC genome browser hub to display all the RNA-Seq data as well as the information on gene trap insertion sites pre- sented in this paper (https://opendata.cemm.at/bar- lowlab/).,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"Results LOC100288798 is a ubiquitously expressed, inefﬁciently processed lncRNA LOC100288798 lncRNA is annotated by several reference gene databases including RefSeq52and GENCODE v19 (http://www.gencodegenes.org/releases/19.html,54)a sa 269kb lncRNA on human chromosome 12 ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
every analyzed sample and its ubiquitous expression is known (http://www.protei natlas.org/ENSG00000134294- SLC38A2/tissue).,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"org/ENSG00000139209-SLC38A4/tissue, Expression Atlas:http://www.ebi.ac.uk/gxa/ge nes/ENSG00000 139209).",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"Importantly, we identi ﬁed 857 GEN- CODE v19 lncRNAs (http://www.gencodegenes.org/ releases/19.html) for which KBM7 gene trap insertions cell lines are available (Methods and https://opendata.",OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Methods RPKM calculation RPKMs were calculated using RPKM_count.py from RSeQC package (https://code.google.com/p/rseqc/) using –skip-multi-hits option.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
KBM7 cell culture All gene trap KBM7 cell lines were obtained frozen from Horizon Genomics GmbH (http://www.horizon-geno mics.com/).,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
50bp single-end RNA- sequencing was performed at the Biomedical Sequencing Facility (http://biomedical-sequencing.at/BSF/) using Illumina HiSeq 2000.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
To determine the number of lncRNAs with gene trap insertion sites we downloaded cassette insertion sites from http://kbm7.genomebrowser.cemm.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Insertion sites can be updated and genetrap insertion sites used in this publication are available from http://opendata.cemm.at/barlowlab.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
GENCODE v19 lncRNA annotation was obtained at ftp://ftp.sanger.ac.uk/pub/ gencode/Gencode_human/release_19/gencode.v19.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
5 A) were deposited in NCBI ’s Gene Expression Omnibus 81and are accessible through GEO Series accession number GSE71284 (http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"Full de novo assembly in the 1Mb region around SLC38A4-AS lncRNA, RNA-seq signal in 8 sequenced KBM7 cell lines as well as location of gene trap insertion cassettes used in the study can be viewed in the related UCSC genome browser hub via https://opendata.cemm.at/barlowlab/.",OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"Acknowledgments We thank Horizon Genomics GmbH for providing the KBM7 cell lines, Claudia Kerzendorfer and Sebastian Nijman for han-dling KBM7 cells and the Biomedical Sequencing Facility(http://biomedical-sequencing.at/) for advice and performing RNA sequencing.",Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell 2013; 154:26 –46; PMID:23827673; http://dx.doi.org/10.1016/j.cell.2013.06.020 2.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Genet 2015; 47(3):199 –208; PMID:25599403; http://dx.doi.org/10.1007/82_2015_444 3.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Br J Cancer2013; 108:2419 –25; PMID:23660942; http://dx.doi.org/ 10.1038/bjc.2013.233 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell 2013;152:1298 –307; PMID:23498938; http://dx.doi.org/10.1016/ j.cell.2013.02.012 5.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Biotechnol 2011; 29:742 –9; PMID:21804560; http://dx.doi.org/ 10.1038/nbt.1914 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature 2015; 518:409 –12; PMID:25470045; http://dx.doi.org/10.1038/nature13975 8.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Rev Drug Dis-cov 2013; 12:433 –46; PMID:23722346; http://dx.doi.org/ 10.1038/nrd4018 9.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Essays Biochem 2013; 54:127 –45; PMID:23829532; http://dx.doi.org/10.1042/bse0540127 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature 2010; 465:1033 –8; PMID:20577206; http://dx.doi.org/ 10.1038/nature09144 12.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature 2010; 464:1071 –6; PMID:20393566; http://dx.doi.org/10.1038/nature08975 13.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature2011; 472:120 –4; PMID:21423168; http://dx.doi.org/ 10.1038/nature09819 14.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Sci- ence 2012; 338:1469 –72; PMID:23239737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genes Dev 2011; 25:1915 – 27; PMID:21890647; http://dx.doi.org/10.1101/ gad.17446611 1 8 .,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Biol 2015; 16:20;PMID:25630241; http://dx.doi.or g/10.1186/s13059-015-0586-4 19.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
GenomeRes 2012; 22:1616 –25; PMID:22955974; http://dx.doi.org/ 10.1101/gr.134445.111 20.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Embo J 2006; 25:3565 –75; PMID:16874305; http://dx.doi.org/10.1038/ sj.emboj.7601245 21.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Biol 2012; 13:R107; PMID:23181609; http://dx.doi.org/10.1186/gb-2012-13-11-r107 22.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Struct Mol Biol 2014; 21:198 –206; PMID:24463464; http://dx.doi.org/ 10.1038/nsmb.2764 23.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature 2011; 477:295 –300; PMID: 21874018; http://dx.doi.org/10.1038/nature10398 24.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell 2011;147:1537 –50; PMID:22196729; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Mol Cell 2010; 39:925 –38; PMID:20797886; http://dx.doi.org/10.1016/j.molcel.2010.08.011 26.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Biotechnol 2014; 32:347 –55; PMID:24584096; http://dx.doi.org/10.1038/ nbt.2842 28.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Elife 2013; 2:e01749; PMID:24381249; http://dx.doi.org/ 10.7554/eLife.01749 29.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell Stem Cell 2015; 16:504 –16; PMID:25891907; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
CellReports 2012; 2:111 –23; PMID:22840402; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
RNA Biol 2014;11:829 –35; PMID:25137067; http://dx.doi.org/10.4161/ rna.29624 32.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Elife 2014; 3:e03058;PMID:25124674; http://dx.doi.org/10.7554/eLife.03058 33.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Genet 2004; 36:543 –4; PMID:15167922; http://dx.doi.org/10.1038/ng0604-543 34.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Mamm Genome 1996; 7:20 –4; PMID:8903723; http://dx.doi.org/10.1007/s003359900006 36.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cold Spring Harb Perspect Biol 2014; 6:a018382;PMID:24492710; http://dx.doi.org/10.1101/cshperspect.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"Biochim Biophys Acta 2015; PMID:26004516; http://dx.doi.org/10.1016/j.bbagrm.2015.05.006 38. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson- Smith AC.",OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Trends Genet 2008; 24:306 –16; PMID: 18471925; http://dx.doi.org/10.1016/j.tig.2008.03.011 39.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell Mol Life Sci 2014; 71:4421 –30; PMID:25098353; http://dx.doi.org/10.1007/s00018-014-1698-9 40.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
The non-coding Air RNA is required for silencing autosomal imprinted genes.Nature 2002; 415:810 –3; PMID:11845212; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
PLoS Genet 2013; 9: e1004039; PMID:24385930; http://dx.doi.org/10.1371/ journal.pgen.1004039 43.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Res2011; 21:1944 –54; PMID:21844124; http://dx.doi.org/ 10.1101/gr.122358.111 45.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Methods2013; 10:965 –71; PMID:24161985; http://dx.doi.org/ 10.1038/nmeth.2609 46.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Development 2013; 140:1184 –95; PMID:23444351; http://dx.doi.org/ 10.1242/dev.088849 47.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cancer Genet Cytogenet 1987; 24:335 –43; PMID: 3466682; http://dx.doi.org/10.1016/0165-4608(87)90116-6 48.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Dev Dyn 1998; 212:214 –28; PMID:9626496; http://dx.do i.org/10.1002/(SICI)1097- 0177(199806)212:2%3c214::A ID-AJA6%3e3.0.CO;2-K 49.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Res 2003; 13:558 –69; PMID:12670997; http://dx.doi.org/10.1101/gr.781503 51.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nucleic Acids Res 2014; 42:D756 –63; PMID:24259432; http://dx.doi.org/10.1093/nar/gkt1114 53.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Struct Mol Biol 2015; 22:5 –7; PMID:25565026; http://dx.doi.org/10.1038/nsmb.2942 54.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Res 2012;22:1760 –74; PMID:22955987; http://dx.doi.org/10.1101/ gr.135350.111 55.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Bioinformatics 2013; 29:15 –21; PMID:23104886; http://dx.doi.org/ 10.1093/bioinformatics/bts635 56.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Res 2012; 22:1775 –89; PMID:22955988; http://dx.doi.org/10.1101/gr.132159.111 57.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell 1992; 71:515 –26; PMID:1423610; http://dx.doi.org/ 10.1016/0092-8674(92)90519-I 59.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Protoc 2012; 7:562 –78; PMID:22383036; http://dx.doi.org/10.1038/ nprot.2012.016 60.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
PLoS One 2011; 6:e27288; PMID:22102886; http://dx.doi.org/10.1371/journal.pone.0027288 62.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Biotechnol 2013;31:46 –53; PMID:23222703; http://dx.doi.org/10.1038/ nbt.2450 63.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nature 2012; 482:310 –1; PMID:22337043; http://dx.doi.org/10.1038/482310a 64.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Rev Genet 2011; 12:542 –53; PMID:21765457; http://dx.doi.org/10.1038/nrg3035 65.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Mol Cell 2002; 10:1441 –52; PMID:12504018; http://dx.doi.org/ 10.1016/S1097-2765(02)00778-5 66.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Curr Opin Genet Dev 2011;21:366 –72; PMID:21497503; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Hum Gene Ther 2007; 18:849 –60; PMID:17767401; http://dx.doi.org/10.1089/hum.2007.067 68.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genes Dev 2001; 15:2361 –6; PMID:11562346; http://dx.doi.org/ 10.1101/gad.20620169.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Science 2008; 322:1717 –20; PMID:18988810; http://dx.doi.org/10.1126/science.1163802 70.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Genet 2015; 47:544 –9; PMID:25848752; http://dx.doi.org/10.1038/ng.3274 71.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Genome Res 2015; 25:927 –36; PMID:25953952; http://dx.doi.org/10.1101/ gr.192278.115 72.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
J Cell Sci 2014; 127:3641 –8; PMID:25128561; http://dx.doi.org/10.1242/jcs.154906 73.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Cell Rep 2013; 4:642 –8; PMID: 23954783; http://dx.doi.org/10.1016/j.celrep.2013.07.020 74.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Blood 2010; 115:4039 –42; PMID:20233975; http://dx.doi.org/10.1182/blood-2009-07-231845 75.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Annu Rev Physiol 2014; 76:177 –95; PMID:24215441; http://dx.doi.org/10.1146/annurev-physiol-030212-183758 78.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Stem CellsDev 2011; 20:1937 –50; PMID:21542696; http://dx.doi.org/ 10.1089/scd.2010.0574 79.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nat Biotechnol2011; 29:542 –6; PMID:21623355; http://dx.doi.org/ 10.1038/nbt.1857 80.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Biochem Biophysi- cal Res Commun 2012; 422:643 –6; PMID:22609201; http://dx.doi.org/10.1016/j.bbrc.2012.05.043RNA BIOLOGY 219,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
Nucleic Acids Res 2002; 30:207-10; PMID:11752295; http://dx.doi.org/10.1093/nar/ 30.1.20782.,OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
A promoter-level mammalian expression atlas.Nature 2014; 507:462 –70; PMID:24670764; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/b6/krnb-13-02-1110676.PMC4829315.pdf
"21In other words, the requirement for a double- stranded structural context is much more important than the pri-mary nucleotide composition in specifying a potential ADAR © Alborz Mazloomian and Irmtraud M meyer *Correspondence to: Irmtraud Meyer; Email: irmtraud.meyer@cantab.netSubmitted: 07/13/2015; Revised: 09/16/2015; Accepted: 10/08/2015 http://dx.doi.org/10.1080/15476286.2015.1107703 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
"Next, we employ P ICARD -TOOLS (http://broadinstitute.github.io/picard)to remove duplicates from each techni-cal replicate.",Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nature 2001; 409:814-6; PMID:11236992; http://dx.doi.org/ 10.1038/35057267 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nature 1970; 227:561-3; PMID:4913914; http://dx.doi.org/ 10.1038/227561a0 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
TRENDS Genet 2001; 17:100-7; PMID:11173120; http://dx.doi.org/ 10.1016/S0168-9525(00)02176-4 4.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
PLoS Biol 2004; 2:e391;PMID:15534692; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Biotechnol 2012; 30:253-60; PMID:22327324; http://dx.doi.org/ 10.1038/nbt.2122 7.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Annu Rev Biochem 2010; 79:321-49; PMID:20192758; http://dx.doi.org/ 10.1146/annurev-biochem-060208-105251 8.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Major transcript of the frame- shifted coxll gene from trypanosome mitochondria con- tains four nucleotides that are not encoded in the DNA.Cell 1986; 46:819-26; PMID:3019552; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Science 2009; 324:1210-3; PMID:19478186; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Methods 2012; 9:579-81; PMID:22484847; http://dx.doi.org/ 10.1038/nmeth.1982 13.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res 2012; 22:142-50; PMID:21960545; http://dx.doi.org/10.1101/gr.124107.111 14.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res 2012; 22:1477-87; PMID:22645261; http://dx.doi.org/10.1101/gr.131912.111 15.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
PloS ONE 2012; 7:e33720; PMID:22448268; http://dx.doi.org/ 10.1371/journal.pone.0033720 16.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nature 2011; 471:473-9; PMID:21179090; http://dx.doi.org/10.1038/nature 09715 18.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nature Methods2013; 10:128-32; PMID:23291724; http://dx.doi.org/ 10.1038/nmeth.2330 19.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Mol Cell 2012; 47:27-37; PMID:22658416;http://dx.doi.org/10.1016/j.molcel.2012.05.002 20.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res2004; 14:2379-87; PMID:15545495; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Annu Rev Biochem 2002; 71:817-46; PMID:12045112; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Biochem Biophys Res Commun 2011; 412:407-12; PMID:21835166; http://dx.doi.org/10.1016/j.bbrc.2011.07.075 23.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
RNA 2006; 12:1802-9; PMID:16940548; http://dx.do i.org/10.1261/rna.165106 2 4 .,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Science 2003; 301:832-6; PMID:12907802;http://dx.doi.org/10.1126/science.1086763 25.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
SeminCell Dev Biol 2012:281-8; http://dx.doi.org/10.1016/ j.semcdb.2011.11.004 26.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2005; 33:1162-8; PMID:15731336; http://dx.doi.org/ 10.1093/nar/gki239 27.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Struct Mol Biol 2005; 12:489-96; PMID:15895094;http://dx.doi.org/10.1038/nsmb936 29.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
PloS ONE2011; 6:e18129; PMID:21448465; http://dx.doi.org/ 10.1371/journal.pone.0018129 31.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Commun 2011; 2:319; PMID:21587236; http://dx.doi.org/ 10.1038/ncomms1324 1400 Volume 12 Issue 12 RNA Biology,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2013; 41:2581-93; PMID:23275536; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res 2009; 19:978-86; PMID:19420382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
RNA 2013; 19:591-604; PMID:23474544; http://dx.doi.org/10.1261/rna.038042.112 36.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
J Biol Chem 2004; 279:4941-51; PMID:14660658; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Cross-map- ping and the identiﬁcation of editing sites in mature microRNAs in high-throughput sequencing libraries.Genome Res 2010; 20:257-64; PMID:20051556; http://dx.doi.org/10.1101/gr.095273.109 39.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nature 2009; 459:927-30; PMID:19536255; http://dx.doi.org/10.1038/459927a 41.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Biotech- nol 2012; 30:246-7; PMID:22398619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2014; 42:5245-55; PMID:24561617; http://dx.doi.org/10.1093/nar/gku145 44.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res 2012;22:1468-76; PMID:22310477; http://dx.doi.org/ 10.1101/gr.133025.111 45.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Bioinformatics2006; 22:614-5; PMID:16368769; http://dx.doi.org/ 10.1093/bioinformatics/btk014 47.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nat Protoc 2008; 4:44-57; http://dx.doi.org/10.1038/nprot.2008.211 48.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
J Biol Chem 2011; 286:8325-37; PMID:21078670; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Res 2012; 22:2008-17; PMID:22722343; http://dx.doi.org/ 10.1101/gr.133744.111 51.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
PLoS Comput Biol 2010; 6:e1000823; PMID:20589081; http://dx.doi.org/10.1371/journal.pcbi.1000823 52.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2003; 31:3423-8; PMID:12824339; http://dx.doi.org/10.1093/nar/gkg614 54.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
BMC Bioinformatics 2008; 9:474; PMID:19014431; http://dx.doi.org/10.1186/1471-2105-9-474 55.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
PLoS Computat Biol 2007; 3:1441-54; http://dx.doi.org/10.1371/journal.pcbi.0030149 56.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genes Dev 2011; 25:2502-12; PMID:22156210; http://dx.doi.org/ 10.1101/gad.178962.111 57.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2002; 30:2478-83; PMID:12034836; http://dx.doi.org/10.1093/nar/ 30.11.2478 58.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 1999; 27:2369-76; PMID:10325427; http://dx.doi.org/10.1093/nar/ 27.11.2369 59.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
J Mol Biol 1970; 48:443-53; PMID:5420325; http://dx.doi.org/10.1016/0022-2836(70)90057-4 60.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2014; 42: D749-D55; PMID:24316576; http://dx.doi.org/10.1093/nar/gkt1196 61.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Genome Biol 2013; 14:R36; PMID:23618408; http://dx.doi.org/10.1186/gb-2013-14-4-r36 62.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Bioinformatics2010; 26:730-6; PMID:20130035; http://dx.doi.org/ 10.1093/bioinformatics/btq040 63.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Cell 1993; 75:1361-70;PMID:8269514; http://dx.doi.org/10.1016/0092- 8674(93)90622-W 65.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2012; 40:9876-86;PMID:22848101; http://dx.doi.org/10.1093/nar/ gks691 66.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 1981; 9:133-48; PMID:6163133; http://dx.doi.org/10.1093/nar/9.1.133 67.,OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
Nucleic Acids Res 2012; 40:e95; PMID:22434875; http://dx.doi.org/10.1093/nar/ gks241 www.tandfonline.com 1401 RNA Biology,Non-OADS,/arxiv_data1/oa_pdf/bd/18/krnb-12-12-1107703.PMC4829317.pdf
"2, 128 –133 http://dx.doi.org/10.1080/15476286.2015.1096484",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
PeerJ 2013; 1:e2; PMID:23638354; http://dx.doi.org/10.7717/peerj.2 2.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
PLoS Comput Biol 2012; 8:e1002641; PMID:22912569;http://dx.doi.org/10.1371/journal.pcbi.1002641 3.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Cold Spring Harb Perspect Biol 2011; 3:a003707; PMID:21441581; http://dx.doi.org/10.1101/cshperspect.a003707 5.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Curr Opin Struct Biol 2014; 24:141-9; PMID:24530854; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nat Struct Mol Biol 2009; 16:1237-43; PMID:19935684;http://dx.doi.org/10.1038/nsmb.1729 7.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
RNA 2010; 16:2384-403; PMID:20980672; http://dx.doi.org/ 10.1261/rna.2456210RNA BIOLOGY 131,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
FEBS Lett 2002; 528:171-6; PMID:12297299; http://dx.doi.org/10.1016/S0014-5793(02)03294-5 10.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nature 2011;475:408-11; PMID:21753750; http://dx.doi.org/10.1038/nature10171 11.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Mol Cell 2003;11:965-76; PMID:12718882; http://dx.doi.org/10.1016/S1097-2765(03)00115-1 12.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nucleic Acids Res 2013; 41:3859-73; PMID:23376934; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Annu Rev Genet 2002; 36:333-60; PMID:12429696; http://dx.doi.org/10.1146/ annurev.genet.36.043002.091635 14.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nat Chem Biol 2008; 4:435-9; PMID:18641616; http://dx.doi.org/10.1038/nchembio0808-435 15.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
EMBO J 2004; 23:4847-56; PMID:15565172; http://dx.doi.org/ 10.1038/sj.emboj.7600482 16.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nat Struct Mol Biol 2014; 21:911-8; PMID:25218446; http://dx.doi.org/10.1038/nsmb.2889 17.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
MolCell Biol 2001; 21:3037-46; PMID:11287609; http://dx.doi.org/10.1128/MCB.21.9.3037-3046.2001 18.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Genes Dev 2013; 27:413-28; PMID:23431055; http://dx.doi.org/10.1101/gad.207779.112 19.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
GenesDev 2015; 29:94-107; PMID:25561498; http://dx.doi.org/10.1101/gad.253070.114 20.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Biol Chem 2014; 289:28640-50;PMID:25160624; http://dx.doi.org/10.1074/jbc.M114.592311 21.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Sci Rep 2015; 5:12545;PMID:26212312; http://dx.doi.org/10.1038/srep12545 22.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nucleic Acids Res 2013; 41:5669-78; PMID:23605039; http://dx.doi.org/10.1093/nar/gkt269 23.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Biol Chem 2008;283:32317-27; PMID:18809678; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Struct Biol 2011; 175:147-58; PMID:21463689; http://dx.doi.org/10.1016/j.jsb.2011.03.018 25.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nucleic Acids Res2009; 37:129-43; PMID:19033360; http://dx.doi.org/10.1093/nar/ gkn894 26.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Mol Biol 2006; 356:664-83; PMID:16376933; http://dx.doi.org/10.1016/j.jmb.2005.11.067 27.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Biol Chem 2014; 289:17325-37; PMID:24795046; http://dx.doi.org/10.1074/jbc.M114.558825 28.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nat Struct Mol Biol 2007; 14:620-9; PMID:17589525; http://dx.doi.org/10.1038/ nsmb1260 29.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
J Mol Biol 2008; 378:1-11; PMID:18353365; http://dx.doi.org/10.1016/j.jmb.2008.02.034 30.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Biochemistry 2014; 53:3529-39; PMID:24849693; http://dx.doi.org/10.1021/bi500192a 32.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nature 2013; 498:390-4;PMID:23783631; http://dx.doi.org/10.1038/nature12294 33.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Structure2013; 21:2162-74; PMID:24183573; http://dx.doi.org/10.1016/j.str.2013.09.014 34.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Cell 2010; 142:101-11; PMID:20603017; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Nature 2015; 519:106-9; PMID:25533957; http://dx.doi.org/10.1038/nature13999 38.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
"Spingola M, Armisen J, Ares M, Jr. Mer1p is a modular splicing factor whose function depends on the conserved U2 snRNP protein Snu17p.Nucleic Acids Res 2004; 32:1242-50; PMID:14973223; http://dx.doi.org/10.1093/nar/gkh281 39.",OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
FEMS Yeast Res 2008; 8:276-86; PMID:17995956;http://dx.doi.org/10.1111/j.1567-1364.2007.00322.x 40.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
e47621; PMID:23118884; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Mol Cell Biol 2005; 25:10745-54; PMID:16314500; http://dx.doi.org/10.1128/MCB.25.24.10745-10754.2005 42.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Mol Biol Cell2005; 16:5258-68; PMID:16162818; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
Trends Cell Biol 2008; 18:174-83; PMID:18313922; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/d8/krnb-13-02-1096484.PMC4829318.pdf
"2, 177 –195 http://dx.doi.org/10.1080/15476286.2015.1110674",Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
"ScriptMinerTMSmall RNA-Seq Library Preparation Kit (Multiplex, Illumina® compatible, Epicentre) was used to prepare the library using Tobacco Acid Pyrophosphatase (TAP) (Epicentre).cDNAs were sequenced at the Next Generation Sequenc- ing (CSF NGS Unit; http://csf.ac.at/)) facility of the Vienna Biocenter, Vienna, Austria (Illumina single end sequencing).",OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
The sequences were downloaded from NCBI (ftp://ftp.ncbi.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Curr Opin Microbiol 2006; 9:229-36; PMID:16529986; http://dx.doi.org/10.1016/j.mib.2006.02.005 2.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Curr Opin Microbiol 2007; 10:182-8; PMID:17383223; http://dx.doi.org/10.1016/j.mib.2007.03.004 3.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Cell 2009; 136:615 –28; PMID:19239884; http://dx.doi.org/ 10.1016/j.cell.2009.01.043 4.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Trends Genet TIG 2005; 21:399 –404; PMID:15913835; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Annu Rev Biochem 2005; 74:199 –217; PMID:15952886; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Cell 2011; 43:880 –91; PMID:21925377; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 2012; 9:372 –8; PMID:22336762; http://dx.doi.org/10.4161/ rna.19235 8.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 2014; 11:443 –56; PMID:24576839; http://dx.doi.org/10.4161/rna.28036 9.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Curr Opin Microbiol 2007; 10:102 –9; PMID:17387036; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Annu Rev Genet2010; 44:167 –88; PMID:20707673; http://dx.doi.org/ 10.1146/annurev-genet-102209-163523 11.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nat Rev Microbiol 2008; 6:181 –6; PMID:18157154; http://dx.doi.org/10.1038/nrmicro1793 12.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Proc Natl Acad Sci U S A 2001; 98:4658 –63; PMID:11296296; http://dx.doi.org/10.1073/ pnas.071559398 13.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2005; 33:4096 – 105; PMID:16049021; http://dx.doi.org/10.1093/nar/gki715 14.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2006; 34:3484 –93; PMID:16870723; http://dx.doi.org/10.1093/ nar/gkl453 15.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS ONE 2008; 3:e3197;PMID:18787707; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS ONE 2010; 5:e11970; PMID:20700540;http://dx.doi.org/10.1371/journal.pone.0011970 17.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
BMC Bioinformatics 2010; 11:491; PMID:20920260; http://dx.doi.org/10.1186/1471-2105-11-491 18.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS ONE 2013; 8:e64021; PMID:23762235; http://dx.doi.org/10.1371/journal.pone.0064021 19.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS ONE 2009; 4:e7668; PMID:19888332; http://dx.doi.org/10.1371/ journal.pone.0007668 20.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
BMC Geno- mics 2012; 13:550; PMID:23062031; http://dx.doi.org/ 10.1186/1471-2164-13-550 21.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nature 2011; 471:602 –7; PMID:21455174; http://dx.doi.org/10.1038/nature09886 22.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 2012; 9:414 –26; PMID:22546939; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Front Genet 2015; 6:110;PMID:25859258; http://dx.doi.org/10.3389/fgene.2015.00110 25.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2004; 53:1515 –27; PMID:15387826; http://dx.doi.org/ 10.1111/j.1365-2958.2004.04222.x 26.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2012; 86:140 –54; PMID:22882718; http://dx.doi.org/10.1111/j.1365-2958.2012.08178.x 28.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2001;39:392 –406; PMID:11136460; http://dx.doi.org/10.1046/ j.1365-2958.2001.02226.x 29.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2010; 78:1332 –47; http://dx.doi.org/10.1111/j.1365-2958.2010.07427.x 30.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2015; 96:249 –62; PMID:25586884; http://dx.doi.org/ 10.1111/mmi.12935 31.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
BMC Genomics 2010; 11:661; PMID:21106082; http://dx.doi.org/10.1186/1471-2164-11-661 33.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2013;89:334 –49; PMID:23710838; http://dx.doi.org/10.1111/ mmi.12277 34.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2014; 42:6091 –105; PMID:24728998; http://dx.doi.org/10.1093/nar/gku241 36.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2014; 42:2577 – 90; PMID:24270795; http://dx.doi.org/10.1093/nar/gkt1074 37.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Science2012; 337:816 –21; PMID:22745249; http://dx.doi.org/ 10.1126/science.1225829 38.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nat Methods 2013; 10:957 –63; PMID:24076990; http://dx.doi.org/10.1038/nmeth.2649 39.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Science 2014; 346:1258096; PMID:25430774; http://dx.doi.org/10.1126/ science.1258096 41.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Cell 2014; 157:1262 –78; PMID:24906146; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 7:140 –4; PMID:20220305; http://dx.doi.org/10.4161/ rna.7.2.11056 46.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Annu Rev Genet 2013; 47:405 – 31; PMID:24274754; http://dx.doi.org/10.1146/annurev- genet-110711-155618 47.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 2008; 5:230 –43; PMID:18981732; http://dx.doi.org/10.4161/rna.6915RNA BIOLOGY 193,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
The seed region of a small RNA drives the controlled destruction of the target mRNA by theendoribonuclease RNase E. Mol Cell 2012; 47:943 –53; PMID:22902561; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2012; 85:817 –32; PMID:22780584; http://dx.doi.org/ 10.1111/j.1365-2958.2012.08144.x 51.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
EMBO J 2009; 28:3523 –33; PMID:19779461; http://dx.doi.org/10.1038/ emboj.2009.283 52.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
J Bacteriol 2013; 195:2585 –94; PMID:23543715; http://dx.doi.org/10.1128/JB.00097-13 53.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS Genet 2012; 8:e1003181; PMID:23300471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2005; 33:D121 –4; PMID:15608160; http://dx.doi.org/10.1093/nar/gki081 56.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Genome Biol 2010; 11:R31;PMID:20230605; http://dx.doi.org/10.1186/gb-2010-11-3- r31 58.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2008; 36:W70 –4; PMID:18424795; http://dx.doi.org/10.1093/ nar/gkn188 59.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Algorithms Mol Biol AMB 2011; 6:26;PMID:22115189; http://dx.doi.org/10.1186/1748-7188-6- 26 60.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2007; 35:4809 –19; PMID:17621584; http://dx.doi.org/ 10.1093/nar/gkm487 61.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Science 2006; 314:1601 –3; PMID:17158328; http://dx.doi.org/ 10.1126/science.1134830 63.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nat Rev Microbiol 2013; 11:75 – 82; PMID:23268228; http://dx.doi.org/10.1038/nrmicro2934 64.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Microbiol Mol Biol Rev 2011;75:286 –300; PMID:21646430; http://dx.doi.org/10.1128/ MMBR.00032-10 65.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
ProcNatl Acad Sci U S A 2011; 108:20172 –7; PMID:22123973; http://dx.doi.org/10.1073/ pnas.1113521108 66.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
RNA Biol 2012; 9:1039 –44; PMID:22858676; http://dx.doi.org/ 10.4161/rna.21167 67.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Future Microbiol 2012; 7:853 –71; PMID:22827307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic Acids Res 2012; 40:2846 – 61; PMID:22139924; http://dx.doi.org/10.1093/nar/gkr1141 69.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Microbiol 2005; 55:469 –81; PMID:15659164; http://dx.doi.org/ 10.1111/j.1365-2958.2004.04428.x 73.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PLoS One 2013; 8:e54062; PMID:23326572; http://dx.doi.org/10.1371/journal.pone.0054062 74.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
PMID:1658571; http://dx.doi.org/10.1016/0076-6879(91) 04028-M 75.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Appl Environ Micro- biol 2007; 73:1126 –35; PMID:17142375; http://dx.doi.org/ 10.1128/AEM.01473-06 76.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nat Protoc 2008;3:1077 –84; PMID:18536652; http://dx.doi.org/10.1038/ nprot.2008.67 77.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
EMBnet.journal 2011;17:10 –2; http://dx.doi.org/10.14806/ej.17.1.200 78.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nat Biotechnol 2011; 29:24 –6; PMID:21221095; http://dx.doi.org/10.1038/nbt.1754 79.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Nucleic AcidsRes 2003; 31:439 –41; PMID:12520045; http://dx.doi.org/ 10.1093/nar/gkg006 80.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
J Mol Biol 1990; 215:403 –10; PMID:2231712; http://dx.doi.org/10.1016/ S0022-2836(05)80360-2 81.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
BMC Bioinformatics 2009; 10:421; PMID:20003500;http://dx.doi.org/10.1186/1471-2105-10-421 82.,OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Mol Biol Evol 2013; 30:772 –80; PMID:23329690; http://dx.doi.org/10.1093/molbev/ mst010 83.,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
Genome Biol 2007; 8:R22; PMID:17313685; http://dx.doi.org/10.1186/gb-2007-8-2-r22RNA BIOLOGY 195,Non-OADS,/arxiv_data1/oa_pdf/1f/b9/krnb-13-02-1110674.PMC4829319.pdf
"3, 306 –315 http://dx.doi.org/10.1080/15476286.2015.1137421",Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
"Population 7-GGC (%) 9-GGC (%) 10-GGC (%) 11-GGC (%) 12-GGC (%) CountaReferences Portugese 7.1 0.7 69.2 21.2 1.9 94022,23 Iranian 5.6 0.0 66.5 26.0 1.9 100024 Europeen American 6.7 4.9 75.3 13.1 0.0 838 NHLBI Exome Sequencing Projectb African American 5.4 4.9 78.3 11.4 0.0 184 NHLBI Exome Sequencing Projectb aTotal count of alleles bhttp://www.ensembl.org/Homo_sapiens/Variation/Population?db Dcore;gDENSG00000103342;r D16:11868128-11916082;v DTMP_ESP_16_12009531_12009539; vdbDvariation;vf D118359499310 S. JERBI ET AL.",Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Biol Cell 2002; 94:205-16; PMID:12489690; http://dx.doi.org/10.1016/S0248-4900(02)01194-2 2.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Wiley Interdiscip Rev RNA 2012; 3:743-57;PMID:22965901; http://dx.doi.org/10.1002/wrna.1133 4.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Biochem Soc Trans 2010; 38:1517-22;PMID:21118118; http://dx.doi.org/10.1042/BST0381517 5.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 1989; 9:659-70; PMID:2565532; http://dx.doi.org/10.1128/MCB.9.2.659 6.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 2007; 27:7791-801; PMID:17785442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Nat Struct Mol Biol 2005; 12:1054-63; PMID:16284618; http://dx.doi.org/10.1038/nsmb1016 10.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Genes Dev 2007;21:3135-48; PMID:18056425; http://dx.doi.org/10.1101/gad.1597707 11.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
RNA 2012; 18:1957-67; PMID:23019593; http://dx.doi.org/ 10.1261/rna.035311.112 12.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
PloS One 2010; 5:e10169; PMID:20418951; http://dx.doi.org/10.1371/journal.pone.0010169 13.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Biochem Soc Trans 2012; 40:856- 64; PMID:22817748; http://dx.doi.org/10.1371/journal.pone.0010169 14.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Nucleic Acids Res 2010; 38:548-58; PMID:19906736; http://dx.doi.org/10.1093/nar/gkp908 15.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
RNA 2015; 21:124-34; PMID:25411355; http://dx.doi.org/10.1261/rna.047282.114 17.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
J Biol Chem 1998; 273:22254-9; PMID:9712840; http://dx.doi.org/10.1074/jbc.273.35.22254 18.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
RNA 2008; 14:240-5; PMID:18083835; http://dx.doi.org/10.1261/rna.728608 20.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 2005; 25:5801-11; PMID:15987998; http://dx.doi.org/ 10.1128/MCB.25.14.5801-5811.2005 21.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Carcinogenesis2005; 26:2046-9; PMID:15987717; http://dx.doi/10.1093/carcin/bgi168 23.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Oncol Rep 2009; 21:1551-8; PMID:19424636; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Med Oncol 2012; 29:1581- 5; PMID:22101789; http://dx.doi.org/10.1007/s12032-011-0111-x 25.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 2001; 21:5200-13; PMID:11438674; http://dx.doi.org/ 10.1128/MCB.21.15.5200-5213.2001 26.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
MolCell Biol 2002; 22:3769-82; PMID:11997512; http://dx.doi.org/ 10.1128/MCB.22.11.3769-3782.2002 27.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Cell Mol Life Sci 2005; 62:355-61; PMID:15723170; http://dx.doi.org/10.1007/s00018-004-4477-1 28.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Nucleic Acids Res 2005; 33:2917-28; PMID:15914668; http://dx.doi.org/10.1093/nar/gki602 29.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 2000; 20:4765-72; PMID:10848602;http://dx.doi.org/10.1128/MCB.20.13.4765-4772.2000 30.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
J Mol Biol 1996; 256:20-30; PMID:8609610; http://dx.doi.org/10.1006/jmbi.1996.0065 31.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol Cell Biol 1987; 7:3268-76; PMID:3313012; http://dx.doi.org/10.1128/MCB.7.9.3268 32.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Biophys J2012; 102:1427-34; PMID:22455926; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
"Structural basis of ligand recognition by PABC, a highly speci ﬁc peptide-binding domain found in poly(A)-binding protein and a HECT ubiquitin ligase.EMBO J 2004; 23:272-81; PMID:14685257; http://dx.doi.org/10.1038/sj.emboj.7600048 34.",OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
PLoS Biol 2008; 6:e111;PMID:18447585; http://dx.doi.org/10.1371/journal.pbio.0060111 35.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Mol CellBiol 1997; 17:3164-72; PMID:9154815; http://dx.doi.org/10.1128/ MCB.17.6.3164 36.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Biochem J 2006; 400:337-47; PMID:16834569; http://dx.doi.org/10.1042/BJ20060328 37.,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
Me thods Mol Biol 2009; 493:323-43; PMID:18839357; http://dx.doi.org/10.1007/978-1-59745-523-7_20RNA BIOLOGY 315,Non-OADS,/arxiv_data1/oa_pdf/0b/56/krnb-13-03-1137421.PMC4829321.pdf
"1, 1 –5 http://dx.doi.org/10.1080/15476286.2015.1107700",Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Trends Biochem Sci 2001; 26:733-40; PMID:11738597; http://dx.doi.org/10.1016/S0968-0004(01)01978-8 2.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid.Nucleic Acids Res 2012; 40:7541-51; PMID:22638585; http://dx.doi.org/10.1093/nar/gks471 4 .,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Nat Rev Mol Cell Biol 2010; 11:113-27; PMID:20094052; http://dx.doi.org/10.1038/nrm2838 5.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
J Virol 2003; 77:12441-9; PMID:14610168; http://dx.doi.org/ 10.1128/JVI.77.23.12441-12449.2003 6.,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Annu Rev Microbiol 2013; 67:21-42; PMID:23682606;http://dx.doi.org/10.1146/annurev-micro-092412-155609 7.,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Nature 1998;392:516-20; PMID:9548259; http://dx.doi.org/10.1038/33192 8.,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Gene 2005; 349:97-105; PMID:15777708; http://dx.doi.or g/10.1016/j.gene.2004.11.041 9.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Bioinfor- matics 2001; 17:890-900; PMID:11673233; http://dx.doi.org/10.1093/bioinformatics/17.10.890 10.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
Cell1986; 44:283-92; PMID:3943125; http://dx.doi.org/10.1016/0092-8674(86)90762-2 11.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
RNA 2006; 12:1338-49; PMID:16682564; http://dx.doi.org/10.1261/rna.67906 12.,OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
2006; 20:624-36; PMID:16510876; http://dx.doi.org/ 10.1101/gad.1397906RNA BOILOGY 5,Non-OADS,/arxiv_data1/oa_pdf/bb/7b/krnb-13-01-1107700.PMC4829323.pdf
"Kieft@ucdenver.edu Submitted: 07/27/2015Revised: 08/31/2015Accepted: 09/02/2015 http://dx.doi.org/10.1080/15476286.2015.1094599 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Lancet 2015; 385:453-65; PMID:25230594; http://dx.doi.org/ 10.1016/S0140-6736(14)60572-9 2.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Int J Gen Med2014; 7:193-203; PMID:24748813; http://dx.doi.org/ 10.2147/IJGM.S59902 3.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Emerg Infect Dis 2009; 15:1347-50; PMID:19788800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Vet Microbiol 2010; 140:271-80; PMID:19762169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Nat Med 2004; 10:S98-109; PMID:15577938; http://dx.doi.org/10.1038/ nm1144 6.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
"Adv Virus Res 2003; 59:177-228; PMID:14696330; http://dx.doi.org/10.1016/S0065-3527(03)59006-6 7. de Borba L, Villordo SM, Iglesias NG, Filomatori CV, Gebhard LG, Gamarnik AV.",Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2015; 89:3430-7; PMID:25589642; http://dx.doi.org/ 10.1128/JVI.02677-14 8.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2009; 83:1161-6; PMID:19004957; http://dx.doi.org/10.1128/JVI.01362-08 9.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Mol Biol 1987; 198:33-41; PMID:2828633; http://dx.doi.org/10.1016/0022-2836(87)90455-4 11.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2001; 75:6719-28; PMID:11413342; http://dx.doi.org/10.1128/JVI.75.14.6719-6728.2001 12.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2005; 79:6631-43; PMID:15890901; http://dx.doi.org/ 10.1128/JVI.79.11.6631-6643.2005 1176 Volume 12 Issue 11 RNA Biology,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Virus Res 2009; 139:230-9; PMID:18703097; http://dx.doi.org/ 10.1016/j.virusres.2008.07.016 14.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
RNA 2010; 16:2325-35; PMID:20980673; http://dx.doi.org/ 10.1261/rna.2120410 15.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Virology 2005; 339:200-12; PMID:16002117; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Gen Virol 1997; 78(Pt1):23-9; PMID:9010281; http://dx.doi.org/10.1099/ 0022-1317-78-1-23 18.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol2004; 78:5133-8; PMID:15113895; http://dx.doi.org/ 10.1128/JVI.78.10.5133-5138.2004 19.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Cell Host Microbe 2008; 4:579-91; PMID:19064258; http://dx.doi.org/10.1016/j.chom.2008.10.007 20.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
RNA 2012; 18:2029-40; PMID:23006624; http://dx.doi.org/10.1261/ rna.034330.112 21.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2012; 86:13486-500;PMID:23035235; http://dx.doi.org/10.1128/JVI.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2012; 86:5708-18; PMID:22379089; http://dx.doi.org/10.1128/ JVI.00207-12 23.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Vet Microbiol 2013; 166:11-21; PMID:23755934; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
PLoS Pathog 2014; 10:e1004242; PMID:24992036; http://dx.doi.org/ 10.1371/journal.ppat.1004242 25.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Virol J 2011; 8:492; PMID:22040380; http://dx.doi.org/10.1186/1743-422X-8-492 27.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Viruses-Basel 2014; 6:404-27;PMID:24473339; http://dx.doi.org/10.3390/ v6020404 28.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Virus Res 2015; 206:53-61; PMID:25660582; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
PLoS Pathog 2013; 9:e1003762; PMID:24339774; http://dx.doi.org/ 10.1371/journal.ppat.1003762 30.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2010; 84:11407- 17; PMID:20719943; http://dx.doi.org/10.1128/ JVI.01159-10 34.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
J Virol 2010; 84:11395-406; PMID:20739539; http://dx.doi.org/10.1128/ JVI.01047-10 35.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
eLife 2014; 3:e01892; PMID:24692447; http://dx.doi.org/10.7554/ eLife.01892 36.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
Science 2014; 344:307-10; PMID:24744377; http://dx.doi.org/10.1126/science.1250897 37.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
PLoS Pathog 2015; 11: e1004708; PMID:25747802; http://dx.doi.org/10.1371/journal.ppat.1004708 38.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
PLoS Patho 2015; 11:e1004604; PMID:25635835; http://dx.doi.org/10.1371/journal.ppat.1004604 39.,Non-OADS,/arxiv_data1/oa_pdf/1a/f8/krnb-12-11-1094599.PMC4829329.pdf
"2, 140 –144 http://dx.doi.org/10.1080/15476286.2015.1128064",Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Trends Genet 2015; 31:239-51; PMID:25869999; http://dx.doi.org/10.1016/j.tig.2015.03.007.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Trends BiochemSci 2015; 40:4-7; PMID:25435401; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
J Biol Chem 2005; 280:42477-85; PMID:16230341; http://dx.doi.org/10.1074/jbc.X500006200.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Anal Biochem 1966; 17:263-7; PMID:5339429; http://dx.doi.org/10.1016/0003-2697(66)90204-1.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
J Mol Biol 1968; 38:289-304; PMID:5718554; http://dx.doi.org/10.1016/0022-2836(68)90387-2.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Science 1965; 147:1462-5; PMID:14263761; http://dx.doi.org/10.1126/science.147.3664.1462.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
DNA Res 2010; 17:51-9; PMID:20211845; http://dx.doi.org/10.1093/dnares/dsq006.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
PLoS Biol 2011; 9:e1000625; discussion e1102; PMID:21765801; http://dx.doi.org/10.1371/journal.pbio.1000625.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Bioessays 2003; 25:930-9; PMID:14505360; http://dx.doi.org/10.1002/bies.10332.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 2012; 489:57-74; PMID:22955616; http://dx.doi.org/10.1038/ nature11247.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 2012; 482:310-1; PMID:22337043; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nat Struct Mol Biol 2007; 14:103-5; PMID:17277804;http://dx.doi.org/10.1038/nsmb0207-103.23.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Cell 2008; 135:216-26;PMID:18957198; http://dx.doi.org/10.1016/j.cell.2008.09.050.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Cell 2013; 154:26-46; PMID:23827673; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genome BiolEvol 2013; 5:578-90; PMID:23431001; http://dx.doi.org/10.1093/gbe/evt028.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Mol Cell 2013; 52:473-84; PMID:24267449; http://dx.doi.org/10.1016/j.molcel.2013.10.032.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genome Res 2013; 23:1961-73; PMID:24172201; http://dx.doi.org/10.1101/gr.161315.113.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
PLoS Biol 2010; 8: e1000371; PMID:20502517; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 1996; 379:464-6; PMID:8559254; http://dx.doi.org/10.1038/379464a0 31.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Cell 2002; 108:431-4; PMID:11909514; http://dx.doi.org/10.1016/S0092-8674(02)00645-1.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
RNA 2009; 15:2147-60; PMID:19850906; http://dx.doi.org/ 10.1261/rna.1738409.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genes Dev 2009; 23:2639-49;PMID:19933153; http://dx.doi.org/10.1101/gad.1837609.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Endocrinology 2010; 151:1391-7; PMID:20332203; http://dx.doi.org/10.1210/en.2009-1250.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Curr Med Chem 2012; 19:5187-98; PMID:22680642; http://dx.doi.org/10.2174/092986712803530485.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Hum Mol Genet 2010; 19:1153-64; PMID:20053671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
RNA Biol 2013; 10:1798-806; PMID:24351723; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature2004; 429:571-4; PMID:15175754; http://dx.doi.org/10.1038/ nature02538.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Mol Cell 2009; 34:545-55; PMID:19524535; http://dx.doi.org/10.1016/j.molcel.2009.04.018.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
BMC Biol 2013;11:59; PMID:23721193; http://dx.doi.org/10.1186/1741-7007-11-59.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Cell 2006; 127:1209-21; PMID:17174895; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Science 2012; 338:1469-72;PMID:23239737; http://dx.doi.org/10.1126/science.1228110.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Bull Math Biol 1989; 51:417-32; PMID:2673451; http://dx.doi.org/10.1007/BF02460081.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genome Res 2007; 17:682-90; PMID:17567989; http://dx.doi.org/10.1101/gr.6525007.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 2009; 457:1033-7; PMID:19169243; http://dx.doi.org/10.1038/nature07728.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
eLife 2014; 3: e03058; PMID:25124674; http://dx.doi.org/10.7554/eLife.03058.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
RNA Biol 2004; 1:81-3; PMID:17179746; http://dx.doi.org/10.4161/rna.1.2.1228.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
BMC Evol Biol 2007; 7 Suppl 1:S9; PMID:17288582;http://dx.doi.org/10.1186/1471-2148-7-S1-S9.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
PLoS Com-put Biol 2008; 4:e1000176; PMID:19043537; http://dx.doi.org/10.1371/journal.pcbi.1000176.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Bio-chimie 2011; 93:1981-6; PMID:21729735; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genome Biol 2002; 3:REVIEWS0004; PMID:11897027;http://dx.doi.org/10.1186/gb-2002-3-3-reviews0004.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Cell Rep2014; 8:1365-79; PMID:25159147; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Mol Ther 2006; 14:54-62; PMID:16580882; http://dx.doi.org/10.1016/j.ymthe.2006.01.012.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Biochimie 2011; 93:633-44; PMID:21111023; http://dx.doi.org/10.1016/j.biochi.2010.11.004.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Biochimie 2011; 93:1928-34;PMID:21787833; http://dx.doi.org/10.1016/j.biochi.2011.07.014.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
J Theor Biol 2012; 293:27-33; PMID:22001319; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Genome Biol Evol 2011; 3:1245-52; PMID:21948395; http://dx.doi.org/10.1093/gbe/evr099.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Curr Opin Microbiol 2007; 10:156-63; PMID:17383221; http://dx.doi.org/10.1016/j.mib.2007.03.007.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Plant SignalBehav 2012; 7:1188-93; PMID:22899065; http://dx.doi.org/10.4161/ psb.21299.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nat Genet 2007; 39:1033-7; PMID:17643101; http://dx.doi.org/10.1038/ng2079.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 2010; 465:1033-8; PMID:20577206;http://dx.doi.org/10.1038/nature09144.,Non-OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nat Biotechnol 2014; 32:453-61; PMID:24811520; http://dx.doi.org/ 10.1038/nbt.2890.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Science 2013; 340:440-1; PMID:23620042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
Nature 2013; 497:188; PMID:23657339; http://dx.doi.org/10.1038/497188d.144 J. BROSIUS AND C. A. RAABE,OADS,/arxiv_data1/oa_pdf/f8/91/krnb-13-02-1128064.PMC4829331.pdf
"We present RiboGalaxy (http://riboga laxy.ucc.ie), a freely available Galaxy-based web server for processing and analyzing ribosome pro ﬁling data with the visualization functionality provided by GWIPS-viz (http://gwips.ucc.ie).",OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
"In addition we provide a forum (http://gwips.ucc.ie/Forum) where we encourage users to post theirquestions and feedback to improve the overall RiboGalaxy service.KEYWORDS Galaxy; gene expression; mRNA; protein synthesis;ribosome footprinting;ribosome pro ﬁling; ribo-seq; RNA-seq; translation;translatomics Introduction Ribosome pro ﬁling, also known as ribo-seq, is a high through- put technique where mRNA fragments protected by ribosomes are isolated and sequenced.1This allows the ribosome density along all mRNA transcripts present in the cell to be measuredproviding genome-wide information on protein synthesis(GWIPS) in vivo .",Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
"3, 316 –319 http://dx.doi.org/10.1080/15476286.2016.1141862",Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
RiboGalalxy help pages and forum RiboGalaxy is publicly available at http://riboseq.org/ and is accompanied by extensive documentation and tips for helpingusers.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
In addition we provide a RiboGalaxy forum (http://gwips.ucc.ie/Forum) where we encourage users to post their questionsand feedback to improve the overall RiboGalaxy service.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Science (80-) 2009; 324:218-23; PMID:19213877; http://dx.doi.org/10.1126/science.1168978 2.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Science (80-) 2011; 334:1509-10; PMID:22174241; http://dx.doi.org/10.1126/science.1216974 3.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Wiley Interdiscip RevRNA 2013; 4:473-90; PMID:23696005; http://dx.doi.org/10.1002/ wrna.1172 4.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Nat Rev Genet 2014; 15:205-13;PMID:24468696; http://dx.doi.org/10.1038/nrg3645 5.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Genome Res 2012; 22(11):2219-29; PMID:22593554; http://dx.doi.org/10.1101/gr.133249.111 6.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
EMBO J 2014; 33:981-93; PMID:24705786; http://dx.doi.org/10.1002/embj.201488411 8.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Cold Spring Harb Protoc 2015; 2015:pdb.top083667; PMID:25655493; http://dx.doi.org/ 10.1101/pdb.top0836679.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
EMBnet Journal 2011; 17:10; http://dx.doi.org/10.14806/ej.17.1.200 10.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/10.1186/gb-2009-10-3-r25 11.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Nucleic Acids Res 2014; 42:D859-64; PMID:24185699; http://dx.doi.org/ 10.1093/nar/gkt1035 12.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
bioRxiv do i http://dx.doi.org/10.1101/ 0187622015; 14.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Bioinformatics 2015; 31(15):2586-8; PMID:25812744; http://dx.doi.org/ 10.1093/bio- informatics/btv174 15.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
BMC Bioin- formatics 2010; 11:422; PMID:20698981; http://dx.doi.org/10.1186/ 1471-2105-11-422 16.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Elife 2015; 4:1-21; PMID:25621764; http://dx.doi.org/10.7554/eLife.03971 17.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Nucleic AcidsRes 2014; 43:D670-81; PMID:25428374; http://dx.doi.org/10.1093/ nar/gku1177 18.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
bioRxiv doi http://dx.doi.org/101101/017111 2015; 19.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Nat Biotechnol 2012; 30:1036-9;PMID:23138293; http://dx.doi.org/10.1038/nbt.2404 20.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Genome Biol 2014; 15:403; PMID:25001293; http://dx.doi.org/10.1186/gb4161 21.,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
"Andreev DE, O ’Connor PB, Zhdanov AV, Dmitriev RI, Shatsky IN, Papkovsky DB, Baranov P V. Oxygen and glucose deprivation induceswidespread alterations in mRNA translation within 20 minutes.Genome Biol 2015; 16:1-14; PMID:25583448; http://dx.doi.org/ 10.1186/s13059-015-0651-z 22.",Non-OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Cell Rep 2014; 8:439-48; PMID:25043188; http://dx.doi.org/10.1016/j.celrep.2014.06.036RNA BIOLOGY 319,OADS,/arxiv_data1/oa_pdf/00/c8/krnb-13-03-1141862.PMC4829337.pdf
Journal of  Preventive Medicine  & Public Health 79 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:79     •  http://dx.doi.org/10.3961/jpmph.,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/jpmph-49-2-79.PMC4829366.pdf
"A Comment on “Quaternary   Prevention in Public  Health” by  Dr. Jong-Myon  Bae Marc Jamoulle Wonca International Classification Committee Member and Depart - ment of General Practice, University of Liège, Liège, Belgium Correspondence pISSN 1975-8375 eISSN 2233-4521  Letter to the Editor Corresponding author:  Marc Jamoulle, MD Rue du Calvaire 98, B-6060 Gilly, Belgium Tel: +32-247-759-4257 E-mail : marc.jamoulle@doct.ulg.ac.be This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.J Prev Med Public Health 2016;49:139-140    •  http://dx.doi.org/10.3961/jpmph.16.031",Non-OADS,/arxiv_data1/oa_pdf/a7/e2/jpmph-49-2-139.PMC4829367.pdf
ORCID Marc Jamoulle http://orcid.org/0000-0003-0479-3856 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a7/e2/jpmph-49-2-139.PMC4829367.pdf
"Journal of  Preventive Medicine  & Public Health 129 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:129-133    •  http://dx.doi.org/10.3961/jpmph.15.074 Citation Discovery Tools for Conducting Adaptive Meta- analyses to Update Systematic Reviews Jong-Myon Bae, Eun Hee Kim Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, KoreaBrief Report Objectives: The systematic review (SR) is a research methodology that aims to synthesize related evidence.",Non-OADS,/arxiv_data1/oa_pdf/11/91/jpmph-49-2-129.PMC4829368.pdf
"Conclusions: The AMA, which involves using both citation discovery tools in PubMed, and optionally, the ‘related’ tool in Scopus, was  found to be useful for updating an SR.  Key words:  Meta-analysis, Review, Database, Research design, Computing methodologies Received:   December 24, 2015  Accepted:  March 7, 2016 Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehak-ro, Jeju 63243, Korea Tel: +82-64-755-5567, Fax:  +82-64-725-2593 E-mail:  jmbae@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.extracted results.",Non-OADS,/arxiv_data1/oa_pdf/11/91/jpmph-49-2-129.PMC4829368.pdf
ORCID Jong-Myon Bae http://orcid.org/0000-0003-3080-7852Eun Hee Kim  http://orcid.org/0000-0002-1065-1080 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/11/91/jpmph-49-2-129.PMC4829368.pdf
"Journal of  Preventive Medicine  & Public Health 80 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:80-96    •  http://dx.doi.org/10.3961/jpmph.16.002 Proving Causation With Epidemiological Evidence in   Tobacco Lawsuits Sun Goo Lee Gachon University School of Medicine, Seongnam, KoreaSpecial Article Recently, a series of lawsuits were filed in Korea claiming tort liability against tobacco companies.",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
"Key words:  Tobacco, Lawsuit, Torts, Causation, Epidemiological evidence Received:  January 9, 2016  Accepted:  March 15, 2016 Corresponding author:  Sun Goo Lee, SJD 1342 Seongnam-daero, Sujeong-gu, Seongnam 13120, Korea  Tel: +82-31-750-6925, Fax:  +82-31-750-6925  E-mail:  sgl@gachon.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Recently, a number of lawsuits have been filed in Korea  claiming tort liability for damages caused by allegedly un -lawful acts of tobacco companies.",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
SUPPLEMENTAL MATERIAL Supplemental material (Korean version) is available at  http://www.jpmph.org/.,Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
Sun Goo Lee 88ORCID Sun Goo Lee http://orcid.org/0000-0003-3894-6224 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
Avail - able from: https://www.lawtimes.co.kr/Legal-News/Print- News?serial =91705 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
Sun Goo Lee 96able from: https://www.lawtimes.co.kr/Legal-News/Print- News?serial =91705 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/cc/c4/jpmph-49-2-80.PMC4829369.pdf
"Journal of  Preventive Medicine  & Public Health 108 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:108-117    •  http://dx.doi.org/10.3961/jpmph.15.062 The Association Between Smoking Tobacco After a   Diagnosis of Diabetes and the Prevalence of Diabetic   Nephropathy in the Korean Male Population Hyungseon Yeom1, Jung Hyun Lee2, Hyeon Chang Kim1, Il Suh1 1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 2 Department of Preventive Medicine, Graduate School of Public  Health, Yonsei University, Seoul, KoreaOriginal Article Objectives: Smoking is known to be associated with nephropathy in patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d3/d2/jpmph-49-2-108.PMC4829370.pdf
"Key words:  Diabetes mellitus, Diabetic nephropathies, Smoking, Diagnosis Received:  November 11, 2015 Accepted:  March 13, 2016 Corresponding author:  Hyeon Chang Kim, MD, PhD 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-1873, Fax:  +82-2-392-8133 E-mail:  hckim@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Diabetic nephropathy is the leading cause of end-stage re - nal disease and is also responsible for cardiovascular mortality  [1-3].",Non-OADS,/arxiv_data1/oa_pdf/d3/d2/jpmph-49-2-108.PMC4829370.pdf
CONFLICT OF INTEREST The authors have no conflicts of interest associated with the  material presented in this paper.ORCID Hyungseon Yeom http://orcid.org/0000-0002-8004-8244 Jung Hyun Lee http://orcid.org/0000-0001-7141-4532 Hyeon Chang Kim http://orcid.org/0000-0001-7867-1240 Il Suh http://orcid.org/0000-0002-9689-7849   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/d2/jpmph-49-2-108.PMC4829370.pdf
"Journal of  Preventive Medicine  & Public Health 134 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:134-138    •  http://dx.doi.org/10.3961/jpmph.16.018 Month and Season of Birth as a Risk Factor for   Alzheimer’s Disease: A Nationwide Nested Case-control  Study  Anna-Maija Tolppanen1,2, Riitta Ahonen1, Marjaana Koponen1,3, Piia Lavikainen1,3, Maija Purhonen4, Heidi Taipale1,3,   Antti Tanskanen5,6,7, Jari Tiihonen5,6, Miia Tiihonen1,3, Sirpa Hartikainen1,3 1School of Pharmacy, University of Eastern Finland, Kuopio; 2Research Center for Comparative Effectiveness and Patient Safety, University of Eastern  Finland, Kuopio; 3Kuopio Research Center of Geriatric Care, School of Pharmacy, University of Eastern Finland, Kuopio; 4Department of Psychiatry,  Kuopio University Hospital, Kuopio; 5Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio, Finland;   6Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 7National Institute for Health and Welfare, Helsinki, FinlandBrief Report Objectives: Season of birth, an exogenous indicator of early life environment, has been related to higher risk of adverse psychiatric  outcomes but the findings for Alzheimer’s disease (AD) have been inconsistent.",OADS,/arxiv_data1/oa_pdf/db/d3/jpmph-49-2-134.PMC4829371.pdf
"Key words:  Risk factors, Seasons, Case-control studies, Alzheimer disease Received:  February 10, 2016 Accepted:  March 19, 2016 Corresponding author:  Anna-Maija Tolppanen,PhD P .O.Box 1627, 70211 Kuopio, Finland  Tel: +358-50-575-9530, Fax:  +358-17-162424 E-mail:  anna-maija.tolppanen@uef.fi This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION  The importance of life-course perspective in dementia pre - vention has been acknowledged [1] and according to the  Barker’s hypothesis, or the developmental origins of health  and disease (DOHAD), the susceptibility to many chronic dis - eases is determined already in utero  [2].",Non-OADS,/arxiv_data1/oa_pdf/db/d3/jpmph-49-2-134.PMC4829371.pdf
ORCID Anna-Maija Tolppanen http://orcid.org/0000-0001-9270- 9268 Jari Tiihonen http ://orcid.org/0000-0002-0400-6798 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/db/d3/jpmph-49-2-134.PMC4829371.pdf
"Journal of  Preventive Medicine  & Public Health 118 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:118-128    •  http://dx.doi.org/10.3961/jpmph.16.003 Enrollment in Private Medical Insurance and Utilization of  Medical Services Among Children and Adolescents: Data  From the 2009-2012 Korea Health Panel Surveys Dong Hee Ryu1, Sin Kam1, Young-Taek Doo2 1Department of Preventive Medicine, Kyungpook National University School of Medicine, Daegu; 2Department of Physical Therapy, Kwangju Wom - en’s University, Gwangju, KoreaOriginal Article Objectives: The purposes of this study were to examine the status of children and adolescents with regard to enrollment in private  medical insurance (PMI) and to investigate its influence on their utilization of medical services.",Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
"Key words:  Insurance, Health services, Child, Adolescent Received:  January 11, 2016 Accepted:  March 17, 2016 Corresponding author:  Sin Kam, MD, PhD 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Korea Tel: +82-53-420-4865, Fax:  +82-53-425-2447 E-mail: kamshin@knu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION  The utilization of medical services is increasing in Korea.",Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
ORCID Dong Hee Ryu http://orcid.org/0000-0002-2860-8849 Sin Kam http://orcid.org/0000-0002-5424-3820REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
Available from: http://dlps.nanet.go.kr/SearchDetailView.,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
Available from: http://dlps.nanet.go.kr/SearchDetailView.,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
Avail - able from: http://www.oecd.org/els/health-systems/health- data.htm.,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
Available  from: http://www.kidi.or.kr/stats/life_contract.asp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
Available from: http://www.google.co.kr/url?url =http:// stats.oecd.org/ fileview2.aspx%3FIDFile%3De11b92da-6cc5- 4cea-afe9-1d4cce02e5a4&rct =j&frm=1&q=&esrc=s&sa=U &ved=0ahUKEwip1ee0icfLAhUlK6YKHQ6JDJMQFgg9MAk&si g2=W-Rvs4uBTfbQILja2gM0kg&usg =AFQjCNHaKSQWWqTc FwggvtP6KYAGhH1tCA.,OADS,/arxiv_data1/oa_pdf/2f/58/jpmph-49-2-118.PMC4829372.pdf
"Journal of  Preventive Medicine  & Public Health 97 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:97-107    •  http://dx.doi.org/10.3961/jpmph.15.068 Epstein-Barr Virus and Gastric Cancer Risk: A Meta-   analysis With Meta-regression of Case-control Studies Jong-Myon Bae, Eun Hee Kim Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, KoreaReview Objectives: Research on how the risk of gastric cancer increases with Epstein-Barr virus (EBV) infection is lacking.",Non-OADS,/arxiv_data1/oa_pdf/4e/50/jpmph-49-2-97.PMC4829373.pdf
"Key words:  Gastric neoplasms, Risk factor, Epstein-Barr virus, Meta-analysis Received:  November 27, 2015 Accepted:  February 1, 2016 Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehak-ro, Jeju 63243, Korea Tel: +82-64-755-5567, Fax:  +82-64-725-2593  E-mail:  jmbae@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION  Globally, gastric cancer is the primary cancer that has the  third highest mortality rate [1].",Non-OADS,/arxiv_data1/oa_pdf/4e/50/jpmph-49-2-97.PMC4829373.pdf
ORCID Jong-Myon Bae http://orcid.org/0000-0003-3080-7852 Eun Hee Kim http://orcid.org/0000-0002-1065-1080 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/50/jpmph-49-2-97.PMC4829373.pdf
Available from: http://monographs.iarc.fr/ENG/Classi - fication/ClassificationsGroupOrder.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/50/jpmph-49-2-97.PMC4829373.pdf
ORCID Jong-Myon Bae http://orcid.org/0000-0003-3080-7852 REFERENCE 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/14/jpmph-49-2-141.PMC4829374.pdf
"I think that  your suggestions of replacing ‘Conclusion’ with ‘Hypothesis’ The Author Reply: A Com - ment on “Quaternary Pre - vention in Public Health” Jong-Myon Bae Department of Preventive Medicine, Jeju National University School of  Medicine, Jeju, KoreaCorrespondence pISSN 1975-8375 eISSN 2233-4521  Author Response Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehak-ro, Jeju 63243, Korea Tel: +82-64-755-5567, Fax: +82-64-702-2687 E-mail : jmbae@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.J Prev Med Public Health 2016;49:141    •  http://dx.doi.org/10.3961/jpmph.16.032",Non-OADS,/arxiv_data1/oa_pdf/d2/14/jpmph-49-2-141.PMC4829374.pdf
e-mail: dongbosun@126.com (D. Sun); fl@hvri.ac.cn (L. Feng) ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ea/08/jvms-78-355.PMC4829501.pdf
e-mail: kannot@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/4a/jvms-78-365.PMC4829502.pdf
Avail-able from http://www.wrlfmd.org/ref_labs/ref_lab_reports/OIE- FAO%20FMD%20Ref%20Lab%20Network%20Report%20 2013.pdf.,OADS,/arxiv_data1/oa_pdf/53/4a/jvms-78-365.PMC4829502.pdf
Available from http://www.fao.org/ag/againfo/ commissions/docs/research_group/paphos/App51.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/4a/jvms-78-365.PMC4829502.pdf
Available from http://www.oie.int/international- standard-setting/terrestrial-code/access-online/.,Non-OADS,/arxiv_data1/oa_pdf/53/4a/jvms-78-365.PMC4829502.pdf
Available  from http://www.oie.int/fileadmin/Home/eng/Health_standards/ tahm/2.01.05_FMD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/4a/jvms-78-365.PMC4829502.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/71/7d/jvms-78-375.PMC4829503.pdf
e-mail: tmizutan@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/jvms-78-383.PMC4829504.pdf
e-mail: Nuvee.P@chula.ac.th ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9e/8d/jvms-78-391.PMC4829505.pdf
th; aaey2000@yahoo.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/jvms-78-397.PMC4829506.pdf
"This  animal is important for the rural economy of Thailand, but  is often affected by bacterial infections that can reduce its  food-production ability (http://www.dld.go.th/th/index.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/jvms-78-397.PMC4829506.pdf
"http://www.dld.go.th/th/index.php/2010-02-16–08-16; 6 July, 2010.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/jvms-78-397.PMC4829506.pdf
e-mail: ykawagu@ims.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/jvms-78-405.PMC4829507.pdf
e-mail: katsumi@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5f/1f/jvms-78-411.PMC4829508.pdf
e-mail: kmseo@snu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/77/fa/jvms-78-419.PMC4829509.pdf
1.46r; http://rsbweb.nih.gov/ ij/).,OADS,/arxiv_data1/oa_pdf/77/fa/jvms-78-419.PMC4829509.pdf
e-mail: domenico.caivano@unipg.it ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e8/0a/jvms-78-427.PMC4829510.pdf
e-mail: hyun5188@kangwon.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/37/38/jvms-78-431.PMC4829511.pdf
e-mail: fujihara.masatoshi@pref.hokkaido.lg.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/00/1b/jvms-78-435.PMC4829512.pdf
Each primer  pair was designed using Primer3 (http://primer3.source- forge.net/) with the goal of the amplicon size as shown in  Table S1.,OADS,/arxiv_data1/oa_pdf/bc/a0/jvms-78-439.PMC4829513.pdf
e-mail: aytake@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bc/a0/jvms-78-439.PMC4829513.pdf
There is a theory that the number of Shiba Inus decreased  dramatically because of food shortage after World War II  and the distemper epidemic in 1952 (http://www.akc.org/ dog-breeds/shiba-inu/detail/#history and http://www.shibas.,Non-OADS,/arxiv_data1/oa_pdf/bc/a0/jvms-78-439.PMC4829513.pdf
e-mail: shuando@nih.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6b/a1/jvms-78-443.PMC4829514.pdf
"However, the goat industry in Japan is not very large, with  only approximately 19,000 goats throughout the country  in 2014, according to the Japan Livestock Technology As- sociation (Statistics of number of goats in each prefecture;  http://jlta.lin.gr.jp/sheepandgoat/goat/toukei.html), and thus,  information on goat herd operations is limited.",Non-OADS,/arxiv_data1/oa_pdf/03/ee/jvms-78-447.PMC4829515.pdf
e-mail: mkonishi@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/03/ee/jvms-78-447.PMC4829515.pdf
e-mail: yhidaka@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/b1/jvms-78-451.PMC4829516.pdf
e-mail: Padet.T@chula.ac.th ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bc/8e/jvms-78-457.PMC4829517.pdf
e-mail: inokuma@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/30/jvms-78-463.PMC4829518.pdf
e-mail: baku@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/55/54/jvms-78-467.PMC4829519.pdf
e-mail: Yukako_Shimojima@member.metro.tokyo.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/db/f6/jvms-78-477.PMC4829520.pdf
According to the Japan Kennel Club (http://www.jkc.,Non-OADS,/arxiv_data1/oa_pdf/7f/69/jvms-78-481.PMC4829521.pdf
"or.jp/), a certified club by the Federation Cynologique  Internationale (http://www.fci.be/), Poodles, Chihuahuas  and Dachshunds have been the three most popular breeds  in Japan.",Non-OADS,/arxiv_data1/oa_pdf/7f/69/jvms-78-481.PMC4829521.pdf
e-mail: osam@vet.kagoshima-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7f/69/jvms-78-481.PMC4829521.pdf
Primers and probes used in the real-time PCR assay for rapid genotyping and large-scale screening for the mutation of canine  progressive rod-cone degeneration Primer/probe Sequence 5ʹ→3ʹ (mer) Reporter (5ʹ) Quencher (3ʹ) Tm (°C) Concentration (nM) Forward primer CCTTTCTCCTGCAGACTCTGT (21) NA NA 56.5 450 Reverse primer CCAAGGTGCTGAGTAGGAAGAG (22) NA NA 57.0 450 Probe for wild-type allele TGAGCCATGTGCACCAC (17) VIC NFQ 55.8 100 Probe for mutant allele TGAGCCATGT ACACCAC (17) FAM NFQ 51.8 100 Tm: melting temperature calculated by OligoAnalizer 3.1 (https://sg.idtdna.com/calc/analyzer).,Non-OADS,/arxiv_data1/oa_pdf/7f/69/jvms-78-481.PMC4829521.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/64/f3/jvms-78-485.PMC4829522.pdf
e-mail: iguchi@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/19/b9/jvms-78-489.PMC4829523.pdf
e-mail: torisu@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/ac/jvms-78-493.PMC4829524.pdf
e-mail: kizaki@iwate-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7b/a4/jvms-78-499.PMC4829525.pdf
e-mail: seiya-m@rakuno.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/66/cf/jvms-78-505.PMC4829526.pdf
e-mail: dmkwak@knu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/58/be/jvms-78-509.PMC4829527.pdf
http://www.iuc- nredlist.org/details/22727981/0.,Non-OADS,/arxiv_data1/oa_pdf/58/be/jvms-78-509.PMC4829527.pdf
e-mail: yabu@vet.kagoshima-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the creative  commons Attribution Non-commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4a/21/jvms-78-513.PMC4829528.pdf
e-mail: yoshikazu.adachi.colobra@vc.ibaraki.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/60/ad/jvms-78-517.PMC4829529.pdf
e-mail: kanai@azabu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jvms-78-521.PMC4829530.pdf
e-mail: tamada@vet.osakafu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/03/61/jvms-78-525.PMC4829531.pdf
"85) with ‘non_chimera_retention’ set to ‘intersection.’ After removing identiﬁed chimeras (with function ﬁlter_fasta.py), the function pick_open_reference_otus.py was usedto call USEARCH v6.1, pick OTUs and generate the associated phylogeny using SILVA (97% similarity, release 111) (http://www.arb-silva.de/) as the reference; default parameters were used, except for the following modiﬁcations:‘suppress_de_novo_chimera_detection’, ‘suppress_reference_chimera_detection’ and ‘derep_fullseq’ were all set to ‘True’ and ‘preﬁlter_percent_id’ was set to 0.",OADS,/arxiv_data1/oa_pdf/33/56/ncomms11237.PMC4829693.pdf
All additional analyses were carried out in R (http://cran.r-project.org/).,OADS,/arxiv_data1/oa_pdf/33/56/ncomms11237.PMC4829693.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ncomms11237.PMC4829693.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Stegen, J. C. et al.",Non-OADS,/arxiv_data1/oa_pdf/33/56/ncomms11237.PMC4829693.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11237 12 NATURE COMMUNICATIONS | 7:11237 | DOI: 10.1038/ncomms11237 | www.nature.com/naturecommunications",Non-OADS,/arxiv_data1/oa_pdf/33/56/ncomms11237.PMC4829693.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ec/main.PMC4829709.pdf
Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ec/main.PMC4829709.pdf
"http://dx.doi.org/10.1016/j.ejvs.2015.12.018Eur J Vasc Endovasc Surg (2016) 51, 518 e526",OADS,/arxiv_data1/oa_pdf/89/ec/main.PMC4829709.pdf
SUPPLEMENTARY MATERIAL Supplementary material related to this article can be found athttp://dx.doi.org/10.1016/j.ejvs.2015.12.018524 O.M.B.,Non-OADS,/arxiv_data1/oa_pdf/89/ec/main.PMC4829709.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/4a/67/WO-20-27104.PMC4829743.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/4a/67/WO-20-27104.PMC4829743.pdf
12 contemporary oncology References 1. http://www.cdc.gov/cancer/breast/statistics/ (retrieved 7.12.2014).,Non-OADS,/arxiv_data1/oa_pdf/60/44/WO-20-27105.PMC4829744.pdf
Screening of differentially expressed genes  The original CEL files were downloaded and analysed  using the R package (3.0.2) (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/46/d7/WO-20-27106.PMC4829745.pdf
The probe set ID list of selected  differentially expressed genes was then uploaded to the  NetAffx™ Analysis Centre (http://Affymetrix.com/analy- sis/index/affx) to obtain the corresponding gene symbols  and gene titles.,OADS,/arxiv_data1/oa_pdf/46/d7/WO-20-27106.PMC4829745.pdf
"Functional analysis of differentially expressed genes  GenCLiP (a software program for clustering gene lists  by literature profiling, and for constructing gene co-oc- currence networks related to keywords of interest; http://ci.smu.edu.cn/GenCLip/) [14, 15] was used to analyse the differentially expressed genes, explore the pathogenesis,  and construct gene networks related to important biologi- cal processes in tumours, such as metastasis, cell growth, and cell cycle progression.",OADS,/arxiv_data1/oa_pdf/46/d7/WO-20-27106.PMC4829745.pdf
"To better investigate the func-tion of these DEGs, a functional annotation tool, DAVID (Database for Annotation, Visualisation, and Integrated Discovery) v6.7 (http://david.abcc.ncifcrf.gov/), was used to cluster enriched function-related gene groups according  to gene ontology (GO) terms, including molecular function,  biological process, and cellular component [18].",OADS,/arxiv_data1/oa_pdf/46/d7/WO-20-27106.PMC4829745.pdf
"Small molecule identification The Connectivity Map (CMap, build version build O2,  http://www.broadinstitute.org/cmap/) was used to com-pare the differentially expressed genes with those in the CMap database, to identify the small molecules associat- ed with these DEGs.",OADS,/arxiv_data1/oa_pdf/46/d7/WO-20-27106.PMC4829745.pdf
"Avail-able at: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/testis/, accessed on June 6, 2014.9.",Non-OADS,/arxiv_data1/oa_pdf/d4/30/WO-20-27110.PMC4829749.pdf
"Epidemiologia – dane statystyczne KRN, available at website  http://onkologia.org.pl./k/epidemiologia, accessed on June 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d4/30/WO-20-27110.PMC4829749.pdf
"Available at:  http://onkologia.org.pl/raporty/, accessed on June 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d4/30/WO-20-27110.PMC4829749.pdf
Access: http://globocan.iarc.fr [up-dated 15/10/2013].,Non-OADS,/arxiv_data1/oa_pdf/9b/64/WO-20-27113.PMC4829752.pdf
http://esid.org/Working-Parties/Registry/Di-agnosis-criteria.,Non-OADS,/arxiv_data1/oa_pdf/cc/73/CEJI-41-26263.PMC4829808.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ 286 Pediatric ReSeARCH       Volume 79  |  N umber 2  |  February 2016",Non-OADS,/arxiv_data1/oa_pdf/ae/f5/pr2015226a.PMC4829879.pdf
41.	 http://dx.doi.org/10.1093/ejo/cjv087.,Non-OADS,/arxiv_data1/oa_pdf/8f/14/JOS-5-57.PMC4830139.pdf
http://definitions.uslegal.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/IJABMR-6-123.PMC4830152.pdf
Available from: http://www.lankanewspapers.com/news/2012/1/74095.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/IJABMR-6-123.PMC4830152.pdf
Available  from: http://www.police.lk/index.php/crime‑trends.,OADS,/arxiv_data1/oa_pdf/7f/4a/IJABMR-6-123.PMC4830152.pdf
Available  from: http://www.mea.gov.lk/index.Php/news‑from‑other‑media/3266.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/IJABMR-6-123.PMC4830152.pdf
Available from: http://www.en.wikipedia.org/ wiki/List_of_Sri_Lankan_mobsters.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/IJABMR-6-123.PMC4830152.pdf
"CNVs showing .90% coverage of variants of a frequency of$0.1% of the same type, reported in the Database of Genomic Variants (http://dgv.tcag.ca/dgv/app/home), using array comparative genomic hybridization or SNP arrays, were considered copy numberpolymorphisms and were excluded from further analysis (i.e., CNVs reported in this study are designated as “rare”).",OADS,/arxiv_data1/oa_pdf/02/89/NG2015001099.PMC4830185.pdf
Gene products were annotated for Gene Ontology (GO) categories within biologicalprocesses and molecular funct ions using the Gene Ontology Consortium Web tool at http://geneontology.org/.,OADS,/arxiv_data1/oa_pdf/02/89/NG2015001099.PMC4830185.pdf
"Using TargetScan 6.2 (http://targetscan.org/), we predicted 7 genes ( SRSF6 ,FUS,SPG7 ,ITPKA ,GRIK3 ,GRIN2B , and GAD2 ) to be target genes of microRNA-1292 (table e-3).",OADS,/arxiv_data1/oa_pdf/df/5f/NG2015000976.PMC4830187.pdf
Available at: http://symphonyhealth.com/wp-content/uploads/2013/06/Tecfidera.inThought.4Mar.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/25/NEURIMMINFL2016009217.PMC4830190.pdf
"He has been seizure-free for more than 1 year on a regimen of zonisamide and levetiracetam.Array comparative genomic hybridization using BCM Oligo V8.1 array (https://www.bcm.edu/ research/medical-genetics-labs/) revealed a copy num- ber loss of ;0.5 kb in 3q24, including exon 2 of SLC9A9 , and a de novo copy number loss of ;0.4 kb in 2p22.3, including exon 12 of SPG4 (figure, D).",Non-OADS,/arxiv_data1/oa_pdf/12/33/NG2015001461.PMC4830193.pdf
"After alignment to the reference genome(Hg19) and variant calling, we removed variantsthat were called less than X8; were off-target,synonymous, or heterozygous; those with minorallele frequency (MAF) .1% in the Exome Aggregation Consortium (ExAC), Cambridge, MA(http://exac.broadinstitute.org); and those withMAF.2% in the Hadassah in-house database.",OADS,/arxiv_data1/oa_pdf/01/5f/NG2015001362.PMC4830197.pdf
"The Dystonia Coalition (DC, www.rarediseasesnetwork.org/dystonia/) has developed a biospecimen repository (Coriell; Camden, NJ) and an associated clinical database to be used as a resource fordystonia research (http://clinicaltrials.gov/show/NCT01373424).",OADS,/arxiv_data1/oa_pdf/06/67/NG2016002071.PMC4830199.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
Such  age-dependent  changes  of  the  frequency http://dx.doi.org/10.1016/j.dcn.2014.10.004 1878-9293/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
"Supplementary  data Supplementary  material  related  to  this  article  can  be found,  in  the  online  version,  at  http://dx.doi.org/10.1016/ j.dcn.2014.10.004 .",OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
"Cortex,  http://dx.doi.org/10.1093/cercor/bht1312 .",OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
"Funct.,  http://dx.doi.org/10.1007/s00429-014-0710-3 .",Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4830279.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/f2/bhv292.PMC4830299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/98/bhw001.PMC4830301.pdf
Supplementary material Supplementary Material can be found at http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/71/98/bhw001.PMC4830301.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/f1/bhw026.PMC4830302.pdf
"However, theory-driven data ana- lysis focused on the 2 “critical ”words (i.e., “kick”and “kiss”)t h a t were selected according to semantic criteria and were matched for psycholinguistic features, including absolute lexical frequency (“kick”= 2270; “kiss”= 2484 per 100 million words; British National Corpus: http://www.natcorp.ox.ac.uk/ ) and lexical status (both being lexically ambiguous as noun and verb).",Non-OADS,/arxiv_data1/oa_pdf/56/f1/bhw026.PMC4830302.pdf
"Likewise, Latent Semantic Analysis metrics from http://swoogle.umbc.edu/ (Ding et al.",Non-OADS,/arxiv_data1/oa_pdf/56/f1/bhw026.PMC4830302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/39/bhw027.PMC4830303.pdf
"2015 ;https://github.com/ zuoxinian/CCS ), which integrates the functionalities of AFNI (Cox 1996 ), FSL ( Jenkinson et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/39/bhw027.PMC4830303.pdf
Registration number for  this trial was ChiCTR‑TRC‑13003776 (http://www.chictr.,Non-OADS,/arxiv_data1/oa_pdf/d7/64/CMJ-128-1279.PMC4830304.pdf
Available from: http://www.moh.gov.cn/ publicfiles/business/htmlfiles/mohjbyfkzj/s5878/201205/54755.,Non-OADS,/arxiv_data1/oa_pdf/a1/d5/CMJ-128-1293.PMC4830306.pdf
Available from: http://www.who.int/violence_ injury_prevention/publications/road_traffic/world_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/6b/95/CMJ-128-1301.PMC4830307.pdf
Available  from: http://www.who/int/violence‑injury‑prevention.,Non-OADS,/arxiv_data1/oa_pdf/6b/95/CMJ-128-1301.PMC4830307.pdf
The indel  is not reported in the public dbSNP  (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/51/0a/CMJ-128-1336.PMC4830313.pdf
Available from: https://www.dbresearch.com/PROD/ DBR_INTERNET_EN‑PR OD/PROD00000000 00343857.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/52/CMJ-128-1420.PMC4830329.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc- sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/ee/cc/mtm201617.PMC4830361.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/74/7e/mtm201628.PMC4830379.pdf
"ESV = EBI structural variant ( http://dgv.tcag.ca/dgv/app/faq);  NGS = next-generation sequencing; PolyPhen-2 = Polymorphism  Phenotyping v2, a tool that predicts possible impact of an amino acid substitution on the structure and function of a human protein using straightforward physical  and comparative considerations ( http://genetics.bwh.harvard.edu/pph2/);  SIFT = predicts whether an amino acid substitution affects protein function ( www.sift.jcvi.",Non-OADS,/arxiv_data1/oa_pdf/38/ed/djv362.PMC4830395.pdf
"All of the above to be considered in presence   or absence of downstream resistance biomarkers- * PolyPhen-2 = Polymorphism Phenotyping v2, a tool that predicts possible impact of an amino acid substitution on the structure and function of a human protein  using straightforward physical and comparative considerations ( http://genetics.bwh.harvard.edu/pph2/);  RTK = receptor tyrosine kinase; SIFT = predicts whether an  amino acid substitution affects protein function ( www.sift.jcvi.org ).Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/38/ed/djv362.PMC4830395.pdf
"Furthermore, gene augmentation therapy with  RPGRorf15 preserves function and prevents degeneration in  these diseases [ 14,15].Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> Received 8 February 2016 | Accepted 7 April 2016 | Published 9 April 2016© 2016 Molecular Vision 319Molecular studies of phenotype variation in canine RPGR - XLPRA1 Tatyana Appelbaum, Doreen Becker, Evelyn Santana, Gustavo D. Aguirre Section of Ophthalmology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, P A Purpose:  Canine X-linked progressive retinal atrophy 1 (XLPRA1) caused by a mutation in retinitis pigmentosa (RP)  GTPase regulator ( RPGR ) exon ORF15 showed significant variability in disease onset in a colony of dogs that all inher - ited the same mutant X chromosome.",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
"Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  320To date, the X-linked progressive retinal atrophy  (XLPRA) dog is the only known naturally occurring large  animal model of RPGR  mutations [ 12].",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
"Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  321Severe, nine as Moderate, and one as Mild.",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  322(catalog No.,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
Molecular Vision  2016; 22:319-331 <http://www.molvis.org/molvis/v 22/319> © 2016 Molecular Vision  323RESULTS Characterization of XLPRA1-affected dogs with different  severity phenotype:  Examination of hematoxylin and eosin  (H&E)-stained cryosections from XLPRA1-affected dogs of  comparable ages (3–4 years) showed morphological altera - tions compatible with an ongoing disease process (Figure  1A–D).,Non-OADS,/arxiv_data1/oa_pdf/39/1c/mv-v22-319.PMC4830396.pdf
